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Astrocytic transforming growth factor beta 1 protects
synapses against Ab oligomers in Alzheimer’s disease
model
L. Diniz1, I. MAtias1, V. Tortelli1, J. Morgado1, A. P. Araujo1,
H. Melo2, G. de Silva2, S. Ferreira2, F. de Felice2, F. Gomes1
1UFRJ, Institute of biomedical sciences, Rio de Janeiro, Brazil
2UFRJ, Institute of Medical Biochemistry Leopoldo de Meis, Rio de
Janeiro, Brazil
Alzheimer’s disease (AD) is characterized by progressive decline
of cognitive functions, mainly due to neuronal/synaptic dysfunction
induced by amyloid-b peptide oligomers (AbOs). Although the
effects of AbOs in neurons have been extensively studied, if and how
AbOs impact astrocytes remain largely unknown. Given the key role
of astrocytes in synaptic formation and plasticity, we investigated the
effect of AbOs on astrocytes and how it impacts synapse formation
and function. Here, we show that murine hippocampal astrocytes are
able to bind and internalize AbOs in vitro. Astrocyte conditioned
medium (ACM) reduced AbOs binding to neurons, preventing AbO-
induced synaptic loss. This ‘synaptic protection’ ability of astrocytes
was impaired by prior stimulation of astrocytes with AbOs. Also,
protection provided by ACM was severely inhibited by blocking the
signaling of TGF-b (Transforming growth factor-b), previously
identiﬁed as a neuroprotective and synaptogenic factor secreted by
astrocytes (Diniz et al., 2012; 2014). Intracerebroventricular injection
of AbOs led to synaptic loss and memory deﬁcit, followed by
reduction in the levels of TGF-b1 in the hippocampus. Injection of
TGF-b1 in the brain of these mice rescued synaptic/memory deﬁcits
caused by AbOs. Thus, we show that astrocytes and their soluble
factors, particularly TGF-b1, can repress synaptic loss and AD
progression. Further, we show that astrocytes are targets for AbOs,
shedding light into a new mechanism underlying AbOs synaptotox-
icity, indirect through glial cells. The protocol of this study was
approved by the Committee for Animal Research of the Federal
University of Rio de Janeiro.
MTU01-02
The role of lysophosphatidic acid in the microglia-
gliblastoma interaction
R. D. Amaral, T. Spohr, M. Lamas, F. Mendes, F. Lima
Federal University of Rio de Janeiro, Institute of Biomedical
Sciences, Rio de Janeiro, Brazil
The microglial activation is a key event in the nervous
parenchyma defense against ischemia, neurodegenerative diseases
and inﬂammation. However, it can be controlled by the tumor cells.
Microglia in this context supports progression and tumor invasion.
Glioblastomas (GBMs) are characterized by their high proliferation
index, aggressiveness, invasiveness, insensitivity to chemotherapy
and short survival of patients. Lysophosphatidic acid (LPA) is a
lysophospholipid that act also as bioactive signaling molecules that
play important roles in diverse biological processes, including
migration of tumor cells. It was previously described that microglia
is the glial cell that over expresses the mRNA of Autotaxin (ATX), a
multifunctional phosphodiesterase which produces LPA. In the
context of microglia-GBM interaction, the present study aimed to
investigate the inﬂuence of LPA on tumor growth and invasion.
Highly pure cultures of microglial cells from neonatal mice and
cultures of tumor cells from GBM02 human cell line, established in
our lab, were performed. We veriﬁed by Thin Layer Chromatog-
raphy analysis, that both conditioned media from microglia (MG
CM) and GBM02 (GBM02 CM) were able to secrete LPA. In
addition, the GBM02 CM cells induced an increase of ATX and
LPA1 (receptor of LPA) expressions in microglia. On the other
hand, the MG CM, promoted migration and proliferation of GBM02
cells, but failed when Ki16425, a LPA receptor antagonist with
selectivity for LPA1 and LPA3, was added to conditioned medium.
These results suggest that microglia-GBM interaction through LPA
is important for microglial recruitment and also in tumor progres-
sion. Better understanding of this interaction as well as factors
implicated in it can lead to the development of new therapeutic
strategies in the treatment of GBMs. Supported by: FAPERJ, CNPq,
CAPES, Cancer Foundation RJ, INCT-INNT.
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Reduction of the water-soluble tetrazolium salt 1 as
indicator for substrate metabolization by cultured brain
astrocytes
E. Ehrke1, 2, R. Dringen1, 2
1Center for Biomolecular Interactions Bremen (CBIB), Faculty 2
(Biology/Chemistry), University of Bremen, Bremen, Germany
2Center for Environmental Research and Sustainable Technology
(UFT), University of Bremen, Bremen, Germany
The water-soluble tetrazolium salt WST-1 is frequently used to
determine the vitality of cells, as the formation of its colored formazan
product depends on intracellular reduction equivalents and can easily
be quantiﬁed by photometry. Incubation of astrocyteswithWST-1 in a
glucose-containingmedium in the presence of amembrane-permeable
electron cycler caused an almost linear increase in the absorption of
extracellular WST-1 formazan. The extracellular reduction of WST-1
strongly depended on the presence of glucose in the medium and was
almost completely abolished during incubation in the absence of
glucose. Formation of WST-1 formazan increased with the concen-
tration of glucose applied andmaximal formazan productionwithin 30
and 60 min incubation was already observed in the presence of
0.5 mM glucose and not accelerated by an increase in glucose
concentration up to 10 mM. Application of potential alternative
substrates that may replace glucose as cellular substrate to deliver
electrons forWST-1 reduction revealed that mannosewas able to fully
replace glucose. In contrast, neither the hexoses fructose and galactose
nor the mitochondrial substrates pyruvate, lactate or b-hydroxybuty-
rate were able to substitute for glucose to provide electrons forWST-1
reduction in viable astrocytes. The glucose-dependent WST-1 reduc-
tion by viable astrocytes was strongly lowered by the alkylating
substance 3-bromopyruvate (3-BP), a known inhibitor of astrocytic
glycolysis, in a concentration-dependent manner causing half-
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maximal inhibition of WST-1 reduction at a concentration of
147  37 lM 3-BP. These data demonstrate that the reduction of
WST-1 to its formazan product can be used as a tool to study the ability
of cultured cells to take up and metabolize extracellular substrates.
MTU01-04
Functionalized lipidic nanocapsules internalization by
oligodendrocytes in vitro
C. Fressinaud1, 2, A. M. Umerska2, P. Saulnier2, J. Eyer2
1University of Angers, Dept. of Neurology, Angers, France
2University of Angers, MINT, INSERM 1066/CNRS 6021, Angers,
France
Lipidic nanocapsules (LNC) could serve as putative vector for
targeted cell therapy. We have studied their potential to reach
speciﬁcally oligodendocytes (OL). Intracellular penetration of LNC
vectorized with NFL-TBS.40-63 peptide was studied. This peptide is
known to penetrate into OL through endocytosis, and has prore-
myelinating effects (Fressinaud and Eyer, 2015). Secondary OL
cultures from newborn rat brain (Fressinaud, 2005) grown in
chemically deﬁned medium, were treated with various concentrations
of LNC (Anton et al., 2010) labelled with DiD (dialkyl aminostyryl
analog), and adsorbed or not with NFL-TBS. Intracellular location of
LNC (100 nmdiameter)was determined by confocalmicroscopy, and
the number of DiD labelled OL was quantiﬁed.
The effects of LNC on OL development were characterized by
double/triple immunocytochemistry using known markers of OL
progenitors (A2B5), differentiated OL (CNP), or mature OL (MBP).
Experiments were run in triplicate. LNC did not penetrate
signiﬁcantly into astrocytes grown in the same conditions than OL.
Around 29% OL incorporated ‘blank’ DiD-LNC, while NFL-TBS
vectorized LNC were observed in around 83% OL. Colocation of
DiD-LNC and OL markers, and the intracellular location of LNC
were conﬁrmed by confocal microscopy. LNC were abundant in the
perinuclear region and sometimes in large processes of OL.
Persistance of LNC into OL up to 4 days did not alter their
differentiation or maturation. Highly differentiated OL with numer-
ous processes, ramiﬁcations and membranous extension were
present as well as in controls. LNC internalization is speciﬁc to
OL. Internalization of LNC with appropriate diameter and concen-
tration does not alter OL development. This endocytic process is
strongly upregulated (+180%) by the adsorption of NFL-TBS.40-63
on LNC. LNC fonctionalized by NFL-TBS.40-63 could represent
efﬁcient vectors to deliver targeted therapeutics in MS. Internaliza-
tion of LNC vectorized with NFL-TBS.40-63 into OL in vitro
suggests their potential as cargos to deliver speciﬁcally therapeutic
molecules during MS.
MTU01-05
Astrocytes protect dopaminergic neurons from synaptic
loss induced by alpha-synuclein oligomers in Parkinson’s
disease model
F. Gomes1, L. Diniz1, I. Matias1, M. Garcia1, A. P. Araujo1, C.
Figueiredo2, D. Foguel3, C. Braga4, L. Rom~ao4
1Federal University of Rio de Janeiro, Institute of Biomedical
Sciences, Rio de Janeiro, Brazil
2UFRJ, Faculty of Pharmacy, Rio de Janeiro, Brazil
3UFRJ, Institute of Medical Biochemistry, Rio de Janeiro, Brazil
4UFRJ, Xerem, Xerem, Brazil
Parkinson’s disease (PD) is one of the most common neurode-
generation in the world. Its features include the preferential loss of
dopaminergic neurons in the substantia nigra and changes in the
basal ganglia circuit. a-Synuclein (a-syn) aggregation is a common
characteristic of sporadic and familial forms of PD. Considerable
evidence suggest that a-syn oligomers (aSO), formed as pre-
ﬁbrillary intermediates, may contribute to dopaminergic neurons
toxicity in PD. Astrocytes are closely associated with synapses
contributing signiﬁcantly to the regulation of synapse formation and
neurotransmitters levels in the synaptic cleft. Although the direct
effects of aSO have been evaluated in neurons, their effects on
astrocytes have not. The main objective of this work is to evaluate
the direct effect of aSO on astrocyte synaptogenic ability and on the
regulation of glutamate-glutamine metabolism. Using primary
cultures of mesencephalic astrocytes and animals injected with
aSO, we demonstrated that aSO-treated astrocytes exhibited an
increase in the levels of the glutamate transporters, GLAST and
GLT1, and in the levels of the glutamine synthase enzyme. These
alterations resulted in increased astrocytic intracellular glutamate
levels and higher rates of glutamate uptake in astrocyte cultures.
Additionally, we observed that treatment of cultured astrocytes with
aSO led to enhancement in their synaptogenic capacity. Moreover,
we veriﬁed that animals injected with aSO showed higher numbers
of astrocytes and excitatory synapses in caudate-putamen. Together,
our data demonstrate that alterations in astrocytic functions is
present in PD progression models and corroborate the recent
evidence that astrocytes are correlated with the increase of the
activity of the striatal glutamatergic system in PD. Furthermore, we
describe a new endogenous astrocyte molecule involved in increas-
ing striatal glutamatergic synaptic density.
MTU01-06
Reactivation of astrocytes correlated to recovery from
blood-brain barrier breakdown in the mouse brain injury
H. Ikeshima-Kataoka1, 2, M. Furukawa2, S. Inui2, Y. Honjyo2,
M. Imamura2, M. Yasui2
1Waseda University, Faculty of Science and Engineering, Tokyo,
Japan
2Keio University School of Medicine, Department of Pharmacology
and Neuroscience, Tokyo, Japan
Astrocytes and microglial cells will be activated when the brain
had injury or inﬂammation; however, the biological signiﬁcance is
yet to be clariﬁed. We have been used stab wound injury to the
mouse cerebral cortex as a brain injury model to examine the
functional role of reactive astrocytes and microglial cells. Our study
with stab wound injury to the mouse brain induces blood-brain
barrier (BBB) breakdown but it will be recovered in a week. We
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have previously reported that extracellular matrix molecule tenascin-
C might concerned in activation of astrocytes and have the
functional role for recovery from BBB breakdown. In this study,
to know the relationship between astrocyte activation and BBB
recovery from breakdown after the brain injury, we analyzed IgG
leakage using immunoﬂuorescent staining with anti-mouse IgG
antibody for evaluation of recovery from BBB breakdown. IgG
leakage was highest at 1 day after the stab wound injury but it
diminished by 7 days after that. We used bromo-deoxy uridine
(BrdU) incorporation with drinking water for mice to analyze the
proliferation rate of astrocytes using anti-BrdU antibody for the
brain sections. At the same time, anti-GFAP antibody was used to
examine activation of astrocytes by co-immunostaining. The
number of GFAP-positive astrocyte was highest at day after 3 of
injury, and then decreased by day after 7. RT-qPCR method was
performed to study the expression level of the genes related to the
BBB integrity and astrocyte activation, and found that most of the
genes concerned in BBB integrity were down regulated just after the
BBB breakdown, while they recovered to basal level within 7 days
after the brain injury. These results indicated that astrocyte
activation might be correlated to the BBB recovery from breakdown
caused by stab wound brain injury.
MTU01-07
Copper accumulation and acute toxicity in C6 glioma cells
after application of copper oxide nanoparticles
A. Joshi1, 2, W. Rastedt1, 2, K. Faber1, 2, A. Schultz3, F. Bulcke1, 2,
R. Dringen1, 2
1University of Bremen, Center for Biomolecular Interactions,
Faculty 2(Biology/Chemistry), Bremen, Germany
2University of Bremen, Center for Environmental Research and
Sustainable Technology, Bremen, Germany
3Deakin University, School of Life and Environmental Sciences,
Centre for Molecular and Medical Research, Geelong, Australia
The rat C6 glioma cell-line is frequently used as an experimental
model for glial tumors. To investigate the potential use of copper
oxide nanoparticles (CuO-NPs) as a therapeutic drug for glioma
treatment, the consequences of an application of CuO-NPs on the
cellular copper content and cell viability of C6 glioma cells was
investigated. CuO-NPs were synthesized by a wet-chemical method
and were coated with dimercaptosuccinic acid and bovine serum
albumin to improve colloidal stability in physiological media.
Application of these protein-coated nanoparticles (pCuO-NPs) to
C6 cells caused a strong time-, concentration- and temperature-
dependent copper accumulation. This cellular copper accumulation
was accompanied by severe toxicity as indicated by the loss in cellular
MTT-reduction capacity, the loss in cellular LDH activity, and by an
increase in the number of propidium iodide-positive cells. Toxicity of
pCuO-NPs to C6 cells was only observed for incubation conditions
that increased the speciﬁc cellular copper contents above 20 nmol
copper per mg protein. Despite severe toxicity, no obvious formation
of reactive oxygen species was found in pCuO-NP-treated C6 cells.
Unexpectedly, C6 glioma cells were less vulnerable to pCuO-NPs
than cultured primary brain astrocytes. Both cellular copper accumu-
lation and pCuO-NP-induced toxicity in C6 cells were prevented by
application of cell membrane-permeable and -impermeable copper
chelators, but not by frequently used endocytosis inhibitors. These
data suggest that uptake of copper ions liberated extracellularly from
the pCuO-NPs, rather than uptake of intact pCuO-NPs, leads to the
observed toxicity of pCuO-NP-treated glioma cells.
MTU01-08
Noradrenergic modulation of cerebellar glial activity
during nociception
S. K. Kim1, S. H. Kim2, 3, H. Yoon1, S.-E. Roh2, S. J. Kim2, 3
1Kyung Hee University College of Korean Medicine, Department of
Physiology, Seoul, Korea South
2Seoul National University College of Medicine, Department of
Physiology, Seoul, Korea South
3Seoul National University College of Medicine, Department of
Biomedical Science, Seoul, Korea South
Cerebellar activation and increase in metabolic changes during
pain processing have been reported in previous human brain
imaging studies. However, it is still unknown whether and how
the cerebellar Bergmann glia (BG) is involved in noxious
information processing. To monitor the calcium activity of BG
in intact cerebellar cortex lobule IV/V, we performed in vivo two-
photon calcium imaging in anesthetized mice. Various noxious
electrical stimuli were delivered to the mouse hind paw during
calcium imaging and pharmacological manipulation. Formalin was
also injected to the hind paw to monitor BG calcium responses
under an acute spontaneous pain condition. We show that 1)
noxious electrical stimulation (ES) in anesthetized mice results in
norepinephrine release and subsequent activation of BG network
in the cerebellum, 2) the ES-induced BG calcium response was
completely blocked by prazosin, an alpha1-adrenergic receptor
blocker, and 3) the formalin injection induces strong BG calcium
responses during the early phase (~10 min) rather than the late
phase (20~50 min) of the formalin test. Taken together, we
suggest that noradrenergic signaling mediates the activation of the
glial network during noxious information processing in the
cerebellum.
This work was supported by a Basic Science Research Program
through the National Research Foundation of Korea (NRF) funded
by the Ministry of Education (NRF-2016R1D1A1A02937329).
MTU01-09
Ischemic tolerance mediated by glia-neuron interactions
S. Koizumi, Y. Hirayama
University of Yamanashi, Department of Neuropharmacology,
Interdisciplinary Graduate School of Medicine, Yamanashi, Japan
A mild ischemic episode (preconditioning; PC) induces resis-
tance to a subsequent severe ischemic injury. This phenomenon,
known as ischemic tolerance, is an endogenous process that
provides robust neuroprotection. We have worked on glia-neuron
interaction, and found that phenotypical changes glia could affect a
big variety of brain functions, which include both beneﬁcial and
hazardous phenomena. We previously showed that astrocytes
become a neuroprotective phenotype in response to PC, which
was essential for induction of ischemic tolerance. Such an astrocyte-
mediated ischemic tolerance requires activation of astrocytes and
subsequent upregulation of P2X7 receptors and expression of HIF-
1a in astrocytes. Although PC also increased HIF-1a in neurons,
this was not involved in ischemic tolerance. Here, we show the
difference in mechanism of HIF-1a increase between neurons and
astrocytes, and answer why astrocytic HIF-1a is more important. It
is well-known that an increase in HIF-1a in neurons was dependent
on hypoxia/PHD2. In fact, neurons in vitro caused a transient HIF-
1a increase in response to hypoxia, but, interestingly, astrocytes did
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not. Astrocytes did not express even PHD2, an oxygen-dependent
HIF-1a degrading enzyme or constitutive HIF-1a. Instead, they
showed persistent increase in P2X7 receptor by PC, which was a
main mechanism for upregulation of HIF-1a in astrocytes. Such
novel hypoxia-independent machinery for HIF-1a increase would
allow astrocytes to cause persistent HIF-1a and subsequent strong
ischemic tolerance. We also discuss a possible mechanism of P2X7
receptor activation in this phenomenon.
MTU01-10
The role of parenchymal cellular prion protein during
glioblastoma progression
F. Lima, C. Garcia, L. H. Geraldo, A. C. Fonseca, A. H. Correa, F.
Tovar-Moll
Universidade Federal do Rio de Janeiro (UFRJ), Instituto de
Ciencias Biomedicas/ Centro de Cie^ncias da Saude, Rio de Janeiro,
Brazil
Glioblastoma (GBM) is the most aggressive primary glial tumor
that affects the central nervous system (CNS). These tumors are
highly heterogeneous, angiogenic and insensitive to radio and
chemotherapy. The cellular prion protein (PrPc) is highly expressed
in the CNS and plays a key role in the differentiation of neural cells
during development. Here we have investigated the tumor growth
produced by the injection of cells from the human GBM cell lineage
GBM95, established in our laboratory, into the brain parenchyma of
wild type (WT), PrPc knockout (KO) and PrPc over-expressing
(TG20) mice. In this context, the role of PrPc was investigated
during tumor progression. During 2 weeks, the animals were
submitted to magnetic resonance imaging (MRI) and histopatho-
logical analysis. Our data showed that after this period, the
xenografted tumor was similar to a human GBM and was able to
produce reactive gliosis in the adjacent parenchyma, angiogenesis
and an intense recruitment of macrophage and microglial cells. MRI
showed that the tumor mass had enhanced contrast suggesting a
blood brain barrier disruption. In addition, analyzing the tumor
volume (mm3), we have observed that tumors produced in KO
animals were bigger than those produced in WT mice. Whereas
tumors produced in TG20 animals were the smallest ones.
Interestingly, in in vitro cell migration assays, when GBM95 cells
were cultured with conditioned medium (CM) obtained from brain
primary cultures, these cells migrated almost twice less when
compared to the GBM95 cells that were cultured with CM obtained
from WT primary cultures, conﬁrming our results in vivo. Our recent
results suggest that the parenchymal PrPc should play a protective
role in a dose-dependent manner from tumor invasion. Supported
by: FAPERJ, CNPq, CAPES, Cancer Foundation RJ, INCT-INNT.
MTU01-11
Dopamine attenuates LPS-induced cytokine expression
by inhibiting the nuclear translocation of nf-kb p65 in
microglial BV-2 cells
S. Maeda, Y. Sugino, T. Sudo, Y. Ishimaru, A. Yamamuro, Y.
Yoshioka
Setsunan Univ., Pharmaceutical Sci./Pharmacotherapeutics,
Hirakata, Japan
It has been reported that inﬂammatory cytokines and nitric oxide
(NO) produced by microglial cells mediate neuronal cell death in
brain ischemia/reperfusion injury and traumatic brain injury. Release
of dopamine in the brain has been known to be accelerated in
cerebral ischemia and trauma. We recently reported that dopamine
attenuated lipopolysaccharide (LPS)-induced NO production in
mouse microglial cell line BV-2. In this study, we investigated the
effect of dopamine on LPS-induced mRNA expression of cytokines
in BV-2 cells. The mRNA levels of cytokines were determined by
RT-PCR and real-time RT-PCR, and the levels of NF-jB p65 and
IjBa were determined by Western blotting. LPS (10 lg/mL)
increased mRNA levels of IL-1b, IL-6 and TNF-a. Pretreatment
with dopamine (1–30 lM) for 24 h concentration-dependently
attenuated the LPS-induced mRNA expression of these cytokines.
Neither SCH23390 nor sulpiride, D1-like and D2-like dopamine
receptor antagonists, respectively, affected the attenuation of LPS-
induced mRNA expression of cytokines by dopamine. N-acetylcys-
teine (NAC), a free radical scavenger, inhibited the attenuation of
LPS-induced mRNA expression of cytokines by dopamine. On the
other hand, hypoxanthine/xanthine oxidase, a super oxide generating
system, did not affect the LPS-induced mRNA expression of
cytokines. Dopamine concentration-dependently increased the level
of quinoproteins, and the increase was inhibited by NAC. LPS
increased the levels of NF-jB p65 in nuclei of BV-2 cells, and
decreased the levels of IjBa in the cytosol. Although dopamine did
not affect the LPS-induced decrease of IjBa, dopamine attenuated
the increase in the levels of NF-jB p65 in the nuclei. NAC inhibited
the effect of dopamine on the levels of NF-jB p65. These results
suggest that dopamine attenuates LPS-induced expression of
cytokines by inhibiting the nuclear translocation of NF-jB p65
through the formation of quinoprotein in microglial cells.
MTU01-12
Mitotic defects in neural cells after aberrant nuclear entry
of neuroﬁbromin
D. Mangoura, F. Sereti, E. Papanikolaou, I. Georgiou, A. Gaitanaki,
E. Tsirimonaki, X. Koliou, T. Kalpahidou, G. Kalaras
Institute of Biomedical Research of the Academy of Athens,
Neurosciences Center, Athens, Greece
Neuroﬁbromin is a regulator of cellular proliferation, yet its
actions as a tumor suppressor may not be solely explained on its
ability to de-activate Ras. Recent evidence has established that
tumor suppressors enter the nucleus and regulate microtubule
dynamics for mitotic spindle integrity and proper capturing of
chromosomes. Our most recent data postulate that neuroﬁbromin
belongs in this functional category. Speciﬁcally, we have now
established that neuroﬁbromin controls the pivotal function of
chromosome congression. Through a functional NLS on its primary
sequence, neuroﬁbromin accumulates in the nucleus at G2 phase,
and its nuclear entry depends on intense, PKCe-dependent
MTU01 Glia
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phosphorylation on Ser2808, a C-terminus residue, adjacent to NLS.
Moreover, we discovered that depletion of neuroﬁbromin by RNAi
causes a striking phenotype of aberrant chromosome congression
with daughter cells exhibiting increased aneuploidy. We now show
that overexpression of the C-terminal domain (CTD) of neuroﬁ-
bromin, led to nuclear accumulation of the recombinant protein in a
dose-dependent manner. Moreover, when Ser2808 was mutagenized
to the phosphomimetic Asp (CTD-D), nuclear accumulation was
almost as quick as translation. Interestingly, its phosphoablating
mutation showed the highest afﬁnity of binding to cytosolic tubulins
in co-immunoprecipitation assays, when compared to the afﬁnities
of wild-type CTD or CTD-D. Next, we examined the effect of CTD
constructs, wild-type or mimicking patient mutations, on the
proliferation rate of glioma cells. We found that some CTD
constructs increased the mitotic index, some produced mitotic
catastrophe, while other constructs induced spindle and chromo-
some congression and/or segregation defects. Most importantly, we
observed such mitotic phenotypes in similarly transfected primary
astrocytes. Thus, our results show that neuroﬁbromin, through its
nuclear entry and tubulin-binding abilities, actively participates in
the mitotic process at least in astrocytic backgrounds, as also
implied by the cell type-speciﬁc abnormalities in proliferation and
frequent formation of benign and/or malignant tumors in patients
with Neuroﬁbromatosis 1 (NF-1).
MTU01-13
Ablation of NG2 glia in the CNS induces anxiety-like
behaviour in adult mice
T. Merson1, 2, B. Chuang1, T. Kilpatrick3, S. Mitew1, Y. L. Xing1
1Monash University, Australian Regenerative Medicine Institute,
Clayton, Australia
2Florey Institute of Neuroscience and Mental Health, MS Division,
Parkville, Australia
3University of Melbourne, Department of Anatomy and
Neuroscience, Parkville, Australia
NG2 glia, also known as oligodendrocyte progenitor cells
(OPCs), are mitotically active cells known primarily for their role
in producing myelin-forming oligodendrocytes in the central
nervous system (CNS). Additional roles of NG2 glia in adult brain
physiology, particularly the modulation of neural processing, have
been suggested but the underlying mechanisms remain elusive.
Attempts to investigate the function of NG2 glia by targeted cell
ablation in the adult CNS have been limited by methodological
challenges resulting in in only partial and transient OPC ablation. To
overcome these limitations we have developed a novel transgenic
mouse model of conditional NG2 glia ablation. By crossing Pdgfra-
CreERT2 mice with a Cre-conditional cell ablation line called Sox10-
DTA mice, tamoxifen-mediated Cre recombination resulted in both
the deletion of GFP cassette in the recombined PdgfRa+ cells and
the expression of a suicide gene (diphtheria toxin fragment A,
DTA), which rendered NG2 glia selectively sensitive to DTA-
mediated apoptosis. In combination with intracisternal infusion of
the antimitotic drug cytosine-ß-D-arabinofuranoside (AraC), tamox-
ifen-administered Pdgfra-CreERT2: Sox10-DTA mice exhibit com-
plete ablation of NG2 glia throughout the entire brain for up to
10 days post AraC infusion. To determine the functional conse-
quences of NG2 glia ablation, we assessed cohorts of animals using
a range of behavioural tests. Our data reveal that ablation of NG2
glia precipitates anxiety-like behaviours consistent with a possible
role for these cells in modulating neuronal function in the CNS.
MTU01-14
Docosahexaenoic acid maintains GFAP levels of
developing rat brain via PI3K-dependent FABP7-pparg
interaction in astrocytes
J. Mishra, S. Tripathi, R. Kushwaha, S. Bandyopadhyay
CSIR-Indian Institute of Toxicology Research, Developmental
Toxicology Division, Lucknow, India
Introduction: The omega-3 fatty acid, docosahexaenoic acid
(DHA), supports brain growth and is known to be neuroprotective.
Glial ﬁbrillary acidic protein (GFAP) is a key component of brain
astrocytes. However, very few reports are available regarding the
effect of DHA on GFAP levels in astrocytes, particularly during
GFAP-suppressed conditions.
Objective: Here, we examined whether DHA could have a
protective effect on the astrocytes, and if it may involve GFAP
restoration.
Method: We fed pregnant and lactating rats with DHA and co-
treated with troglitazone (TZ), an agonist of peroxisome-prolif-
erator-activated-receptor-gamma (PPARc) that suppresses GFAP
and induces astrocyte damage. Primary astrocytes were cultured and
treated with DHA and TZ. Western-blotting, immunohistochem-
istry, EMSA, ChIP, luciferase assay, FRET and CoIP analysis were
done to conﬁrm our objectives.
Results: We observed an augmentation of DHA levels in the rat
brain, which inhibited the TZ-mediated suppression in GFAP levels.
Investigating the mechanism revealed a DHA-mediated up-regula-
tion in phosphatidylinositol-3-kinase (PI3K)/AKT levels in the
astrocytes. We also observed elevated levels of fatty acid-binding
protein-7 (FABP7), a molecule responsible for fatty acid uptake,
transport, and metabolism. We detected that PI3K/AKT and FABP7
participated in GFAP augmentation, as evident from GFAP
attenuation by PI3K/AKT-inhibitor or FABP7-siRNA in TZ-treated
cultured astrocytes. Furthermore, the FABP7 expression was found
to be PI3K/AKT dependent. Examining the participation of PPARg
revealed that DHA-mediated PPARg binding to response-elements
(PPRE) within the FABP7-gene was actually responsible for the
FABP7 expression. FABP7 then underwent protein-protein interac-
tion with PPARg, which suppressed the cyclin-dependent-kinase-5
(CDK5)-PPARg-complex. Therefore, DHA attenuated the reported
CDK5-PPARg-dependent phospho-PPARg(Ser112) pathway that
reduces GFAP expression.
Conclusion: Overall, we demonstrate that DHA is capable of
protecting astrocytes via restoration of GFAP. Mechanism unearthed
is a PI3K/AKT-dependent increase in FABP7, which stimulates
FABP7-PPARg at the cost of CDK5-PPARg, causing GFAP
augmentation in the astrocytes.
MTU01-15
Multiple origins of perilesional nestin-expressing reactive
astrocytes following closed-head injury
M. Morita, N. Okazaki, E. Tsuji
Kobe University, Department of Biology, Kobe, Japan
The expression of a neural stem cell marker, nestin in perilesional
reactive astrocytes is common in brain injuries, and the multipo-
tency of reactive astrocytes for producing neurons is suggested by
culturing cells from brain lesion. These neural stem cell-like
behaviors of reactive astrocytes are assumed to reﬂect the injury-
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induced reprogramming of astrocytes or the migration of SVZ or
RMS cells to lesion. In order to address this issue, the present study
have determined the origin and fate of nestin-expressing reactive
astrocytes in a mouse model of closed-head injury. For this purpose,
nestin-creERT2/CAG-CATf/f-GFP mice were used for labelling
nestin-expressing cells. As results, GFP+ reactive astrocytes were
found to originate from SVZ, as well as from lesion core. GFP+
reactive astrocytes from SVZ increased the expression of astrocyte
markers during their migration to lesion, and this astrocyte
differentiation was suppressed by ablating STAT3 gene. Thus, the
induction of astrocyte differentiation and pathological activation of
neural stem cells in SVZ by brain injury were indicated. The
generation of reactive astrocyte from SVZ correlated with the
deposit of IgG and microglial activation in SVZ, suggesting the
activation of SVZ by hemorrhage and following inﬂammation. The
GFP+ reactive astrocytes were also derived from NG2 + and partly
laminin+ cells in lesion core, indicating the generation of reactive
astrocytes from NG2 glia and/or pericytes. GFP+ reactive astrocytes
from SVZ and lesion core were indistinguishable after incorporated
in the perilesional reactive astrocytes. Nestin-creERT2 failed in the
GFP-labeling of perilesional reactive astrocyte derived from pre-
existing astrocytes, which is the majority of nestin-expressing
reactive astroytes during the early period of injury. These results
indicate the multiple origins of perilesional reactive astrocytes,
which form glial scar. The number perilesional GFAP+ reactive
astrocytes reduced drastically after wound healing, and this
resolution of gliosis accompanied by the disappearance of most
GFP+ reactive astrocytes. Thus, reactive astrocytes were likely
eliminated, rather than de-activated to normal astrocyte. The present
study has excluded the multipotency of reactive astrocytes and
revealed multiple layers of astrogliosis.
MTU01-16
Role of serotonergic signaling in regulation of astrocytes
morphology
F. Mu¨ller, V. Cherkas, E. Ponimaskin, A. Zeug
Hannover Medical School, Cellular Neurophysiology, Hannover,
Germany
Serotonin is an important neurotransmitter regulating various brain
functions via activation of speciﬁc serotonin receptors. In neurons,
serotonin receptors can modulate multiple signaling pathways
including activation of small GTPases of the Rho family which
determine cell morphology. Interestingly, serotonin receptors are also
expressed by astrocytes. These glial cells possess a unique morphol-
ogy allowing single astrocytes to modulate thousands of synapses
over deﬁned anatomical regions. It is also known that astrocytes’Ca2+
signaling is implicated in these functions. Properties and propagation
of Ca2+ signals depend on diffusion and therefore on astrocyte
morphology, which is dynamic itself. Therefore, it is important to
understand which signaling cascades are involved in controlling
astrocyte morphology. We investigate molecular mechanisms by
which serotonin receptors regulate small GTPases of the Rho family to
control astrocyte morphology and astrocyte Ca2+ signaling.
We show that knockdown of deﬁned serotonin receptors leads to
a more ramiﬁed morphology in cultured mouse hippocampal
astrocytes. Furthermore, transient expression of constitutively active
variants of the small GTPase RhoA results in drastic morphological
changes with decreased size and perimeter of the cells. Sholl
analysis also reveals impact of RhoA on the arborization of mouse
hippocampal astrocytes. Moreover, our data suggest that astrocytes
Ca2+ dynamics correlate with their morphology. Together, these
data indicate that serotonin receptors are critically involved in
regulation of astrocyte morphology and Ca2+ signaling.
MTU01-17
The endoplasmic reticulum of astrocytes constitutes a
dynamic glucose pool
M. Mu¨ller, C. W. Taylor
University of Cambridge, Department of Pharmacology,
Cambridge, United Kingdom
Glucose-6-Phosphatase (G6PC) is an ER luminal enzyme that in
glucose-releasing cells catalyses the dephosphorylation of glucose-6-
phosphate, generating free glucose inside the ER and allowing it to be
releasedbythecell.G6PC3istheubiquitousisoformofG6PC,expressed
throughout most cell types and tissues, yet its role in non glucose-
releasing cells remains unknown. However, mutations in the G6PC3
gene cause severe congenital neutropenia and about half of the patients
suffer fromdevelopmentalbraindefects.Apreviousstudyreported that
G6PC3 is highly expressed in rodent astrocytes, despite the fact that
astrocytesdonotreleaseglucose.WeinvestigatethefunctionofG6PC3in
astrocytes, usingbothhumancells and rodent tissue.
Using immunohistochemistry in cortical brain slices from rats we
conﬁrm previous reports that G6PC3 is strongly expressed in rat
astrocytes. Using qPCR and immunocytochemistry we show that the
protein is also highly expressed in the ER of primary cultures of
human astrocytes. In order to test whether G6PC3 is functional in
astrocytes, we generated lentiviral versions of previously published
glucose nanosensors targeted to the ER lumen. We show that the ER
of human astrocytes is able accumulate glucose. To investigate the
spatial dynamics of this luminal glucose pool, we developed a
culturing protocol for growing primary human astrocytes in a
microﬂuidic device that allows separation of soma and processes,
with the processes growing throughout a channel of 500um length.
We demonstrate that the ER can extend in form of a single tube
throughout astrocytic processes of 500um length. Combining
glucose nanosensors and microﬂuidics, we are currently investigat-
ing the existence of a diffusive transport of glucose from the distal
end of the astrocytic processes to the soma.
We propose that the ER constitutes a dynamic pool of glucose
that in astrocytes facilitates a more efﬁcient uptake of glucose, and
allows free glucose to diffuse throughout the cell inside a protected
compartment that lacks enzymes able to metabolize it.
MTU01-18
The novel dual-action prodrug Q-PAC targets glutathione
and LSD1 to trigger apoptosis in glioblastoma cells
L. Ooi1, M. Engel1, Y. S. Gee2, C. Hyland2
1University of Wollongong, Illawarra Health and Medical Research
Institute, Wollongong, Australia
2University of Wollongong, School of Chemistry, Wollongong,
Australia
Glioblastoma (GBM) is a highly aggressive cancer of the brain
with a poor prognosis for patients and few treatments. Targeting
epigenetic mechanisms has shown promising results against several
cancers, but has so far been unsuccessful against GBM. Altered
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histone 3 lysine 4 methylation and increased lysine-speciﬁc histone
demethylase 1A (LSD1) expression in GBM tumours nonetheless
suggests that epigenetic mechanisms are involved in gliomagenesis
and progression. We therefore engineered a dual-action prodrug,
which is activated by the high hydrogen peroxide levels associated
with GBM cells. The quinone-methide-phenylaminecyclopropane
(Q-PAC) prodrug combines the LSD1 inhibitor properties of 2-
phenylcyclopropylamine with the glutathione (GSH) scavenging
properties of para-quinone methide to trigger apoptosis in GBM
cells. Q-PAC selectively impaired key GBM cell behaviours, such
as migration, proliferation and invasion, and triggered cell apoptosis
through its hybrid action in several primary and immortal GBM cell
cultures. These results support our double-hit hypothesis of
inhibiting LSD1 and quenching GSH, in order to impair and
ultimately kill GBM cells whilst sparing healthy astrocytes.
Together our data suggest that such a strategy is effective at
selectively targeting GBM and potentially other types of cancers.
MTU01-19
Glutamine synthetase translational control in cerebellar
bergmann glia cells
A. Ortega1, L. C. Hernandez-Kelly1, R. Tiburcio-Felix2, D. Martınez2,
T. N. Olivares-Ba~nuelos3, S. Zinker2, E. Lopez-Bayghen1
1Cinvestav-Mexico, Department of Toxicology, Mexico City, Mexico
2Cinvestav-Mexico, Department of Genetics, Mexico City, Mexico
3Universidad Autonoma de Baja California, Instituto de
Investigaciones Oceanologicas, Ensenada, Baja California,
Mexico
Glutamate is the major excitatory transmitter of the vertebrate
brain. Exerts its actions through the activation of speciﬁc plasma
membrane receptors expressed both in neurons and glial cells. Recent
evidences have shown that glutamate uptake systems, particularly
enriched in glia cells, trigger biochemical cascades in a similar fashion
as receptors. A tight regulation of glutamate extracellular levels
prevents neuronal over-stimulation and cell death and it is critically
involved in glutamate turnover. Glial glutamate transporters are
responsible of the majority of the brain glutamate uptake activity.
Once internalized, this excitatory amino acid is rapidly metabolized to
glutamine via the astrocyte enriched enzyme glutamine synthetase. A
coupling between glutamate uptake and glutamine synthesis and
release has been commonly known as the glutamate/glutamine shuttle.
Taking advantage of the established model of cultured Bergmann glia
cells, in this contribution, we explored the gene expression regulation
of glutamine synthetase. A time and dose dependent regulation of
Glutamine synthetase protein and activity levels was found. More-
over, glutamate exposure resulted in the transient shift of glutamine
synthetase mRNA from the monosomal to the polysomal fraction.
These results demonstrate a novel mode of glutamate-dependent
glutamine synthetase regulation and strengthen the notion of an
exquisite glia neuronal interaction in glutamatergic synapses.
MTU01-20
The glutamate-cystine exchanger (XCT) is expressed in a
subpopulation of astrocytes at signiﬁcant levels
compared to EAAT3
S. Ottestad-Hansen1, Q.-X. Hu1, V. Follin-Arbelet1, H. Sato2,
A. Massie3, Y. Zhou1, N. C. Danbolt1
1Institute of Basic Medical Sciences, Faculty of Medicine, University
of Oslo, Department of Molecular Medicine, Division of Anatomy,
Oslo, Norway
2Laboratory of Biochemistry and Molecular Biology, Niigata
University, Department of Medical Technology, Niigata, Japan
3Center for Neurosciences, Vrije Universiteit Brussel, Department
of Pharmaceutical Biotechnology and Molecular Biology, Brussel,
Belgium
The glutamate-cystine antiporter (xCT, Slc7a11) mediates cystine
uptake and glutamate release. This is thought to promote glutathione
synthesis and increase extracellular glutamate possibly to toxic
levels in certain pathological situations. There is, however, a great
deal of uncertainty, at least in part, due to unresolved questions
concerning xCT localization and expression levels. Here, we
determined the localization of xCT in the mouse brain immunohis-
tochemically using xCT-deﬁcient tissue to validate antibody speci-
ﬁcity. Our results show that xCT is expressed in a subpopulation of
astrocytes and is highly present in the leptomeninges and along
larger blood vessels. We did not detect xCT in oligodendrocytes and
neurons. Further, we neither detected xCT in resting microglia nor
in reactive microglia induced by glutamine synthetase deﬁciency.
All main brain regions express xCT with the lowest levels in the
cerebellum and brain stem. Using a chimeric xCT-EAAT3 protein to
normalize the differences in antibody binding, we compared the
levels of xCT and EAAT3 by Western blotting and found that
mouse hippocampus contains similar amounts of xCT and EAAT3.
Thus, the estimated quantities of xCT are sufﬁcient to support the
hypothesized physiological roles.
MTU01-21
Trkb receptor mediates BDNF protection of astrocytes
J. Saba, D. Ramirez, J. Turati, L. Carniglia, D. Durand, M. Lasaga,
C. Caruso
INBIOMED UBA-CONICET, School of Medicine, University of
Buenos Aires, Buenos Aires, Argentina
Brain-derived neurotrophic factor (BDNF) is a neurotrophin that
promotes neuronal survival and inhibits apoptosis. Since little is
known about BDNF action in astrocytes, we examined the effect of
BDNF on astrocyte viability and the involvement of TrkB in this
action. BDNF treatment for 24 h increased astrocyte viability by
reducing apoptosis induced by serum deprivation (SD). BDNF also
reduced p53 and active caspase-3 expression induced by SD. Next,
we determined TrkB participation by using the selective and potent
TrkB antagonist ANA-12 (which inhibits TrkB- full length (TrkB-
FL) and TrkB-Truncated1 (TrkB-T1) isoforms) or K252a which is a
tyrosine kinase inhibitor of TrkB-FL receptors. The presence of each
inhibitor blocked the decrease in cell death induced by BDNF. In
order to identify which TrkB isoform is involved in BDNF
protective effect we analyzed mRNA expression levels of TrkB-
FL and TrkB-T1 by RT-qPCR, both isoforms TrkB-FL and TrkB-T1
are expressed in cultured astrocytes although TrkB-FL is expressed
at lower levels than TrkB-T1. Western Blot of TrkB showed that
only TrkB-T1 protein is present in cultured astrocytes. Thus,
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although astrocytes express mRNA for TrkB-FL, this is not
translated into detectable protein levels in these cells. However,
BDNF induced ERK activation in astrocytes and blocking this
pathway abolished BDNF protection from SD-induced apoptosis.
Finally, we evaluated if BDNF could protect astrocytes from 3-
nitropropionic acid (3NP)-induced cell death, being 3NP a toxin
widely used as an in vitro model of Huntington’s disease. We found
that BDNF prevented astrocyte death induced by 3NP and this effect
was blocked by both TrkB and ERK inhibitors. In conclusion, our
results indicate that TrkB mediates BDNF antiapoptotic effect on
astrocytes through ERK activation. Since astrocytes are key players
in neuroprotection, understanding BDNF protective mechanisms in
these cells may help develop new strategies for treating neurode-
generation.
MTU01-22
Transcription factor MAFB mediates activation of spinal
microglia relating to neuropathic pain after peripheral
nerve injury
H. Saitoh1, J. Masuda2, R. Kawada2, C. Kojima2, S. Yoneda2, T.
Masuda1, M. Tsuda1, K. Inoue2
1Kyushu University, Department of Life innovation, Fuku, Japan
2Kyushu University, Department of Molecular and System
Pharmacology, Fuku, Japan
Microglia as a pathological effector and ampliﬁer in the central
nervous system undergo various form of activation. Some kinds of
microglial activation alters neuronal environment leading to patho-
logical symptom, but the critical determinants for the spectrum of
microglial activation is not fully understood. Among the well-
studied microglia induced-pathological paradigms, it is known that
spinal microglial activation following peripheral nerve injury is a
key event for developing neuropathic pain. The factors critical for
pain-inducing function of activated microglia are extensively
studied, but the factors contributing the activation of microglia are
also less uncovered.
Herein, we demonstrate that MafB, a known pivotal transcrip-
tional regulator of macrophage differentiation, is involved in the
activation of microglia in the mouse model of neuropathic pain.
Peripheral nerve transection caused rapid and marked increase of
MafB expression selectively in the spinal microglia that displayed
activation phenotype represented by a proliferation and CD68.
MafB knockdown by siRNA suppressed the expression levels of
pain-related genes and alleviated development of tactile allodynia.
CCL21, a chemokine involved in the onset of neuropathic pain and
derived from injured neurons, enhanced microglial MafB expression
in vivo. Taken together, we propose that MafB is a key mediator in
the peripheral nerve injury-induced phenotypic alteration of spinal
microglia which contributes to development of neuropathic pain.
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Location matters: the role of calmodulin-mediated AQP4
translocation in human astrocyte response to hypoxia
and mild hypothermia
M. Salman1, P. Kitchen2, P. Heath3, A. Belli2, M. N. Woodroofe1,
R. Bill4, A. Conner2, M. Conner5
1Shefﬁeld Hallam University, Biosciences and Chemistry, Shefﬁeld,
United Kingdom
2University of Birmingham, Institute of Clinical Sciences,
Birmingham, United Kingdom
3University of Shefﬁeld, Shefﬁeld Institute for Translational
Neuroscience, Shefﬁeld, United Kingdom
4Aston University, School of Life & Health Sciences, Birmingham,
United Kingdom
5Wolverhampton University, School of Biology, Chemistry and
Forensic Science, Wolverhampton, United Kingdom
Therapeutic hypothermia is one of the effective measures
following brain injury. Astrocytes are the brain’s most abundant
cell type so it is essential to understand their stress response
following hypothermia. One of the main mechanisms by which
hypothermia attenuates oedema formation, is preserving the brain’s
water homeostasis. This is tightly regulated in astrocytes by a group
of membrane proteins called aquaporins (AQPs). It is established
that calmodulin is a key element in the regulatory mechanism of
AQP translocation. In this study, we investigated the alterations in
the expression proﬁle of cerebral AQPs, with a particular interest in
AQP4 membrane expression and calmodulin levels in astrocytes
cultured under hypoxic conditions for 6 h at mild hypothermia
(32°C).
The microarray data and subsequent KEGG analysis, suggested
the involvement of MAPK and the wnt signalling pathways, which
was conﬁrmed by Proﬁler PCR Arrays (184 genes). All the
investigated cerebral AQPs genes were expressed and RT-qPCR
data showed signiﬁcant upregulation of AQP4 accompanied by a
signiﬁcant down-regulation of AQPs 1, 5, 9 and calmodulin. ELISA
results conﬁrmed these ﬁndings for AQP4 and calmodulin.
Hypothermia has a well-known protective effect against brain
ischemia and hypoxia. This upregulation of AQP4, at both the gene
and protein levels, during this acute phase does not appear to ﬁt well
with the fact that hypothermia attenuates oedema formation by
preserving the brain’s water balance. This could be explained
through the signiﬁcant decrease in AQP4 surface expression after
inducing hypothermia obtained from the CSB data. This ﬁnding
indicates the involvement of impairment of AQP4 translocation; and
hence its function, as one of the possible mechanisms in mediating
the neuroprotection effect of mild hypothermia. This hypothermia
effect could be mediated through the signiﬁcant inhibition of
calmodulin at both the transcriptional and translational levels.
Hypothermia has a complex effect and there is no single factor
that could explain its neuroprotective effect. The data reported here
reveals the involvement of inhibition of MAPK and wnt signalling
pathways and impairment of AQP4 translocation that is mediated by
calmodulin; could be one of the many mechanisms through which
hypothermia mediates its neuroprotective effect.
MTU01 Glia
© 2017 The Authors
Journal of Neurochemistry © 2017 International Society for Neurochemistry, J. Neurochem. (2017) 142 (Suppl. 1), 78--164 85
MTU01-24
Regional differences in nitric oxide synthesis and HSP27
expression between spinal cord and cortical glia
R. S. Gil1, 2, B. Kalmar2, J. Yip2, H. Ecroyd1, L. Greensmith2
1University of Wollongong, Illawarra Health and Medical Research
Institute, Wollongong, Australia
2University College London, Sobell Department of Motor
Neuroscience and Movement Disorders, London, United Kingdom
As a non-cell autonomous disease, motor neuron disease (MND)
initiation and progression depends on both the molecular pathologies
developed within motor neurons, and the subsequent reactivity of
non-neuronal cell populations such as astroglia and microglia. Given
that spinal cord motor neurons are the primary target of the disease
over neurons in other regions in the brain, regional differences in
cytoprotective glial stress responses to pathological stimuli might be
responsible for the susceptibility of these motor neurons. Therefore,
we compared inﬂammatory and heat shock responses (HSR) in glia
from the cortex and spinal cord after treatment with lipopolysaccha-
ride (LPS). Griess assay showed that spinal cord mixed glial cultures
had a 2-4 fold greater synthesis of nitric oxide (NO) after LPS
treatment compared to cortical glial cultures. However, there was no
difference in upregulated iNOS protein expression or total number of
iNOS+ve microglia in either CNS region with LPS stimulation.
Immunoblot analysis of Hsp70 and Hsp27 expression in LPS treated
cultures showed that these treatments were not sufﬁcient to induce a
heat shock response. However, ﬂow cytometric analysis revealed that
double the number of Hsp27+ve astroglia were present in the spinal
cord compared to cortical cultures under basal conditions. We
propose that greater numbers of Hsp27+ve astroglia in the wild-type
spinal cord could play a role in supporting motor neuron growth and
maturation, and/or provide a cytoprotective buffer in pathological
conditions. On the other hand, enhanced NO synthesis in spinal cord
glial cultures might suggest that these cells have a lower threshold
regarding turning cell protective inﬂammatory reactions into
destructive processes. This could lead to diminishing support and
death of spinal cord motor neurons.
MTU01-25
5% O2 improves oligodendroglial development in vitro as
compared to 21% O2
T. Schmitz, T. Scheuer, C. Brill, S. Endesfelder, C. B€uhrer
Charite, Neonatology, Berlin, Germany
Immature oligodendroglia and oligodendroglial precursor cells
(OPCs) are very vulnerable to oxygen toxicity and oxidative stress.
In the brain tissue, the physiological O2 saturation of is at around 3–
5%, while standard protocols foresee 21% O2 for cell cultures. We
hypothesized that the 21% O2 pose a hyperoxic challenge to OPCs
and oligodendroglia which interferes with their development.
Primary rat OPCs and cells of the OLN93 cell line were
incubated in culture wells for 48 and 96 h at 5% and at 21% O2.
Immunocytochemistry was performed with antibodies against
A2B5 + and O4+. Proliferating cells were labeled using Ki67
antibodies, apoptosis was measured by TUNEL staining. The
expression of oligodendroglial transcription factors Olig1, Olig2,
Sox9, Sox10, and also of maturation markers MBP and CNP were
determined by realtime qPCR. Oxidative challenge in the cultures
was described by gene expression analysis of SOD2 and NRF2 and
by Western blot quantiﬁcation of nitrotyrosine. A potential
relevance of HIF1a pathways was investigated by comparison to
cells with HIF1a knockdown.
As a result, the morphology of OPCs and of oligodendroglia was
between the two oxygen culture conditions. After 48 h, O4+
oligodendroglia commonly showed complex process formation at
the lower 5% O2, while they had a much less differentiated structure
at 21% O2, as revealed through Sholl analysis. Levels of MBP,
CNP, Olig1, and Olig2 in the extracted RNA samples were
signiﬁcantly diminished, and the expression of antioxidant genes
were signiﬁcantly induced after 48 h at 21% O2. Elevated nitroty-
rosine pointed towards oxidative stress at 21% O2. There was no
difference in apoptosis. In OLN93 cells kept at 5% O2, HIF1a
knockdown induced a reduction in the expression of oligoden-
droglial transcription factors and maturation markers comparable to
the one found at 21% O2.
According to these data, the commonly used 21% O2 for OPC
cultures may impair oligodendroglial development in vitro. Oxida-
tive stress and dysregulation of HIF1a pathways are underlying
mechanisms of impaired development caused by oxygen.
MTU01-26
Major glial expression and cell population changes in the
aging human brain
L. Soreq1, 5, J. Rose2, E. Soreq3, J. Hardy1, C. Smith2, M. Ryten1,
R. Patani1, 5, J. Ule1, 5
1UCL, Molecular Neuroscience, London, United Kingdom
2MRC Edinburgh Brain Bank, Academic Neuropathology,
Edinburgh, Scotland
3Imperial College London, Cognitive and Clinical NeuroImaging
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4King’s College London, Department of Medical and Molecular
Genetics, London, UK
5Francis Crick Institute, Biomedical Institute, London, UK
The current main hallmarks of aging mainly include signalling
and cellular pathways. However, the relative role of RNA, in
particular in human brain aging, was hardly studied so far. Age is the
major risk factor for neurodegenerative diseases and a better
understanding of the underlying molecular processes will enable a
better understanding of the leading diseases. In our recent study, we
analysed a large expression data-set produced from human post-
mortem brain samples of individuals from 16 or over 100 years old
and overall 10 brain regions. The data was composed of microarrays
(a total of 1231 samples), as well as massive direct cell quantiﬁcation
based on tailored analysis of data produced by high resolution
imaging from cell speciﬁc stained brain sections (for neurons and
oligodendrocytes). We applied machine learning analysis techniques
as well as additional data mining techniques to analysed these
extensive data-sets. We detected signiﬁcant changes in glial cell
marker genes, including brain-wide increased expression of micro-
glia markers, in contrast to global down-regulation of neuronal
markers. Other glial cell-type markers showed regional speciﬁc
expression changes patterns, in particular in regions relevant to
neurodegenerative diseases (e.g. Alzheimer’s and Parkinson’s dis-
ease). Additionally, glial genes expression could predict the biolog-
ical age in greater sensitivity compared to neuronal cell markers. A
decrease of both cell types was found in cortex from old compared to
young individuals. As glial cells can be replenished in the brain (in
contract to neurons), our ﬁndings may yield a better understanding of
these diseases, as well as to novel future therapeutic approaches.
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Astrocytic reduction of menadione is catalysed by
cytosolic NAD(P)H: quinone acceptor reductase 1
J. Steinmeier1, E. Ehrke1, 2, R. Dringen1, 2
1University of Bremen, Centre for Biomolecular Interactions
Bremen (CBIB), Bremen, Germany
2University of Bremen, Centre for Environmental Research and
Sustainable Technology (UFT), Bremen, Germany
Menadione (2-methyl-1,4-naphtoquinone, vitamin K3) is a
synthetic derivate of vitamin K1 and an excellent redox cycler that
can mediate the formation of reactive oxygen species. As astrocytes
are known to contain a highly efﬁcient enzymatic antioxidant
defence system, which protects them as well as neighbouring cells
against adverse effects of oxidants and toxins, it is not surprising
that intact astrocytes are capable to reduce menadione at an
impressive rate. The assumption that astrocytic menadione reduction
is an enzyme catalysed process was validated by the investigation of
cell lysates of astrocyte cultures. Menadione reduction was depen-
dent on the lysate volume applied and was prevented by heat
inactivation (5 min, 90°C) or ﬁltration (size exclusion: 5 kDa) of
the lysate. Determination of the kinetic parameters of the menadione
reduction by astrocyte lysates revealed a Km-value of 11  4 lM
and a Vmax-value of 213  27 nmol/(min*mg). Suitable electron
donors to facilitate menadione reduction were both NADH and
NADPH as demonstrated by similar Km- and Vmax-values.
Digitonin lysis of astrocyte cultures and subsequent separation of
the cytosolic and mitochondrial fractions allowed to demonstrate
that the menadione-reducing capacity of astrocytes was localised
almost exclusively to the cytosol. In addition, the menadione
reduction activity of astrocyte lysates was extremely sensitive to the
NAD(P)H: quinone acceptor oxidoreductase 1 (NQO1) inhibitor
dicoumarol as demonstrated by the Ki-value of 1.2  0.3 nM.
These ﬁndings strongly suggest that the cytosolic NQO1 is the
enzyme responsible for the efﬁcient reduction of menadione in
astrocytes.
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OLIG2-lineage astrocytes: a subtype of astrocytes differs
from GFAP-positive astrocytes
K. Tatsumi, A. Isonishi, Y. Kawabe, S. M-Takemura, T. Tanaka, A.
Wanaka
Nara Medical University, Anatomy & Neuroscience, Kashihara,
Japan
Accumulating evidence revealed that astrocytes modulate synap-
tic activities by promoting neurotransmitter uptake from synaptic
clefts and/or by releasing gliotransmitters such as glutamate, D-
serine, and ATP to synaptic clefts. The tripartite synapse that
consists of pre-, post-synaptic neurons, and astrocytic ﬁne processes
functions in various brain regions.
During lineage-tracing studies of Olig2 expressing cells using
Olig2creER: ROSA-GAP43-EGFP mice, we found that Olig2-lineage
mature astrocytes preferentially cluster in some regions, for
example, the globus pallidus (GP). Taking advantage of mem-
brane-targeted GAP43-EGFP, which can visualize the morphology
of Olig2-lineage cells in detail, we performed morphometric
analyses of astrocytic ﬁne processes that underwent plastic changes
in response to overall running activities in the GP. We suggested
that astrocytes actively modulate neuronal activities in the GP that
play pivotal roles in motor control.
Given the fact that Olig2-lineage astrocytes clustered in speciﬁc
brain nuclei other than the GP, we further mapped distribution of
Olig2-lineage astrocytes in the whole brain. We then compared the
distribution pattern with that of GFAP-positive astrocytes visualized
in GFAPcre: ROSA-GAP43-EGFP mice. The brain regions rich in
Olig2-lineage astrocytes often lacked GFAP-positive astrocytes and
vice versa. In a single brain nucleus, Olig2-lineage astrocytes and
GFAP astrocytes tended to occupy different territories. These
ﬁndings implied that the Olig2-lineage astrocyte is a subtype of
astrocyte playing different roles from those of the GFAP-positive
astrocyte in the adult brain. Interestingly, the brain nuclei rich in
Olig2-lineage astrocytes strongly expressed GABA-transporter 3
(GAT-3) and vesicular GABA transporter (vGAT), suggesting that
Olig2-lineage astrocytes may be involved in inhibitory neuronal
transmission.
MTU01-29
Extracellular GAL-3 induces oligodendroglial
differentiation through the modulation of ERK and
cytoskeleton pathways
L. Thomas, L. Pasquini
IQUIFIB, Department of Biological Chemistry, Buenos Aires,
Argentina
Galectin-3 (Gal-3), a chimeric protein structurally composed of
unusual tandem repeats of proline and short glycine-rich segments
fused onto a carbohydrate recognition domain, possesses multi-
faceted roles in physiological processes including the regulation of
innate and adaptive immune responses. Our studies have previ-
ously demonstrated that recombinant Gal-3 (rGal-3) treatment
accelerates oligodendrocyte (OLG) differentiation, and that a
permissive glycophenotype to Gal-3 binding is only found in
immature OLG. The cytoskeleton has been shown to play a key
role in OLG maturation and the morphological changes necessary
to create fully mature OLG capable of myelination. Recent studies
demonstrate that the initial stage of OLG process extension
requires actin ﬁlament assembly, while subsequent myelin wrap-
ping coincides with upregulation of actin disassembly proteins
which are dependent on MPB expression. The aim of our work is
to elucidate the mechanism by which rGal3 expedites OLG
maturation, giving special attention to the actin cytoskeleton. Our
results show that, in primary rat OLG cultured in vitro in the
presence of rGal-3 and with rGal-3 renewal every 48 h, the total
area of polymerized actin at 150, 300 and 1 h of treatment was
greater than the area measured in OLG cultured in the absence of
rGal-3, accompanied by a concomitant decrease in pERK at all
times evaluated. At day in vitro 1 (DIV1), a decrease was observed
in the polymerized actin area and in the number of PDGFRalpha+
cells in rGal-3-treated OLG, and an increase was detected in the
number of CNPase+ cells, with no changes in the number of
NG2 + and MBP+ cells. At DIV5, a decrease was observed in the
polymerized actin area, accompanied by an increase in the number
of MBP+ cells at the expense of a decrease in the number of
PDGFRalpha+ and NG2 + cells. Results indicate that rGal-3 may
favor OLG maturation by mediating the necessary changes in the
actin cytoskeleton.
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Noradrenaline protects neurons against H2O2-induced cell
death by increasing the supply of glutathione from
astrocytes
Y. Yoshioka, R. Negoro, H. Kadoi, A. Yamamuro, Y. Ishimaru,
S. Maeda
Setsunan University, Pharmaceutical Sciences, Hirakata, Japan
Hydrogen peroxide (H2O2) has been implicated in a variety of
neurodegenerative disorders, such as Alzheimer’s and Parkinson’s
disease. Astrocytes express many types of functional neurotrans-
mitter receptors, and play a signiﬁcant role in maintaining survival
of neurons by supplying antioxidants such as glutathione (GSH) to
neurons. Recently, we found that noradrenaline increased GSH in
astrocytes via b3-adrenoceptor stimulation. Thus, noradrenaline may
protect neurons from oxidative stress-induced death by increasing
the supply of GSH from astrocytes to neurons via the stimulation of
b3-adrenoceptor in astrocytes. In this study, we investigated the
neuroprotective effect of noradrenaline against H2O2-induced neu-
rotoxicity using the mixed cultures of neurons and astrocytes
prepared from the E14 mouse embryonic cerebellum of C57BL/6
mice. To assess the viability of neurons, we carried out immunos-
taining with anti-neuronal nuclei (NeuN) antibody and counted the
number of NeuN-positive cells. Pretreatment with noradrenaline
(10 lM) for 24 h protected neurons against H2O2-induced death in
the mixed cultures, but not in puriﬁed neuronal cultures. SR
59230A, a selective b3-adrenoceptor antagonist, inhibited the
cytoprotective effect of noradrenaline in the mixed culture.
CL316243, a selective b3-adrenoceptor agonist, attenuated H2O2-
induced neuronal cell death in the mixed culture. DL-buthionine-[S,
R]-sulfoximine, a GSH synthesis inhibitor, negated the cytoprotec-
tive effect of noradrenaline in the mixed cultures. MK-571, which
inhibits the export of GSH from astrocyte mediated by multidrug
resistance-associated protein 1, also prevented the cytoprotective
effect of noradrenaline. These results suggest that noradrenaline
protects neurons against H2O2-induced death by increasing the
supply of GSH from astrocytes via b3-adrenoceptor stimulation in
mixed culture of neurons and astrocytes.
MTU01-31
Ovarian hormones induce the expression and release of
astroglial mitochondrial-encoded rat humanin in vitro
S. Zarate1, 3, M. B. Dening1, 3, M. Codagnone2, 4, M. Traetta2, 4, A.
Seilicovich1, A. Reines2, 4
1INBIOMED, University of Buenos Aires-CONICET, Buenos Aires,
Argentina
2IBCN, University of Buenos Aires-CONICET, Buenos Aires,
Argentina
3Department of Cell Biology, Histology, Embriology and Genetics,
FMed-University of Buenos Aires, Buenos Aires, Argentina
4Department of Pharmacology, FFyB-University of Buenos Aires,
Buenos Aires, Argentina
Ovarian hormones exert neuroprotective actions in part by direct
effects on neurons but also indirectly by regulating the release of
neurotrophic factors by astrocytes. Ovarian hormone loss during
menopause is associated with brain hypometabolism, synaptic
failure and increased risk of neurodegeneration. Humanin (HN) is
a mitochondrial-derived peptide with cytoprotective, metabolic, and
anti-inﬂammatory effects in multiple cell types and animal models;
it is localized in tissues with high metabolic rates and its expression
decreases with age. Our previous studies in vivo show that HN
colocalizes with astrocyte markers and its expression decreases in
the hippocampus of hormone-deprived female rats. Still, little is
known about ovarian hormone regulation of HN expression and
secretion by astrocytes and the effects of this peptide on neuronal
function. The aim of this work was to study the direct actions of
estradiol and progesterone on the expression and release of HN by
hippocampal astrocytes in vitro. To this aim, cultured astrocytes
were incubated with estradiol (E, 1 nM), progesterone (P, 1 lM),
E+P or vehicle for 24 h. Intracellular HNr expression was evaluated
by immunocytochemistry and secreted HNr was determined by
ELISA in the conditioned media. Our results show that HNr is
expressed in astrocytes in vitro and that ovarian hormones increased
its levels. The incubation with E+P was the most effective treatment
to induce HNr secretion by astrocytes. Our results indicate that
ovarian hormones positively regulate HN expression and release by
astrocytes. Further experiments will assess the effect of astrocyte
HN on neuronal function. The knowledge of HN effects in brain
cells and its regulation by ovarian hormones could help ﬁnd new
therapeutic targets for interventions that may promote a healthier
lifespan for post-menopausal women.
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MTU02-01
Transcriptional regulation of monoamine oxidase b under
basal and dopamine-induced conditions: key roles of SP1,
EGR1 and CREB
V. Arige, A. Agarwal, K. Ananthamohan, A. A. Khan, B. Natarajan, V.
Gupta, N. R. Mahapatra
Indian Institute of Technology Madras, Biotechnology, Chennai,
India
Monoamine oxidase B (MAO-B) is a ﬂavoenzyme, which is
located on the outer mitochondrial membrane, involved in the
catabolism of endogenous and exogenous monoamines. Hydrogen
peroxide, one of the byproducts of MAO-B catabolic reaction causes
oxidative stress, DNA damage and apoptosis of native and
surrounding cells. Altered levels of MAO-B have been associated
with several neurological, cardiovascular diseases and diabetes.
However, the regulatory mechanisms of MAO-B expression
remains incompletely understood. We systematically investigated
the roles of putative transcription factors that might regulate MAO-
B gene expression. Generation of varying lengths of deletion-
reporter constructs of the promoter followed by transfection into
various cell lines led to identiﬁcation of the core promoter region
(viz. -144 to +25 bp). Stringent in silico analysis of this promoter
domain revealed putative binding sites for transcription factors Sp1,
Egr1 and CREB. Co-transfection of MAO-B core promoter-reporter
construct with Sp1/Egr1/CREB expression plasmid augmented the
promoter-reporter activity, whereas down-regulation of endogenous
Sp1/Egr1/CREB level diminished the promoter-reporter activity.
Site-directed mutagenesis of putative Sp1/Egr1 binding sites in the
MAO-B promoter drastically reduced the promoter-reporter activ-
ities leading to the identiﬁcation of cis-elements on the promoter.
Competitive electrophoretic mobility shift assays (EMSA) using
labeled/unlabeled-wild-type/mutant MAO-B promoter oligonu-
cleotides displayed formation of speciﬁc complexes. In vivo
interaction of Sp1, Egr1 and CREB with the MAO-B promoter
was conﬁrmed by chromatin immunoprecipitation (ChIP) assays
using MAO-B promoter speciﬁc primers. 8-Br-cAMP (cAMP
analogue), and forskolin (activator of adenylyl cylase), augmented
the MAO-B promoter-reporter activities, whereas PKI (PKA
inhibitor alpha) decreased the MAO-B promoter-reporter activity.
Dopamine dose-dependently enhanced the MAO-B promoter-
reporter activities, mRNA and protein levels. Taken together, this
study unraveled crucial roles of the transcription factors Sp1, Egr1
and CREB in MAO-B gene regulation and provides insights into the
mechanism of dopamine-induced activation of MAO-B gene
expression. This study has implications for pathological conditions
involving dysregulated catecholamine homeostasis.
MTU02-02
A novel genetic screen identiﬁes modiﬁers of age-
dependent amyloid b toxicity in the drosophila brain
L. B. Carrasco, M. Silvina Marcora, N. I. Bocai, M. Fernanda
Ceriani, L. Morelli, E. Casta~no
Fundacion Instituto Leloir - IIBBA-CONICET, Amyloidosis and
Neurodegeneration, Buenos Aires, AArgentina
Accumulation of amyloid b peptide (Ab) is one of the major
hallmarks of Alzheimer0s disease (AD) and its accumulation begins
many years before clinical onset. Such process has been proposed to
be pathogenic through the toxicity of Ab soluble oligomers leading
to synaptic dysfunction, phospho-tau aggregation and neuronal loss.
Yet, massive accumulation of Ab can be found in approximately
30% of aged individuals with preserved cognitive function.
Therefore, compensatory mechanisms and additional neurotoxic or
protective factors are the main issues to be elucidated. We carried
out a modiﬁer genetic screen in Drosophila designed to identify
genes that modulate toxicity of Ab42 in the CNS on aged ﬂies.
Expression of Ab42 led to its accumulation in the brain and a
moderate impairment of negative geotaxis at 18 days post-eclosion
(d.p.e) as compared with genetic or parental controls. These ﬂies
were mated with a collection of lines carrying chromosomal
deletions and negative geotaxis was assessed at 5 and 18 d.p.e.
199 deﬁciency lines accounting for ~6300 genes were analyzed. 6
lines, including the deletion of 52 Drosophila genes with human
orthologs, signiﬁcantly modiﬁed Ab42 neurotoxicity at 18 d.p.e. We
have validated CG17249 and CG11796 (whose human orthologs are
PRCC and HPD, respectively) by using RNAi or mutant hemizy-
gous lines. PRCC encodes proline-rich protein-PRCC of unknown
function associated with papillary renal cell carcinoma. HPD
encodes 4-hydroxyphenylpyruvate dioxygenase, a key enzyme in
tyrosine degradation whose deﬁciency causes autosomal recessive
Tyrosinemia type 3, characterized by mental retardation. Our screen
is the ﬁrst to take into account features relevant to sporadic AD: pan-
neuronal expression of wild-type Ab42; a quantiﬁable complex
behavior; Ab neurotoxicity associated with progressive accumula-
tion of the peptide and improvement or worsening of climbing
ability only evident in aged animals. These new modiﬁers of Ab42
neurotoxicity in Drosophila warrant further study to validate their
possible role and signiﬁcance in sporadic AD.
MTU02-03
Polymorphisms of ENT4 modulate the behavioral
phenotypes of autism spectrum disorder (ASD) in male
subjects
B. Chakraborti1, S. Chakraborty1, S. Sinha2, U. Rajamma3
1Manovikas Kendra, MBRDC, Kolkata, India
2Manovikas Kendra, OPD, Kolkata, India
3IUCBR, CDAR, Kerala, India
ASD is a group of behaviorally deﬁned neurodevelopmental
disorders having genetic origin. Recent decade witnessed alarming
rise in prevalence besides having male predominancy. Serotonin (5-
HT), monoamine neurotransmitter that modulates behavior is
elevated in the platelets of a subset of autistic probands and it
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formed the basis to suggest involvement of serotonergic system
dysfunction in ASD behavioral phenotypes. Several possibilities
may underlie the serotonergic dysfunctions, which include the
defect of ENT4 function. ENT4 is encoded by SLC29A4, located at
chromosome 7p22 and functions in the reuptake of 5-HT into
presynaptic neurons. ENT4, also known as plasma membrane
monoamine transporter (PMAT) is a low afﬁnity, high capacity, pH
dependent transporter and its dysfunction affects the 5-HT neuro-
genesis. As ENT4 regulates the serotonergic function and the gene
location being on chromosome 7, which is a QTL for autism language
and speech problems, SLC29A4 is considered as a potential suscep-
tibility gene for autism. Therefore, the objective of the present study is
to investigate the genetic association of SLC29A4 with behavioral
problems of ASD. Study covered analysis of three markers
(rs4724512-intron1, rs6965716-intron5 and rs6971788-30UTR) in
West Bengal cohort of 181 ASD subjects and 240 controls. PCR-
based RFLP/sequencing was adopted for genotyping analysis and
behavioral severity was measured using childhood autism rating scale
(CARS). Online available software was used for population-based
association and genetic correlation of the variants with ASD and
associated behaviors. All the threemarkers conformed to HWE. Case-
control association analysis revealed signiﬁcant effect for rs6971788
on ASD. Quantitative trait (QT) analysis to test the genetic effect of
the markers on the behavioral severity revealed signiﬁcant male-
speciﬁc effect on total CARS score (p = 0.010), listening response
(p = 0.001), verbal communication (p = 0.001), nonverbal commu-
nication (p = 0.007), visual response (p = 0.005) and general
impression (p = 0.028). Results of the present study suggest likely
involvement of ENT4 markers on the behavioral phenotypes of male
ASD subjects in the Indian population.
MTU02-04
Disease-associated mutations in RP58 disrupt its
neuronal functions through a mechanism involving
transcriptional regulation
I. A. Hemming*1, O. Clement*1, I. E. Gladwyn-Ng1, H. L. Ng2,
E. See3, L. Ngo1, D. Ulgiati2, K. D. G. Pfleger3, 4, J. I.-T. Heng1, 4
1The Harry Perkins Institute of Medical Research, Brain Growth
and Disease Laboratory, Nedlands, Australia
2The University of Western Australia, School of Pathology and
Laboratory Medicine, Crawley, Australia
3The Harry Perkins Institute of Medical Research, Molecular
Endocrinology and Pharmacology, Nedlands, Australia
4The University of Western Australia, Centre for Medical Research,
Crawley, Australia
During the development of the mammalian cerebral cortex,
appropriate numbers of neurons, glial cells, and oligodendrocytes
must be generated and functionally integrated to form appropriate
neuronal circuitry. The regulation of gene expression by DNA-
binding transcription factors is crucial for this development, and
abnormal brain development can result in intellectual disability. The
transcription factor RP58 has been reported to regulate cerebral
cortical development by suppressing the transcription of target
genes. Human genetic association studies have recognised the
importance of RP58 for human neuronal development, with genetic
mutations to RP58 associated with abnormal brain development and
intellectual disability in humans. However, the causative nature of
genetic mutations to RP58 remains to be clariﬁed. This study
investigates the possible pathological consequences of two
individual de novo, missense mutations in RP58 (N461S and
R495G), detected in two unrelated patients diagnosed with
intellectual disability. Immunolocalisation studies revealed that the
subcellular localisation of the two mutated proteins differs to the
wild-type protein. Strikingly, a luciferase reporter assay revealed a
unique outcome for the R495G mutation, which exhibited tran-
scriptional activation rather than repression. The N461S mutation
was also observed to disrupt the transcriptional regulatory activity of
RP58. Thirdly, in utero electroporation experiments show that both
missense mutations have different capacities to restore the defective
migration of Rp58 shRNA-treated cells. Altogether, the ﬁndings
demonstrate that these disease-associated mutations alter the tran-
scriptional regulatory function of RP58, and impair its capacity to
control radial migration during cerebral cortex development.
* These authors contributed equally to this work.
MTU02-05
Investigation of GLI2 functions in regulating primary cilia
and cell cycle re-entry using CRISPR/Cas 9 technology
C.-J. Hsaio1, C. H. Chang2, J.-W. Tsai1
1National Yang-Ming University, Institute of Brain Science, Taipei,
Taiwan
2National Yang-Ming University and Academia Sinica, TIGP in
Molecular Medicine, Taipei, Taiwan
The central nervous system arises from the neural tube, consisting
of neural stem cells, which give rise to neurons and glia cells.
Interestingly, many neural stem cells contain the primary cilium, a
microtubule-based organelle projecting from the plasma membrane.
Primary cilia are critical in numerous functions ranging from
mechanosensation, proliferation, and differentiation. Importantly,
primary cilia participate in patterning of the central nervous system by
functioning as cellular antennae for transmitting molecular signals,
such as Sonic Hedgehog (SHH) signaling. Gli2, a fundamental player
in the SHH signaling, is known for regulating cell cycle progression.
Interestingly, Gli2 is also involved in cell cycle re-entry from G0 in
many cell types, including neural progenitors. However, unlike Gli2-
dependent cell cycle progression, how Gli2 regulates cell cycle re-
entry is not fully elucidated. Notably, numerous studies demonstrated
a negative correlation between ciliary length and cell cycle re-entry.
Therefore, we aim to investigate the impacts of Gli2 on the regulation
of ciliary length. Here, we generated a Gli2-knockout cell line by
CRISPR/Cas9 technology to investigate the potential function of Gli2
in regulating the primary cilium. We validated that cells depleted of
Gli2 possess longer primary cilia by immunostaining and live cell
imaging of ciliary markers. Meanwhile, we found a delay in cell cycle
re-entry in Gli2-knockout cells by ﬂow cytometry. Surprisingly,
ablation of the primary cilium by Kif3a knockdown promotes cell
cycle re-entry in Gli2-knockout cells, suggesting a potential role of
primary cilia in this process. We are currently investigating how
primary cilia and Gli2 together regulate cell cycle progression and re-
entry. This line of investigation may provide insights into how
primary cilia regulate the development of the nervous system through
cell cycle regulation.
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Monoamine oxidase b gene polymorphisms revealed
association with male ADHD probands
A. Karmakar1, B. Chakraborti1, D. Verma1, S. Sinha1, K. P.
Mohanakumar2, U. Rajamma2, K. Mukhopadhyay1
1Manovikas Kendra, Biomedical Research & Diagnostic Centre,
Kolkata, India
2IUCBR, IUCBR, Kerala, India
Attention deﬁcit hyperactivity disorder (ADHD) is a childhood-
onset neuropsychiatric disorder characterized by age-inappropriate
symptoms of inattention, hyperactivity, and impulsivity. A male
predominance was reported in the probands. Inﬂuence of mono-
amine neurotransmitter (such as dopamine, serotonin, and epinephr-
ine/norepinephrine) in ADHD associated symptoms is well
accepted. Monoamine oxidase B (MAOB) partially mediates
degradation of these neurotransmitters thus regulating the circulating
level. Few MAOB variants showed association with ADHD in
different populations. In this pilot study, we have tested association
of three MAOB polymorphisms (i.e., rs2283728, rs6324 and
rs3027440) in the Indo-Caucasoid families with ADHD probands
(N = 190) recruited following the Diagnostic and Statistical Manual
for Mental Disorders-4th edition. Comparative analysis was carried
out with ethnically matched control individuals (N = 156). Geno-
typing was performed by ampliﬁcation of target sites followed by
DNA sequencing and data obtained were analyzed by population
based statistical methods and validated by family based statistical
methods. rs2283728 ‘C’ (p = 2.38E-07), rs3027440 ‘T’ (p = 0.002)
alleles and rs2283728-rs6324 ‘C-C’ (p = 1.53E-08), rs2283728-
rs3027440 ‘C-T’ (p = 7.73E-11), rs6324-rs3027440 ‘C-T’
(p = 0.0004) haplotypes showed higher frequencies in ADHD
probands as compared to controls. Gender based stratiﬁed analysis
revealed higher frequencies of rs2283728 ‘C’ (p = 4.38E-08),
rs3027440 ‘T’ (p = 0.0006) alleles and rs2283728-rs6324 ‘C-C’
(p = 1.15E-09), rs2283728-rs3027440 ‘C-T’ (p = 2.28E-13),
rs6324-rs3027440 ‘C-T’ (p = 5.42E-05) haplotypes in the male
ADHD probands as compared to sex-matched controls. rs2283728
‘C’ (p = 0.0008), rs6324 ‘C’ (p = 0.003), rs3027440 ‘T’
(p = 0.0002) alleles and rs2283728-rs6324 ‘C-C’ (p = 2.73E-05),
rs2283728-rs3027440 ‘C-T’ (p = 1.66E-05), rs6324-rs3027440 ‘C-
T’ (p = 0.0002) haplotypes also showed statistically signiﬁcant
maternal transmission to the male ADHD probands. In the female
probands, no such biased occurrences were noticed. It may be
inferred that these MAOB polymorphisms may contribute to the
etiology of ADHD, more so in the male probands, warranting
further in depth analysis.
MTU02-07
Estrous cycle-related changes in transient receptor
potential vanilloid (TRPV) ion channels gene expression
in mouse brain
S. Kumar1, 2, P. Singru1, 2
1National Institute of Science Education and Research,
Bhubaneswer, School of Biological Sciences, Khurda, India
2Homi Bhabha National Institute, Training School Complex,
Mumbai, India
TRPV-subfamily of ion channels are expressed in the brain and
serve as novel players in neurotransmission, Ca2+ signalling,
synaptic plasticity, and behaviour. Although the TRPV-expressing
elements are widely organized in the brain, their importance in CNS
is poorly understood. Since TRPV ion channels are polymodal in
nature and estradiol has emerged as potential regulator of these ion
channels, we determined if TRPV1-6 genes contain estrogen
receptor alpha binding sites and their expression in different
compartments of the mouse brain is modulated during estrous
cycle. Analysis of TRPV1-6 genes sequences showed the presence
of putative functional estrogen response element in their promoter
regions. Subjects were adult, male and female BALB/c mice. The
estrous cycle stages were identiﬁed using vaginal smear cytology.
The brains of male mice and mice during each stage of estrous cycle
were dissected out and processed for qRT-PCR analysis. TRPV1-6
mRNA expression was observed in the olfactory bulb, cortex,
hypothalamus, hippocampus, brainstem, and cerebellum. In these
regions, compared to estrus, metestrus, and diestrus, while signif-
icant decrease was observed in TRPV1 and TRPV5 mRNA levels,
expression of TRPV2 and TRPV6 mRNA were elevated during
proestrus. Although lower levels of TRPV3 and TRPV4 mRNA
levels were seen during estrus, higher expression of these ion
channels was observed during metestrus and diestrus. TRPV2
mRNA was abundantly expressed during all stages of the estrous
cycle. Reduced levels of TRPV5 and TRPV6 were observed during
proestrus and other stages of the estrous cycle, respectively. Except
TRPV4 expression in the hippocampus and TRPV6 expression in
hippocampus and brainstem, the expression of ion channels in
different brain regions of male mice were comparable to that in
respective brain regions of female mice during metestrus and
diestrus. We suggest that TRPV channels serve as direct target of
estradiol and the hormone-ion channel cross talk may modulate
neural substrates regulating reproduction.
MTU02-08
Microrna regulation in medial prefrontal cortex after nerve
injury
K. Kummer, T. Kalpachidou, M. Kress
Medical University of Innsbruck, Division of Physiology, Innsbruck,
Austria
MicroRNAs are small non-coding RNA molecules that constitute
post-transcriptional regulators of gene expression. Recently, it has
been shown that besides their prominent role in the regulation of
physiological mechanisms they are also important for the modula-
tion of pain pathways. Nerve injury can lead to long lasting
neuropathic pain, affecting a large proportion of the population and
exerting major impacts on the patients’ quality of life. A brain
region involved in central processing and modulation of pain is the
medial prefrontal cortex (mPFC), which shows alterations in chronic
pain patients.
We employed a combination of in vitro electrophysiology,
pharmacological stimulation and RNA sequencing, to explore the
changes in the mPFC that underlie the transition to a neuropathic
pain state on a neuronal and microRNA network level.
We found that the induction of neuropathic pain in a mouse
model of sciatic nerve injury led to speciﬁc expression proﬁles of
microRNAs and mRNAs in mPFC samples. Interactions between
microRNA and mRNA expression are currently being analyzed.
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A critical role for the transcription coactivators in the
regulation of the human tryptophan hydroxylase-2 gene
expression
H. Matsui1, H. Kaneko1, Y. Nawa1, M. Tsubonoya1, T. Hiroi1, R.
Takahashi2
1St. Marianna Univ Grad Sch Med, Mol Behav Neurosci, Kawasaki,
Japan
2Toho Univ, Dep Biochem Fac Pharma Sci, Funahashi, Japan
Dysfunction of the central 5-HT system has been implicated in
the etiology of the wide range of neurodevelopmental disorders. As
the rate-limiting enzyme for the synthesis of central 5-HT,
tryptophan hydroxylase-2(TPH2) is thus a promising therapeutic
target for the treatment of neuropsychiatric disorders. However, the
mechanism by which human (hTPH2) gene expression is activated
remains unresolved. In the present study, we characterized how the
hTPH2 promoter activity is regulated by cAMP-mediated signaling
pathways. A 2-kb of the hTPH2 gene (1850/+141) was cloned into
pGL4-Basic and promoter activities were assessed by transient
transfections into RN46A cells. Forskolin increased the hTPH2
promoter activity. Whereas PKA activators (Sp-cAMPS or N6-
phenyl-cAMP) increased the hTPH2 promoter activity, the speciﬁc
EPAC (exchange protein directly activated by cAMP) activator (8-
pCPT-20-O-Me-cAMP) did not show any appreciable effects.
Forskolin-induced increase in the hTPH2 promoter activity was
reversed by the PKA speciﬁc inhibitor (H-89), but not by the EPAC
speciﬁc antagonists (ESI-09 or HJC0197). Overexpression of CREB
and PKA-alpha, either alone or in combination, only caused
marginal effects. Overexpression of either CREB-regulated tran-
scription coactivator CRTC1 or 3 with PKA-alpha and CREB
remarkably increased the hTPH2 promoter activity. Forskolin- or
PKA-alpha/CREB/CRTC-mediated increase in the hTPH2 promoter
activity was abolished when the inverted CRE (cAMP response
element) motif was mutated. CRTC-mediated increase in the hTPH2
promoter activity was attenuated either by overexpression of
R314A-CREB (defective for interaction with CRTCs) or R301L-
CREB (defective for interaction with CRE) instead of wild-type
CREB. In contrast, overexpression of S131A-CREB (defective for
phosphorylation by PKA) increased the hTPH2 promoter activity
comparable to wild-type CREB, suggesting that CREB phosphory-
lation itself is not necessarily essential. Collectively, these results
indicate that CRTCs play a critical role for positive transcriptional
regulation of the hTPH2 gene via cAMP-mediated signaling
pathways and interaction with CRE-bound CREB.
MTU02-10
Characterization of natriuretic peptides and their
receptors in the avian brain
H. Ohki-Hamazaki, Y. Chiba, T. Nakamori
Kitasato University, College of Liberal Arts and Sciences,
Sagamihara, Japan
The natriuretic peptide family includes structurally related peptides
that have important roles in body ﬂuid balance and cardiovascular
homeostasis. In mammals, these peptides comprise a family of three
structurally related molecules: atrial natriuretic peptides (ANP), B-
type natriuretic peptide (BNP) and C-type natriuretic peptide (CNP).
In birds, genomic analysis showed that the genes encoding BNP and
CNPwere retained,whereas theANPgenewas lost. Somemembers of
NP family are expressed in both the mammalian and avian brain, but
their functional roles in brain have not been fully elucidated. Three
receptors for NPs have been identiﬁed in mammals, but the
information concerning avian NP receptors is limited. To gain insight
into the functional roles of NP systems in brain, we aimed to
characterize the NPs and their receptors in chick brain, because the
avian system has an advantage for studying early learning.
MTU02-11
Elucidating the transcriptional regulation of NUR77 in
neurons
M. Olivares, M. Estela Andres
Pontiﬁcia Universidad Catolica de Chile, Department of Cellular
and Molecular Biology, Faculty of Biological Sciences, Santiago,
Chile
Nur77 is a transcription factor encoded by an early gene that
belongs to orphan members of the nuclear receptor superfamily. The
expression of Nur77 is regulated by dopamine in brain nuclei as the
striatum and prefrontal cortex, which are targets of dopaminergic
projections frommidbrain. Even thoughNur77 has been implicated in
stress response and drug addiction, the mechanisms regulating its
expression have not been elucidated. Recently, it has been shown that
the transcriptional repressor Lysine-Speciﬁc Histone Demethylase 1
(LSD1) plays an important role regulating the expression of early
genes. LSD1 has four splice variants. Two of these splice variants
include the micro exon 8a that encode 4 amino acids among them a
phosphorylatable threonine. Neuro-LSD1, which is expressed only in
neurons, has lower transcriptional repressive activity although
displays similar demethylase activity compared with ubiquitous
LSD1. The effect of LSD1 and neuro-LSD1 over early genes in the
brain seems to be mediated by the Serum Responsive Factor (SRF).
Here, we show that both LSD1 and neuro-LSD1 induce Nur77
expression in neurons. A phospho-mimetic but not a phospho-
deﬁcient mutant of neuro-LSD1 displays the same inductive effect
over Nur77, suggesting that dephosphorylation of neuro-LSD1 limits
its transactivation function. Reporter genes assays showed that SRF
induces Nur77 expression in an independent way of LSD1. CArG-
Box element present in the Nur77 proximal promoter is necessary for
SRFmediated induction, but not for the effect of LSD1. Besides, PCR
using exon-inclusion frequency by relative quantity ﬂuorescent
indicates that LSD1/neuro-LSD1 ratio in the striatum is regulated
by ligands of the dopamine D2 receptor.
Funded by Fondecyt Project N° 1150200 to MEA and Conicyt
Project N 21140438 to MO.
MTU02-12
DNA methylation and gene expression of astroglia before,
during and after oxygen and glucose deprivation
I. Ponce-Arias, L. B. Tovar-y-Romo
Universidad Nacional Autonoma de Mexico, Department of
Molecular Pathology - Instituto de Fisiologia Celular, Mexico City,
Mexico
Epigenetic mechanisms such as DNA methylation are well
known regulators of genetic expression and they play key roles in
the development of neurodegenerative diseases, mainly through a
substantial transcriptional regulation of active and inactive
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promoters and by modifying transcription elongation and splicing in
CpG islands located intra and intergenically. It is also widely
recognized that astrocytes, that are critical regulators of neuronal
function, play a crucial role in neurovascular-related disorders like
ischemic stroke. However, few studies have addressed at the
molecular resolution the overall genetic and epigenetic changes of
these complex phenomena, and in events like the reperfusion
damage that occurs after ischemic stroke these processes are
practically unknown. We performed RNA-seq and methylated DNA
immunoprecipitation sequencing (MeDIP-seq) analysis of cultured
human astrocyte-like cells derived from grade I non-tumorigenic
glioblastoma subjected to oxygen and glucose deprivation (OGD),
in order to establish a relationship between DNA methylation and
gene expression under normoxia, OGD and recovery. We identiﬁed
several genomic features including promoters and enhancers whose
methylation levels change not only during OGD but also after 8 h of
recovery that showed statistically signiﬁcant differences in both;
high (housekeeping and ubiquitous genes) and low (cell lineage-
speciﬁc genes) CG promoters. Moreover, DNA methylation
remodeling was correlated with gene expression of several genes
under OGD and recovery, and the organization of the transcriptome
and methylome resulted different under normoxia, OGD and
recovery. These results can help to elucidate the overall transfor-
mation of cells in terms of transcription and DNA methylation in
pathological occurrences involving ischemia and characterize the
damage that occurs during reperfusion at the genomic scale that has
been incompletely described until now. Supported by PAPIIT-
DGAPA IN226617 and CONACYT 219542.
MTU02-13
Serotonin transporter gene, SLC6A4 polymorphisms
regulate SERT expression and 5-HT levels to inﬂuence
severity of ASD symptoms
U. Rajamma1, S. Guhathakurta2, D. Verma2, S. Sinha2, K. P.
Mohanakumar1, P. Jaiswal2
1Inter University Centre for Biomedical Research & Super
Speciality Hospital (IUCBR & SSH), Centre for Development and
Aging Research, Kottayam, India
2Manovikas Kendra, Biomedical Research & Diagnostic Centre,
Kolkata, India
Autism spectrum disorder (ASD) is a group of childhood onset
neurodevelopmental disorders. Neurochemical, behavioral and phar-
macological studies reveal serotonergic dysfunction in ASD. Platelet
hyperserotonemia in ASD subsets and efﬁcacy of selective serotonin
reuptake inhibitors in reducing the behavioural symptoms suggest
defects in serotonin (5-HT) reuptake as a possible cause for ASD-
speciﬁc behavioural impairments. Serotonin transporter (SERT), a
key determinant for 5-HT uptake is encoded by SLC6A4, which is a
QTL for blood 5-HT levels. Therefore SERT has gained much
attention as a target for hyperserotonemia. Here we report the genetic
association of SLC6A4 polymorphisms with ASD using case-control
and family-based approaches and examined its genetic correlation
with platelet 5-HT levels, SERT mRNA expression and severity of
ASD behavioural symptoms. Results of genetic association analyses
reveal that SLC6A4 markers increase the risk for ASD. Its polymor-
phisms showed signiﬁcant genetic effect on speciﬁc behavioural
phenotypes as measured by CARS. Low expressing genotypes, C/C
and S/S of rs6354 and 5-HTTLPR respectively and A/A of rs7224199
displayed reduced severity for certain behaviours such as activity
level, adaptation to change, taste, touch & smell use, and body use.
Haplotypes formed of L allele of 5-HTTLPR increased the severity
for fear or nervousness. ASD children demonstrated higher 5-HT
levels and SERT mRNA expression in platelets and lymphocytes
respectively. When 12-repeat allele of STin2 showed association with
elevated mRNA expression and platelet 5-HT levels, the C/C
genotype of rs6354 showed correlation with low platelet 5-HT
levels. Overall results suggest that SLC6A4 markers inﬂuence the
severity of ASD symptoms, through 5-HT modulation by SERT. Our
ﬁndings imply its signiﬁcance in pharmacogenomics research, as
genotype-based personalised medication can be strategically imple-
mented as a treatment mode for ASD.
MTU02-14
Lactic acid mediates the effects of physical exercise on
learning and memory through Sirt dependent activation of
hippocampal BDNF
S. Sleiman, L. El-Hayek, V. Zibara, R. A. Assaad, N. Emmanuel, N.
Karnib, R. El-Ghandour
Lebanese American University, Natural Sciences, Byblos, Lebanon
Exercise induces beneﬁcial responses in the brain, which is
accompanied by an increase in BDNF, a growth factor associated with
cognitive improvement and the alleviation of depression and anxiety.
However, the exact mechanisms by which physical exercise produces
an induction in brain Bdnf gene expression are not completely
understood. Here, we report that an endogenous molecule released
after exercise is capable of inducing key promoters of the Mus
musculus Bdnf gene. The metabolite lactate, which is increased after
prolonged exercise in the blood, induces Bdnf expression and Trkb
signaling in the hippocampus. Indeed, we ﬁnd that lactate-dependent
increases in hippocampal BDNF are associated with improved spatial
learning and memory retention. We have discovered that the action of
lactate is dependent on Sirt induction and activation potentially by
affecting the activity of the transcriptional coactivator PGC1a. These
results reveal an endogenous mechanism to explain how physical
exercise leads to the induction of BDNF and identify novel targets that
allow us to harness the therapeutic potential of exercise.
MTU02-15
Increased serum miRNAs as potential diagnosis and
prognosis biomarker for human mild traumatic brain
injury
J.-x. Song, X.-m. Bu, C. Wang, J. Wu, J.-j. Wang
Jinling Hospital, Medical School of Nanjing University, Department
of Clinical Laboratory, Nan Jing, China
Objective: Circulating microRNAs (miRNAs) are emerging
disease biomarkers. However, comprehensive characterization of
the serum miRNA proﬁle in patients with traumatic brain injury
(TBI) has rarely been reported. Our study aims to investigate the
value of novel serum miRNAs for diagnosing TBI, especially mTBI,
and further predicting therapeutic efﬁcacy and clinical outcome.
Methods: ATaqManLowDensity Array was initiated to analyzed
the expression of 754 serum miRNAs in two pooled samples from 15
severe traumatic brain injury (sTBI) (GlasgowComaScale [GCS] score
≤ 8) patients with unfavorable outcome and 15 normal controls.
Markedly upregulated miRNAs in sTBI cases were subsequently
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validated by qRT-PCR in another cohort consisting of 85 with severe
TBI, 85withmild traumatic brain injury (mTBI) (GlasgowComaScale
[GCS] score > 12) and 85 controls arranged in two stages. Clinical
outcome was evaluated at 6 months using Glasgow Outcome Scale
(GOS) score.Anunfavorable outcomewas deﬁned asGOSof 1–3 and a
favorable outcome was named as GOS of 4–5.
Result: Seven miRNAs including miR-103a, miR-219a,
miR302d, miR-422a, miR-518f, miR-520d and miR-627 were
signiﬁcantly elevated (p < 0.001) in both sTBI and mTBI within
24 h post-injury compared with the controls. miR-520d was
declined markly in post-treatment samples versus pre-treatment
samples (p < 0.05). The levels of seven miRNAs were signiﬁcantly
higher in the patients with an unfavorable outcome than in those
with a favorable outcome (p < 0.05).
Conclusion: The seven miRNAs identifed in our study repre-
sented potential diagnostic and prognostic biomarkers for TBI.
MTU02-16
Inﬂuence of placental allopregnanolone on adult brain
transcriptome
C.-M. Vacher, J. Salzbank, D. Bakalar, H. Lacaille, A. Penn
Children s National Medical Center, Center for Neuroscience
Research, Washington, USA
Allopregnanolone (AP), along with its precursor progesterone, is
a neuroactive steroid primarily synthesized during pregnancy by the
placenta, and later, the brain. AP exerts neurodevelopmental and
neuroprotective actions through allosteric activation of the GABA-A
receptor. In the fetal brain, AP notably promotes neurogenesis and
myelination, and protects developing neurons and glial cells from
damage. Preterm infants with very low birth weight are highly
vulnerable to brain injuries, with possible long-term neurological
consequences, including learning impairment, attention deﬁcit
hyperactivity disorder (ADHD) and cerebral palsy.
Since preterm delivery is associated with premature loss of
placental AP and its accompanying neurotrophic and neuroprotective
actions,we hypothesize that some of the neurological outcomes linked
to premature birth are due in part to the early withdrawal of AP.
To test this hypothesis, we have generated a transgenic mouse
model in which the gene encoding the synthesis enzyme of AP
(AKR1C14) is speciﬁcally knocked-out in trophoblastic cells
expressing Cyp19-Cre transgene. In these mice, named AKR1C14-
Cyp19, the recombination may result in a dramatic reduction of AP
production in the placenta only. We chose to use an unbiased RNA
sequencing approach to analyze gene expression changes that may
result from the lack of placental AP in the adult brain of
AKR1C14Cyp19 mice.
Our RNA sequencing analysis reveals that placenta AP with-
drawal is associated with long term and sex-speciﬁc gene expression
changes in the cerebral cortex, hippocampus, hypothalamus and
cerebellum. The differentially expressed genes cover a variety of
ubiquitous functions such as neural development and plasticity,
neurotransmission and epigenetics, as well as region-speciﬁc
functions such as energy homeostasis and body growth.
By providing new evidence of the importance of placental
hormones in shaping and programing the developing brain, our data
paves the way for future investigation in the ﬁeld of neuroplacen-
tology. Furthermore these ﬁndings may contribute to the develop-
ment of novel therapeutic approaches to address the negative
neurological outcomes of preterm birth.
MTU02-17
Region-speciﬁc microrna changes during avulsion-
induced spinal motoneuron degeneration of adult rats
following unilateral brachial plexus root avulsion:
ipsilateral vs contralateral spinal cord
L. Zhou, Y. Tang, Z. Ling, R. Fu, Y. Li, L. Liu, G. Yu, H. Luo
Zhong Shan School of Medicine Sun Yat-sen University, Department
of Anatomy, Guangzhou, China
Elucidation of the pathophysiological events underlying spinal
root avulsion is expected to discover effective therapeutic methods.
Currently, microRNAs are thought to play an important role in the
gene changes involved in spinal cord injury. In the rats with right
brachial plexus root avulsion, the spinal cords of all the animals
were harvested 3 and 14 days after injury and divided into ipsilateral
and controlateral ventral and dorsal horn, preparing for microarray
analysis. The expression of 8 miRNAs (up, 6 miRNAs; down, 2
miRNAs) was signiﬁcantly altered in Day 3 and the expression of 17
miRNAs (up, 16 miRNAs; down, 1 miRNAs) was signiﬁcantly
altered in Day 14 post-injury. It is worth to notice that miR-106b-3p
was continuously upregulated in the ipsilateral ventral horn on both
the 3rd and 14th days after the injury. Moreover, the upregulation of
miR-106b-3p was also observed in the ipsilateral dorsal horn on the
14th days after the injury. Only miR-496-3p was continuously
downregulated in both the ventral and dorsal horn of the affected
spinal cord on the 14th day after injury. The present data revealed
previously unknown region-speciﬁc alterations of a large set of
miRNAs in affected spinal cord after root avulsion.
MTU02-18
Novel mutation in HTRA1 identiﬁed in a family with diffuse
demyelination lesions
A. Ziaei1, 2, X. Xu1, L. Dehghani3, C. Bonnard4, B. Reversade4,
V. Shaygannejad3, M. A. Pouladi1, 2
1A*STAR, TLGM, Singapore, Singapore
2National University of Singapore, Medicine, Singapore, Singapore
3Isfahan University of Medical Sciences, Neurology, Singapore,
Singapore
4A*STAR, Institute of Medical Biology, Singapore, Singapore
Here we report on three siblings born to healthy Iranian parents
with ataxia, behavioral and mood changes, dysarthria, dementia, low
back pain and recurrent respiratory infections. Brain MRIs in the
siblings showed diffuse demyelination lesions and also spinal
stenosis was diagnosed. Based on the occurrence in siblings, no
signiﬁcant difference in phenotype between the siblings, absence of
manifestations in parents, and several level consanguinity in the
pedigree, we performed sought to discover possible genetic risk
factors in this family. Using a combination of homozygosity
mapping and whole exome sequencing, we identiﬁed an indel in
High-Temperature Requirement A Serine Peptidase 1 (HTRA-1)
gene, which showed complete segregation in the pedigree. The
patient’s clinical manifestations appear consistent with cerebral
autosomal recessive arteriopathy with subcortical infarcts and
leukoencephalopathy (CARASIL), which has previously been
reported to be associated with HTRA-1 mutations. Studies are
currently underway to examine the functional effects of the novel
HTRA-1 mutation we identiﬁed. As some aspects of the clinical
presentation in this family deviate from those reported for
CARASIL, our study expands the spectrum of clinical consequences
of mutations in HTRA-1.
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MTU03-01
Pioglitazone attenuates lipopolysaccharide (LPS) induced
neuro-inﬂammation and depressive-like behaviour in
experimental mice
S. Ahmed1, M. Kwatra1, V. G. M. Naidu1, B. Bezbaurah1, 2
1National Institute of Pharmaceutical Education and Research
Guwahati, Pharmacology and Toxicology, Guwahati, India
2Gauhati Medical College, Pharmacology, Guwahati, India
Depression is a stern neuro-psychiatric hitch with a lifetime
prevalence exceeding 15% and has become the fourth leading cause
of disability worldwide. According to a report by WHO mental
illness affects around 450 million people globally of which 10–20
million commits suicide every year. Despite having several
medications the disease is still a challenging with approximately a
large number of populations do not respond to their ﬁrst line
medication. Hence there exists a necessity to explore new targeted
drugs. Microglia’s are resident immune defence cells of the brain
and comprises ~ 12% of the total neurons. Upon activation,
microglia undergoes proliferation, chemotaxis and morphological
alteration to engender plethora mediators including cytokines,
chemokines, reactive oxygen species (ROS) and reactive nitrogen
species (RNS) which may alter the serotoninergic and glutamatergic
neurotransmission. NF-jB(Nuclear factor kappa beta) is an impor-
tant transcription factor is activated by LPS(lipopolysaccharide)
causing transcription of many proinﬂammatory cytokine genes(IL-
1b, TNF-a, IL-6) and thus microglia acts as a sensor for
pathological events that occurs in the brain. Furthermore, LPS
evoked brain alternation through hyperactivation of the hypothala-
mic–pituitary–adrenal axis (HPA axis) axis results in the rise of
circulating serum corticosterone level. LPS evokes generation of
free radicals causing ER stress and up-regulation of unfolded-
protein response (UPR). LPS also alter the p-38MAP kinase and
Nrf-2 signalling pathways causing an add on to neuroinﬂammation.
Pioglitazone belongs to peroxisome proliferator-activated receptor
gamma (PPAR-c) agonist class regulates lipid metabolism, exerts
potent central and peripheral anti-neuroinﬂammatory action and
possesses neuroprotective effect. Several studies have also reported
the protective role of Pioglitazone at a dose of 30 mg/kg body
weight for 14 days inhibits the oxidative-nitrosative stress and other
inﬂammatory cytokine markers. Thus, this has pushed us to explore
the neuroprotective nature of Pioglitazone especially with psychi-
atric disorders associated with inﬂammation and oxidative stress.
MTU03-02
Extracellular CGMP normalizes TNF-a and membrane
expression of AMPA receptors and spatial reference
memory in hyperammonemic rats
A. Cabrera-Pastor, L. Taoro-Gonzalez, T. Balzano, V. Felipo
Centro de Investigacion Principe Felipe, Neurobiology, Valencia,
Spain
Patients with hepatic encephalopathy (HE) show working
memory and visuo-spatial orientation deﬁcits. Hyperammonemia
is a main contributor to cognitive impairment in HE. Hyperam-
monemic rats show impaired spatial learning and learning ability in
the Y maze. Intracerebral administration of extracellular cGMP
restores learning in the Y-maze. The underlying mechanisms remain
unknown. It also remains unknown whether extracellular cGMP
improves neuroinﬂammation or restores spatial learning in hyper-
ammonemic rats and if it affects differently reference and working
memory. The aims of this work were:
a) assess whether treatment with extracellular cGMP reduces
hippocampal neuroinﬂammation and restores spatial learning in
hyperammonemic rats.
b) analyze the underlying mechanisms, including changes in
membrane expression of NMDA and AMPA receptors.
Spatial working and reference memory were assessed using the
radial and Morris water mazes and neuroinﬂammation by immuno-
histochemistry and western blot. Membrane expression of NMDA
and AMPA receptor subunits was analyzed using the BS3
crosslinker. Extracellular cGMP was administered intracerebrally
using osmotic minipumps.
Chronic hyperammonemia induces neuroinﬂammation in hip-
pocampus, with astrocytes activation and increased IL-1b, which are
associated with increased NMDA receptors membrane expression
and impaired working memory. This process is not affected by
extracellular cGMP. Hyperammonemia also activates microglia and
increases TNF-a, alters membrane expression of AMPA receptor
subunits (increased GluA1 and reduced GluA2) and impairs
reference memory. All these changes are reversed by extracellular
cGMP. These results show that extracellular cGMP modulates
spatial reference memory but not working memory. This would be
mediated by modulation of TNF-a levels and of membrane
expression of GluA1 and GluA2 subunits of AMPA receptors.
MTU03-03
Melatonin attenuates cognitive impairment and
neuroinﬂammation via interleukin-6 signaling pathway in
hippocampus of aged mice
P. Chancharoen1, 2, S. Ngampramuan1, P. Govitrapong1, 3, 4,
S. Mukda1
1Research Center for Neuroscience, Institute of Molecular
Biosciences, Mahidol University, Neuroscience, NakhonPathom,
Thailand
2Faculty of Allied Health Sciences, Burapha University, Biomedical
Sciences, Chonburi, Thailand
3Center for Neuroscience, Faculty of Science, Mahidol University,
Pharmacology, Bangkok, Thailand
4Chulabhorn Graduate Institute, Chulabhorn Royal Academy,
Bangkok, Thailand
Aging is a natural process that deﬁned as progressive decline of
biological functions and is the most risk factor for several
neurodegenerative disorders. This process is accompanied by the
impairment of cognitive functions and variety of neurobiological
changes, one of which is neuroinﬂammation. Overproduction of
inﬂammatory cytokines such as interleukin-6 (IL-6), a major
cytokines in the central nervous system, can lead to neuronal
dysfunctions. Several studies suggested IL-6 signaling cascade is
not only associated with neuroinﬂammation but could also be
associated with cognitive function especially in hippocampal-
dependent memory. Futhermore, during aging the level of mela-
tonin, neuronal hormone synthesized and secreted by the pineal
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gland, is found to be signiﬁcantly decline. Therefore, this study
hypothesizes that the anti-inﬂammatory property of melatonin could
help ameliorate the cognitive decline in aging and might be
associated with the IL-6 signaling pathway. Mice were received
melatonin (10 mg/kg body weight) in drinking water from 16 to
22 months of age (6 months). The Morris water maze (MWM) task
was used to evaluate the cognitive function of animals, and the level
of IL-6 and it signaling pathway were measured. The results
revealed that aged mice show cognitive impairment in both learning
ability and working capacity when compare with adult (2 months
old) mice. However, aged mice which were received melatonin for
6 months show cognitive improvement when compare to aged
without melatonin. Moreover, the IL-6 pathways are also activated
in the aged mouse hippocampus which could be ameliorated by
long-term administration of melatonin. The present data show
melatonin supplement could be considered as a beneﬁcial therapeu-
tic strategy to prevent the cognitive decline and overproduction of
inﬂammatory cytokines in aging. This work was supported by a
Mahidol University Research Grant to SM, and a Ph.D scholarship
from Burapha University to PC.
MTU03-04
A molecular characterisation of meningeal inﬂammatory
inﬁltrates in the progressive multiple sclerosis brain
L. Fuentes-Font1, C. Glover2, R. Reynolds1
1Imperial College London, Centre for Neuroinﬂammation and
Neurodegeneration - Division of Brain Sciences, London, United
Kingdom
2MedImmune PLC, RIA, Cambridge, United Kingdom
Post-mortem tissue studies suggest that the presence of chronic
inﬂammatory inﬁltrates in the leptomeninges may promote cortical
pathology and thereby play a role in accumulating clinical disability
in progressive multiple sclerosis. In a proportion of MS cases, these
inﬂammatory inﬁltrates begin to approximate the composition and
structure of tertiary lymphoid organs. However, we know little about
the mechanisms by which they form and how they affect the
underlying cortical tissue. In order to explore the upstream
regulators as well as the molecular mechanisms and signaling
pathways that might drive these pathological processes, we have
studied a cohort of 40 SPMS patients and 10 non-neurological
controls from the UK MS Society Tissue Bank. Cryosections were
cut from ﬁve cerebral cortical blocks per case and meningeal tissue
was dissected and RNA extracted for transcriptional proﬁling.
Immunohistochemistry was used to determine the extent of
lymphocytic inﬁltration and demyelination. Cases were then segre-
gated into groups according to the level of inﬂammation. To
interrogate all transcripts, a new high resolution array from
Affymetrix, the GeneChip Human Transcriptome array, was used
and data subsequently analysed using Affymetrix Expression
Console Software and Affymetrix Transcriptome Analysis Con-
sole Software.
In those cases with the highest inﬂammation level, there were
large increases in a signiﬁcant number of immunoglobulin-related
genes when compared to healthy controls or low inﬂamed MS cases.
In addition, alterations were mainly found in gene expression of
homing chemokines and receptors, such as CCL19, CXCR4, CCL5,
CCR2, as well as cytokines that enhance B cell survival, prolifer-
ation and antibody and IFNg production, such as IL10 and IL18.
Furthermore, modiﬁcations in genes that enact functions in the
development of lymphatic vessels (e.g. LYVE1) and cell motility,
survival and antigen presentation (e.g. HLA-B) were prominent.
We have demonstrated that the molecular cues mediating
meningeal inﬂammation suggest a dysregulation of pathways that
are critical for the trafﬁcking and recruitment of B and T
lymphocytes into the CNS. The resulting formation of self-
maintaining ectopic lymphoid tissues would result in inﬂammatory
tissue damage to the underlying grey matter of the progressive MS
brain.
MTU03-05
Axo-glial pathology in multiple sclerosis and its effects on
neurotransmission
P. G. Delgado1, R. Reynolds1, A. Faisal2
1Imperial College London, Division of Brain Sciences, London,
United Kingdom
2Imperial College London, Department of Bioengineering, London,
United Kingdom
Saltatory conduction in the nervous system is enabled through the
association between the axolemma and the leading loops of the
myelin sheaths, which form the paranodal axo-glial junctions (PNJs)
and deﬁne the nodes of Ranvier. Moreover, the proper clustering of
voltage sodium channels (Nav) at the node and potassium channels
(Kv1.2) at the juxtaparanode is crucial for correct conduction.
Previous studies have identiﬁed changes to the structure of the nodes
of Ranvier in the normal appearing white matter (NAWM) in the
multiple sclerosis (MS) brain. In order to understand how these
changes affect saltatory conduction in MS we have examined the
spatial expression of Caspr, Nav and Kv1.2 in NAWM areas from
post-mortem brains. N = 20 cases of neuropathologically conﬁrmed
multiple sclerosis, comprising 47 blocks with 470 NAWM areas,
were analysed in the neuroanatomical part of our study. In order to
determine axonal abnormalities such as channel dislocation, inten-
sity proﬁles were measured from our imaging database for each
axon and compared across all the cases. A signiﬁcant increase in
length of the PNJs was found in MS NAWM tissue and associated
with stressed/damaged axons and activation of microglia. This
underlying axonal pathology points to PNJ disruption as a crucial
event in the cascade of events that may culminate in axon pathology
and loss. Furthermore, we found a higher proportion of axons in MS
NAWM with Kv 1.2 channels dislocated towards the PNJs, and a
small proportion of axons with Nav channels also dislocated
towards the PNJs. We have then integrated this axo-geometrical data
into our computational model, and preliminary indications suggest a
potential reduction in conduction velocity in the NAWM. We
investigated also the reliability and metabolic cost of conduction.
Overall, our results point to an ongoing disruption of the axonal-
oligodendrocyte complex, which can affect greatly CNS neuro-
transmission and might contribute to non-lesion disease symptoms
such as neurofatigue.
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Anti-inﬂammatory compound with sIPSC blocking
potential, a promising therapeutic approach for
neurological pain disorders
M. Gangadhar1, O. Isava2, Y. Perumal1
1BITS-Pilani Hyderabad, Pharmacy, HYDERABAD, India
2Bogomoletz institute of Physiology, Molecular biology, Kiev,
Ukraine
Objective: The objective of present study is to explore multiple
effects of the compound MG9 and relate them to achieve better
therapeutic potential against neuroinﬂammation related disorders.
We examined whether our compound is acting through regulating
neuroinﬂammatory mediators and by blocking spontaneous inhibi-
tory post synaptic currents (sIPSC) in brain hippocampal slice
preparations.
Methods: Preliminary in-silico docking studies using glide and
gold soft wares and behavioral screening studies using rodent
models of peripheral nerve injury encouraged us to shortlist the
derivatives and to extend our screening studies to explore the test
compounds efﬁcacy on other related peripheral neurological disor-
ders such as Streptozotocin-induced diabetic peripheral neuropathy
(DPN) and methyl mercury (MeHg) induced neurodegeneration in
rats. Pro-inﬂammatory cytokines interleukin-1b (IL-1b), interleukin-
6 (IL-6) and tumor necrosis factor-a (TNF-a) were quantiﬁed with
RT-qPCR studies and histopathology studies were performed taking
tissue samples from MeHg induced neurodegeneration rats. sIPSCs
were recorded from CA1 pyramidal cells using patch-clamp
technique in a whole-cell conﬁguration.
Results: The effect of MG9 was assessed on local and acute
inﬂammation through carrageenan-induced rat paw edema model.
We observed the reduction in nociceptive response in DPN rats.
Pain threshold was reduced greater than 50% in various pain
assessment modules. Upregulated pro-inﬂammatory cytokines
which are thought to have the prominent role in neuroinﬂammation
was controlled near to normal level quantiﬁed by RT-PCR studies.
However, MG9 was able to regulate IL-6 and TNF-a but not IL-1b.
sIPSCs were blocked more than 50% by MG9 which is very crucial
to stop the continuous throbbing pain in neuropathic pain states.
Conclusion: Our results clearly suggest the beneﬁcial potential
of compound MG9 through regulation of proinﬂammatory cytokines
release and also by blocking sIPSCs. MG9 could be an intriguing
therapeutic approach in diabetes-related neuro-pathophysiological
conditions.
MTU03-07
Intrathecal administration of a cannabinoid type 1
receptor agonist attenuates acute postoperative pain in
rats
M. Gautam, R. Kumar, S. Gupta, P. Prasoon, S. B. Ray
All India Institute of Medical Sciences (AIIMS), Department of
Anatomy, New Delhi, India
The endocannabinoid system which includes endogenously
synthesized cannabinoids like anandamide,cannabinoid receptors
(type 1 & 2) and enzymes associated with their synthesis and
breakdown contributes towards maintaining a basal antinociceptive
tone in rodents.Besides,systemic administration of cannabinoid
drugs produces a distinct antinociceptive effect.However,this is
associated with psychomotor alterations and other side effects.One
option to possibly avoid the side effects is to selectively activate the
cannabinoid type 1 receptors (CB1r) in the spinal cord.In the present
study,we aimed to evaluate the antinociceptive effect of arachi-
donylcyclopropylamide (ACPA),a speciﬁc CB1r agonist in the rat
hind paw incision model,which is a preclinical model of postoper-
ative pain.Sprague-Dawley rats were initially implanted with
intrathecal catheters.Then,they were subjected to hind paw incision
following preemptive one-time intrathecal administration of 1, 3 and
10 lg ACPA.Antinociceptive effect was investigated by the guard-
ing behavior,mechanical allodynia and thermal hyperalgesia. These
were compared to morphine (3, 10 and 30 lg). The antinociceptive
effect was tested for reversibility by AM251,a CB1r antago-
nist.Motor coordination was examined by rotarod appara-
tus.Antinociceptive effect of ACPA was also evaluated by the
formalin test.Spinal CB1r expression was investigated by immuno-
histochemistry.Both intrathecal morphine (3, 10 and 30 lg) and
ACPA (1, 3 and 10 lg) signiﬁcantly decreased guarding score in
comparison to control group between 2 h to day 2 and 2 h to day 4
respectively. Signiﬁcant decrease in allodynia was observed for
ACPA (2 h-day 5) and morphine (2 h and days 3–5).Unlike
guarding,in allodynia,signiﬁcant difference between ACPA and
morphine was absent.Thermal hyperalgesia was signiﬁcantly
decreased by 3 lg ACPA only (2 h, 8 h-day 5) and 3, 10 and
30 lg morphine (2 h) in comparison to control. Moreover,ACPA-
induced antinociception was reversed by AM251.However,it did not
affect formalin related ﬂinching behavior.Immunohistochemistry
showed selective CB1r expression in the superﬁcial laminae of the
spinal cord.Post-incision,ACPA increased at 2 h, but decreased
thereafter.Thus, ACPA treatment likely activated the CB1 receptors
to produce antinociception.This information could have clinical
relevance.
MTU03-08
Rage mediates the increase in neurodegenerative
markers and cognitive impairment following recovery
from polymicrobial sepsis
D. Gelain1, J. Gasparotto1, C. Girardi1, N. Somensi1, J. C. Moreira1,
M. Michels2, B. Sonai2, M. Rocha2, A. Steckert2, 3, T. Barichello2, 3,
J. Quevedo2, 3, F. Dal-Pizzol2
1Universidade Federal do Rio Grande do Sul, Departamento de
Bioquimica, Porto Alegre, Brazil
2Universidade do Extremo Sul Catarinense, Unidade de Ciencias da
Saude, Criciuma, Brazil
3University of Texas, Health Science Center at Houston, Houston,
USA
Patients that recover from sepsis have higher rates of central
nervous system (CNS) morbidities associated with long-lasting
impairment of cognitive functions, including neurodegenerative
diseases. Here, we investigated the role of the receptor for advanced
glycation endproducts (RAGE) in the neuroinﬂammation, neurode-
generative-associated changes and cognitive dysfunction arising
after sepsis recovery in adult Wistar rats subjected to cecal ligation
and perforation (CLP). Serum and brain (hippocampus and
prefrontal cortex) samples were obtained at days 1, 15 and 30 after
CLP for examination of systemic and brain inﬂammation, amyloid b
peptide (Ab) and phosphorylated tau at ser202 (p-tauser202) content,
RAGE, RAGE ligands and RAGE intracellular signaling. The effect
of RAGE immune neutralization in the hippocampus, using RAGE
antibody (RAGEab) injection at days 15, 17 and 19 after CLP, was
MTU03 Neuroinflammation
© 2017 The Authors
Journal of Neurochemistry © 2017 International Society for Neurochemistry, J. Neurochem. (2017) 142 (Suppl. 1), 78--164 97
studied for the parameters of neuroinﬂammation, Ab and p-tauser202
accumulation and cognitive impairment. In the course of 30 days
following CLP, a decrease in serum markers associated with the
acute pro-inﬂammatory phase of sepsis (TNF-a, IL-1b and IL-6)
was observed, concomitant with a progressive increase in RAGE
ligands (S100B, Ne-(carboxymethyl)lysine, HSP70 and HMGB1).
In the brain, the content of RAGE and TLR4, GFAP and nNOS, as
well as Ab and p-tauser202 also increased following the acute phase
of sepsis. RAGEab inhibited Ab and p-tauser202 accumulation, Akt/
mTOR signaling, Iba-1 and GFAP increases, and hindered behav-
ioral changes associated to cognitive decline. These data demon-
strate that brain RAGE is an essential factor in the pathogenesis of
neurological disorders following an episode of acute systemic
inﬂammation. Funding: CNPq, FAPERGS, FAPESC and CAPES.
MTU03-09
Physical exercise reverses pain and pathological changes
in dorsal root ganglia induced by systemic
lipoplolysaccharide in mice
M. Hanani, E. Blum
Hadassah-Hebrew University Medical Center, Experimental
Surgery, Jerusalem, Israel
Background: Emerging research indicates that physical activity
can ameliorate chronic pain, but the underlying mechanisms are still
obscure. We have shown previously that systemic inﬂammation
induced in mice by intraperitoneal (i.p.) injection of lipopolysac-
charide (LPS) caused mechanical hypersensitivity and activated
satellite glial cells (SGCs) in dorsal root ganglia (DRG). LPS
injection also caused a large increase in gap junction-mediated
coupling among SGCs and also between neurons. In the present
work we asked whether physical exercise can reduce the pain by
reversing the changes in SGCs induced by LPS.
Results: We assessed pain with von Frey ﬁlaments and
characterized SGCs in L4,5 DRG using dye injection, measured
respo3nses to the pain mediator ATP by calcium imaging, and
immunostained for the activation marker glial ﬁbrillary acidic
protein (GFAP). Seven days post-LPS, SGCs were activated, as
evidenced by GFAP upregulation, and dye coupling among SGCs
increased 3–4.5-fold. Sensitivity of SGCs to ATP increased 2-fold.
Pain threshold decreased 3.5 fold. Injecting gap junction blockers
i.p. reduced pain behavior in LPS-treated mice, indicating a role for
SGCs in pain. The results suggest that SGC activation plays a role in
pain mechanisms. LPS-injected mice were given 1 week of free
wheel running, after which we characterized the changes in SGCs in
DRG. Pain threshold increased back to control level, dye coupling
among SGCs and neurons was restored to control level and
sensitivity of SGCs to ATP was reduced 2-fold. GFAP levels
decreased back to control level.
Conclusions: Physical exercise reverses SGC activation caused
by systemic inﬂammation, which may explain the amelioration in
pain in the systemic inﬂammation model by exercise.
Supported by ISF, BSF.
MTU03-10
Linking inﬂammasome activation with mitochondrial
alterations and oxidative stress, or not
G. J. Harry, C. Perry, C. McPherson
National Institute of Environmental Health Sciences, National
Toxicology Program Laboratory, Research Triangle Park, USA
Neuroinﬂammation is mediated by protein complexes, inﬂam-
masomes, functioning as intracellular sensors. Once primed,
purinergic receptors (PXR) or Nod-like receptor, pyrin domain 3
(NLRP3) respond to various stimuli (ATP) and assemble an
inﬂammasome aggregate. The process involves potassium efﬂux,
mitochondrial ROS generation, apoptosis-associated speck-like
protein (ASC) aggregation, caspase-1 cleavage, and mature inter-
leukin-1b (IL-1b) release. It is thought that mitochondrial DNA and
mitochondrial ROS activate the NLRP3 inﬂammasome and that
canonical inﬂammasome activators work via disrupting mitochon-
drial membrane potential (MMP). Recent work identiﬁed hundreds
of environmental/industrial compounds that acutely decrease MMP.
We hypothesize that many of these mitotoxicants may also activate
the NLRP3 inﬂammasome. We examined the ability of two of these
toxicants to serve as a secondary trigger for inﬂammasome
activation in LPS primed (33 ng/mL; 3 h) RAW264.7 macrophages.
We selected toxicants known to induce a macrophage response
in vitro, trimethyltin; trimethyltin, and to cause selective damage to
the hippocampus and myelin sheath, respectively. A 6 h exposure to
TMT (10 lM) or TET (1.25 lM), resulted in an 80% viability/40%
MMP disruption. Following priming with lipopolysaccharide
(33 ng/mL; 3 h) TMT and TET induced inﬂammasome assembly
in 20% of the cells as indicated by ASC aggregation, active caspase
1, and pyroptosis. These changes occurred in the absence of a nitric
oxide production or evidence of ROS production. This was
accompanied by IL-1b release, predominantly pro-IL-1b. Inﬂam-
masome activation was conﬁrmed in primary bone marrow
macrophages with the release of mature IL-1b in TET dosed cells
at 6 and 16 h and in TMT dosed cells at 16 h. Overall the data
showed a stimulation of IL-1 and an association between MMP
disruption and inﬂammasome assembly with TET or TMT expo-
sure; however, the robustness of the inﬂammasome response
differed between the two compounds yet, with equivalent MMP
disruption. The question now is if this is preceeded by alterations in
mitochondrial function that can more closely distinguish between
the two levels of induction and predict inﬂammasome activation.
MTU03-11
Role of microglial metabolism in perinatal
neuroinﬂammation
P. Joshi1, M. Lombardi2, 3, I. Geric4, I. Prada2, M. Baes4,
C. Verderio2, 3, P. Gressens1
1Robert Debre Hospital, Inserm UMR 1141, Paris, France
2CNR Institute of Neuroscience, Department of Neuroscience,
Milan, Italy
3Universita degli Studi di Milan, Department of Pharmacological
and Biomolecular Sciences, Milan, Italy
4University of Leuven, Laboratory for Cell Metabolism, Leuven,
Belgium
Inﬂammation within brain plays a central role in perinatal brain
injury. Microglia (MG) cells, the immune cells of brain regulates
both neuroinﬂammatory and normal brain development. They
98 Journal of Neurochemistry © 2017 International Society for Neurochemistry, J. Neurochem. (2017) 142 (Suppl. 1), 78--164
© 2017 The Authors
MTU03 Neuroinflammation
acquire distinct phenotypes/activation states in response to maternal/
foetal inﬂammation or infection and disrupt normal developmental
process. To date metabolic features of MG in their different
activation states have not been investigated. Previous ﬁndings in our
lab points to early developing, robust pro-inﬂammatory activation of
MG. Transcriptomic analysis of these MG linked their injurious
activation state with disrupted fatty acid/phospholipid processing.
Furthermore untargeted lipidomic proﬁling of these ex-vivo MG
show distinct IL-1b proﬁle.
Objective: Here we investigated the role of MG metabolism in
inﬂammation and how altered lipid metabolism inﬂuences pheno-
type of MG.
Methods: MACS isolated CD11b +MG, IL-1b model of
perinatal brain injury, TRPS technology with qNANO, luminex
cytokine assay, radioactive tracer studies.
Results: (i) Pro-inﬂammatory state of MG show upregulation in
glycolysis and downregulation in mitochondrial b -oxidation, (ii)
Studies conducted in in-vitro and ex-vivo MACS isolated CD11b
+MG shows that altered lipid metabolism plays important role in
MG polarization and protects the neuron from toxicity induced by
pro-inﬂammatory MG (iii) Extracellular vesicles derived from pro-
inﬂammatory microglia alters dendritic spine density and morphol-
ogy, however alteration in MG lipid metabolism has a beneﬁcial
effect. (iv) Extracellular vesicles derived from pro-inﬂammatory and
anti–inﬂammatory MG effects OPC proliferation and differentiation.
Conclusion: Altered microglial lipid metabolism responsible for
detrimental phenotype acquired by MG following prolonged
inﬂammation. Acknowledgement:Supported by European Research
Projects on Neuroinﬂammation Era-net neuron- MicroMet.
MTU03-12
Mitochondrial impairment ampliﬁes NLRP3
inﬂammasome proinﬂammatory signaling in microglia in
cell culture & animal models of PD
A. Kanthasamy, S. Sarkar, D. Harischandra, N. Panicker, A. Charli,
S. Ghaisas, H. Jin, V. Anantharam, A. Kanthasamy
Iowa State University, Dept. Biomedical Sciences, Ames, USA
The NLRP3 inﬂammasome signaling pathway has recently been
recognized as a major contributor of neuro-inﬂammatory process in
the CNS. Oxidative stress and mitochondrial dysfunction are long
been recognized as key pathophysiological processes of many
chronic neurodegenerative diseases, including Parkinson’s disease
(PD). However, the inter-relationship between mitochondrial defects
and neuro-inﬂammation is not well understood. In the present study,
we show that impaired mitochondrial function can greatly augment
the NLRP3 inﬂammasome pro-inﬂammatory cascade in microglia.
Primary mouse microglia treated with the common inﬂammagen,
LPS induced NLRP3 and pro-IL1b expression. Interestingly, LPS-
primed microglial cells exposed to the mitochondrial complex I
inhibitory pesticides, rotenone and tebufenpyrad, speciﬁcally poten-
tiated the NLRP3 inﬂammasome activation, and ASC Speck
formation and pro-IL-1b processing to IL-1b in a time and dose-
dependent manner, indicating that mitochondrial impairment height-
ened the pro-inﬂammatory response in microglia. The neurotoxic
pesticide induced NLRP3 inﬂammasome activation was accompa-
nied by bioenergetic defects, mitochondrial ﬁssion and autophag-
some formation in microglia. Furthermore, neurotoxic pesticides
enhanced mitochondrial ROS generation in primary microglia while
amelioration of mitochondrial derived ROS by mito-targeted
antioxidant mitoapocynin completely abolished IL-1b level, indi-
cating mitochondrial ROS drives the potentiation of NLRP3
inﬂammasome in microglia. Additionally, co-culturing mitochon-
dria impaired microglia with human dopaminergic neuronal cells
(LUHMES) induced dopaminergic neurodegeneration. Notably, our
in vivo results with rotenone neurotoxicity model of PD further
supported the activation of NLRP3 inﬂammasome signaling due to
mitochondrial dysfunction. Collectively, our results demonstrate
that mitochondrial impairment in microglia can amplify NLRP3
inﬂammasome signaling to augment dopaminergic neurodegenera-
tive process.
MTU03-13
Withania somnifera ameliorates neuroinﬂammation
caused by high fat diet consumption in rat model of
obesity
T. Kaur, G. Kaur
Guru Nanak Dev University, Department of Biotechnology,
Amritsar, India
The current century has witnessed enormous growth in technol-
ogy which is, in part, responsible for sedentary lifestyle. Sub-
optimal work schedules have made people more accustomed to
consumption of junk or processed food items which has led to the
disruption of energy balance. Both factors are the major contributors
for obesity. Intake of high calorie diet has been linked to psychiatric
and metabolic disorders which are intrigued by neuroinﬂammation.
This study elucidates the potential beneﬁcial effects of dry leaf
powder of Withania somnifera (Ashwagandha) in amelioration of
neuroinﬂammation caused by diet induced obesity. Young albino
female Wistar rats were used for the study. The animals were
divided into four groups: Low fat diet (LFD) rats fed with regular
chow feed, High fat diet (HFD) rats maintained on feed with 30% fat
by weight, Low fat diet plus extract (LFDE) rats fed with regular
chow feed supplemented with dry leaf powder of W. somnifera
1 mg/g body weight (ASH) and High fat diet plus extract (HFDE)
rats fed with high fat diet supplemented with ASH. All groups were
maintained on respective feeding regimen for 12 weeks. ASH
treated rats show reduction in anxiety-like behavior as compared to
HFD group as evident from Elevated Plus Maze test. At molecular
level, treatment with ASH led to the reduction in inﬂammation as
seen by downregulation of JNK, phospho-MSK1, P38, Iba1, JAK2,
COX2, PPARc, IL-1b and IL-6 in both Western blotting and Real-
Time PCR in piriform cortex and hippocampus regions of the brain.
Further, ASH also inhibited apoptosis and promoted cell survival as
indicated by downregulation of AP-1, phospho c-Jun and upregu-
lation of Bcl-xL. ASH also improved leptin sensitivity as shown by
upregulation of leptin receptor OB-Rb expression. Thus, ASH may
be a potential candidate for mitigating neuroinﬂammation caused by
consumption of calorie-rich diets and may serve as an effective
dietary supplement for weight management and amelioration of
obesity related pathological co-morbid conditions.
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Analgesic effects of bee venom and bee venom derived
phospholipase A2 in a mouse model of oxaliplatin-
induced neuropathic pain
W. Kim, J. H. Lee, S. K. Kim
Kyung Hee University, Department of Physiology, College of
Korean Medicine, Seoul, Korea South
Oxaliplatin, a chemotherapeutic drug, induces severe peripheral
neuropathy. Bee venom (BV) is widely used in Korea to alleviate
pain, and we assessed the curative and preventive effects of BV and
BV derived phospholipase A2 (bvPLA2) on oxaliplatin (6 mg/kg,
i.p.)-induced neuropathic pain in mice. BV (1 mg/kg, s.c.) alone or
with morphine (2 mg/kg, i.p.) signiﬁcantly attenuated peiripheral
neuropathy. Furthermore, pretreatment of bvPLA2 (0.2 mg/kg, i.p.)
inhibited the development of allodynia, and suppressed the increase
of macrophages and IL-1b level in the DRG. Such effects were
shown to be mediated by regulatory T cells. Altogether, these results
suggest that BV and bvPLA2 may by effective in releiving
oxaliplatin-induced neuropathic pain. This work was supported by
National Research Foundation of Korea grant funded by the
Ministry of Education, Science and Technology
(2016R1D1A1A02937335).
MTU03-15
Encapsulated mesenchymal stem cells to modulate
inﬂammation and facilitate functional recovery in spinal
cord injury
S. Kumar1, 2, J. Babiarz2, S. Basak2, J. Kim2, J. Barminko1, A.
Gray1, P. Mendapara2, R. Schloss1, M. Yarmush1, M. Grumet1
1Rutgers, The State University of New Jersey, Biomedical
Engineering, Piscataway, USA
2Rutgers, The State University of New Jersey, W.M. Keck Center for
Collaborative Neuroscience (The Spinal Cord Injury Project),
Piscataway, USA
Encapsulation of mesenchymal stem cells (eMSC) in alginate
facilitates cell delivery, survival, and modulates inﬂammation
in vivo. However, the delivery of eMSC to spinal cord injury
(SCI) rats is constrained because large (~0.5 mm) diameter capsules
that are used widely are not suitable for intrathecal injection into the
rat spine whereas sufﬁcient quantities of small eMSC (~0.2 mm) for
larger studies was not feasible. Therefore, we have prepared medium
sized eMSC (~0.35 mm) that can be delivered into the lumbar rat
spine. The MSC incorporated/capsule and total yield of eMSC for
medium sized capsule was ~5-fold and ~20-fold greater than of the
small capsules, respectively. Assays with all eMSC capsules
suggested no major difference in their anti-inﬂammatory activity
in vitro. The in vivo activity of the medium sized eMSC was tested
after injecting them into the lumbar spine post-SCI day 1.
Histological analyses post-SCI week 1 showed that eMSC reduced
levels of activated macrophages (IB4 staining) and increased white
matter sparing in similar regions adjacent to the SCI site. Retrieval
of eMSC post-SCI week 1 showed ~50% survival of MSC,
suggesting that the surviving MSC may have prolonged effects. We
also found the facilitation in locomotor recovery and attenuation of
mechanical allodynia after 4 weeks of eMSC transplantation. The
data indicates that medium size eMSC reduced macrophage
inﬂammation in regions where white matter was preserved during
critical early phases and functional recovery in later phase after SCI.
These techniques enable preparation of eMSC in sufﬁcient quan-
tities to perform pre-clinical SCI studies with much larger numbers
of subjects that will provide functional analyses of several critical
parameters in rodent models for CNS inﬂammatory injury.
MTU03-16
Glial ﬁbrillary antigen protein (GFAP) expression in the
hippocampal formation of meﬂoqine induced-seizured
rats
D. Lekpa1, F. Hakeem1, I. Amadi2, O. Sonny1
1University of Port Harcourt, Choba Rievers State, Nigeria,
Anatomy, Port Harcourt, Nigeria
2University of Witwatersrand, School of Anatomical Science,
Johanesburg, South Africa
Luffa aegyptiaca mill normally known as sponge gourd, belong
to the family called cucurbitaceous. The aim of this study was to
investigate the antiepileptic and anxiolytic effects of aqueous leaf
extract of Luffa aegyptiaca Mill on the hippocampus of the brain of
Albino Wistar rats with Meﬂoquine induced seizure. Thirty albino
wistar rats (190–250 g) were grouped into 6 groups of 5 rats each.
Group 1 was control. Group 2 was induced with meﬂoquine only
(4.28 mg/kg). Group 3 were given average dose of luffa extract only
(800 mg/kg). Group four rats were induced with meﬂoquine
(4.28 mg/kg) and treated with diazepam (5 mg/kg). Group 5 rats
were induced with (4.28 kg/kg) with meﬂoquine and treated with
low dose luffa aergyptiaca mill (400 mg/kg). Group 6 were induced
with meﬂoquine (4.28 mg/kg) and treated with high dose luffa
aergyptiaca mill (1200 mg/kg). The rats were then perfused
transcardially and sacriﬁced. Brain sections were analyzed for
histological (H&E) and immunohistochemical staining for glial
ﬁbrillary acidic protein (GFAP), marker for astrocytes were carried
out. The histological results showed disruption of pyramidal cells
layer in CA3 subﬁeld of hippocampus and regional selectivity of
pyramidal cell loss in seizured rats indicating induction of seizure
with meﬂoquine. There was some restoration of pyramidal cells with
the treated groups but no disruptions in the control group. There was
less expression of GFAP positive cells in the control group and
treated groups and more expression in the seizure rats. The
expression of GFAP positive cells was an indication of different
levels of neuroinﬂammation. The reactive astrocytes being predom-
inant in the seizure group. The present study therefore provides
empirical data on GFAP expression in the hippocampus of seizure
animal model treated with aqueous extract of luffa leaves.
MTU03-17
Bakuchiol suppresses inﬂammatory responses via
downregulation of the p38 MAPK/ERK signaling pathway
in BV-2 microglia
H.-S. Lim1, Y. J. Kim1, B.-Y. Kim1, E. Sohn1, S.-J. Jeong1, 2
1Korea Institute of Oriental Medicine, Herbal Medicine Research
Division, Daejeon, Korea South
2University of Science & Technology, Korean Medicine Life
Science, Daejeon, Korea South
Purpose: The purpose of the present study was to evaluate the
effects of bakuchiol on the inﬂammation response along with a
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molecular mechanism of the inﬂammatory effects in lipopolysac-
charide (LPS)-stimulated BV-2 mouse microglia cell line.
Methods: The production of prostaglandin E2 (PGE2), tumor
necrosis factor-a (TNF-a), and interlukin-6 (IL-6) were measured by
enzyme linked immunesorbent assay. The mRNA expression of
inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2),
TNF-a, and IL-6 were measured using reverse transcription–
polymerase chain reaction analysis. Mitogen-activated protein
kinases (MAPK) phosphorylation were determined by western blot
analysis.
Results: Bakuchiol signiﬁcantly suppressed the production of
PGE2 and IL-6 in LPS-stimulated BV-2 cells without causing
cytotoxicity. In parallel, bakuchiol signiﬁcantly inhibited LPS-
stimulated expression of iNOS, COX-2, and IL-6 in BV-2 cells.
However, bakuchiol had no effect LPS-stimulated production and
mRNA expression of TNF-a. This also had no effect on LPS-
stimulated c-Jun NH2-terminal kinase phosphorylation, whereas
p38 and extracellular signal-regulated kinase (ERK) phosphoryla-
tion was inhibited by bakuchiol.
Conclusions: These results indicate that anti-neuroinﬂammatory
effects of bakuchiol in the activated microglia is mainly regulated by
the inhibition of p38 MAPK and ERK pathways. We suggest that
bakuchiol could be beneﬁcial for various neuroinﬂammatory
diseases.
MTU03-18
TREM2 regulation of microglial phagocytosis is age-,
activation- and target-dependent
A. Madany, M. Carson
University of California Riverside, BIomedical Science, Riverside,
USA
Microglia are the resident macrophages of the central nervous
system (CNS) and act as the primary phagocyte in the CNS during
normal development, tissue homeostasis and disease. In the CNS,
Triggering Receptor Expressed on Myeloid cells-2 (TREM2) is
expressed only by microglia. Lack of a functional TREM2 leads to
cognitive dementia by the third decade of life, while a single amino
acid mutation in TREM2 correlates with a 3-fold increased risk of
Alzheimer’s disease. We and others have previously demonstrated
that TREM2 deﬁciency decreases phagocytosis using microglia cell
lines and primary neonatal glial cultures. Because cultured microglia
display signiﬁcantly different phenotypes from microglia differen-
tiated in vivo, we sought to conﬁrm that TREM2 regulated
phagocytosis in microglia differentiated within the intact mouse
brain. While many reports of cultured microglia display low
percentages of phagocytosing cells, we found that nearly all
microglia assayed immediately after isolation from brain tissue
displayed phagocytic activity. In general, phagocytic activity
decreased with age. At all ages examined, wild-type activated
microglia show greater phagocytosis of both targets than those
isolated from untreated mice. By contrast, TREM2 deﬁciency
decreased phagocytosis only of in vivo activated microglia and only
at p15. However, the effect was target dependent. TREM2
deﬁciency decreased the percentage of microglia phagocytosing
Staph aureus but not the amount phagocytosed per cell. By contrast,
TREM2 deﬁciency did not alter the percentage of microglia
phagocytosing synaptosomes but did decrease the amount phago-
cytosed per cell. Using ﬂow cytometry, we quantiﬁed the surface
expression of receptors for Staph aureus (TLR2) and for cellular
targets (Tyro3, Axl and Mer). IPLPS regulated expression of these
molecules but TREM2 deﬁciency did not. In total, our data suggest
that TREM2 deﬁciency has little effect on homeostatic phagocytosis
but has large effects on injury or inﬂammation-associated phago-
cytosis. Thus, we speculate that TREM2 mutations may increase the
risk of Alzheimer’s disease due to the cumulative effect of altered
responses to lifelong environmental insults.
MTU03-20
Cypermethrin disrupts HB-EGF-EGFR signaling leading to
neuroinﬂammation and memory loss in young rats: role of
exogeneous HB-EGF
S. Maurya1, 2, J. Mishra2, S. Bandyopadhyay2, N. Chattopadhyay1
1CSIR-Central Drug Research Institute, Endocrinology, Lucknow,
India
2CSIR-Indian Institute of Toxicology Research, Developmental
Toxicology Division, Lucknow, India
Introduction: Cypermethrin is a type-II synthetic pyrethroid,
used as an insecticide in commercial agricultural and domestic
purposes. Cypermethrin is reported to affect the development of
central nervous system (CNS). However relatively less is known
about its mechanism of action on neuron survival. Here, we
hypothesized that cypermethrin promotes neuronal apoptosis in
young rat through inﬂammation where disrupted HB-EGF-EGFR
signaling plays a signiﬁcant role.
Method: We treated 24-day old rats with cypermethrin (10 mg/
Kg) for 3 weeks, and examined neuronal apoptosis and modulation
of different inﬂammatory proteins, and HB-EGF-EGFR signaling
molecules by western blotting and immuno-histochemistry in the rat
brain.
Results: Cypetrmethrin treatment increases neuronal apoptosis
in the young rats. We then investigated the mechanism responsible
for apoptosis and detected an elevated levels of inﬂammatory
proteins. Increase in interleukin-1 (IL-1), its receptor and an increase
in the NFjb promoted neuronal apoptosis. Exploring the mechanism
revealed an attenuated signaling of growth factor HB-EGF. We
observed a decrease in HB-EGF, EGFR and p-EGFR levels,
indicating a compromised cell-survival pathway. This signaling
pathway could be restored by exogenous supply of recombinant
HB-EF, highlighting the signiﬁcance of HB-EGF in cell survival.
We also observed that recombinant HB-EGF cause attenuation of
the Cypermethrin mediated inﬂammation and neuronal apoptosis.
Furthermore, cypermethrin induced learning-memory impairments
in the young rats, which could be prevented by recombinant HB-
EGF administration.
Conclusion: Together, these data demonstrate that cypermethrin
disrupts HB-EGF-EGFR signaling and increases inﬂammation-
dependent neuronal apoptosisc which culminates into cognitive loss.
The current study therefore underscores the therapeutic role
exogenous recombinant HB-EGF.
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Parasympathetic cholinergic and peptidergic
mechanisms of trigeminal pain
N. Mikhailov1, I. Shelukhina1, 2, K. Koroleva1, C. Vitale1, R.
Giniatullin1, 3
1AIV Institute of UEF, Neurobiology, Kuopio, Finland
2Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry,
Molecular Basis of Neurosignaling, Moscow, Russia
3ITMO University, Photonics, Saint-Petersburg, Russia
Parasympathetic neurochemical mechanisms of primary head-
aches such as cluster headache and migraine remain little under-
stood. In the current study, we explored the neurochemical
mechanisms of this nociceptive signaling, which likely originates
from interacting trigeminal and parasympathetic nerves densely
innervating meninges. For his aim, we used two rat models:
dissected hemiskulls with preserved innervation and isolated
trigeminal neurons. We found that the main parasympathetic
neurotransmitter acetylcholine (ACh), as well as its stable analogue
carbachol, largely increased the nociceptive activity of meningeal
trigeminal nerves. Spiking activity was also induced by nicotine
indicating the primary role of nicotinic receptors in excitation of
primary afferents. Similar pro-nociceptive effect was observed with
the peptidergic co-transmitter of parasympathetic nerves, the
neuropeptide PACAP. In contrast to neuronal mechanisms, carba-
chol, but not nicotine was able to degranulate meningeal mast cells,
which are likely implicated in headache by releasing multiple
cytokines and monoamines such as serotonin and histamine. In
isolated trigeminal ganglion cultures, nicotine activated a fraction of
nociceptive neuronal cells. Taken together, our data suggest that
cholinergic and peptidergic mechanisms similarly contribute to
induction of peripheral trigeminal pain underlying headache in
migraine and likely also in other types of primary headaches.
Acknowledgment: supported by CIMO (MN), Finnish Academy
(grant 277442) and RNF (grant 15-15-20012).
MTU03-22
Activated perk pathway in the brainstem was induced by
masseter inﬂammation
M. Nakatsuka1, 2, S. Kumabe1
1Osaka Dental University, Oral Anatomy, Hirakata, Japan
2Osaka Dental University, Oral Health Engineering, Hirakata,
Japan
Object: To evaluate the inﬂammatory hyperalgesia induced by
noxious stimulation of the masticatory muscle, we performed an
immunohistochemical study on the expressions of phosphorylated-
extracellular signal-regulated kinase (pERK) and distribution of
activated microglia in the brainstem trigeminal subnucleus caudalis
(Vc).
Methods: The left masseter muscle (LMM) of Sprague Dawley
rats (male, 250 g) was prepared in the followingmethods: (i) L group;
the LMM was injected with lipopolysaccharide (LPS, 2 lg/kg,
100 lL) on the 1st day of the experiment. On day 2, the same site was
injected with LPS (100 lL, 5 times per 90 min). (ii) S group; the
LMM was injected with LPS (2 lg/kg, 100 lL) on the 1st day of the
experiment. On day 2, the same site was injectedwith sodium chloride
solution (100 lL, 5 times per 90 min). (iii) HS group; the LMM was
injected with LPS (2 lg/kg, 100 lL) on the 1st day of the experiment.
On day 2, the same site was injectedwith 6% sodium chloride solution
(100 lL, 5 times per 90 min). The rats were allowed to survive for
14 days or 25 days after the last injection. The brainstems were
dissected and cut with a cryostat (at 30 lm thickness). These
specimens were investigated with anti-pERK or anti-GFAP (glial
ﬁbrillary acidic protein: a marker for astrocyte) using the enzyme-
labeled antibodymethod. The specimenswere observed, recorded and
analyzed using a light microscope mounted with an 3CCD digital
camera system connectedwith a FLvFs software (Flovel Image Filling
System, Tokyo, Japan).
Results: In the HS group, analysis of the IHC histology indicate
that pERK-immunoreactive (IR) and GFAP-IR cells were particu-
larly localized in the Vc until 14 days after stimulation. On the other
hand, 14 days after nociception, the cells are little found in the Vc in
the L and S groups.
Conclusion: The prolonged MAPK activity is related to the
central sensitization and chronic pain.
MTU03-23
Evaluation of dendrimer-4 phenylbutyrate in X-linked
adrenoleukodystrophy patient derived cells
C. Nemeth1, 2, B. Turk1, 2, O. Gok2, C. Tiffany1, C. Murray1, S.
Kambhampati2, R. Ramireddy2, A. Moser1, 2, P. Watkins1, 2,
R. Kannan1, 2, S. Kannan1, 2, A. Fatemi1, 2
1Kennedy Krieger Institute, Moser Center for Leukodystrophies,
Baltimore, USA
2Johns Hopkins University, School of Medicine, Baltimore, USA
X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative
disorder due to defects in the peroxisomal membrane transporter
protein, ABCD1, with variable phenotypes ranging from a rapidly
progressive, inﬂammatory cerebral demyelination (cerebral ALD) in
young boys and adult men to the chronic slowly progressive adult
onset adrenomyeloneuropathy affecting men and women. Hallmark
pathophysiology includes accumulation of very long chain fatty acids
(VLCFA), increased oxidative stress, and progressive axonopathy,
with little to no genotype-phenotype correlation. Allogeneic
hematopoietic cell transplantation is effective in early stages of
cerebral ALD only, and no other effective interventions exist.
Nanoparticle dendrimer-drug conjugates enable targeted and intra-
cellular slow release of drugs requiring fewer treatments at lower drug
concentrations. 4-Phenylbutyrate (4PBA) has been shown to increase
expression of ABCD2 and proliferation of peroxisomes in models of
X-ALD; however, the short half-life precludes its utility in the clinic.
We have demonstrated uptake of dendrimer-drug conjugates in spinal
cord neurons of the ABCD1 knockout mouse and within patient-
derived primary macrophages and ﬁbroblasts. Here, we demonstrate
efﬁcacy in ALD andAMNpatient derived cells treated with PAMAM
dendrimer conjugated to 4PBA (D-4PBA) as treatment signiﬁcantly
altered biochemical and inﬂammatory abnormalities. Reduced
VLCFA (C26:0 and C26/C22) was detected in ALD and AMN
patient derived ﬁbroblasts after a 16-day exposure to 30 lM (AMN
p = 0.017) or 100 lM D-4PBA (ALD p = 0.026; AMN
p = 0.0006). In ALD patient monocyte-derived macrophages, a 6 h
stimulation of 30 lM VLCFA leads to signiﬁcant release of TNF
(p = 0.009, compared to unstimulated cells) and pretreatment with D-
4PBA prevents these increases (30 lM D-4PBA, p = 0.0018;
100 lM D-4PBA, p = 0.002; 300 lM D-4PBA, p = 0.002).
Together, these data support feasibility and efﬁcacy of low dose and
versatile nanoparticle therapy to reduce ALD-related disease burden
in patient derived cells and sets the stage for new therapeutic
opportunities for complex diseases such as X-ALD.
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Behavioral changes, oxidative stress, brain metal and
neuro-inﬂammatory proﬁles after chronic vanadium
administration
J. Olopade1, O. Folarin1, 3, F. Olopade2, D. Peter4, O. Adaramoye1,
O. Akanni1, S. Onwuka1, J. Connor4
1University of Ibadan, Veterinary Anatomy/Neuroscience, Ibadan,
Nigeria
2University of Ibadan, Anatomy, Ibadan, Nigeria
3Ladoke Akintola University, Anatomy, Ogbomosho, Nigeria
4Pennsylvania State University, Neurosurgery, Hershey, USA
5University of Ibadan, Biochemistry, Ibadan, Nigeria
Vanadium is a potentially toxic environmental pollutant. Most
studies on vanadium neurotoxicity have been after acute exposure
but in reality some populations are exposed for a lifetime. BALB/c
mice were divided into vanadium treated, matched controls, and
animals exposed to vanadium for 3 months and thereafter vanadium
withdrawn. Animals were tested using Morris water maze at 3, 6, 9,
and 12 months of age. Mice were also subjected to biochemical,
metal proﬁling and immunohistochemistry. The results showed that
mice had signiﬁcant loss in memory abilities from 3 to 12 months of
vanadium exposure. Animals recovered signiﬁcantly only 9 months
after vanadium withdrawal. Vanadium exposure caused increases in
levels of oxidative stress markers with a decrease in the activities of
intrinsic oxidative defense markers from 6 months of vanadium
exposure in the brain. Withdrawal after 3 months of vanadium
exposure reversed oxidative stress from 9 to 15 months. Metal
proﬁling showed progressive increase in vanadium uptake with
regional variabilities in latter age. The withdrawal brains still show
presence of vanadium metal in the brain though less than controls.
There were disruption of laying pattern, and cell loss in the pre
frontal cortex, Hippocampal CA1 pyramidal cells, and Purkinje cells
of the cerebellum in vanadium exposed brain. With exposure into
latter age, the evident neuropathology was microgliosis rather than
progressive astrogliosis. In conclusion, administration of vanadium
over a life time in mice resulted in behavioral deﬁcits, derangements
in brain antioxidant defense system and brain cell architecture,
neuroinﬂammation and brain metal accumulation. While memory
scores was recovered over time, the metal load and pathological
effects were not completely eliminated from the brain even after a
long time withdrawal from vanadium metal.
MTU03-25
Pharmacological intervention to study the effect of
antinociceptive curcumin analogue in a rat model of
migraine
A. Sawale, G. Matharasala, Y. Perumal, S. Dharmarajan
BITS Pilani Hyderabad, Pharmacy, Hyderabad, India
Objective: Migraine is a multifactorial primary headache disor-
der is also a disabling neurological symptoms. It is characterized by
unilateral pulsatile intense headache. The pathophysiology known
behind migraine is activation of the trigeminovascular system with
the release of neuropeptides, results into dilation of intracranial and
extracranial blood vessel. Neurogenic inﬂammation occurs mainly at
the vascular levels, where in it comprises CGRP-mediated arteriole
vasodilatation. In the present work we portrayed MG24, a novel
semicarbazone as CGRP protein inhibitor. The main objective of the
proposed work is to carry out in vivo evaluation of the newly
synthesized compound to screen their antimigraine activity, it’s
effect on CGRP and endogenous inﬂammatory mediators levels of
tumour necrosis factor –a (TNF-a), Interleukin-1beta (IL-1b) in
animal model of migraine.
Methods: Since the CGRP receptor antagonists have recently
been shown to be effective in migraine therapy, the pharmacology of
the control mechanisms for dural CGRP release are of direct
relevance to the development of newer migraine therapies. Migraine
was induced by injecting Complete Freund’s Adjuvant (CFA), a
chemical stimulant through intracisternal route (IC) into cisterna
magna of rats and effect of compound on expression levels of CGRP
neuropeptide, a biomarker of trigeminal nerve activation was
evaluated. To examine, blood samples were collected from retro-
orbital sinus at 1, 4 and 24 h time interval. The gene expression
levels of CGRP mRNA was investigated by real time quantitative
reverse transcription polymerase chain reaction (RT-qPCR).
Results: CFA administration caused a signiﬁcant increase in
CGRP levels after 1 h when compared with baseline. The
intraperitoneal treatment MG24 1 h post CFA administration lead
to reduction in levels of CGRP and other endogeneous inﬂammatory
mediators gene expression signiﬁcantly.
Conclusion: The inhibition of CGRP, TNF-a and IL-1b mRNA
levels by this compound offers possible mechanism in part that can
account for the preventative antimigraine activity.
MTU03-26
HY2093 ameliorates brain inﬂammation and improves
memory impairments in Alzheimer’s disease mouse
model
S.-Y. Seong1, 2, 3, J.-A. Cho2, 3, T.-J. Kim1, 3, 4, H.-E. Jung1, 4,
Y.-H. Kim1, 4, S.-Y. Moon2, Y.-J. Kim2, H. Park2, D.-Y. Choi2, J.-H.
Park2, S.-J. Yoon2, E.-Y. Lee2
1Seoul National University College of Medicine, 3Department of
Microbiology and Immunology, Seoul, Korea South
2Seoul National University College of Medicine, Wide River
Institude of Immunology, Hong-chun, Korea South
3BK21plus, biomedical project, Seoul, Korea South
4Seoul National University College of Medicine, Department of
Biomedical Sciences, Seoul, Korea South
Alzheimer’s disease (AD) is the most common cause of
dementia. Progressive deposition of amyloid beta (Aß) in the brain
is the major pathognomonic feature. Moreover, neuroinﬂammation
and neuronal apoptosis incur defects in cognition and memory. We
have previously suggested that endogenous surfactant molecules
might have co-evolved to regulate immune responses through the
activation of various anti-inﬂammatory pathways. In this study, we
showed that HY2093 could improve memory deﬁcits in AD mice
model (5XFAD). The mice were given 1 mg/kg HY2093 i.p. twice
a week for 2.5 months. As a control group, the AD mice were given
PBS. HY2093 signiﬁcantly reduced the time to ﬁnd platform,
increased platform crosses and quadrant occupancy in water maze
test, suggesting improvement in learning and memory of 5XFAD
mice after treatment with HY2093 compared with control group.
Furthermore HY2093 treatment signiﬁcantly decreased the amyloid
plaque formation, the number of astrocyte, microglia, and inﬂam-
mation factors in the frontal cortex. In the frontal cortex, iNOS
expression of astrocyte was drastically decreased by HY2093
treatment. TUNEL (+) apoptotic cells in the frontal cortex were
signiﬁcantly lower in HY2093 group of mice. The number of
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astrocyte was decreased by HY2093 treatment in hippocampus also.
Interestingly, CD11b+Gr1-F4/80 + myeloid cells were signiﬁ-
cantly increased in the spleen and in brain of 5XFAD mice that were
treated with HY2093. Blood CCL3 was signiﬁcantly lower in
HY2093 group of mice. These ﬁndings suggest that HY2093 might
be a new molecular entity that can control pathogenesis of
Alzheimer disease.
MTU03-27
Lambda-cyhalothrin synergies the stress induced
neuroinﬂammatory cytokines in rat brain through
mitochondrial biogenesis
R. Shukla, R. Gupta, A. B. Pant, V. K. Khanna
CSIR - Indian Institute of Toxicology Research, Developmental
Toxicology Laboratory, Lucknow, India
Recently, we have found that pre-exposure to immobilization
stress (IMS), a psychological stressors and forced swim stress (FSS),
a physical stressors exacerbated lambda-cyhalothrin (LCT) induced
brain cholinergic dysfunctions in rats. In continuation to this, studies
have been carried out to understand the impact of IMS and FSS on
LCT induced neuroinﬂammation associated with mitochondrial
impairments. No signiﬁcant change in the levels of brain proin-
ﬂammatory (TNF-a, IL1b, IL6) and anti-inﬂammatory (IL10)
cytokines was observed in frontal cortex and hippocampus in rats
subjected to IMS (one session, placed in plastic restrainer, 15 min/
day) or FSS (one session, 3 min/day) for 28 days or exposed to
LCT (3.0 mg/kg body weight, p.o.) for 3 days (on days 26, 27 and
28) alone in comparison to controls. Marginal changes in mito-
chondrial activity, ROS generation and membrane potential both in
frontal cortex and hippocampus were evident in rats subjected to
IMS or FSS or those exposed to LCT alone as compared to controls.
Pre-exposure to IMS or FSS for 28 days followed by LCT treatment
for 3 days in rats resulted to alter the levels of brain proinﬂamma-
tory and anti-inﬂammatory cytokines through affect the mitochon-
drial bioenergetics as compared to rats exposed to IMS or FSS or
LCT alone. Further, pre-exposure to IMS or FSS caused a marked
enhanced ROS generation and decrease in mitochondrial membrane
potential in frontal cortex and hippocampus on LCT treatment as
compared to rats exposed to IMS or FSS or LCT alone. These
changes affect the learning and memory activities on pre exposure to
IMS or FSS for 28 days followed by LCT treatment rats. The results
clearly exhibit that both psychological and physical stressors con-
tribute in the LCT inducedmitochondrial impairments associatedwith
neuroinﬂammatory pathway. However, alterations in behavioural and
neurochemical end points were more intense in LCT treated rats pre-
exposed to IMS as compared to those pre-exposed to FSS.
MTU03-28
HSP60 plays a regulatory role in il-1b-induced microglial
inﬂammation via TLR4-p38 MAPK axis
S. Swaroop
National Brain Research Centre, Cellular and Molecular
Neuroscience, Gurgaon, India
Neuroinﬂammation being the innate immune machinery of the
Central Nervous System (CNS) helps to combat any neuronal insult
and neurodegeneration. But as they say “excess of everything is
bad”, an exaggerated neuroinfalmmatory response may be detri-
mental for the neuronal health itself and an excessive inﬂammatory
response associated with various neurodegenerative diseases sug-
gests the same. The role of microglia, the resident immune cells of
CNS, in neuroinﬂammation is evident from a number of studies. It
gets activated in response to harmful stimuli and secretes various
pro- and anti-inﬂammatory cyto-chemokines, among which IL-1b is
known as “the master regulator of inﬂammation”, as it can induce a
vicious cycle of inﬂammation. The role of IL-1b in various
neurodegenerative diseases has been extensively studied over the
years but the overall molecular mechanism underlying its action are
yet not well understood. Our study, therefore, focuses on a holistic
approach to reveal key molecules involved in IL-1b induced
inﬂammation in microglia. To achieve our aim, we have performed
proteomic proﬁling of the microglial cells in response to IL-1b and
identiﬁed 18 types of proteins to be differentially expressed under its
inﬂuence, many of them belonging to the cellular stress pathways.
Out of these proteins, we set out to analyze the role of HSP60, a
mitochondrial chaperone, which is reported to be involved in
neuron-glia crosstalk during neurodegeneration and appeared to be a
key hub molecule by in silico analysis of the identiﬁed proteins.
The results show that, IL-1b induces the expression as well as
secretion of HSP60 in extracellular milieu, whiche then binds with
TLR4 of microglia to exert its effects. We further established that
HSP60 increases the phosphorylation of ERK, JNK, and p38
MAPKs in microglia during inﬂammation but speciﬁc inhibition of
p38 only resulted in decreased inﬂammation by HSP60. We thus
propose that, HSP60 plays a regulatory role in IL-1b induced
inﬂammation in microglia by activating TLR4-p38 MAPK axis,
which can be speciﬁcally targeted to develop novel approaches for
therapeutic applications.
MTU03-29
Nogo receptor complex (lingo-1, p75, troy) expression
pattern in inﬂammatory foci of experimental autoimmune
demyelination
P. Theotokis, O. Touloumi, R. Lagoudaki, E. Nousiopoulou,
E. Kesidou, N. Grigoriadis
Aristotle University of Thessaloniki, B’ Department of Neurology,
AHEPA University Hospital, Thessaloniki, Greece
Nogo-A and its receptor complex (NgR complex) have already
been implicated to inhibitory, axonal guiding and other central
nervous system (CNS) modulatory aspects of the injured and
demyelinating tissue. The purpose of this study was to describe the
spatiotemporal expression of NgR complex molecules LINGO-1, p75
and TROYwithin the inﬂammatory sites of the experimental model of
Multiple Sclerosis (MS) in mice. Thirty C57BL/6 mice were
subcutaneously injected with the myelin oligodendrocyte glycopro-
tein (MOG) 35–55 peptide and developed chronic experimental
autoimmune encephalomyelitis (EAE). The study included acute
(days 18–22) and chronic (day 50) time points that were compared to
controls respectively. All animals were examined daily using a 6-
grade scale. Localization and neuropathological study of NgR
complex was performed with double immunoﬂuorescence (dIF) on
6 lm coronal parafﬁn sections while molecular analysis was
performed with real-time PCR in spinal cord extracts. MOG-
inoculated animals developed a typical chronic-MOG EAE pattern
with mean maximal score (MMS) = 3.76  0.28. The levels of the
NgR complexwere found to ﬂuctuate, depending on the stage studied;
LINGO-1 was increased in perivascular inﬂammatory foci
(467.8  48.18 cells/mm2) of acute phase while an additional
increase was detected in axonal structures (Integrated density,
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249.156  26.177) of chronic phase. Expression of p75 was
increased only in residual inﬂammatory foci of chronic phase (IntDen,
121.521  15.709) while TROY was restricted within inﬂammatory
cells at the lesion sites of acute phase (106.7  9.57 cells/mm2). Such
dynamic expression of the Nogo receptor complex, it may support an
alternative role that could include the conﬁnement of the inﬂammatory
reaction or the rampant sprouting of axons in chronic EAE lesions.
MTU03-30
The neuroprotective properties of vitamin D, in a
Parkinson’s disease model, are related to its anti-
inﬂammatory actions
G. Viana1, 2, L. Lima1, J. Lopes2, K. R. Neves1, I. Calou3
1Federal University of Ceara, Physiology and Pharmacology,
Fortaleza, Brazil
2Faculty of Medicine Estacio of Juazeiro do Norte, Biophysiology,
Juazeiro do Norte, Brazil
3Federal University of Piauı, Pharmacology, Picos, Btazil
The decrease in serum levels of Vitamin D seems to be related to
inﬂammatory diseases and this drug may exhibit neuroprotective
actions. Parkinson’s disease (PD) is characterized by loss of
dopaminergic neurons in the substantia nigra and neuroinﬂammation
is a hallmark of PD pathophysiology. The objectives were to evaluate
the neuroprotective properties of vitamin D on parkinsonian rats.
Male Wistar rats were untreated or treated (1 lg/kg) with vitamin D,
previously or after the unilateral striatal injection of 6-OHDA. The
sham-operated group was used as control. After treatments, the
animals were subjected to behavioral tests and euthanized for striatal
DA and DOPAC measurements and TH and DAT immunohisto-
chemical assays. The data were analyzed by ANOVA and Tukey as the
post hoc test. The results showed 223 apomorphine-induced rotations/
h, in the untreated group, and only 13 and 77 rotations/h, respectively,
after pre- and post-lesion treatments with vitamin D. No behavioral
changes were noticed in the SO group. In the forced swimming test,
while the untreated group showed a depressive-like behavior
(increasing by 2-fold the immobility time), signiﬁcant decreases were
seen after vitamin D pre- and post-lesion treatments, relatively to the
SO group. The immunohistochemical data for TH and DAT
demonstrated decreases higher than 90% in immunostainings in the
untreated 6-OHDA group, as related to the SO group. Interestingly,
while a great recovery was observed in TH immunostainings after
both vitamin D pre- and post-lesion treatments, this was not seen for
DAT immunoreactivity, where only the pre-lesion treatment showed a
good recovery. In conclusion, we demonstrated that vitamin D
presents neuroprotective effects in this PDmodel in rats and, at least in
part, these effects are related to the antioxidant and anti-inﬂammatory
actions of this drug, as already demonstrated by us.
MTU03-31
Arachidonic acid induces are/NRF2-dependent heme
oxygenase-1 transcription in rat brain astrocytes
C.-M. Yang
Chang Gung University, Physiology/Pharmacology, Kwei-San,
Taiwan
Arachidonic acid (AA) is a major product of phospholipid
hydrolyzed by phospholipase A2 during neurodegenerative diseases.
AA exerts as a second messenger to regulate various signaling
components which may be involved in different pathophysiological
processes. Astrocytes are the main type of CNS resident cells which
maintain and support the physiological function of brain. AA has been
shown to induce ROS generation through activation of NADPH
oxidases (NOX) which may play a key role in the expression of heme
oxygenase-1 (HO-1). Therefore, this study was designed to investi-
gate the mechanisms underlying AA induced HO-1 expression in rat
brain astrocytes (RBA-1). We found that AA induced HO-1 protein
and mRNA expression and promoter activity in RBA-1, which was
mediated through the synthesis of 15d-PGJ2 activated PPARc
receptors. This note was conﬁrmed by transfection with PPARc
siRNA which attenuated the AA-mediated responses. AA-induced
HO-1 expressionwasmediated throughNOX/ROS generation, which
was inhibited by NOX inhibitors (DPI and apocynin) and ROS
scavengers (NAC). Moreover, AA-induced HO-1 expression was
mediated through phosphorylation of Src, Pyk2, PDGFR, PI3K/Akt,
and ERK1/2 which were inhibited by the pharmacological inhibitors
including PP1, PF431396, rotterlin, AG1296, LY294002 and U0126
or by transfection with respective siRNAs. AA-enhanced Nrf2
expression and HO-1 promoter activity was inhibited by transfection
with Nrf2 siRNA or by these pharmacological inhibitors. Further-
more, ChIP assay conﬁrmed that Nrf2 and PPARc were associated
with the proximal ARE binding site on HO-1 promoter, suggesting
that Nrf2/PPARc are key transcription factors modulating HO-1
expression. AA-induced ARE promoter activity was also reduced by
these pharmacological inhibitors. These ﬁndings suggested that AA
increases formation of Nrf2 and PPARc complex and binding with
ARE1 binding site through Src, Pyk2, PI3K/Akt and ERK1/2, which
further induced HO-1 expression in RBA-1 cells.
MTU03-32
Amyloid precursor protein modulates microglia and
macrophage phenotype
C. Combs
University of North Dakota School of Medicine and Health
Sciences, Department of Biomedical Sciences, Grand Forks, USA
Mutations in the gene coding for amyloid precursor protein (APP)
are responsible for autosomal dominant forms of Alzheimer’s disease
and proteolytic processing of the protein leads to a number of
metabolites including the amyloid beta (Ab) peptide. In addition to the
well characterized contribution of APP andAb to plaque deposition in
AD brains, prior work suggests that APP can function as a
proinﬂammatory receptor on immune cells, such as macrophages
and microglia. We hypothesized that APP may modulate the
phenotype of these cells in diverse conditions including both obesity
and Alzheimer’s disease. By comparing C57BL/6 wild type and APP
knockoutmicewe observed that amyloid precursor protein is involved
in regulating the phenotype of both adipocytes and peripheral
macrophages and is required for high fat diet-dependent weight gain
in mice. Moreover, we determined that oligomeric but not ﬁbrillar Ab
peptide binds directly toAPP and is involved in stimulatingmicroglial
activation both in vitro and in vivo. These data suggest thatAPP and/or
its metabolites modulate the phenotypes of peripheral immune system
macrophages as well as brain resident microglia. This biology may be
relevant to not only to the pathophysiology of Alzheimer’s disease but
also diet-associated obesity.
© 2017 The Authors
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Analysis of the functional effects mediated by dopamine
oxidation products at the mitochondrial level
A. Biosa, I. Arduini, M. E. Soriano, L. Bubacco, M. Bisaglia
University of Padova, Department of Biology, Padova, Italy
The neurotransmitter dopamine (DA) plays a critical role in many
mental and physical functions, such as learning, motivation,
movement control. Nevertheless, when DA is not properly stored,
its oxidation could be source of neurodegeneration. In fact, DA
oxidation causes the generation of reactive oxygen species (ROS)
and dopamine quinones (DAQs). Since the molecular effects of
DAQs are still not elucidated and it has been shown the existence of
an interplay between oxidative stress and mitochondrial dysfunc-
tion, we investigated the effects of DAQs inside mitochondria.
Methods: Experiments were performed in rat brain mitochon-
dria and in SH-SY5Y neuroblastoma cells, both exposed to DAQs.
First, mitochondria were incubated with 14C-DAQs to verify the
entrance of these compounds inside the organelles and then, ATP
synthesis and mitochondria morphology assays were performed.
Finally, cell viability, calcium retention capacity (CRC), mitochon-
drial swelling and mitochondria membrane potential (MMP) were
assessed to shed some light on the mechanisms of mitochondria-
related DAQs toxicity.
Results: Our data shows that DAQs enter into isolated mito-
chondria, reduce ATP production, induce mitochondrial swelling
and decrease CRC. In addition, we demonstrated that all above-
mentioned mitochondrial dysfunctional effects are caused by the
opening of the mitochondrial permeability transition pore (mPTP)
in vitro. In cells, DAQs induce mitochondrial morphology changes
and a decrease in MMP and the latter depends on a variation in
mPTP.
Conclusion: Our results suggest that DAQs could induce cell
death through the opening of the mPTP; therefore, inhibitors of
mPTP might be a potential strategy to hamper dopaminergic
neurodegeneration.
MTU04-02
The brain-speciﬁc angiogenesis inhibitor 1 has
neuroprotective effect against mpp+-mediated neuronal
cell death
J.-S. Choi1, W.-Y. Bae1, J.-W. Jeong1, 2
1Kyung Hee University, 1Department of Biomedical Science,
Graduate School, Seoul, Korea South
2Kyung Hee University, Department of Anatomy and Neurobiology,
College of Medicine, Seoul, Korea South
Brain-speciﬁc angiogenesis inhibitor 1 (BAI 1) is a member of
the cell-adhesion G protein-coupled receptor family that has been
studied primarily for its anti-angiogenesis and anti-tumorigenesis.
However, function of BAI 1 in Parkinson’s disease is still unknown.
Parkinson’s disease is primarily resulted from the death of
dopaminergic neurons. The purpose of this study was to explore
the effect of BAI 1 in a model of Parkinson’s disease. In order to
identify the patterns of BAI 1 expression in certain cell types, we
stained the substantia nigra and striatum tissues of MPTP-injected
mouse briain. BAI 1 protein speciﬁcally expressed in neuronal cells
including dopaminergic neurons but not in microglia and astrocytes.
In addition, the level of BAI 1 expression was reduced by 1-methyl-
4-phenylpyridinium (MPP+) in neuronal cells. Because the activa-
tion of AMPK can reduce MPP+-mediated neuronal cell death, we
examined the correlation between AMPK activity and BAI 1
expression. We found that AICAR, a speciﬁc activator of AMPK,
increased the expression of BAI 1 protein level and overexpression
of BAI 1 protected neuronal cells against MPP+-induced neurotox-
icity. Collectively, our experiments suggested that BAI 1 may act as
neuronal cell survival factor in Parkinson’s disease.
MTU04-03
Parkinson’s disease-linked LRRK2 covers a relevant role
in astroglial physiology
L. Civiero1, A. Chiavegato2, A. Lia2, V. Nathalie3, M. Sessolo2, S.
Cogo1, T. Varanita1, L. Bubacco1, M.-E. Tremblay3, G. Carmignoto2,
E. Greggio1
1University of Padova, Department of Biology, Padova, Italy
2University of Padova, Department of Biomedical Sciences, Padova,
Italy
3University of Laval, Department of Molecular Medicine, Quebec
City, Quebec
Mutations in LRRK2 are associated with familiar Parkinson’s
disease (PD). PD is a neurodegenerative disorder characterized by
(i) neuronal death, (ii) the presence of proteinaceous accumulations
in the surviving neurons and astrocytes and (iii) neuroinﬂammation.
Accumulating evidence implicate LRRK2 in regulation of secretory
vesicle trafﬁcking and in lysosomal pathways. Since LRRK2 is
ubiquitously expressed in the CNS cells, one possibility could be
that mutated LRRK2 in astro- and microglia impacts neuronal
functions, thus triggering neurodegeneration. Here, we show for the
ﬁrst time that Lrrk2 is expressed in mouse astrocytes in vivo. By
combining confocal and electron microscopy techniques, we
observe impairment in protein turnover (e.g. glutamate transporter,
GLT-1) as well as abnormal lysosome accumulation in Lrrk2/
striatal astrocytes. Interestingly, by co-culturing wild type primary
cortical neurons with Lrrk2+/+ or Lrrk2/ mouse primary astro-
cytes, we demonstrate that LRRK2 depletion in astrocytes signif-
icantly abates the ability of these cells to support neuronal
development in vitro. Impairment in the lysosomal pathway may
impact calcium homeostasis, a key aspect of astrocyte functionality.
To assess whether LRRK2 plays a role in the regulation of calcium
handling in astrocytes, we injected AAVVs overexpressing genet-
ically encoded calcium indicators under the GFAP promoter in
Lrrk2+/+ or Lrrk2/ mouse brain cortex and performed calcium
imaging in brain slices. Our results revealed that astrocyte calcium
response is signiﬁcantly altered in Lrrk2/ mice. Speciﬁcally, ATP
evoked calcium signals in Lrrk2/ display a shorter latent phase,
reduced oscillations and enhanced extension compared to controls.
Concluding, our ﬁndings reveal a novel role of LRRK2 in the
regulation of glial functions in vivo and in vitro, supporting future
research aimed at understanding the mechanisms behind mutant
LRRK2-linked astrocyte dysfunction in PD neurodegeneration.
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CSF catecholamine and kynurenine metabolites in
Parkinson’s disease and L-DOPA-induced dyskinesia
A. D. Andersen1, 2, 3, J. Havelund6, M. Binzer2, 4, M.
Blaabjerg8, 9, 10, A. Kamal9, H. Thagesen9, T. W. Kjaer9, N. J. K.
Færgeman6, N. H. H. Heegaard11, 12, E. Stenager2, 4, 7, J. B.
Gramsbergen5
1Dept. of Neurology, Hospital of Southern Jutland, Sønderborg,
Denmark
2Institute of Regional Health Research, University of Southern
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Southern Denmark, Odense, Denmark
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8Dept. of Neurology, Odense University Hospital, Odense, Denmark
9Dept. of Neurology, Zealand University Hospital, Roskilde,
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Objective: Identifying potential changes in catecholamine and
kynurenine (KYN) metabolism related to levodopa (L-DOPA)-
induced dyskinesia (LID) in Parkinson’s disease (PD).
Method: Cerebrospinal ﬂuid (CSF) and plasma from 26 PD
patients and 16 controls were analyzed using HPLC for monoamine
analysis and HPLC with mass spectrometry (LC-MS) for KYN
metabolite analysis. Clinical rating of disease severity and dyski-
nesia was performed for each PD patient. Patients were divided into
groups: non-L-DOPA-treated (PD-N), L-DOPA-treated non-dyski-
netic (PD-L), and L-DOPA-treated dyskinetic (PD-LID).
Results: CSF of PD-LID had higher dopamine (DA) levels
compared to age-matched controls, a higher DA/L-DOPA ratio, as
well as a lower DOPAC/DA ratio compared to PD-L. In plasma
changes in kynurenine metabolism differentiated PD-LID patients
from PD-N, PD-L and controls. PD-LID had an increased 3-
hydroxykynurenine (3-HK)/kynurenic acid (KYNA) ratio and
increased 3-HK/KYN ratio compared to PD-N and controls as well
as signiﬁcantly lower KYNA levels compared to PD-L.
Conclusion: Monitoring changes in dopamine and kynurenine
metabolism could potentially be used to identify PD patients at risk
of developing LID.
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RAB7 effector FYCO1 induces clearance of A53T-alpha-
synuclein aggregates
E. Dinter1, T. Saridaki1, M. Nippold1, A. Roos2, L. Diederichs1, L.
Fensky1, B. Falkenburger1, 3
1RWTH University Aachen, Department of Neurology, Aachen,
Germany
2RWTH University Aachen, Institute of Neuropathology, Aachen,
Germany
3FZ J€ulich and RWTH Aachen, JARA BRAIN Institute II, Aachen,
Germany
Introduction: Parkinson’s disease (PD) is characterized by
cytoplasmic aggregates of alpha-synuclein. We have previously
shown that overexpression of the small GTPase Rab7 induces
clearance of alpha-synuclein aggregates in cell and ﬂy models of
PD. Rab7 is known to regulate transport of autophagosomes and
their fusion with lysosomes to degrade cellular content including
protein aggregates. In order to understand the molecular events that
mediate the beneﬁcial effects of Rab7 on alpha-synuclein aggre-
gates, we tested one speciﬁc effector, that mediates the transport of
Rab7-positive vesicles towards the periphery, FYVE and Coiled-
Coil Domain Containing 1 (FYCO1).
Methods: We expressed the A53Tmutant of alpha-synuclein in
HEK293 cells and determined the effects of coexpressing Rab7 and
FYCO1 on the occurrence of alpha-synuclein aggregates, on alpha-
synuclein amounts and on toxicity using ﬂuorescence microscopy,
time-lapse imaging and immunoblots. Additionally, we carried out
electron microscopy and tested the effect of FYCO1 in a ﬂy model
of PD.
Results: We ﬁnd that FYCO1 is enriched around alpha-
synuclein-containing vesicles. Moreover FYCO1 reduces alpha-
synuclein amount and toxicity in a Rab7-dependent manner.
FYCO1 induces the clearance of alpha-synuclein as observed by
time-lapse-imaging. FYCO1 decreased the ratio of green/red
ﬂuorescence with alpha-synuclein tagged by mRFP-GFP, indicating
that more alpha-synuclein is located in acidic compartments,
presumably autolysosomes. Using electron microscopy we observed
alterations in Golgi and rough endoplasmic reticulum when FYCO1
was coexpressed with A53T-alpha-synuclein. Moreover, we found
evidence of exocytosis of electron-dense material, indicating that
FYCO1 could induce secretion of alpha-synuclein. In the ﬂy model
of PD, neuronal expression of FYCO1 rescued the locomotor deﬁcit
induced by A53T-alpha-synuclein.
Conclusion: We conclude, that the Rab7 effector FYCO1 shows
similar effects as Rab7 in inducing aggregate clearance. Our electron
microscopic observations indicate that FYCO1 may induce exocy-
tosis of aggregated alpha-synuclein, consistent with the recent
description of FYCO1-mediated exocytosis of endosomes.
MTU04-06
The small heat shock proteins interact with aggregating ɑ-
synuclein preventing cytotoxicity
H. Ecroyd, D. Cox
University of Wollongong, Illawarra Health and Medical Research
Institute, Wollongong, Australia
Parkinson’s disease (PD) is the second most prevalent age-related
neurodegenerative disorder. The pathogenesis of PD, and other
neurodegenerative diseases, has been inextricably linked with the
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amyloid ﬁbrillar aggregation and deposition of a-synuclein. The cell
has a range of defense mechanisms in place to prevent aggregation
and maintain protein homeostasis (proteostasis). An important
element of this proteostasis network are the molecular chaperone
proteins. However, the persistence of diseases associated with a-
synuclein aggregation indicates that their protective capacity can be
‘overwhelmed’ in the context of these diseases. Our work seeks to
investigate the role of the small heat shock molecular chaperone
proteins (sHsps) in protecting against ɑ-synuclein aggregation.
Speciﬁcally, we have examined interactions between ɑ-synuclein
and sHsps at various stages along ɑ-synuclein’s aggregation
pathway using a range of bulk and single molecule techniques.
Our results demonstrate that sHsps interact transiently with aggre-
gation-prone monomeric ɑ-synuclein to prevent its aggregation
in vitro. However, the efﬁciency by which sHsps prevent a-
synuclein aggregation is highly dependent on the rate at which it
aggregates. In addition, we have characterized the ability of the
sHsps to interact with mature ﬁbrillar aggregates formed by ɑ-
synuclein and established a physiologically relevant role for this
interaction in preventing the cytotoxicity of the aggregates. By
pursuing the mechanistic details of the manner by which sHsps
interact with a-synuclein, we aim to uncover potential mechanism(s)
by which sHsp chaperone activity may be targeted to attenuate
diseases associated with ɑ-synuclein aggregation.
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Effect of oligomerization of the Parkinson’s disease
related protein a-synuclein on its curvature-membrane
sensitivity
J. Ignacio Gallea1, C. Mas1, E. E. Ambroggio1, N. G. James2, D. M.
Jameson2, M. Soledad Celej1
1Universidad Nacional de Cordoba, Dto. Quımica Biologica-
CIQUIBIC, Fac. Ciencias Quımicas, Cordoba, Argentina
2University of Hawaii at Manoa, Department of Cell and Molecular
Biology, John A. Burns School of Medicine, Hawaii, USA
a-synulcein (AS) is a presynaptic protein extremely abundant in
dopaminergic neurons where it participates in synaptic transmission
acting as a critical regulator of vesicle dynamics. The abnormal
amyloid aggregation of AS is related to Parkinson’s disease, a
neurodegenerative movement disorder associated with axon degen-
eration of dopaminergic nigral neurons. Preﬁbrillar soluble oligo-
mers are pointed as neurotoxic species, since they might damage
synapses and dendrites by both altering the physiological function of
AS and acting as active pathogenic species. In this scenario, AS-
membrane interactions play a key role in modulating AS phys-
iopathology. The protein has a greater afﬁnity for highly curved
vesicles, such as that of synaptic vesicles. Therefore, we aimed at
determining the loss-of-function that might be associated to the
conversion of AS from its monomeric functional state to its
pathological oligomeric form by evaluating the impact of AS
oligomerization on its membrane-curvature sensitivity. We used
Fluorescence Correlation Spectroscopy to obtain quantitative infor-
mation on the interaction between monomeric and oligomeric AS
and vesicles varying in sizes. Astonishingly, oligomeric AS also
exhibits a higher afﬁnity for small unilamellar vesicles than for large
unilamellar vesicles. Our ﬁndings provide further evidence for the
gain-of-function toxicity attributed to amyloid oligomeric species in
Parkinson’s disease and other synucleinopathies.
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The subcellular localization of human tyrosine
hydroxylase isoforms
A. Kunzler1, 2, P. G. Sobrinho1, T. Smith1, G. briggs1, P. Dunkley1,
P. Dickson1
1University of Newcastle Australia, Faculty of Health and Medicine,
Newcastle, Australia
2Federal University of Rio Grande do Sul, Department of
Biochemistry, Porto Alegre, Brazil
Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the
biosynthesis of the catecholamines. Humans are unique in that they
have four different isoforms. We hypothesised that they may show
differential subcellular localisation. To examine this the neuroblas-
toma SH-SY5Y cell line was transfected with the human TH
isoform 1 (hTH1) or isoform 4 (hTH4). Subcellular distribution was
determined under basal and muscarine stimulated conditions. In
basal conditions TH was found primarily in the cytosol (hTH1
81  1.3% (meanSEM) and hTH4 78  1.5%) and in the
membrane-associated fraction (hTH1 19  1.2% and hTH4
21  1.7%), with low levels in the nuclear fraction (hTH1
1  0.3% and hTH4 0.7  0.2%). There was no signiﬁcant
difference in the distribution of the two isoforms in these fractions
with respect to total TH protein or for pSer19 TH. In contrast, in the
membrane-associated fraction the level of pSer40 hTH4
(35  0.8%) was around two fold higher than pSer40 hTH1
(19  0.7%) (p < 0.001). After muscarine stimulation, the level of
total hTH4 protein in the cytosolic fraction (68  1%) was
signiﬁcantly decreased compared to hTH1 (81  1.5%) and the
level of hTH4 in the nuclear fraction was 10  0.5%, whereas
hTH1 was not detectable. The level of pSer19 hTH4 (7  0.8%)
was signiﬁcantly lower than pSer19 hTH1 (21  1.2%) (p < 0.01)
in the membrane fraction after muscarine stimulation, whereas there
were no differences in the distribution of the two isoforms in relation
to pSer40 TH. This provides the ﬁrst evidence of differential
distribution of TH isoforms in subcellular fractions and that cellular
stimuli can alter the subcellular distribution of TH.
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CSF biomarkers for Parkinson’s disease: loss of
glucocerebrosidase activity and alterations in modiﬁed
forms of alpha-synuclein
J. B. Gramsbergen1, A. D. Andersen1, 2, 3, P. L. Iversen4, M.
Blaabjerg5, M. Binzer3, B. Pakkenberg4, T. Brudek4, N. H. H.
Heegaard6, E. Stenager2, 3
1University of Southern Denmark, Institute of Molecular Medicine,
Odense, Denmark
2Hospital of Southern Jutland, Focused Research Group in
Neurology, Aabenraa, Denmark
3University of Southern Denmark, Insitute of Regional Health
Research, Aabenraa, Denmark
4Bispebjerg-Frederiksberg Hospital, Research Laboratory for
Stereology and Neuroscience, Copenhagen, Denmark
5Zealand University Hospital, Dept. of Neurology, Roskilde,
Denmark
6Statens Serum Institute, Dept. of Autoimmunology & Biomarkers,
Copenhagen, Denmark
Bioﬂuid markers for the diagnosis, disease activity, and progres-
sion of Parkinson’s disease (PD) are much in demand. Promising
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candidates are total or modiﬁed forms of alpha-synuclein and
lysosomal enzymes, including b-glucocerebrosidase (GCase,
EC = 3.2.1.45) activity, which can be detected in cerebrospinal
ﬂuid (CSF). A bidirectional relationship has been proposed for
lysosomal dysfunction and aggregation of alpha-synuclein in PD
(Parnetti et al., 2014).
CSF was collected from 22 PD patients and 15 controls. Clinical
rating of disease severity (UPDRS) and dyskinesia (UDysRS) was
performed for each PD patient. GCase activity was assesed by a
ﬂuorimetric assay using 25 lL of CSF and 50 lL of a reaction-
buffer containing the ﬂuorigenic substrate 4-Methylumbelliferyl bet-
D-glucopyranoside. Samples were incubated at 37°C for 24 h and
the the ﬂuorescent product 4-Methylumbelliferone was measured on
a plate reader. Total alpha-synuclein was assessed by ELISA as
described (Heegaard et al., 2014). Oligomeric and phosphorylated
species of alpha-synuclein were assessed by multiplex Western Blot
analyses (Brudek et al., 2016).
In this PD cohort, we found signiﬁcantly reduced GCase activity
in CSF (22% reduced, p < 0.01), but no alterations in total alpha-
synuclein levels. Western Blot analysis of PD and control CSF
samples revealed signiﬁcantly reduced monomeric, ser-87-phos-
phorylated and nitrated (Tyr125, Tyr133) alpha-synuclein in PD, but
no changes in oligomeric or ser-129-phosphorylated alpha-synuclein
levels.
In conclusion, reduced GCase activity and speciﬁc alpha-
synuclein species in CSF may serve as biomarkers for PD.
MTU04-10
Interplay between a-synuclein and lipids in Parkinson’s
disease
C. Liu, C. Zhao, J. Tu, C. Wang, D. Li
Chinese Academy of Sciences, Interdisciplinary Research Center on
Biology and Chemistry, Shanghai, China
Abnormal a-synuclein (a-syn) aggregation in Lewy bodies is the
pathological hallmark of Parkinson’s disease (PD) and other
synucleinopathies such as infantile neuroaxonal dystrophy (INAD),
and idiopathic neurodegeneration associated with brain iron accu-
mulation (NBIA)1. Despite its high propensity to aggregate under
pathological conditions and when isolated in vitro, native a-syn is a
highly abundant soluble neuronal protein in the CNS (~1% of the
total proteins) and resists aggregation in normal intracellular
environments2. However, little is known how a-syn maintains its
native structure. Here we systemically investigated lipid-binding
partners of a-syn using untargeted global lipidomic proﬁling. We
found that different a-syn species (e.g. monomer, oligomer and
ﬁbril) have distinct binding preferences to lipid molecules. We
identiﬁed a class of lipid molecules which speciﬁcally bind with the
N-terminal of a-syn monomer, induce a compact a-helical confor-
mation and stabilize a-syn monomer from aggregation. Importantly,
this lipid mediates physiological function of a-syn in synaptic
vesicle trafﬁcking. PD familial A30P a-syn mutant shows reduced
binding afﬁnity with the lipids. Furthermore, decreased production
of this class of lipids dramatically promotes a-syn aggregation in
cells. Our study suggests that dysfunctions in the lipid homeostasis
might be critical in the development of Lewy body diseases.
References:
[1] Lashuel, H. A., et al. Nature Reviews Neuroscience 2013 14, 38-
48.
[2] Theillet, F. X. et al. Nature 2016 530, 45-50.
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HSPA8 expression in nigral and ventral tegmental area
dopaminergic neurons of control and Parkinsonian brain
K. Mohanakumar1, 2, D. Dutta2, N. Ali2, E. Banerjee2
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While dopaminergic neurons of the substantia nigra (SN) region
of the midbrain is lost in Parkinson’s disease (PD), the adjoining
dopaminergic neurons of the ventral tegmental area (VTA) are
relatively spared. 2-Dimensional gel electrophoresis, followed with
MALDI-TOF-TOF analysis identiﬁed several proteins differentially
expressed between these two regions of normal mice and one such
protein, heat shock protein A8 (HSPA8), is characterised in the
present study. A member of the HSC70 class protein, HSPA8 was
found to have higher expression at both protein and transcript level
in SN compared to VTA and this discrepancy in the protein
expression was found to be speciﬁc to tyrosine hydroxylase positive
dopaminergic neurons of these two regions. The parkinsonian
neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-
treated mice, sacriﬁced after 3 days and 7 days following the last
dose of the neurotoxin, were used in the study. MPTP treatment
caused more than 60% loss of dopaminergic neurons in SN after
7 days, but at this juncture the loss of neurons in VTA was
insigniﬁcant. Dopaminergic neuronal death in SN was concomitant
with gradual decrease in HSPA8 level, whereas its expression was
almost 2-fold up-regulated in VTA dopaminergic neurons following
3 days of MPTP treatment. Investigation on human post-mortem
brains recapitulates similar results, where HSPA8 is signiﬁcantly
depleted in SN but its expression was almost 1.5-fold enhanced in
VTA of PD brains. HSPA8 expression was unaltered in PD cybrids
made from platelets of parkinsonian patients compared to the control
cybrids. The ﬁnding signiﬁes that HSPA8 up-regulation might be
one of the strategies adopted by VTA dopaminergic neurons to
combat the cellular stress associated with PD, whereas SN
dopaminergic neurons become more vulnerable with the loss of
this protein.
MTU04-12
Iron regulatory protein 1 (IRP1) is a required mediator in
cell death induced by mitochondrial complex i inhibition
M. Nunez, P. J. Urrutia, P. Aguirre, V. Tapia, C. M. Carrasco, N. P.
Mena
Faculty of Sciences, Universidad de Chile, Dept. of Biology,
Santiago, Chile
Mitochondrial dysfunction and oxidative damage, often accom-
panied by elevated intracellular iron levels, plays an important role
in the development of a number of neurodegenerative pathologies
that include Parkinson’s disease. The capacity of redox-active iron
in generating free radicals underlies the “metal-based neurodegen-
eration hypothesis” in which ROS generated by redox-active metals
(Fe, Cu) cause peroxidation of membrane phospholipids which leads
to the formation of reactive aldehydes that react with proteins,
producing misfolded aggregates that overwhelm the ubiquitin/
proteasome protein degradation system. Here we have evaluated the
role of Iron Regulatory Protein 1 (IRP1) in the death of SH-SY5Y
dopaminergic neuroblastoma cells subjected to mitochondria com-
plex I inhibition. We found that complex I inhibition was associated
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with increased levels of transferrin receptor 1 (TfR1) and iron
uptake transporter divalent metal transporter 1 (DMT1), and
decreased levels of iron efﬂux transporter Ferroportin 1 (FPN1),
together with increased 55Fe uptake activity and an increased
cytoplasmic labile iron pool. Complex I inhibition also resulted in
increased oxidative modiﬁcations and increased cysteine oxidation
that were inhibited by the iron chelators desferoxamine, M30 and
Q1. Silencing of IRP1 abolished the rotenone-induced increase in
55Fe uptake activity and it protected cells from death induced by
complex I inhibition. IRP1 knockdown cells also presented an
increased resistance to cysteine oxidation and decreased oxidative
modiﬁcations. These results support the concept that IRP1 is an
oxidative stress biosensor that when deregulated by mitochondrial
dysfunction mediates iron accumulation and cell death.
Financed by FONDECYT project 1130068.
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Resveratrol restores CYP2D6 enzyme activity and
upregulates NRF2-keap1 pathway in maneb- and
paraquat- treated SH-SY5Y cell line
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Combined exposure to maneb and paraquat is known to induce
Parkinsonism by the inhibition of complex III and I respectively,
thereby increasing oxidative stress. Cytochrome P 450 2D6
(CYP2D6), a highly polymorphic enzyme, is involved in the
metabolism of Parkinsonian toxins other than being involved in the
metabolism of dopamine. Reduced CYP2D6 enzyme activity has
been shown to increase Parkinson’s disease (PD) risk. However, the
role of pesticides exposure on CYP2D6 activity has not been
observed. The present study investigated the role of combined
exposure to maneb (2 lM) and paraquat (100 lM) on CYP2D6
activity in differentiated SH-SY5Y cells. Combined exposure to MB
and PQ for 48 h in cells lead to a signiﬁcant reduction in tyrosine
hydroxylase (TH) expression- a hallmark of PD and CYP2D6
activity, while pretreatment of resveratrol (10 lM) signiﬁcantly
restored TH expression and CYP2D6 activity. Nuclear expression of
Nrf2 and its downstream mediators were upregulated in resveratrol
and MB and PQ treated cells. Resveratrol pretreatment in MB- and
PQ- treated cells further increased the expression of Nrf2 and its
downstream mediators. Similar experiments were also performed in
presence of Quinidine, a CYP2D6 inhibitor. Quinidine (1 lM) lead
to a signiﬁcant reduction in CYP2D6 activity while no change was
observed in expression of TH. However, in presence of combined
MB and PQ, reduction in TH expression along with nuclear Nrf2
expression and its downstream mediators was much more pro-
nounced as compared to either or alone. Pretreatment of resveratrol
signiﬁcantly restored Nrf2, its downstream mediators and level of
CYP2D6 activity. The results thus indicate that resveratrol protects
against maneb- and paraquat- induced Parkinsonism through
restoration of CYP2D6 activity and upregulation of Nrf2-Keap1
pathway in SH-SY5Y cell line.
MTU04-14
Histone deacetylase inhibitor, SAHA, ameliorated the
toxic effects of high fat diet induced insulin resistance in
Hemiparkinson’s
S. Sharma, R. Taliyan
Birla Institute of Technology and Science, Pharmacy, Pilani, India
Objectives: Insulin resistance has been reported as a possible
risk factor for Parkinson’s disease (PD). Preclinical and clinical
studies have suggested reduced insulin receptor expression and
insulin resistance in PD brains. Recently, insulin resistance was
found to be present in 62% of PD patients with dementia. In our
previous study we found reduction in histone H3 acetylation could
be a possible risk factor for insulin resistance induced PD pathology.
Therefore, the present study was designed to explore the therapeutic
potential of histone deacetylases inhibitor, Suberoylanilide hydrox-
amic acid (SAHA), in insulin resistance induced PD pathology.
Methods: High fat diet (HFD) feeding was used for induction of
insulin resistance in animals. Male Wistar rats were subjected to a
normal pellet diet or HFD for 8 weeks before they were infused with
low dose of 6-hydroxydopamine (6-OHDA) into the medial
forebrain bundle. The animals were then divided different groups.
The treatment group received SAHA (25 and 50 mg/kg i.p.)/day for
14 days. Battery of behavioral parameters was performed to check
the locomotor and gait abnormalities in rats. To delineate the
molecular mechanisms, we study the changes in histone acetylation
in striatum region.
Results: The animals subjected to HFD feeding followed by 6-
OHDA infusion showed impaired locomotion and gait abnormal-
ities. These rats also showed signiﬁcant elevation in oxidative stress
markers and neuronal damage along with signiﬁcant reduction in
histone H3 acetylation in striatal region. In contrast, rats treated with
SAHA showed signiﬁcant amelioration of locomotor and gait
abnormalities along with reduced oxidative stress and neuronal
damage. Treatment with HDAC inhibitor, SAHA results in signif-
icant elevation of histone H3 acetylation.
Conclusions: This is the ﬁrst study exploring the role of histone
acetylation/deacetylation in insulin resistance induced PD pathol-
ogy. This study suggests the therapeutic potential of HDAC
inhibitor, SAHA in ameliorating insulin resistance induced PD
pathology. Future studies in this direction might possibly conﬁrms
the role of histone acetylation in PD associated with insulin
resistance.
MTU04-15
Effects of ASIC1a on regulating a-synuclein degradation
via autophagic pathway in the pathogenesis of
Parkinson’s disease
X. Sun, C. Liu
Second Afﬁliated Hospital, Soochow University, Department of
Neurology, Suzhou, China
Acid-sensing ion channels (ASICs) are ligand-gated cation
channels that respond to acidic stimuli, and ASICs are always
activated when tissue acidosis occurs. In our previous study, we
found that ASICs and ASIC1a inhibitors could protect cells against
injury by autophagic clearance in vitro of Parkinson’s disease (PD)
cell model. However, the role and underlying mechanisms of
ASIC1a in PD have not been fully elucidated. Hence, this study is to
examine the potential role of ASIC1a in reducing a-synuclein
110 Journal of Neurochemistry © 2017 International Society for Neurochemistry, J. Neurochem. (2017) 142 (Suppl. 1), 78--164
© 2017 The Authors
MTU04 Molecular Mechanism of Parkinson’s Disease
aggregation via autophagic clearance and its underlying mecha-
nisms. In this study we constructed MPTP-induced PD mice model,
and used gene knockout animal, immunoﬂuorescence, Western Blot
and transmission electron microscopy. We found that the expression
of autophagy maker LC3-II was upregulated in ASIC1a knockout
mice, and p62 and intracellar a-synuclein level was reduced,
protecting cells against injury in vivo. Primary neurons were
extracted and cultured from WT and knockout mice then treated by
MPP+. The results showed that ASIC1a knockout or ASIC1a
blockers PcTx1, increased LC3-II then reduced a-synuclein level,
exerted neuroprotective effects. In summary, these ﬁndings demon-
strated that inhibition of ASICs reduced a-synuclein aggregation by
enhancing its autophagic degradation and thus neurons. These
ﬁndings will make contributions to disclose the possible pathogenic
factor in PD and also provide novel theoretical and experimental
evidence in searching for promising targets for PD therapy.
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Novel superoxide dismutase-1 proteinopathy is
associated with Lewy pathology and neuronal loss in
Parkinson’s disease
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Neuronal loss in numerous neurodegenerative disorders has been
linked to protein aggregation and oxidative stress. Using immuno-
histochemistry, we describe superoxide dismutase-1 (SOD1) pro-
teinopathy, distinct from synucleinopathy, in the Parkinson’s disease
brain. Signiﬁcant expression of this pathology matched the regional
patterns of neuronal loss and increased Lewy neurite pathology.
This is of interest given that SOD1 aggregation is suggested to be
seeded by ﬁbrillar a-synuclein. Our data highlights an association
between SOD1 proteinopathy and neuronal loss in Parkinson’s
disease and suggests SOD1 and a-synuclein deposition may be
linked in Parkinson’s disease. The similarity of these novel
aggregates to neurotoxic SOD1 deposits in familial amyotrophic
lateral sclerosis (ALS) suggests common mechanisms leading to
toxic SOD1 aggregation in these disorders. We demonstrated that
SOD1 in the Parkinson’s disease brain exhibits evidence of
misfolding and metal deﬁciency, a known and potentially tractable
pathway for aggregation of this protein in ALS. An understanding of
the mechanisms leading to the deposition of SOD1 proteinopathy in
Parkinson’s disease may reveal new targets for neuroprotective
therapies.
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Molecular mechanisms of neuroplasticity and
decompensation in the nigrostriatal system at modeling
Parkinson’s disease
M. Ugrumov, E. Mingazov, A. Kim, A. Kolacheva
Institute of Developmental Biology RAS, Lab. of Neural and
Neuroendocrine Regulations, Moscow, Russia
Parkinson’s disease (PD) is characterized by the appearance of
motor symptoms many years after the onset of neurodegeneration,
which explains low efﬁciency of therapy. Therefore, one of the
priorities in neurology is to develop an early diagnosis and
preventive treatment of PD, based on knowledge of molecular
mechanisms of neuroplasticity and decompensation in the nigros-
triatal system. However, due to inability to diagnose PD at
preclinical stage, research must be performed in models by
comparing the nigrostriatal system in the models of asymptomatic
and early symptomatic stages of PD. We showed that despite the
progressive loss of neurons in substantia nigra at both studied stage,
almost no change were observed in the main functional character-
istics, including dopamine (DA) uptake and release, DAT and
VMAT2 expression and activity of MAO-A and MAO-B. In the
striatum of presymptomatic mice, some parameters (DA release and
uptake, MAO-A activity) remained compensatory unchanged or
decreased (MAO-B gene expression and activity), while others - a
reduction in DA levels in tissue and extracellular space and in
VMAT2 and DAT expression, manifest functional failure. In
symptomatic mice, only a few parameters (spontaneous DA release
and uptake, MAO-B gene expression and activity), remained at the
same level as presymptomatic stage, while most parameters (DA
level in tissue and extracellular space, DA stimulated release,
VMAT2 and DAT content), decreased, showing decompensation,
which was enhanced by increasing MAO-A activity. Moreover, we
ﬁrst proved that striatum of mice comprises the monoenzymatic TH-
and AADC-neurons, which synthesize DA in cooperation. Propor-
tion of cooperative synthesis in total DA production increases as
degradation of dopaminergic system proceeds. These data show that
cooperative synthesis of DA is an up-regulated compensatory
reaction, which is among principal mechanisms of neuroplasticity in
Parkinsonism. Thus, we provide a comprehensive assessment of
molecular mechanisms of neuroplasticity and decompensation in
MPTP models of preclinical and clinical stages of PD being a
powerful tool for translational medicine.
MTU04-18
Establishing a three-dimensional human neural cell
culture model of Parkinson’s disease
T. Whiteley1, C. Dalton1, J. Duce2, C. L. Maitre1, D. Smith1
1Shefﬁeld Hallam University, Biomolecular Sciences Research
Centre, Shefﬁeld, United Kingdom
2University of Leeds, School of Biomedical Sciences, Leeds, United
Kingdom
Parkinson’s disease (PD) is the second most common neurode-
generative disorder after Alzheimer’s disease, affecting ~1.5% of the
global population over the age of 65, with increasing prevalence
with advancing age. Extensive loss of dopaminergic neurons and
aggregation of the protein a-synuclein (a-syn) into large insoluble
multimeric structures of Lewy bodies (LBs) represents the major
neuropathology hallmarks of the disease. The inﬂuence of LB
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formation in the development of PD is unknown and very little is
understood regarding the mechanism of LB formation and effect of
LBs on neurons that bear them. A large body of evidence from
in vitro and in vivo studies have suggests a ‘prion-like’ hypothesis of
progression in PD, implicating a-syn as a ‘prion-like’ protein, able
to induce a-syn aggregation and cell-to-cell propagation. However,
both these mechanisms remain poorly understood, mainly due to the
lack of animal and cellular models that recapitulate speciﬁc
neuropathy and/or behavioural features known to occur in PD.
Rodent models exhibit formation of a-syn inclusions that present as
diffuse aggregates present throughout the cells but do not fully
recapitulate LB pathology. Here, we demonstrate addition of
exogenous a-syn species are able to induce LB-pathology in a
differentiated human neuroblastoma (SH-SY5Y) three-dimensional
(3D) culture system as determined by immuno-positive a-syn and
ubiquitin inclusions. Importantly, 3D-differentiated SH-SY5Y cells
express markers of dopaminergic neurons (DRD2, dopamine
receptor 2; DAT, dopamine transporter) and endogenous levels of
a-syn, demonstrating a ‘prion-like’ seeding mechanism of LB
formation that does not require the overexpression of a-syn as in
previous models.
MTU04-19
The potential mechanism of salsolinol synthase induces
apoptosis in PC12 cells
Z. Xiaotong, C. Xuechai*, Z. Rugang
Beijing university of technology, College of life Science and
technology, Beijing, China
Background and aims: Salsolinol (Sal) was the precursor of N-
methyl-Salsolinol (NM-Sal), which can be metabolized to cytotoxic
MPP+-like neurotoxin and ﬁnally leads to the characteristic
symptoms of Parkinson’s disease (PD). Sal synthase is a novel
enzyme which catalyzes the reaction of dopamine and acetaldehyde
to produce Sal. This enzyme was the key protein in the formation of
endogenous neurotoxins. Our previous work had conﬁrmed the
existence and characterization of Sal synthase and obtained its
amino acid sequence. Nevertheless, the physiological function of Sal
synthase has not been investigated thoroughly, especially its
mechanism in the progress of neurons degeneration and the function
in PD. In this study, we aimed to clarify the role of Sal synthase and
the relationship between Sal synthase and PD pathogenesis. This
investigation may provide a new target for the diagnosis and
treatment of PD.
Method: The cDNA sequence of Sal synthase was inquired by
NCBI Blast database. Then the recombinant plasmid pEGFP N2-Sal
and pcDNA3.1+-Sal were obtained and transiently transfected PC12
cells, and the empty plasmid was as control group. After transfection
for 48 h, cells were dually stained with Annexin V/PI to determine
the population of cells in apoptosis stages and loaded JC-I probe to
detect the change of the mitochondrial membrane potential.
Confocal microscopy was used to detect the location of Sal
synthase. Western blot was used to analyze the level of associated
proteins. The content of Sal and NM-Sal was detected by HPLC-
MS/MS.
Results and conclusion: The location analysis of Sal synthase
showed that it was one kind of cytoplasmic protein. Compared with
control, the overexpression of Sal synthase in PC12 cells could
elevate the level of neurotoxins (Sal, NM-Sal) and pro-apoptotic
protein (Bad), and furthermore increase mitochondrial membrane
potential and promote apoptosis (p < 0.05, p < 0.001). The poten-
tial mechanism was proposed that Sal synthase could enhance the
accumulation of neurotoxicity, then lead to mitochondrial dysfunc-
tion and ﬁnally induce the apoptosis of dopaminergic neurons,
which would cause PD.
*Corresponding author, Email: chenxuechai@bjut.edu.cn:
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Short-term docetaxel-induced cognitive impairment in
rats with tumour
H. Basri
Universiti Putra Malaysia, Neurology, Serdang, Malaysia
Purpose: Docetaxel (DTX) is an anti-cancer drug which is used
widely to treat different types of cancer, but it may cause several
unwanted adverse effects. One of the most debilitating side effects is
cognitive impairment. The purpose of this study is to examine the
short-term cognitive impairment of DTX on rats with tumour by
using Morris Water Maze (MWM).
Methods: Female Sprague Dawley rats were injected with LA7
cells into the mammary gland pad to produce the tumour. The rats
were then divided into 3 groups; normal control without tumour
(NC, n = 11), rats with tumour treated with DTX (single dose 5 mg/
kg i.p.) (DTX, n = 11) and cancer control without DTX (CC,
n = 11). A 2 day MWM protocol was used to assess the cognitive
impairment. Hippocampus (responsible for short-memory) was
examined for pro-inﬂammatory cytokine interleukin IL-1b, and
oxidative stress markers thiobarbituric acid-reactive substances
(TBAR) and reactive oxygen species (ROS).
Results: Only 24 h after DTX was injected, the escape latency
to ﬁnd the platform was increased signiﬁcantly to 58.1 s compared
to 8.6 s in NC and 24.7 s in CC, also the latency difference (ﬁrst
hidden platform - last visible platform) was increased signiﬁcantly
due to DTX to 59.7 s compared to 5.5 s in NC and 31.0 s in CC.
Interleukin IL-1b concentration was increased signiﬁcantly in DTX
to 171.56 pg/mL compared to 23.30 pg/mL in NC and 11.67 pg/
mL in CC. TBARS level was increased signiﬁcantly in DTX to 2.7
folds compared to NC, while CC increased it to 1.56 folds, also ROS
level was increased signiﬁcantly in DTX to 2.45 folds while CC
raise it to 1.40 folds compared to NC.
Conclusion: DTX signiﬁcantly induce short-term cognitive
impairment in rats with tumour.
MTU05-02
Inhibiting soluble TNF-a signaling mitigates autonomic
dysreﬂexia after complete high thoracic spinal cord injury
J. Bethea, E. Mironets, V. Bracchi-Ricard, E. Owens, R. Fischer, D.
Wu, S. Hou, P. Osei-Owusu, V. Tom
Drexel University, 3245 Chestnut Street, Philadelphia, USA
Two leading causes of mortality and morbidity in patients with
SCI is cardiovascular disease and increased susceptibility to
infection. A major cause for these is SCI-induced autonomic
dysfunction that results in autonomic dysreﬂexia (AD), a serious and
potentially life-threatening syndrome that develops in people with
SCI above thoracic spinal level 6 (T6). AD is characterized by
episodes of extreme, sudden bouts of hypertension often accompa-
nied by bradycardia that are triggered by a noxious stimulus below
the level of injury, such as expansion of the bladder or constipation.
We hypothesized that inﬂammation mediated by the soluble form of
the pro-inﬂammatory cytokine sTNF-a in tissue below the injury
plays a key role in plasticity associated with the development of AD.
To test this, we completely transected the spinal cord in adult rats at
T3, an injury model that reliably results in AD. Some animals
continuously received XPro1595, a biologic that inhibits soluble
TNF-a signaling, intrathecally while others received saline. All rats
had radiotelemeters implanted into the descending aorta to measure
blood pressure (BP) and heart rate (HR). At 2, 3 and 4 weeks post-
injury, we continuously recorded hemodynamics over a 24-hour
period. Preliminary data suggest that, compared to saline-treated
animals (N = 9), the XPro1595-treated animals (N = 10) had
signiﬁcantly fewer spontaneously elicited AD events and a less
dramatic increase in BP per event. Compared to saline-administered
animals, XPro1595-treated animals exhibited smaller spikes in BP
during CRD and shorter times to return to basal BP after CRD,
implying diminished AD severity. We also found XPro1595
treatment signiﬁcantly diminished SCI-induced vessel hyper-
responsiveness to the vasopressor phenylephrine. Lastly, we found
that XPro1595-treated animals have signiﬁcantly less microglial
reactivity and sprouting of nociceptive primary afferents in lumbar
cord than saline animals, providing some mechanistic insight.
Collectively, these data indicate that sTNF-a plays a critical role in
the development of AD after SCI.
MTU05-03
Changes in behavioral and neurochemical aspects
induced by manganese (ii) chloride exposure in larvae
and adult zebraﬁsh
C. D. Bonan1, S. Altenhofen1, M. T. Wiprich1, L. Nery1, C. E. Leite2,
M. Vianna1
1Pontiﬁcia Universidade Catolica do Rio Grande do Sul, Faculdade
de Biocie^ncias, Porto Alegre, Brazil
2Pontiﬁcia Universidade Catolica do Rio Grande do Sul, Instituto
de Toxicologia e Farmacologia, Porto Alegre, Brazil
Manganese (Mn) is an essential metal for organisms, but high
levels can cause serious neurological damage. The aim of this study
was to evaluate the effects of MnCl2 exposure on cognition and
exploratory behavior in adult and larval zebraﬁsh and correlate these
ﬁndings with brain accumulation of Mn, overall brain tyrosine
hydroxylase (TH) levels, dopamine (DA) levels, 3,4-dihydroxyphe-
nylacetic acid (DOPAC) levels and cell death markers in the nervous
system. Adults exposed to MnCl2 for 4 days (0.5, 1.0 and 1.5 mM)
and larvae exposed for 5 days (0.1, 0.25 and 0.5 mM) displayed
decreased exploratory behaviors, such as distance traveled and
absolute body turn angle, in addition to reduced movement time and
an increased number of immobile episodes in larvae. Adults exposed
to MnCl2 for 4 days showed impaired aversive long-term memory
in the inhibitory avoidance task. The overall brain TH levels were
elevated in adults and larvae evaluated at 5 and 7 days post-
fertilization (dpf). Interestingly, the protein level of this enzyme was
decreased in larval animals at 10 dpf. Furthermore, DOPAC levels
were increased in adult animals exposed to MnCl2. Protein analysis
showed increased apoptotic markers (p53, caspase-8, Bax-a) in both
larvae and adult nervous system. The results demonstrated that
prolonged exposure to MnCl2 leads to locomotor deﬁcits that may
be associated with damage caused by this metal in the CNS,
particularly in the dopaminergic system.
© 2017 The Authors
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Mitochondria pathway mediated neuroprotection by
melatonin in valproic acid induced toxicity
S. Chaudhary, S. Parvez
Jamia Hamdard, Toxicology, Faculty of Science, New Delhi, India
Branched chain fatty acids (BCFAs) are saturated long chain
molecules with methyl groups and major lipid constituents. The
inﬂuence of BCFAs accumulation on different brain cell types in the
pathogenesis of neurodegeneration is an unresolved issue. Valproic
acid (VPA) is a BCFA and its utility as an anticonvulsant has been
supported by clinicians which was subsequently challenged due to
its side-effects and induced neurotoxicity. The objective of this
study was to understand the cellular mechanisms of oxidative stress
mediated neuronal cell death induced by VPA and neuroprotective
role of exogenous melatonin (Mel) on VPA induced cell death by
using cerebral cortex and cerebellum regions of rat brain as an
in vivo model. In addition, pre-administration of Mel (10 mg/kg
body weight, i.p.) with VPA (200 mg/kg body weight, i.p.)
treatment for 15 days rescued behavioral performance of rats
altered by VPA administration, mitigated the level of dopamine
neurotransmitter and inhibited oxidative stress by restoring some
biomarkers such as acetylcholinesterase, Na+, K+-ATPase and
monoamine oxidase, lipid peroxidation, protein carbonylation and
reduced glutathione in cerebral cortex and cerebellum regions of rat
brain induced by the treatment of VPA. In contrast, Mel effectively
exerted an anti-apoptotic and anti-inﬂammatory action by regulating
Bax, Bcl-2, caspase-3, Poly (ADP Ribose) polymerase -1 and
nuclear factor-kappa B in cerebral cortex and cerebellum. The
results of the present investigation emphasize novel insights of Mel
as a supplement for the prevention and treatment of neuronal
dysfunction induced by VPA.
MTU05-05
Direct modulatory effects of antiepileptic drugs on glycine
receptors
S. Devenish1, 2, N. Absalom1, 3, B. Winters4, L. Anderson2, 3, T.
Bakas1, J. Arnold2, 3, 5, C. Vaughan4, I. McGregor2, 3, M. Chebib1, 3
1The University of Sydney, Faculty of Pharmacy, Sydney, Australia
2The University of Sydney, Lambert Initiative of Cannabinoid
Therapeutics, Sydney, Australia
3The University of Sydney, Brain and Mind Centre, Sydney,
Australia
4The University of Sydney, Kolling Institute of Medical Research,
Sydney, Australia
5The University of Sydney, Discipline of Pharmacology, Sydney,
Australia
Despite the commonly held notion that glycinergic neurotrans-
mission only occurs in lower areas of the central nervous system
(CNS), mounting evidence also supports a functional role for
glycine receptors (GlyR) in higher regions of the CNS. This is
particularly true in the hippocampus, where electrophysiological
studies have established the presence of extrasynaptic GlyR which
contribute to the regulation of neuronal excitability. With consid-
eration given to the importance hippocampal networks play in the
generation of seizures, the inhibitory tone provided by GlyR has
been proposed to play a homeostatic, antiepileptic role. In this study,
we explored the possibility that conventional antiepileptic drugs
partially exert their therapeutic effects via modulation of GlyR. Two
electrode voltage clamp electrophysiology of a1-3 GlyR expressed in
Xenopus laevis oocytes was employed in screening 24 antiepileptic
drugs. The agents zonisamide, stiripentol and ganaxolone all
potentiated EC5 glycine responses within their therapeutic range,
warranting full characterisation on a1-3 and a1b GlyR. The results
from this study suggests that the targeting of cerebral GlyR may
represent a new strategy in the treatment of epilepsy.
MTU05-06
Individual and dual combined effects of ﬂavonoid
compounds on the inhibition of the P-glycoprotein drug
efﬂux transporter
A. F. Ferreira1, 2, M. Rodrigues1, 3, A. Santos1, A. Fortuna2, 4, A.
Falc~ao2, 4, G. Alves1, 2
1University of Beira Interior, Health Sciences Research Centre
(CICS-UBI), Covilh~a, Portugal
2University of Coimbra, Center for Neuroscience and Cell Biology,
Coimbra, Portugal
3Polytechnic Institute of Guarda, Research Unit for Inland
Development, Guarda, Portugal
4University of Coimbra, Laboratory of Pharmacology, Faculty of
Pharmacy, Coimbra, Portugal
The recognition that P-glycoprotein (P-gp)–mediated multidrug
resistance is clinically important in several central nervous system
disorders has promoted concerted efforts to search for therapeuti-
cally useful P-gp inhibitors, in order to overcome the inﬂuence of
this functional barrier and increase drug availability into the brain. In
the present work, the aim was to identify P-gp inhibitors among
several ﬂavonoid compounds and to investigate the inhibitory
potential of dual combinations of the most promising ﬂavonoids.
Rhodamine 123 (a P-gp ﬂuorescent probe substrate) intracellular
accumulation assays were performed using the Madin-Darby canine
kidney cell line expressing the human multidrug resistance-1
(MDR1) gene encoding P-gp (MDCK-MDR1), obtained from The
Netherlands Cancer Institute (NKI-AVL; Amsterdam, Netherlands).
Individual ﬂavonoids were studied at 50, 100 and 200 lM. Overall,
the results showed that baicalein, (-)-epigallocatechin gallate,
kaempferol, quercetin and silymarin, at 100 and 200 lM, produced
a signiﬁcant increase (up to 18-fold) in the intracellular accumula-
tion of rhodamine 123 in MDCK-MDR1 cells (p < 0.05), poten-
tially through inhibiting the P-gp-mediated activity. Additionally,
most of the dual ﬂavonoid combinations increased the rhodamine
123 intracellular uptake in a greater extent than the individual
ﬂavonoids at similar concentrations. These results suggest the
interest of some ﬂavonoids [baicalein, (-)-epigallocatechin gallate,
kaempferol, quercetin and silymarin], and particularly, of their dual
combinations on the inhibition of the P-gp activity. Thus, baicalein,
(-)-epigallocatechin gallate, kaempferol, quercetin and silymarin
may be promising agents in circumventing the P-gp-mediated
pharmacoresistance recognised as a major problem in several
diseases of the central nervous system.
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Comorbid pain and depression is mediated by
upregulated metabotropic glutamate receptor 5 in the
prelimbic cortex
C. Kim1, 2, G. Chung1, 3, S. J. Kim1, 2, 3
1SNU school of medicine, Neurophysiology, Seoul, Korea South
2SNU school of medicine, Biomedical Sciences, Seoul, Korea South
3SNU school of Natural Sciences, Brain & Cognitive Sciences,
Seoul, Korea South
Patients with chronic pain easily accompany the negative mood
symptoms such as depression and anxiety, and these affective and
emotional disturbances in return reinforce the aversive perception.
However, the underlying mechanisms are largely unknown. Here we
propose that the alteration of metabotropic glutamate receptor 5
(mGluR5) in the brain underlies such an aberrant ampliﬁcation of
tonic-aversive states. We assessed the mGluR5 level in the brain of
the chronic neuropathic pain model rats and control rats using
positron emission tomography (PET) technique with an mGluR5-
selective radiotracer [11C] ABP688 and sought to identify the brain
regions of which the mGluR5 level is relevant to the negative
symptoms. We found various pain-related and mood-related brain
regions show altered mGluR5 level in chronic neuropathic pain
state. Among the regions, a prominent increase of mGluR5 was
shown in the prelimbic region of the medial prefrontal cortex of
chronic neuropathic pain animals. A pharmacological blockade of
upregulated mGluR5 in the prelimbic cortex (PrL) ameliorated the
negative symptoms including tactile hypersensitivity, depressive-
like behavior, and anxiety-like behavior, which relieved the subjects
from the unpleasant state of chronic neuropathic pain condition.
Conversely, lentiviral overexpression of the mGluR5 in the PrL of
na€ıve rats successfully induced comorbid pain and negative moods.
Our data provide deeper insight into the shared mechanism of pain
perception and negative emotions, identifying a therapeutic target
for the treatment of chronic pain and mood disorders.
MTU05-08
Pathophysiological mechanism of Munc18-1 mutations in
early infantile epilepsies
K.-I. Nagata, N. Hamada
Institute for Developmental Research Aichi Human Service Cen,
Molecular Neurobiology, Aichi, Japan
Objective: While Munc18-1 is essential for presynaptic vesicle
fusion in developed neurons, this molecule is likely to be involved
in brain development since gene abnormalities in MUNC18-1
(STXBP1) cause early infantile epileptic encephalopathy with
suppression-burst (Ohtahara syndrome), neonatal epileptic
encephalopathy and other neurodevelopmental disorders. We ana-
lyzed physiological and pathophysiological relevance of Munc18-1
during the cortical development.
Methods: With acute knockdown and expression with the in
utero electroporation technique, we performed in vivo and in vitro
investigation, including confocal laser microscope-associated live-
imaging, to clarify the role of Munc18-1 and its epilepsy-causing
mutants in the mouse corticogenesis.
Results: Munc18-1-knockdown caused abnormal migration of
cortical neurons during corticogenesis. The phenotype was rescued
by an RNAi-resistant Munc18-1. Protein kinase C, but not Cyclin-
dependent kinase 5, was likely to be implicated in the migration.
Notably, Munc18-1-binding partner, Syntaxin1A but not B, rescued
the knockdown phenotype. Time-lapse imaging revealed that the
radial migration step was hampered in the cortical plate. Although
functional synapses are not formed in the neocortex during the
embryonic stage, these results suggest that Munc18-1 has a speciﬁc
role in Syntaxin1A regulation, which is modulated by Protein kinase
C, in the radial migration during the corticogenesis. In addition,
disruption of N-Cadherin localization by hampered vesicle trafﬁck-
ing appeared to be involved in the migration defects.
Interpretation: Functional abnormalities of MUNC18-1 may
induce aberrant cortical neuron migration leading to functional
defects of the cerebral cortex, and consequently contribute to the
pathophysiologies of epilepsies and other disorders withMUNC18-1
abnormalities.
MTU05-09
Retrosplenial cortex modulates neuropathic pain via
NMDA-glutamate receptors
A. L. O. Poleto, G. de Melo Reis, A. A. Anet, R. A. Panizzutti
Universidade Federal do Rio de Janeiro, Instituto de Cie^ncias
Biomedicas, Rio de Janeiro, Brazil
Retrosplenial cortex (RSC) activates descending mechanisms of
pain control and plays a relevant role in the modulation of phasic
and persistent nociception. However, the role of RSC in the
modulation of chronic neuropathic pain is unknown. Thus, we
evaluated the role of RSC in a model of neuropathic pain in rats and
explored the involvement of NMDA-glutamate receptors in this
process.
To induce neuropathic pain, male Wistar rats were submitted to a
complete spinal nerve ligation (SNL), while serine racemase (SRR)
mutant mice were submitted to chronic nerve constriction. Changes
in mechanical allodynia were evaluated using the Von Frey test in 2,
7, 14 and 21 days after surgery.
Lidocaine administration in RSC increased tactile hipersensivity
2 and 7 days after SNL. On the other hand, optogenetic stimulation
of the RSC decreased the tactile hypersensitivity observed in 2 and
7 days after SNL, but did not have effect after 14 and 21 days after
SNL. The NMDA receptors stimulation with glutamate or the
NMDA receptor co-agonist D-serine in the RSC also decreased
tactile hypersensitivity observed 2 days after SNL. In contrast, the
concomitant injection of glutamate and D-serine reduced tactile
hipersensivity not only 2 days after SNL, but also 7 and 14 days
after SNL. To further study the role of D-serine on these processes
we investigated the effect of chronic constriction injury in SRR
mutant mice. Chronic lidocaine inactivation of RSC increased tactile
hypersensitivity in wild type (WT) and SRR mutant mice and this
effect was more robust and prolonged in the SRR mutant group.
Finally, D-serine administration in the RSC signiﬁcantly reduced
tactile hipersensivity in WT and SRR mutant mice.
Our ﬁndings indicates that RSC modulated the severity of
neuropathic pain, and this effect is mediated by the activation of
glutamate receptors, including the activation of the co-agonist site of
NMDA-glutamate receptors.
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The progression of kaolin-induced hydrocephalus: light
and electron microscopic features in rats
F. Olopade1, T. Shokunbi1, 2, J. Plendl3
1University of Ibadan, Anatomy - Department of Anatomy, Ibadan,
Nigeria
2University of Ibadan, Neurosurgery, Ibadan, Nigeria
3Freie University Berlin, Veterinary Anatomy, Berlin, Germany
Hydrocephalus is a common neurological disorder caused by an
abnormal accumulation of cerebrospinal ﬂuid (CSF) within the brain
which results in injury to the surrounding brain tissue with
neurological deﬁcits. A major factor not accounted for in most
studies is the progressive change over time. In this study, we
examined, the changes that occur with time in neurons, glia,
extracellular space in the brain parenchyma and ependymal lining of
the ventricles in neonatal rats with kaolin-induced hydrocephalus.
We induced hydrocephalus in 12 three week-old Wistar rat pups
by intracisternal injection of 0.05 mL of kaolin solution (250 mg/
mL in sterile water) while 12 controls had sham injection. The
hydrocephalic rats were divided into 3 groups consisting of 4 rats
each which were sacriﬁced at 1, 4and 8 weeks post-induction of
hydrocephalus along with their age-matched controls. Following
sacriﬁce, half of the brain samples were stained with haematoxylin
and eosin, cell counts were determined and data analysed using
ANOVA at a0.05. The other half were processed for Transmission
and Scanning Electron Microscopy (TEM and SEM) and the images
analysed descriptively.
The laminar organisation of the cerebral cortex was disrupted in
all hydrocephalic rats, but neuronal density was signiﬁcantly
increased at 8 weeks (127.80  8.68 / HPF vs 85.50  5.42 /
HPF in controls). An initial denudation observed in the ependymal
cell cilia of the ventricular wall was followed by gradual restoration
of cilia size and population over time. Ultrastructural changes in the
brain parenchyma including enlargement of extracellular space,
disruption of intracellular architecture, neuronal degeneration and
hydropic changes in cell organelles like the mitochondria were
observed with increasing severity as the duration of hydrocephalus
increased.
Hydrocephalus produces signiﬁcant structural injury within the
brain parenchyma which increases with duration and severity, but
there is also evidence of partial structural recovery on the ventricular
wall over time.
MTU05-11
Arsenic induces apoptosis in hippocampal neurons and
cognitive impairment in rats via BMP2 dependent BDNF/
PTRKB signaling pathway
R. Pandey1, 2, V. Rai1, S. Bandyopadhyay1, 2
1CSIR-Indian Institute of Toxicology Research, Developmental
Toxicology Laboratory, Systems Toxicology and Health Risk
Assessment Group, Lucknow, India
2Academy of Scientiﬁc and Innovative Research (AcSIR), CSIR-IITR
campus, Lucknow, India
Arsenic stimulates apoptosis in the brain cells and induces
cognitive deﬁcits. However, mechanism promoting arsenic-
mediated neuronal apoptosis and cognitive impairment is less
investigated. Bone morphogenetic proteins (BMP) are expressed in
the hippocampus, that controls cognitive performances, and we
hypothesized that a deregulated BMP signaling may affect the
hippocampal neuronal apoptosis and cognitive functions. We ﬁrst
validated an arsenic-mediated dose-dependent loss in the hippocam-
pal neurons, through Western blotting (WB) and Nissl’s staining.
Increased Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL)-reactivity in the neuronal nuclei (NeuN) cells and
an enhanced cleaved Poly ADP-ribose polymerase (c-PARP) and
cleaved caspase-3, detected through Immunoﬂourescence (IF) and
WB, veriﬁed As-induced neuronal apoptosis. Investigating the
mechanism through in vivo and in vitro studies revealed that arsenic
promoted Bone Morphogenetic protein-2 (BMP2) expression, and a
downstream BMP Receptor2 (BMPR2) level and p-SMAD1/5
signaling in the hippocampal neurons. Interestingly, a BMP
antagonist, noggin, reduced the arsenic–induced TUNEL reactivity
and neuronal loss, proving participation of increased BMP2 in
neuronal apoptosis. We further found that the increased BMP2
signaling suppressed Brain-Derived Neurotrophic Factor (BDNF)
expression levels and BDNF/TrkB signaling in the arsenic-treated
hippocampal neurons. This decreased BDNF/TrkB pathway
appeared essential for neuronal apoptosis, as evident from a TrkB
inhibitor (K252a)-mediated abrogation of noggin-induced protection
to the hippocampal neurons. Ultimately, we veriﬁed cognitive
impairments in the arsenic-treated rats through Passive avoidance
test and Y-Maze test, and proved a restoration following noggin
treatment. Overall present study proves that arsenic induces
apoptosis in the hippocampal neurons through a BMP2/p-Smad1/
5-dependent BDNF/TrkB pathway, affecting normal cognitive
performances.
MTU05-12
Response of dorsal root ganglion neurons innervating
intervertebral disc to TRPV1 agonist capsaicin
E. H. Park1, 2, S. W. Moon1, 2, H. R. Suh1, 2, H. C. Han1, 2
1Korea University College of Medicine, Physiology, Seoul, South
Korea
2Neuroscience Research Institute, Physiology, Seoul, South Korea
Intervertebral disc (IVD) can be a major source of low back pain
(LBP). Some studies reported that degenerated IVD release
cytokines, beta-nerve growth factor (b-NGF), and brain-derived
neurotrophic factor (BDNF) and in dorsal root ganglion (DRG)
these neurotrophins induce the upregulation of transient receptor
potential cation channel subfamily V member 1 (TRPV1). However,
it is not clear whether TRPV1 can participate in sensory or
nociceptive processing associated with IVD. The purpose of this
study was to characterize the inward current and calcium inﬂux
activated by TRPV1 agonist capsaicin in DRG neurons innervating
lumbar IVD.
We used male SD rats (300 ~ 350 g, South Korea) and injected
DiI (3 lL; a lipophilic and ﬂuorescent dye) into L4-5 IVD under
anesthesia. Two weeks later, neural cells were extracted from T13-
L4 DRG and the dissociated cells were plated onto circular glass
coverslips coated with poly D-lysine. Intracellular calcium imaging
and whole-cell patch clamp technique were used to check capsaicin
response in DiI-labeled neurons.
Intracellular calcium imaging revealed that 37 (71%) of 52
labeled neurons responded to 1 lΜ capsaicin. Capsaicin-induced
peak inward current density (pA/pF) of labeled neurons was
measured in dose-dependent manner (responder/tested cells;
n = 2/10, 0.03 lM; n = 8/12, 0.1 lM; n = 7/12, 0.3 lM; n = 8/
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11, 1 lM; n = 7/11, 3 lM; n = 8/12, 10 lM), and a calculated
EC50 of dose-response curve (ﬁtted to four-parameter logistic
equation) was 0.82 lM.
The present study implicate that the nociceptive information from
IVDs can be multisegmentally transmitted to lumbar DRG neurons
and TRPV1 in these DRGs can have a critical role in discogenic low
back pain.
MTU05-13
Ubiquitination and stability of choline acetyltransferase
mutants are regulated by molecular chaperones HSC/
HSP70 and HSP90
R. J. Rylett1, 2, W. Winick-Ng1, 2, C. Seah1, T. M. Morey1, 2
1Robarts Research Institute, Molecular Medicine Research
Laboratories, London, Canada
2University of Western Ontario, Physiology and Pharmacology,
London, Canada
Choline acetyltransferase (ChAT) synthesizes the neurotransmit-
ter acetylcholine required for cholinergic neurotransmission and
some mutations in ChAT have been linked to congenital myasthenic
syndrome (CMS), a rare neuromuscular disorder. The CMS-related
ChAT mutation V18M is located within a highly-conserved proline-
rich motif [residues 14-PKLPVPP-20] that shares homology with
SH3-binding motifs and reduces ChAT enzyme activity and steady-
state protein levels. We showed previously that mutation of this
proline-rich motif enhances ChAT ubiquitination and reduces
cellular protein levels of P17A/P19A and V18M-ChAT, though
the mechanism is unclear. Using a proximity-dependent biotin
identiﬁcation (BioID) assay followed by mass spectrometry, we
identiﬁed HSC/HSP70 and HSP90, members of the heat shock
protein (HSP) family of molecular chaperones, as novel ChAT
protein interactors; these interactions are enriched in HEK-293 cells
expressing P17A/P19A-ChAT. By anti-ChAT co-immunoprecipita-
tion (co-IP) we conﬁrm these interactions in both HEK-293 and
cholinergic SN56 cells and show that they are enhanced for both
P17A/P19A and V18M-ChAT. HSC/HSP70 inhibition by 2-
phenylethynesulfonamide (PES) results in accumulation of Triton
X-100-insoluble wild-type (WT) ChAT and aggregation of mutant
P17A/P19A, V18M, and CMS-related A513T-ChAT. Additionally,
HSC/HSP70 inhibition by VER-155008 enhances ubiquitination
and promotes proteasomal degradation of WT and mutant ChAT,
whereas HSP90 inhibition by 17-AAG speciﬁcally promotes
proteasomal degradation of mutant ChAT. Lastly, we show that
ChAT interacts with the E3 ubiquitin ligase C-terminus of HSC70-
interacting protein (CHIP) using both anti-ChAT co-IP and in situ
proximity-ligation assays, though siRNA-mediated knock-down of
endogenous CHIP had no effect on steady-state protein levels of WT
or mutant ChAT. Collectively, these results identify a novel role for
the heat shock family of molecular chaperones in the regulation of
ChAT protein solubility and stability, and support further research
into the regulation of ChAT ubiquitination by HSPs and the role that
ubiquitination may play in relation to ChAT function during cellular
stress and disease.
MTU05-14
The sigma-1 receptor binds hexanucleotide repeat
expansions of C9orf72: implication in ALS and FTD
T.-P. Su, P.-T. Lee
IRP/NIDA/NIH/DHHS, Cellular Pathobiology Section, Baltimore,
USA
The GGGGCC (G4C2) hexanucleotide expansions in the non-
coding region of C9orf72 gene have been reported in cases of
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia
(FTD). Recent studies from large-scale genetic screen in Drosophila
showed that G4C2 repeat expansion compromises the nucleocyto-
plasmic transport at the nuclear pore complex (NPC) that represents
a newly discovered mechanism of neurodegeneration. Sigma-1
receptors (Sig-1Rs) are ligand-regulated molecular chaperones and
are known to be a pluripotent modulator in living systems. Previous
studies showed that a missense mutation at Sig-1R amino acid
residue 102 (E102Q) was seen in familial ALS patients. However,
whether Sig-1Rs are involved in G4C2 repeats-mediated ALS/FTD
is unknown. Here we found that Sig-1Rs exist also at the NPC.
Further, by using the biotin pull-down assay we found that biotin-
labeled (G4C2)10 RNA repeats binds and interacts with Sig-1R-
YFP in Neuro2A cells. The endogenous Sig-1R in rat liver
microsomes was also found to bind the (G4C2)10 RNA repeats.
To further dissect the interaction domains between Sig-1R and
G4C2 RNA repeats in vitro, we generated recombinant glutathione
S-transferase (GST)-tagged proteins including full-length and 3
truncated fragments of mouse Sig-1R. The pull-down assay revealed
that full-length of recombinant Sig-1R (amino acids 1–223)
physically interacts with G4C2 RNA repeats, but not GST alone.
The majority of the Sig-1R-(G4C2)10 RNA interaction occurs on
the N-terminal (amino acids 1–79) and C-terminal fragments (amino
acids 174–223) of the recombinant Sig-1R. We propose here a novel
regulatory mechanism that Sig-1R may participate in the regulation
of hexanucleotide repeat expansions in C9orf72 by serving as a
molecular ‘sponge’ to reduce the toxicity of the RNA repeats. The
dysfunction of Sig-1R may thus relate to the disease state of ALS
and FTD. (This work was supported by IRP/NIDA/NIH/DHHS)
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Phospho- and ubiquitinated-proteomics of aging mice
brain by ITRAQ-based quantitative analysis
M. Takano1, K. Maekura1, Y. Ohnishi1, C. Ushie1, K. Matsuura2, S.
Matsuyama3
1Kobe Gakuin University, School of Pharmaceutical Sciences,
Kobe, Japan
2Osaka Ohtani University, Faculty of Pharmacy, Osaka, Japan
3Kobe University, Biosignal Research Center, Kobe, Japan
Aim: Aging is thought as the main risk to develop neurode-
generative disorders and dementia. To elucidate the mechanism of
protein modiﬁcation in the normal aging brain, we evaluated the
change of phosopho- and ubiquitinated-proteins.
Methods: C57BL/6 mice were sacriﬁced at 3 or 21 months of
age, and their coritices were isolated and sonicated. Phospho-
proteins and ubiquitinated-proteins were enriched by using PhosPro
or Ubiquitinated protein enrichment kit. After phospho-proteins and
ubiquitinated-proteins were labeled by iTRAQ, labeled peptides
were analyzed by MALDI-TOF MS/MS.
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Results: There were 328 phospho-proteins to be identiﬁed in
mice cortex, and 15 phospho-proteins were signiﬁcantly changed
between 3 vs 21 months mice cortex. Six proteins were increased in
21 months mice cortex. Nine proteins were decreased in 21 months
mice cortex. Moreover, there were ~200 ubiquitinated-proteins to be
identiﬁed in mice cortex, and 7 ubiquitinated -proteins were changed
between 3 vs 21 months mice cortex.
Conclusion: These ﬁndings indicate that the changed post-
transcriptional modiﬁcations may play an important role in devel-
oping neurodegenerative disorders and dementia.
MTU05-16
In vivo regulation of chondroitin sulfate gene to recovery
from spinal cord injury and brain infarction
K. Takeuchi1, N. Matsushita1, H. Kawano2, M. Igarashi3
1Aichi Medical University, Dept. of Cell Biology, Nagakute, Japan
2Teikyo University, Dept. of Health Sciences, Tokyo, Japan
3Niigata University, Div. of Mol. Cell Biol., Niigata, Japan
Injured adult neurons in the mammalian central nervous system
(CNS) rarely regenerate, because some of the intracellular and cell-
surface environmental factors inhibit axon regrowth. Chondroitin
sulfate (CS) is the most abundant and potent exogenous inhibitor of
axonal regeneration. CS degradation induces some of the axonal
regrowth following spinal cord injury by treatment of chondroitinase
ABC (ChABC). We generated null (KO) mice of CSGalNAcT1, a
key enzyme in CS biosynthesis. We show that KO mice recovered
much faster and more completely from induced SCI than do wild-
type mice and even ChABC treatment mice (Takeuchi et al., Nature
Commun.). Cerebral Infarct volumes of CSGalNAcT1 KO mice
were smaller than those of WT in mice subjected to cerebral artery
ligation. Our results show that reduction of CS synthesis by the
controlling the CSGalNAcT1-expression is a best strategy for spinal
cord injury and stroke treatment. We try to establish the accurate
inhibition systems of CS-expressions in vivo from the drug
screening system (small molecule compound) and siRNA and
antisense oligo study, to regulate of the CSGalNAcT1-expression in
the injury area. We selected the many kinds of drugs to regulate the
CS-expressions and siRNAs to inhibit the up-regulations of those
genes. The sponge forms biomaterials impregnated with a mixture
containing small molecule compounds or siRNAs was placed on the
lesion area in mice suffered neural injuries. The recovery of these
mice which treated with drug delivery systems reached the levels of
satisfactory amelioration comparable to those of KO mice. Taken
together, our results indicated that our drug and delivery system is a
promising therapeutic target for treatment of the spinal cord injury
and brain infarction, and many treatments of the neural damage.
MTU05-17
Protective role of PTEN in cardiovascular regulation
during experimental brain stem death
J. C. C. Wu, S. H. H. Chan, C.-Y. Tsai
Kaohsiung Chang Gung Memorial Hospital, Institute for
Translational Research in Biomedicine, Kaohsiung City, Taiwan
We established previously that activation of PI3K/Akt signaling,
leading to upregulation of nitric oxide synthase II (NOS II)/
peroxynitrite cascade in the rostral ventrolateral medulla (RVLM),
the origin of a ‘life-and-death’ signal detected from arterial pressure
that reﬂects failure of central cardiovascular regulation that precedes
brain stem death, underpins the cardiovascular depression induced
by the organophosphate pesticide mevinphos. The tumor suppressor
phosphatase and tensin homolog (PTEN) is a lipid phosphatase and
a major negative regulator of PI3K/Akt signaling. This study
investigated the role of PTEN in cardiovascular regulation during
experimental brain stem death. In adult male Sprague-Dawley rats
maintained under propofol anesthesia (25 mg/kg/h, i.v.), microin-
jection of Mev (10 nmol) into the RVLM induced an increase (pro-
life phase), followed by a decrease (pro-death phase) in the ‘life-
and-death’ signal and elicited cardiovascular depression (pro-death
phase) during experimental brain stem death. Real-time PCR or
Western blot analysis showed that the mRNA or protein level of
PTEN was insigniﬁcant changes in RVLM during experimental
brain stem death. However, progressive augmentation in PI3K, Akt
or PTEN activity and decrease in oxidized form of PTEN that
paralleled the increase in NOS II or peroxynitrite level in RVLM.
Pretreatment by microinjection into the bilateral RVLM of anti-
PTEN antiserum 1 h before or PTEN siRNA 48 h before admin-
istration of Mev signiﬁcantly diminished the augmented in ‘life-and-
death’ signal during pro-life phase and enhanced the progressive
hypotension during pro-death phase, and potentiated the increase in
Akt activity, NOS II or peroxynitrite level. We conclude that PTEN
in RVLM sustains cardiovascular regulatory functions during
experimental brain stem death via downregulation of NOS II/
peroxynitrite signaling pathway as a negative regulator of PI3K/Akt
cascade. In addition, the activation of PTEN was regulated by post-
translational mechanism in this process.
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The ERR gene expression on spinal cord after brachial
plexus root avulsion
P. Zilundu, L. Liu, Y. Tang, Z. Ling, G. Yu
Department of Anatomy, Zhongshan School of Medicine, Sun Yat-
sen University, Human Anatomy, Guangzhou, China
Estrogen-Related Receptor c (ERR c) is a member of a small
group of orphan nuclear receptor transcription factors that been
implicated in diverse physiological and pathological processes. In
the central nervous system of mice, the transcription factor ERR c is
highly expressed during neuronal differentiation and in mature
gamma but not alpha motor neurons. Studies in mice provided
evidence that transcriptional programs deﬁne functionally distinct
motor neuron subpopulations, even within anatomically deﬁned
motor pools. Therefore, ERR c is a potential therapeutic target and
also a subject of further signalling inquiry due to co-localisation
with other transcription factors. In our rat model of brachial plexus
injury, the pattern of expression of ERR c and its co-localisation
with other transcription factors in the rat spinal cord is unknown
hence this pilot study. The expression proﬁle of ERR c and its co-
localisation with NeuN or ATF-3 in motor neurons of brachial
plexus avulsed rats was assessed using Western Blotting, Immuno-
histochemistry and Immunoﬂuorescence. The results of western
blotting showed that the level of ERR c protein at 3, 7 and 14 days
post avulsion was signiﬁcantly lower in the ipsilateral half than that
in the contralateral half of spinal cord (All p < 0.05). ERR c
positive motor neurons were also notably lower in number in the
ipsilateral side compared to that in the contralateral side at 3, 7 and
14 days post avulsion; implying they were progressively being lost.
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ATF-3-positive motor neurons were the same as Fluorogold or ERR
c-positive motor neurons at day three. Almost all large (alpha) and
small (gamma) ERR c-positive motor neurons were also NeuN-
positive. However, a few of these were ERR con/NeuNoff. These
results provide proof that ERR c is a non-speciﬁc marker of gamma
motor neurons in rats; as such this speciﬁc transcriptional program
cannot be used to deﬁne functionally distinct motor neuron
subpopulations in rats as was the situation in mice.
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Differential distribution of kainate receptor auxiliary
subunits Neto1 and Neto2 in the developing central
nervous system
E. A. Momany, E. Molnar
University of Bristol, Centre for synaptic Plasticity, School of
Physiology, Pharmacology and Neuroscience, Bristol, United
Kingdom
Neuropilin and tolloid like proteins (Neto1 and Neto2) were
identiﬁed as auxiliary subunits of endogenous kainate receptors
(KARs) in the central nervous system (CNS). They affect almost all
aspects of KAR signalling, including channel gating, pharmacology
and trafﬁcking. The regional distribution and spatio-temporal corre-
lation between pore-forming (GluK1-5) and auxiliary KAR subunits
is fundamental to understand the molecular composition and func-
tional properties of these receptors in the developing and adult CNS.
Here, we show the regional expression proﬁles of Neto1 and Neto2
proteins at different stages of rat brain development from embryonic
day E14 to postnatal day P90 using an in situ blotting technique. Our
results established a complementary and often overlapping expression
proﬁles of Neto1, Neto2 and pore-forming KAR subunits GluK2/3
and GluK5 in developing and mature CNS. In the hippocampus,
Neto1 is mainly expressed in the stratum lucidum of the CA3 region
whereas Neto2 was identiﬁed mainly in the hilus of the dentate gyrus
region of the hippocampus. The immunoreactivity of Neto1 in the
cerebellum was very weak and correlated to GluK5 subunit protein
expression pattern. On the other hand, Neto2 was strongly expressed
in the cerebellar granular cell layer in the same way as GluK2/3 KAR
subunit proteins. Both Neto1 and Neto2 showed a higher expression
level in the inner cortical layers than the outer layers, a ﬁnding that
well matched with pore-forming KAR subunits expression proﬁles.
Our experiments established different spatio-temporal changes for
individual KAR proteins during development. For example, we have
detected a gradual increase in Neto1 expression between P0 and P90
in the stratum lacunosum moleculare area of the hippocampus, while
Neto2 expression increased until P14 followed by a gradual decrease
until P90 in the same region, which indicates a differential change in
subunit ratios. Collectively these results suggest region-speciﬁc
changes in subunit compositions and functional properties of KARs
throughout development. This work was supported by the Hashemite
University, Jordan and BBSRC, UK (grant BB/J015938/1).
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A novel role for very long chain fatty acids in brain
function
R. Anderson1, 2, 3, B. Hopiavuori1, 3, R. B. Brush2, 3, D. Sherry1, 4,
F. Deak1, 5, M.-P. Agbaga1, 2, 3
1OUHSC, Oklahoma Center for Neuroscience, Oklahoma City, USA
2OUHSC, Ophthalmology, Oklahoma, USA
3OUHSC, Dean McGee Eye Institute, Oklahoma, USA
4OUHSC, Cell Biology, Oklahoma, USA
5OUHSC, Geriatric Medicine, Oklahoma, USA
Purpose: ELOngation of Very Long chain fatty acids-4
(ELOVL4) is an elongase responsible for biosynthesis of very long
chain (VLC; ≥ C28) fatty acids, making VLC polyunsaturated fatty
acids (VLC-PUFA) in retina and testes, and VLC saturated fatty
acids (VLC-SFA) in skin and brain. Homozygous inheritance of the
Stargardt (STGD3) mutation in ELOVL4 causes a CNS phenotype
in humans, including seizures, intellectual disability, spastic
quadriplegia, and death. We hypothesize that ELOVL4-synthesized
VLC-SFA play an essential role in neural cell structure and function.
Methods: We generated a successful animal model for STGD3/
STGD3 inheritance (/). ELOVL4 localization within the CNS
was determined in wild type mice (+/+) using immunoﬂuorescence
(IF) microscopy. Hippocampal lipids were analyzed by mass
spectrometry. Synaptic membrane fractionation was performed on
baboon hippocampus for lipid analysis. Hippocampal slices from
(+/+) and (/) mice were subjected to spontaneous multi-electrode
array (MEA) recordings. Primary neuronal cultures from hippocam-
pus of (+/+) and (/) mice were subjected to FM1-43 assessment
of synaptic vesicle exocytosis rates.
Results: STGD3/STGD3 mice developed seizures at P19
followed by death at P21. Hippocampal lipidomic analysis of
(+/+) mice conﬁrmed the presence of 28:0/30:0 in sphingolipids.
Membrane fractionation of baboon hippocampus revealed enrich-
ment of 28:0/30:0, but not VLC-PUFA, in synaptic vesicle
membranes. MEA recordings showed a signiﬁcant increase in the
amplitude and decrease in the inter-spike interval of action
potentials in (/) vs (+/+) hippocampal slices. FM1-43 studies
showed a signiﬁcant increase in synaptic vesicle exocytosis rates in
(/) vs (+/+) primary hippocampal neurons.
Conclusions: This is the ﬁrst study to demonstrate that muta-
tions in Elovl4 cause a CNS phenotype in an animal model. These
studies suggest a neuron-speciﬁc role for VLC-SFA in the regulation
of pre-synaptic synaptic function by impacting the rate of synaptic
vesicle release.
MTU07-03
In vivo evaluation of interaction between GTP
cyclohydrolase 1 and its regulatory protein GFRP in the
rat brain stem
J.-P. Bellier1, Y. Xie2, I. Tooyama1, H. Kimura1
1Shiga University of Medical Science, Molecular Neuroscience
Research Center, Otsu, Japan
2Beihua University, Life Science Research Center, Jilin, China
6R-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4) is an essential
co-factor required for the enzymatic activity of the nitric oxide
synthases and the BH4-dependent amino acid hydroxylases:
phenylalanine hydroxylase, tyrosine hydroxylase, and tryptophan
hydroxylase. BH4 is therefore important for the synthesis of nitric
oxide and monoamine neurotransmitters such as 5-hydroxytrypto-
phan (serotonin), dopamine, adrenaline and noradrenaline.
The enzyme GTP cyclohydrolase 1 (GCH1) (EC: 3.5.4.16) is the
ﬁrst and rate-limiting enzyme in the metabolic pathway for de novo
biosynthesis of BH4. Several factors are involved in the regulation
of GCH1 activity. Among them, the GCH1 feedback regulatory
protein (GFRP) is known to mediate the feedback inhibition of
GCH1 activity by BH4 at least in vitro. In vivo, little is known about
regulation of GCH1 activity by GFRP.
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We investigated the distribution and colocalization of GCH1 and
its regulatory protein GFRP on paraformaldehyde-ﬁxed sections of
rat substantia nigra and locus coeruleus using home-made antisera.
Interaction between GFRP and GCH1 was examined using blue-
native-PAGE, and BH4 levels were monitored using ECD-HLPC in
the presence of a GCH1 inhibitor. Immunolocalization revealed
heterogeneous expression of GFRP and GCH1 proteins among the
brain cell groups synthesizing monoamines or nitric oxide. This
preliminary biochemical investigation indicated that GFRP/GCH1
interactions seemed very scarce in these brainstem samples,
implying little or no GFRP regulation of BH4 production by the
monoaminergic neurons. These results suggest that, in vivo in the
brainstem, feedback inhibition of GCH1 activity mediated by GFRP
is unlikely to occur, at least in normal physiological condition.
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A new photochromic modulator of inhibitory CYS-loop
receptor channels
P. Bregestovski1, D. Wutz2, E. Mukhametova1, 3, A. Gomila4, X.
Rovira4, N. Camarero4, A. Nin-Hill5, M. Alfonso-Prieto5, C. Rovira5,
B. Koenig2, P. Gorostiza4, G. Maleeva1
1Institut de Neurosciences des Systemes, Aix-Marseille University,
INSERM, Marseille, France
2University of Regensburg, Institute of Organic Chemistry,
Regensburg, Germany
3Kazan Federal University, OpenLab Motor-Neurorehabilitation,
Kazan, Russia
4ICREA/IBEC, Department Nanoprobes and Nanoswitches,
Barcelona, Spain
5ICREA/UB, Departament Quımica Inorganica i Organica,
Barcelona, Spain
Photoswitchable molecules provide a unique tool for ion
channel’s functioning control. The technique is based on the ability
of certain molecules (azobenzenes, spiropiranes, diarylethenes) to
change their conformation upon speciﬁc wavelength illumination.
We report a soluble photochromic ligand, UR-DW285, composed of
a diazepam moiety and an azobenzene-photoisomerizeable group.
Using the patch-clamp recording of currents mediated by ionic
channels expressed in CHO cells we have analyzed its action on
GABA receptors (GABARs) and 5 subtypes of homomeric glycine
receptors (GlyRs) formed by human alpha1, 3, mouse alpha2 and
zebraﬁsh alpha1, 2 subunits. At a visible light, UR-DW285 (50 lM)
inhibited GABAR-mediated currents by ~60%. UV illumination
abolished the inhibition, suggesting that UR-DW285 depresses
GABARs only in trans-state. UR-DW285 also potently modulated
GlyRs, with distinct effects for different subunits. In trans-state UR-
DW285 inhibited zebraﬁsh alpha1 GlyRs-mediated currents
(34  2%) and UV reinforced the inhibition (47  2%). At
saturating glycine (> 300 lM), the effect of DW285 was negligible,
suggesting a competitive-like mechanism of action. In contrast, on
mammalian alpha2 and alpha3 GlyRs, UR-DW285 was not active at
UV illumination, while at the visible light it caused strong inhibition
(IC50 ~ 20 lM), which was preserved at saturating glycine,
suggesting an additional, non-competitive pore-site of UR-DW285
action. This was supported by experiments with alpha1 GlyRs
containing a mutation in the pore-lining TM2 helix (G254A) and by
molecular modeling. The mutant behaved similarly to alpha2 GlyRs.
However, in behavioral experiments performed with whole-body
illumination of zebraﬁsh, no signiﬁcant effects of UR-DW285 were
observed, possibly due to opposite UV effects imparted by UR-
DW285 to the main inhibitory ligand-gated receptors - GABARs
and alpha1 GlyRs. This discrepancy is currently under study.
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Adenosine A2A receptors stabilizes inhibitory synapses
during development
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Russeau1, 2, 3, R. Cunha5, 6, M. Esclapez4, C. Bernard4, S.
Levi1, 2, 3
1INSERM-U839, Paris, France
2Universite Pierre et Marie Curie, Paris, France
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Marseille, France
5University of Coimbra, Center for Neuroscience and Cell Biology,
Coimbra, Portugal
6University of Coimbra, Institute of Biochemistry, Coimbra,
Portugal
In the adult brain, adenosine, controls neurotransmitter release
mainly through inhibitory A1 and facilitator A2A receptors.
However, its role in development remains to be elucidated. Here,
we addressed the role of A2AR-mediated signalling during
GABAergic synaptogenesis in the hippocampus.
Using rat primary hippocampal cultures, we found an increase of
A2AR expression during the period of synaptogenesis. This
developmental expression of A2AR was correlated with a role of
A2AR in the stabilization of nascent GABA synapses, a regulation
restricted to the period of synaptogenesis. Downregulating A2AR
expression with a shRNA approach in isolated postsynaptic cells led
to a loss of synapses equivalent to that seen upon A2AR activity
blockade, reporting the A2AR-mediated synapse stabilization is a
cell autonomous process that requires A2AR activation in the
postsynaptic cell.
Adenosine can be secreted by both glia and neurons; however we
found that activity-dependent release of neuronal adenosine is
sufﬁcient to stabilize newly formed GABA synapses. Using live cell
imaging, we showed adenosine signalling stabilizes active nascent
inhibitory synapses. We then characterized the molecular mecha-
nism downstream postsynaptic A2AR. We report the contribution of
the Adenylyl cyclase/cAMP/Protein Kinase A (PKA) signalling
cascade and we identiﬁed a key target of PKA in this regulation, the
postsynaptic scaffolding molecule gephyrin. Finally, we showed the
A2AR-mediated stabilization of the post- and pre- synapse required
the trans-synaptic Slitrk3-PTPd complex.
These data allowed us to propose that adenosine signalling acts as
a sensor of active presynaptic terminals to stabilize newly formed
GABAergic synapses during synaptogenesis.
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In vivo photomodulation of GABA and glycine receptor
channels
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The effects of the photochromic compound, UR-DW290,
composed of diazepam and azobenzene groups, were studied in
zebraﬁsh behaviour and function of ionic currents mediated by
heterologously expressed GABARs and GlyRs using whole-cell
patch-clamp recordings. Under visible light, currents mediated by
GABA receptors (a1/b2/c2 subunits) were weakly inhibited by
50 lMUR-DW290, while under UV illumination the inhibition was
entirely absent. GlyRs were more effectively and subunit-speciﬁ-
cally inhibited by UR-DW290. On mammalian or zebraﬁsh a2
GlyRs, at visible light, UR-DW290 provoked inhibition of currents
induced by 20 lM glycine on 38  7% and 32%  3, respectively.
Upon UV illumination suppression was stronger: 73  6% and
64%  2 for mammalian or zebraﬁsh a2 GlyRs, respectively.
Action on a1 GlyRs exhibited similar tendency, although with less
efﬁciency. With increase of glycine concentration inhibitory power
of UR-DW290 decreased, suggesting a competitive mechanism of
the antagonist action. The behavioural analysis of zebraﬁsh larvae (7
and 8 days post fertilization) showed an excitatory effect of UR-
DW290. Animals treated with UR-DW290 (100 lM) experienced
higher activity behaviour during the relaxation period (20 min in
absence of light stimuli) in comparison to controls. Notwithstanding
their permanent excitation state, under 365 nm light animals treated
with UR-DW290 evoked an overreaction to light changes which
was reduced to control animal levels applying blue light (455 nm).
We found signiﬁcant differences for different behavioural param-
eters between UR-DW290 treated groups and controls including
total animal activity and swimming distance, startle responses and
habituation time. We observed how in the presence of UR-DW290
animal responses to light stimuli can be tuned in a dose dependent
way and how swimming behaviour, such as exploratory capacities,
can be triggered.
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Impaired retrieval of synaptobrevin to synaptic vesicles
causes a progressive reduction in exocytosis
S. Gordon1, A. Kokotos2, J. Marland2, M. Cousin2
1Florey Institute of Neuroscience and Mental Health, University of
Melbourne, Parkville, Australia
2University of Edinburgh, Centre for Integrative Physiology,
Edinburgh, UK
Synaptophysin is an integral synaptic vesicle (SV) protein which
is responsible for facilitating the retrieval of the essential v-SNARE
synaptobrevin II (sybII) back to SVs during endocytosis. Here, we
use synaptophysin knockout hippocampal neurons to investigate the
consequence of impaired sybII retrieval on the efﬁciency of
exocytosis. Synaptophysin knockout (KO) hippocampal neurons
were transfected with vGLUT-pHluorin and mCerulean empty
vector (KO) or synaptophysin-mCerulean (rescue), and were
subjected to 4 repeated trains of 300 action potentials (10 Hz),
and changes in pHluorin ﬂuorescence monitored. We ﬁnd that upon
repeated stimulation there is a progressive reduction in evoked
exocytosis in synaptophysin KO neurons (p < 0.05), whilst the
efﬁciency of exocytosis is maintained in neurons rescued with
synaptophysin. This is due to a reduction in sybII retrieval back to
synaptic vesicles, and importantly, can be rescued by increasing the
basal load of sybII on SVs by transfecting neurons with exogenous
sybII. These ﬁndings demonstrate that perturbed sybII retrieval has
knock-on consequences for exocytic efﬁciency, and suggests that
the ﬁdelity of neurotransmission may be compromised in systems
with defective sybII trafﬁcking. This may provide the molecular
basis for the cognitive impairments that are seen in both synapto-
physin knockout mice, and in individuals with X-linked intellectual
disability who harbour mutations in synaptophysin.
MTU07-08
Calcium channel surface dynamic inﬂuences synaptic
transmission
J. Heck1, P. Parutto2, R. Freund1, A. Ciuraszkiewicz1, A. Bikbaev1,
M. Andres-Alonso3, A. Fejtova3, 4, D. Holcman2, M. Heine1
1Leibniz-Institute for Neurobiology, RG Molecular Physiology,
Magdeburg, Germany
2Ecole Normale Superieure, Theoretical Modelling of Cellular
Physiology, Paris, France
3Leibniz-Institute for Neurobiology, RG Presynaptic Plasticity,
Magdeburg, Germany
4Universit€atsklinikum Erlangen, Molekulare Psychiatrie, Erlangen,
Germany
The localization of voltage gated calcium channels (VGCCs)
within the presynaptic active zone is critical for synaptic transmis-
sion. Using single particle tracking photoactivation localization
microscopy (sptPALM) we localize VGCCs within active synapses
and determine their surface dynamics in the membrane. Molecular
interactions between active zone proteins, the C-terminus of VGCCs
and vesicles have been shown to essentially regulate synaptic
transmission. Whether interactions between VGCCs and scaffold
proteins guide channel localization and mobility has been tested by
using Cav2.1 C-terminal splice variants. Here, alternative splicing of
exon 47 results in the expression of a shorter C-terminus (D47)
lacking a variety of described protein-protein interactions.
Both splice variants, CaV2.1D47 and CaV2.1+47 accumulated into
the presynaptic terminals and co-localize with presynaptic proteins
as Bassoon, RIM and Munc13 and the vesicular protein synapsin.
The shorter CaV2.1D47 was signiﬁcantly more mobile compared to
CaV2.1+47 but showed similar conﬁnement and dwell time within
the synapse. Evoked presynaptic calcium signals as well as
postsynaptic currents were similar in CaV2.1+47 or CaV2.1D47
dominated synapses.
Transient light induced immobilization of the presynaptic Cav2.1
via cryptochromes lead to a recruitment of VGCCs to the synapse,
alterations in the presynaptic calcium response and enhancement of
vesicular release probability. Thus, despite their conﬁnement in the
active zone, VGCCs are highly mobile, changing their position in
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respect to ready releasable vesicles and consequently dominating the
mode of vesicular release. Mobile VGCCs primarily promote single
vesicular release, whereas clustering of the channels induces multi-
vesicular release. Here, we postulate that fast reorganization of the
relative positioning of calcium channels towards synaptic vesicles is
a dominant component of short term plasticity and hence most
relevant for sensory input processing and neuronal communication
in local networks.
MTU07-09
New photoswitchable neuromuscular blockers: design,
synthesis, and physicochemical/biological evaluation
C. Herrera-Arozamena 1, O. Martı-Marı1, M. de la Fuente
Revenga2, C. A. Villalba-Galea3, M. I. Rodrıguez-Franco1
1Spanish National Research Council, Medicinal Chemistry Institute,
Madrid, Spain
2Virginia Commonwealth University, Department of Physiology and
Biophysics, Richmond, USA
3University of the Paciﬁc, Department of Physiology and
Pharmacology, Stockton, USA
Nicotinic acetylcholine receptors (nAChRs) are widely dis-
tributed in both central and peripheral nervous system (CNS and
PNS, respectively) and belong to the ligand-gated ion-channel
superfamily. They are composed by combinations of a, b, g, d, and
e subunits, which deﬁne different tissue-speciﬁc nAChR subtypes.
nAChRs can be broadly classiﬁed into 2 classes: neuronal nAChRs
(i.e. a7 or a4b2) and skeletal muscle nAChRs (mainly composed by
acadb subunits). In the PNS, muscle-type nAChRs mediate
synaptic transmission at the neuromuscular junction.
The alkaloid pancuronium is used in general anesthesia as muscle
relaxant. In spite of being common used in the clinic, pancuronium
cause a number of adverse side effects in patients, including
increased heart rate, blood pressure and cardiac output, respiratory
depression and apnea. The cause of these side effects remains
unknown, although a recent study suggests a mechanism involving
targeting of nAChR in the CNS.
Recently, we have started the design, synthesis, and biological
evaluation of new selective photoswitchable ligands of muscular
nAChR with lower afﬁnity for neuronal receptors, with the objective
of inducing light-controlled skeletal muscle paralysis hence reduc-
ing CNS-related adverse effects. In this work, we have obtained new
compounds that combine structural requirements of pancuronium
with a photoisomerizable azobenzene scaffold.
The new photoswitchable diazene-based compounds display
good water solubility, can be easily isomerized between the E- and
Z- conformations by irradiation at 254 and 365 nm and are potent
nicotinic ligands with a clear selectivity (up to 60-fold) for the
muscular nAChRs (Ki = 35–42 nM), compared to neuronal a7
nAChRs (Ki = 910–2500 nM) and a4b2 nAChRs (Ki > 10 lM).
Moreover, all compounds are predicted to be not able to enter in the
CNS, thus avoiding potential undesired central side-effects.
MTU07-10
Sleep deprivation (SD) impair learning and memory by
altering synaptic transmission: a proteomic approach
V. Jain, U. Panjwani
Defence Institute of Physiology and Allied Sciences, Department of
Neurophysiology, Timarpur, New Delhi, India
Sleep quality have shown a direct correlation with good health.
Sleep Deprivation (SD) may increase the risk for neurological
disorders like stroke and Alzheimer’s disease. SD can inﬂuence
cognition, memory, and sleep/wake homeostasis and can cause
impairments in many physiological processes. As, the Hippocampus
plays a pivot role in learning and memory, therefore the present
study was undertaken to examine proteomic changes occurring in
hippocampus following chronic partial SD. Male Sprague Dawley
rats were exposed to 72 h simultaneous SD in a novel SD cage.
After exposure hippocampi was isolated and further processed for
proteome proﬁling through LC-MS/MS. Comparisons of the
proteome proﬁles of hippocampus revealed that chronic SD
exposure cause alteration in (≥1.5-fold) in 71 proteins; these
changes in protein expression were validated by western blot or
immunohistochemistry. String and IPA analyses of identiﬁed
proteins suggested that SD may inﬂuence proteins which belong
to a diverse variety of functional classes including cell death,
proteins involved in synaptic transmission, gliotransmission oxida-
tive stress metabolism, growth factors and proteins associated with
signalling. SD decreases expression of synaptic proteins i.e.
synaptophysin, PSD-95and synapsin which further validated by
western blotting. Golgi staining revealed deceases in dendritic
arborisation and spine density on SD exposure. Present study also
reveals SD mediated impairment in BDNF/TrkB signaling which
may accounts for SD induced memory impairment.
MTU07-11
Physiological roles of glutamate secreted from VGLUT3-
expressing neurons
O. Kljakic1, 3, H. Janickova3, M. Al-Onaizi1, 3, S. Mestikawy4, M.
Prado1, 2, 3, V. Prado1, 2, 3
1University of Western Ontario, Department of Anatomy and Cell
Biology, London, Canada
2University of Western Ontario, Department of Physiology and
Pharmacology, London, Canada
3Robarts Research Institute, Schulich School of Medicine and
Dentistry, University of Western Ontario, London, Canada
4Douglas Mental Health University Institute, Department of
Psychiatry, McGill University, Quebec, Canada
Vesicular glutamate transporter 3 (VGLUT3) stores glutamate
(Glu) in vesicles of neurons that commonly secrete other neuro-
transmitters, such as striatal cholinergic interneurons (CINs) and
serotonergic neurons. In CINs, VGLUT3 expression allows for Glu
release, but can also facilitate vesicular storage of acetylcholine
(ACh). Whether Glu released by VGLUT3-expressing neurons has
signiﬁcant physiological functions beyond supporting ACh neuro-
transmission is still poorly understood. We hypothesized that direct
activation of VGLUT3 neurons can modulate behaviour. To
investigate this possibility, we used a VGLUT3Cre driver to
chemogenetically activate VGLUT3-positive neurons in the mouse
brain. Two mouse lines were generated: one in which an excitatory
Designer Receptor Exclusively Activated by Designer Drugs (qM3-
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DREADD) is expressed in VGLUT3-positive neurons
(VGLUT3Cre-DREADD) and a second line in which we knocked
out release of ACh from these neurons (VGLUT3Cre-VAChTfx/fx-
DREADD) in addition to expressing DREADD. This allowed us to
activate neurotransmitter secretion and start to isolate Glu released
from VGLUT3-positive neurons. Upon clozapine-N-oxide (CNO)
injection, we found that activation of VGLUT3Cre-DREADD
neurons caused decreased exploratory activity. However, the
hypoactivity was not related to motor deﬁcits or alterations in
mood and anxiety. Moreover, elimination of ACh release in
VGLUT3Cre-VAChTfx/fx-DREADD mice produced the same
behavioural phenotypes, indicating ACh release may not impact
the hypoactive phenotype. Thus, these results suggest that activation
of VGLUT3-positive neurons produces an overall suppression of
movement. Future experiments will investigate the brain regions
involved in this phenotype and the contributions of other neuro-
transmitters. Ultimately, these experiments will broaden our under-
standing of glutamatergic transmission, speciﬁcally clarifying if Glu
secretion from VGLUT3 neurons has speciﬁc physiological func-
tions independent of their co-transmitter.
MTU07-12
Novel pharmacological modulators of glycine receptors
function
G. Malieieva1, S. Buldakova1, D. Wutz2, A. Gomila3, E.
Mukhametova1, 4, X. Rovira3, N. Camarero3, B. Koenig2, P.
Gorostiza3, P. Bregestovski1, 5
1Aix-Marseille University, INSERM, Institut de Neurosciences des
Systemes, Marseille, France
2University of Regensburg, Institute of Organic Chemistry,
Regensburg, Germany
3ICREA/IBEC, Nanoprobes and Nanoswitches, Barcelona, Spain
4Kazan Federal University, Open Lab of Motor
Neurorehabilitation, Kazan, Russia
5Kazan State Medical University, Department of Biochemistry,
Kazan, Russia
In our studies, we are searching for new pharmacological ways of
glycine receptors (GlyRs) modulation using the expression of
speciﬁc subunits, mutagenesis, electrophysiology and molecular
modeling. Here will be presented 2 new compounds and photo-
switchable drug for GlyRs activity regulation. Using electrophys-
iological recordings from cells heterologically expressing receptors
of known composition, we discovered that ginkgolic acid (GA) is a
subunit-speciﬁc potentiator of GlyRs. In nanomolar concentration, it
strongly augmented the glycine-induced currents without effect on
alpha2 or alpha3 GlyRs. Mutagenesis analysis suggests that residues
T59A/A261G/A303S are involved in this potentiation. We also
discovered that anti-inﬂammatory drug, niﬂumic acid (NFA), blocks
the ion-conducting pore of GlyRs with higher afﬁnity to alpha2 and
alpha3 subunits in comparison with alpha1. By mutagenesis analysis
and molecular modeling, the bonding sites of NFA action in the pore
of GlyR were determined. Recently, we have developed a ﬁrst
subunit-speciﬁc azobenzene-based photoswitchable modulator of
GlyRs (UR-DW285). At UV illumination, UR-DW285 was not
active on alpha2 and alpha3 GlyRs while at the visible light it
caused strong inhibition (IC50 ~ 20 lM). In contrast, on alpha1
GlyRs, UV illumination reinforced inhibition of currents and UR-
DW285 worked as the competitive antagonist, suggesting 2 different
binding sites for the drug. Mutation G254A in the pore-forming
TM2 domain of alpha1 GlyRs prevented the action of UR-DW285
at UV illumination, indicating one of the sites of UR-DW285 action.
These observations established novel modulators of GlyRs and
might be used for speciﬁc control of glycinergic activity in
experimental conditions and for the development of clinically
relevant modulators.
MTU07-13
Pharmacology and crystal structure of novel 2,3-
quinoxalinediones at kainate receptors
S. Møllerud, J. S. Pallesen, D. Pasini, L. Marconi, L. Han, J.
Bornholt, T. N. Johansen, J. S. Kastrup, D. Pickering, K. Frydenvang
University of Copenhagen, Department of Drug Design and
Pharmacology, Copenhagen, Denmark
Ionotropic glutamate receptors (iGluRs) are the primary media-
tors of fast excitatory neurotransmission in the mammalian CNS
where they are involved in learning and memory formation. iGluRs
are important for normal brain function and thus disturbances in the
iGluR system are associated with the pathophysiology of CNS
diseases such as epilepsy, schizophrenia and depression. Selective
tool compounds are therefore needed to address the functional roles
of different types of iGluRs. A few selective compounds that can
discriminate between AMPA and kainate (KA) receptors are
available. However, within the KA receptor family (GluK1-5) only
compounds with selectivity towards GluK1 exist [1]. Thus, there is
an unmet need for tool compounds with selectivity towards the
remaining KA receptor subunits.
Here we report the pharmacology of a series of novel N1-
substituted 2,3-quinoxalinediones, as well as the crystal structure of
one compound (JP-10-7A) in the GluK1 ligand binding domain
(GluK1-LBD) at 1.85 A resolution. Radioligand binding experi-
ments indicated that most of the compounds had similar binding
afﬁnities at GluK1 and GluK3, but a few had higher afﬁnity at
GluK3 and were thus GluK3-preferring.
The GluK1 binding mode of the JP-10-7A 2,3-quinoxalinedione
scaffold is similar to that of another published 2,3-quinoxalinedione
ligand, (S)-2-amino-4-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-6-
yl)-butanoic acid (PDB-entry 4QF9), with the substituent in the
N1-position pointing out of the binding pocket. Whereas agonists
induce a closure of domain D2 towards D1, antagonists stabilize an
open conformation of the GluK1-LBD. Domain opening of GluK1-
LBD with JP-10-7A bound (compared to glutamate bound GluK1-
LBD PDB-entry 2F36, molA) is ~30°, which is consistent with an
antagonist binding mode. Functional electrophysiological (TEVC)
experiments indeed showed these compounds to be antagonists at
cloned, homomeric KA receptors. The structure and pharmacology
will be valuable for design of new and more GluK3-selective
quinoxalinedione analogues.
References:
[1] Jane et al., (2009) Neuropharmacology, 56, 90–113
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Inﬂuence of astrocytic glutamine transporter SN1
deﬁciency on electrophysiological correlates of
glutamatergic transmission
M. Popek1, B. Bobula2, J. Sowa2, G. Hess2, J. Albrecht1, M.
Zielinska1
1Mossakowski Medical Research Centre PAS, Neurotoxicology,
Warsaw, Poland
2Institute of Pharmacology PAS, Physiology, Cracow, Poland
The N-system glutamine transporter SN1 preferentially transfers
glutamine out of astrocytes (Chaudhry et al., Cell 1999), and its
depletion causes accumulation of ammonia-derived glutamine in
astrocytes in vitro (Zielinska et al., 2015). Since glutamine delivery
to neurons is a prerequisite of active glutamatergic transmission
(Billups et al., 2013), we hypothesized that SN1 deﬁciency will
impair its electrophysiological manifestations.
We used C57Bl6 mice in which knockdown SN1 protein in
prefrontal cortex was induced by vivo-morpholino (VM) technique.
In all groups SN1 protein expression analysis, HNMR measure-
ments and electrophysiological studies of the pertinent brain regions
were conducted.
In the prefrontal cortex of mice with local knockdown we
observed decreased expression of SN1 protein level by ~55%.
HNMR analysis of a pertinent brain region revealed ~12% decrease
in glutamate level (a sum of glutamine plus glutamate was decreased
by ~15%) and a lack of changes in total glutamine level. KO-SN1
mice showed reduced amplitudes of ﬁeld potentials evoked in layer
V horizontal connections (Vmax was reduced by ~50%) while
amplitudes of responses evoked in vertical layer V – layer II/III
connections were unchanged. The resting membrane potential of
KO-SN1 pyramidal neurons from layer II/III was less negative than
control neurons (unchanged in layer V). A tendency toward increase
in the mean frequency of sEPSCs in pyramidal neurons originating
from the layer II/III of KO-SN1 animals was observed, opposite to
the changes in layer V. The causes of insensititvity of cerebral
cortical layers other than layer V to SN1 knockout remains to be
elucidated.
This result supports the hypothesis that SN1 transporter deﬁ-
ciency reduces the neurotransmitter glutamate content and gluta-
matergic tone in a deﬁned layer of the cerebral cortex, and
implicates glutamine retention in astrocytes as a most likely
causative factor.
Supported by Program ‘Core’ grant Pol-Nor/196190/26/2013 and
the Leading National Research Centre (KNOW) and Prelludium10
2015/19/N/NZ5/02249.
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Caffeine exposure during the period of synaptogenesis
alters hippocampal circuitry and related functions
J. Pressey1, 2, 3, F. G. Castro1, 2, 3, M. Goutierre1, 2, 3, J. C.
Poncer1, 2, 3, S. Levi1, 2, 3
1Institute du Fer a Moulin, Paris, France
2Universite Pierre et Marie Curie, Paris, France
3INSERM, UMR-S 839, Paris, France
In the adult brain, adenosine, a degradation product of ATP,
controls neurotransmitter release and synaptic plasticity through G
protein coupled A1 and A2A receptors. The activity of these
receptors is essential in normal behaviour, including learning and
memory, sleep and arousal, locomotor activity and exploration,
feeding behaviour and mood and motivation. However, the role of
these receptors in development is not well known.
Our lab has recently identiﬁed a novel mechanism by which the
adenosine signaling pathway acts as a detector and stabilizer of
active nascent inhibitory GABAergic synapses in the hippocampus.
Based on our recent ﬁndings, we propose that the deleterious
consequences of in utero and post-natal brain exposure to caffeine
(Sci Transl Med. 2013; 5(197), an antagonist of A1 and A2A
receptors, are primarily due to A2A receptor-dependent alterations
in synaptogenesis. We are now testing this hypothesis in vivo by
assessing synaptic protein expression, synapse density as well as
neuronal and network activity in the hippocampus. These experi-
ments are performed in both juvenile and adult mice injected daily
during the period of hippocampal synaptogenesis with caffeine or
the selective A2A receptor antagonist SCH58261. We are also
exploring the impact of these treatments on hippocampal-dependent
memory and susceptibility to seizures. Preliminary data show altered
hippocampal synaptogenesis, increased network activity, cognitive
deﬁcits and sensitivity to pharmacologically induced epilepsy in
treated animals. Our ﬁndings provide a better understanding of the
pathological mechanisms engaged upon early-life exposure to
caffeine.
MTU07-16
Optical control of muscarinic acetylcholine receptors
using photoswitchable bitopic ligands
F. Riefolo1, A. G. Charles1, C. Matera1, E. Claro2, R. Masgrau2, N.
Camarero1, A. G. Juanela1, P. Gorostiza1, 3, 4
1Institute for Bioengineering of Catalonia, (IBEC), Barcelona,
Spain
2Universitat Autonoma de Barcelona, (AUB), Barcelona, Spain
3Catalan Institution for Research and Advanced Studies, (ICREA),
Barcelona, Spain
4Network Biomedical Research Center on Bioengineering,
Biomaterials and Nanomedicine, (CIBER-BBN), Madrid, Spain
Muscarinic acetylcholine receptors (mAChRs) are class A
GPCRs characterized by a widespread tissue distribution and
involved in the control of numerous central and peripheral
physiological responses. The high sequence homology of the
different subtypes (M1–M5) in the transmembrane region hampers
the development of subtype selective orthosteric agonists. On the
other hand, the allosteric site, located in the extracellular loop, is less
conserved, thus muscarinic allosteric agents are commonly endowed
with a more pronounced subtype-selectivity. Recently, a new
strategy was developed towards the selective modulation of
mAChRs, i.e. the development of dualsteric ligands, which are
molecules that can bind simultaneously to both the orthosteric and
the allosteric sites of such receptors. The most interesting bitopic
ligands emerging from this investigation were hybrid derivatives
incorporating (i) iperoxo, an oxotremorine-related unselective
orthosteric superagonist, (ii) a polymethylene spacer, and (iii) a
moiety targeting the allosteric site.
Inspired by this strategy, in the course of our ongoing develop-
ment of photoswitchable ligands for the optical control of (neuro)
biological functions, we designed and synthesized a new set of light-
regulated muscarinic bitopic ligands by replacing the polymethylene
spacer chain with an azobenzene linker to serve as molecular
photoswitch. This modiﬁcation enabled the remote control of the
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mutual position between the 2 pharmacophoric moieties with light,
thus potentially modulating afﬁnity and efﬁcacy of our compounds
as a function of their photoisomerization state. One of our ligands
(P-Azo-Iper) turned out to be a potent activator of M2 receptors
under UV illumination (cis isomer), but inactive after relaxation in
the dark or under illumination with blue light or white light (trans
isomer). All compounds were investigated in binding and enzymatic
experiments. Their cellular responses were evaluated in vitro and
in vivo in the Xenopus tropicalis heart.
MTU07-17
Glycine receptor subunits expressed in retina during rat
development
R. Salceda1, G. Sanchez-Chavez1, M. A. Velazquez-Flores2, R.
Esparza-Ruız2
1Universidad Nacional Autonoma de Mexico (UNAM), Instituto de
Fisiologia Celular, Mexico City, Mexico
2Centro Medico Nacional Siglo XXI, IMSS., Laboratorio de
Genomica Funcional, Unidad de Investigacion Medica en Genetica
Humana del Hospital de Pediatrıa ‘Silvestre Frenk Freund’,
Mexico City, Mexico
Considerable evidence indicates that glycine functions as
inhibitory neurotransmitter in the vertebrate retina. Glycine exerts
its action through the glycine receptor (GlyR), which consists of 2 a
(a 1–4) and 3 b subunits. Immunohistochemical studies demon-
strated the expression of the 4 a subunits in the adult retina;
however, their proportion in adult and immature retina is unknown.
In an attempt to know the relative quantities of these subunits and its
possible signiﬁcance, we studied the mRNA and protein expression
of these subunits in the retina during the postnatal Long Evans rats
development, by qPCR and Western Blot. Animals were handled
according to the Mexican Institutes of Health Research rules. The
oligonucleotide primers employed were those described by Aroeira
et al 2011; for the a4 subunit we used exon 7–8 (Integrated DNA
Technologies). The 18S gene was used to construct a concentration
curve for GlyR subunits quantiﬁcation (T4 Oligo, Mexico). For
Western Blot we used commercially available antibodies for all the
a subunits, and quantiﬁed them using actin as loading control. We
found that mRNA expression of a1, a3, a4 and b GlyR subunits
increased gradually during development; these results match with
the protein expression pattern found for these subunits. The a2 GlyR
subunit showed the highest expression values for both mRNA and
protein, at all stages studied; being the a1 and a2 the predominant
subunits in the adult retina.
We concluded that the expression of GlyR subunits correlated
with retina cells differentiation, supporting also the role of GlyR in
retina development. The highest proportion of the a2 subunit in the
adult retina suggested the presence of monomeric and /or
heteromeric a2 GlyR in the adult and immature retina, emphasizing
its role in retina function.
MTU07-18
NG2 GLIA-speciﬁc gene knockout as a tool to understand
the impact of neuron-GLIA synaptic signaling
G. Seifert1, A. Timmermann1, A. Boehlen1, M. Skubal1, R. Jabs1, F.
Kirchhoff2, C. Steinh€auser1
1University of Bonn, Institute of Cellular Neurosciences, Bonn,
Germany
2University of Saarland, Molecular Physiology, Homburg, Germany
NG2 glia in grey matter receives direct synaptic input from
glutamatergic and GABAergic neurons. However, the functional
consequence of this input is not yet understood. During develop-
ment, NG2 glia upregulates Kir4.1 channels, leading to low
membrane resistance and a resting potential close to the K+
equilibrium potential. To test if Kir currents regulate the efﬁciency
of synaptic activation of NG2 glia, we generated NG2-CreERT2
knock-in mice where conditional knockout of the Kir4.1 gene upon
tamoxifen administration is induced.
In tamoxifen-treated mice, semi-quantitative RT-PCR of FAC
sorted NG2 glial cells proved a downregulation of Kir4.1 mRNA to
15% in the hippocampus and 50% in the cerebellum. NG2 glia
devoid of Kir currents displayed more positive resting potentials as
compared to Kir-expressing cells and a signiﬁcantly increased
membrane resistance. Monitoring NG2 glia responses upon Schaffer
collateral stimulation revealed similar EPSC amplitudes in Kir-
deﬁcient NG2 glia compared to control cells. Interestingly, short-
term plasticity of neuron-NG2 glia synapses was affected as the
presynaptic transmitter release probability at neuron-recombined
NG2 glia synapses was enhanced. To investigate the impact of
Kir4.1 deletion in NG2 glia on neural signaling, ﬁeld potentials were
recorded in the hippocampus after stimulation of Schaffer collater-
als. Long term potentiation, induced by theta-burst stimulation, was
signiﬁcantly impaired in the hippocampal CA1 region of mice with
NG2 glia-targeted Kir4.1-deﬁciency. In the hippocampus and
cerebellum, NG2 glia-targeted deletion of the Kir4.1 gene entailed
an increase of MBP and MAG mRNA in recombined cells and an
upregulation of MBP protein 8 weeks after tamoxifen injection.
These ﬁndings show that Kir4.1 channels in NG2 glial cells regulate
their excitability, inﬂuence myelination and are important for proper
hippocampal synaptic plasticity.
Supported by DFG (Priority Program 1757, STE 552/5, SE 774/6):
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Altered neuronal excitability in system XC- null mice
in vivo uncovered by chemoconvulsant challenge
S. Shahidzadeh, J. A. Hewett, S. J. Hewett
Syracuse University, Biology, Syracuse, USA
System xc
 (Sxc
), a cellular antiporter that links the import of L-
cystine with the export of L-glutamate, is an important contributor to
ambient extracellular glutamate levels. Changes in the concentration
of extracellular glutamate are known to alter synaptic strength and
neuronal excitability. Thus, whether mice null for SLC7a11 ─ the
gene that encodes the substrate speciﬁc light-chain (xCT) for Sxc

─ demonstrate alterations in neuronal excitability was assessed
herein using the chemoconvulsant kainic acid (KA). Male and
female wild-type and SLC7a11 null littermates were administered
KA either acutely (single dose of 12–15 mg/kg) or sub-acutely (6
doses administered over 150 min [22.5 mg/kg total]) after which
behavioral seizure activity as an indirect measure of excitability was
scored by an investigator blinded to genotype. Following a single
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injection of KA, 95% (19/20) of SLC7a11 null mice entered a
hyperexcitable state characterized by clonic seizure activity (i.e.
rearing with forelimb clonus) as compared to only 24% (4/17) of
wild-type mice (p < 0.0001). Strikingly, within 90 min of the sub-
acute KA dosing paradigm, 85% of wild-type mice (23/27) entered
status epilepticus whereas only 28% (7/25) of SLC7a11 null mice
did (p < 0.0001). Most of the SLC7a11 null mice (84%) became
hypomobile. Overall, our data demonstrate that neuronal excitability
in SLC7a11 null mice provoked by chemoconvulsant challenge
deviates from that of wild-type littermates in a complex manner that
differs in sign depending on the KA dosing paradigm employed.
MTU07-20
Alfaxalone alters inhibitory but not excitatory synaptic
transmission or action potential ﬁring in rat hypoglossal
motor neurons
P. Thakre, M. Bellingham
The University of Queensland, School of Biomedical Sciences,
Brisbane, Australia
Owing to its large safety margin, low cardiorespiratory depres-
sion and good pharmacokinetic and pharmacodynamic proﬁle,
alfaxalone is widely used for veterinary anaesthesia in large animals
(horses, pigs and dogs). However, small rodents like rats and mice
often show neuromotor excitation during alfaxalone anaesthesia.
Prior work suggests that alfaxalone suppresses inhibitory synaptic
transmission to hypoglossal (XII) motor neurons (MNs). However,
the effects of alfaxalone on miniature inhibitory transmission, on
spontaneous excitatory transmission, and on action potential (AP)
ﬁring have not been studied. Whole-cell patch-clamp recordings
were made from XII MNs in 300 lm-thick transverse brainstem
slices from 7–14 days-old Wistar rats after sodium pentobarbitone
anaesthesia (n = 46 from 26 rats). Spontaneous and evoked
excitatory postsynaptic currents (EPSCs), miniature inhibitory
glycinergic transmission (miniIPSCs) and AP ﬁring were recorded
at a holding potential of 60 mV using CsCl or K+ methyl sulfate-
based internal solutions, respectively. Our results show that
alfaxalone signiﬁcantly reduces miniIPSCs frequency (63.8%) and
amplitude (70.5%) to XII MNs, consistent with a reduction in
inhibitory transmission to MNs, leading to neuromotor excitation.
This effect on inhibitory transmission was particularly notable, as
alfaxalone, even at higher concentrations (10 nM–3 lM), failed to
signiﬁcantly alter either spontaneous or evoked EPSC frequency,
amplitude, half-width, rise-time and baseline holding current.
Similarly, repetitive action potential ﬁring by XII MNs was not
altered by alfaxalone. Our results show that neuro-muscular
excitation during alfaxalone anaesthesia are most likely to be
mediated by decreases in inhibitory synaptic input, without alter-
ation in spontaneous or evoked excitatory synaptic transmission, and
that alfaxalone does not excite XII MNs sufﬁciently to cause any
changes in action potential ﬁring.
MTU07-21
Probing subunit interfaces using genetically-encoded
photocrosslinkers in glutamate receptors
M. Tian1, 2, P. Paoletti1, S. Ye3
1Ecole Normale Superieure, Institut de Biologie de l’ENS, CNRS
UMR8197, INSERM U1024, Paris, France
2East China Normal University, Shanghai Key Laboratory of Brain
Functional Genomics, Shanghai, China
3University of Pierre and Marie Currie, Laboratory of
Computational and Quantitative Biology, CNRS UMR 7238, Paris,
France
NMDA receptors (NMDARs) are ionotropic receptors activated
by glutamate, the major excitatory neurotransmitter in the brain.
NMDARs are fundamental to brain development and function by
their unique capability to induce long-term synaptic plasticity that
underlies higher cognitive functions such as learning and memory.
Functional NMDARs require at least two different subunits to
assemble as a heterotetrameric complex typically composed of two
GluN1 and two GluN2 subunits, of which there are 4 subtypes
(GluN2A-D). The GluN1 and GluN2 N-terminal domains (NTDs)
which are distinct from the agonist-binding domains and lay most
distal to the pore region, are a major locus for allosteric regulation of
NMDARs. Recent cryo-EM and high-resolution crystal structures of
GluN1/GluN2B NMDARs revealed the dimeric arrangement of the
NTDs and the importance of subunit interfaces in conformational
rearrangements during receptor gating. However, little is known
about the structural basis for conversion between inactive, active
and allosterically-regulated states of the receptor. Here we combined
site-speciﬁc genetic incorporation of a photo-cross-linking unnatural
amino acid (Uaa), p-azido-L-phenylalanine (AzF), and electrophys-
iology to report the dynamics of NTD interfaces in intact receptors.
We identiﬁed GluN1-AzF NTD mutants whose function can be
robustly and speciﬁcally increased by UV stimulation. We then
characterize the inﬂuence of agonists and allosteric modulators
(ifenprodil, zinc, spermine) on this photosensitivity. We propose
that GluN1 and GluN2A/GluN2B NTDs can dimerize through close
apposition of two alpha helices from lower-lobe. The closure of the
dimer interface is required for activation, because locking the
interface with 2 lower-lobes closely apposed increases receptor
activity, whereas allosteric inhibition stabilizes an open interface
conformation. These provide important dynamic information on
structural basis of gating and modulation mechanism, and will guide
screening of therapertic compounds for brain diseases associated
with malfunctioning of NMDARs.
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Hippocampal activity after local administration of
amphetamine into the medial mammillary nucleus in
urethane-anesthetized rats
W. Z˙akowski, L. Braszka, P. Zawistowski, A. Piwka, E. Jurkowlaniec
University of Gdansk, Department of Animal and Human
Physiology, Gdansk, Poland
Although the importance of the mammillary body for memory
and learning processes is well known, its exact role has remained
vague. The fact, that many neurons in one nucleus of the
mammillary body in rats, i.e. the medial mammillary nucleus
(MM), ﬁre according with hippocampal theta rhythm, makes this
structure crucial for a theta rhythm signaling in so-called extended
hippocampal system. In the present study, we investigated the effect
of pharmacological activation (local amphetamine infusion) of the
MM on theta rhythm activity and immediate-early gene (c-fos)
distribution in the hippocampus in urethane-anesthetized rats. We
found that intra-MM amphetamine microinjections have mild
inﬂuence on sensory-elicited theta rhythm in the hippocampus.
Amphetamine infusion decreased the EEG signal power of very low
theta frequency band, i.e. 3–4 Hz, down to 76% in comparison to
pre-injection conditions, whereas in theta frequency bands from 4 to
9 Hz, the infusion increased the hippocampal EEG power, up to
265% in 4–5 Hz band and 174% in 8–9 Hz band. An immunohis-
tochemical analysis has shown a lack of changes in regard to Fos
distribution in the hippocampus after amphetamine infusion to the
MM. These results indicate that pharmacological activation of the
MM may inﬂuence electrophysiological activity of the hippocampus
in urethane-anesthetized rats. This research was supported by the
National Science Centre (DEC-2014/12/S/NZ3/00621).
MTU08-02
Aging in a dish - mechanical signaling in juvenile and
aged neuronal cultures
J. Abele1, 2, A. Mueller2, 1, K. Franze3, D. Dieterich2, 1, 4
1Leibniz Institute for Neurobiology, Reseach Group Neuralomics,
Magdeburg, Germany
2Otto-von-Guericke-University, Institute for Pharmacology and
Toxicology,, Magdeburg, Germany
3University of Cambridge, Department of Physiology, Development
and Neuroscience, Cambridge, UK
4Center for Behavioral Brain Sciences, -, Magdeburg, Germany
From development throughout maturation neurons interact with
their environment by sensing chemical signals in order to regulate
integration into the neuronal network. Recently, evidences increase
that neuronal cells also respond to mechanical cues. Neuronal tissue
and even different cell types are mechanically inhomogeneous and
so cells are exposed to a variety of mechanical stimuli shown to
inﬂuence cell properties like cell differentiation, maturation and
survival.
In consequence, abnormalities in mechanical properties within a
certain micro compartment of the brain can interfere with its
physiological function. The brain stiffens with age and also protein
aggregates like Abeta-42 or alpha-synuclein increase the elastic
modulus drastically, leading to deﬁcits in mechanotransduction.
So far, studies on neuronal responses to substrate rigidity have
mainly focused on axonal outgrowth and regeneration. Further it is
of outstanding interest to understand the properties of mechan-
otransduction during neuronal development and aging.
To examine the potential relationship between mechanical cues
and neuronal development we use polyacrylamide (PAA) gels.
These PAA gels allow the production of cell culture substrates with
deﬁned mechanical properties resembling substrate rigidity of the
living brain: a young brain with elastic modulus of around 100 Pa,
or a mature brain with an elastic modulus beyond 1000 Pa.
First results showed that dendritic arborisations increased up to 5-
fold when neuronal cultures are grown on a soft PAA gel,
mimicking young brain tissue, compared to a hard substrate
(10 kPa). Looking deeper into synaptic development, we observed
a shift in the onset of synaptic development in dependence on
substrate rigidity. Functionally, we showed a clear increase in de
novo protein synthesis for neurons cultured on soft substrates during
development, maturation and aging.
These results point towards mechanic control of synaptogenesis
and synaptic vesicle recycling. Further, the mechanical properties of
the surrounding environment inﬂuence complex cellular processes
like d protein translation control throughout neuronal lifetime.
MTU08-03
Serotonin receptor 5-HT7 mediated activation of CDK5
J. Ackmann, K. R€ohrs, M. Butzlaff, J. Labus, E. Ponimaskin
Hannover Medical School, Cellular Neurophysiology, Hannover,
Germany
Cyclin-dependent kinase 5 (Cdk5) is involved in the regulation of
various aspects of brain development and function. In contrast to
other members of Cdk family, which are activated by cyclin
binding, enzymatic activity of Cdk5 is controlled by the activator
proteins p35/p39. One of Cdk5 substrates is the microtubule-
associated protein tau. Physiologically, tau phosphorylation regu-
lates its binding afﬁnity to microtubules. However, under patho-
logical conditions, tau hyperphosphorylation by Cdk5 and other tau
kinases results in destabilisation of the microtubule network and the
formation of neuroﬁbrillary tangles.
The serotonin receptor 5-HT7 is a G-protein coupled receptor
implicated in learning and memory. On cellular level it regulates
neuronal morphology, is involved in axonal and dendritic outgrowth
and inﬂuences synaptogenesis and spinogenesis. Via Gs protein
coupling the receptor activates adenylylcyclase leading to an
increase of cellular cAMP levels resulting in multiple signalling
cascades including Akt and Erk activation. Additionally, the
receptor couples with G12 protein and activates small GTPases
RhoA and Cdc42, which are important regulators of neuronal
morphology.
Here we demonstrate that the 5-HT7 receptor increases tau
phosphorylation via activation of Cdk5. Moreover, using co-
immunoprecipitation as well as lux-FRET analysis we demonstrated
direct interaction of the 5-HT7 receptor and Cdk5 at the plasma
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membrane both in neuroblastoma cells and in mouse cortex. To
reveal the underlying molecular mechanism of 5-HT7 receptor-
mediated Cdk5 activation we use molecular modelling and site
directed mutagenesis. Based on the interaction model we created
several mutants to identify the interaction domain(s) and specify the
interaction interface. We used these mutants to examine their impact
on the direct interaction of both proteins as well as on Cdk5
activation and localization.
MTU08-04
Intrinsic control of AKT signaling in CNS axon growth and
regeneration by regulation of novel substrates,
J.-Y. Ahn1, 2, H. R. Ko1, E.-J. Jin1, 2, I. Hwang1, 2
1Sungkyunkwan University School of Medicine, Dept. of molecular
cell biology Division of biochemistry, Suwon, Korea South
2Sungkyunkwan University School of Medicine, Single Cell Network
Research Center, Suwon, Korea South
Developmental axon growth or axon regeneration requires active
molecular machinery that regulates speciﬁc transcription factors,
growth cone components, and mediators of signal transduction. Akt
is a crucial growth promoting enzyme which is implicated in axon
elongation. However, molecular mechanism of Akt signaling in
CNS axon growth remains to be determined. Here we demonstrate
that Akt contributes growth cone formation and thus promotes axon
growth employing Id2 and Radixin as novel substrates by speciﬁc
phosphorylation in the developing neurons. Akt mediated phospho-
rylation of Id2 augments its protein stability and steers localization
of Id2 at growth cone. Interruption of Id2 expression or phospho-
rylation abolished the interaction of Id2 with Radixin, which is
important for the construction of normal structure and functional
organization of the growth cone, and resulted in impaired growth
cone formation along with reduced axonal outgrowth. Reconstitu-
tion of Akt/Id2/Radixin signaling after injury in hippocampus slice
culture redeem growth promoting ability, revealing obvious axon
regeneration whereas phosphor-ablated mutant of either Id2 or
Radixin does not demonstrate axon regrowth. Thus, Akt signaling
plays a key role in the regulation of axonal growth and regeneration
by controlling the organization of the growth cone.
MTU08-05
Spider acetylcholine binding proteins: an ideal model to
study the interaction between insect nAChRs and
neonicotinoids
H. Bao1, X. Meng2, Y. Liu1, Z. Liu1, Z. Li3
1Nanjing Agricultual University, College of Plant Protection,
Nanjing, China
2Yangzhou University, College of Horticulture and Plant
Protection, Yangzhou, China
3East China University of Science and Technology, School of
Pharmacy, Shanghai, China
Acetylcholine binding proteins (AChBPs), homologous to extra-
cellular domains of nicotinic acetylcholine receptors (nAChRs),
provide an appropriate model for the studies on nAChRs, especially
for invertebrates due to difﬁculties in heterologous expression of
their nAChRs. Until now, AChBPs were only characterized in
aquatic mollusks, which showed low sensitivities to neonicotinoids,
insecticides targeting on insect nAChRs. Fortunately, AChBP
subunit was also found in spiders based on the sequence and tissue
expression analysis. Here we reported ﬁve AChBP subunits in
Pardosa pseudoannulata, a predator enemy against rice insect pests.
Spider AChBP subunits show higher sequence similarities to
nAChR subunits from both insects and mammals, when compared
to mollusk AChBP subunits. From P. pseudoannulata AChBP1
subunit, the polymer AChBP (Pp-AChBP) was heterologously
recombined in Sf9 cells, and Ls-AChBP from Lymnaea stagnalis
was also constructed for the comparison. For both AChBPs, there
existed one ligand site per subunit in each interface between two
adjacent subunits. Neonicotinoids bound on Pp-AChBP with much
higher afﬁnities (7.9–18.4 times based on Kd or Ki values) than that
on Ls-AChBP, although epibatidine and a-Bgt showed higher
afﬁnities on Ls-AChBP contrarily. The results indicated that the
spider AChBP might be a more suitable model to study the
interaction of insect nAChRs and neonicotinoids. The discussion on
physiological roles and adverse effects of AChBPs in spiders was
included, due to the high afﬁnity binding of neonicotinoid on spider
AChBPs.
MTU08-06
Dopamine-induced phosphorylation of NPAS4 through
MAPK regulates reward-related learning and memory
Y. Funahashi1, A. Ariza1, K. Suzuki1, S. Wei2, S. Kozawa1, T.
Takano1, K. Kuroda1, T. Nagai2, K. Kaibuchi1
1Nagoya University, Graduate School of Medicine, Department of
Cell Pharmacology, Nagoya, Japan
2Nagoya University, Graduate School of Medicine, Department of
Neuropsychopharmacology and Hospital Pharmacy, Nagoya,
Japan
Dopamine (DA) type 1 receptor (D1R) signaling activates
cAMP/PKA and then activates MAPK through Rap1 in striatal
medium spiny neurons (MSNs) and plays a pivotal role in regulating
neuronal excitability and reward-related behaviors (Nagai et al.,
Neuron., 2016). However, how D1R signaling regulates reward-
related learning and memory through the gene expression is not
fully understood. To isolate and concentrate the transcriptional
factors (TFs) regulated by D1R signaling in mouse striatum, we
performed proteomic analyses using afﬁnity beads coated with
CREB-binding protein (CBP), which acts as co-activator of
numerous TFs and is involved in reward-related learning and
memory. We identiﬁed Neuronal Per Arnt Sim domain protein 4
(NPAS4), as a novel CBP-interacting protein in striatum. NPAS4
was phosphorylated at Thr-427 by MAPK downstream of the D1R
and the phosphorylation of NPAS4 increased the interaction of
NPAS4 with CBP. The phosphomimic mutant of NPAS4 enhanced
the BDNF exon I and IV promoter activity. Furthermore, the
deletion of NPAS4 in accumbal D1R-expressing MSNs impaired
the cocaine-induced place preference. The deﬁcit in cocaine-induced
place preference in NPAS4 deletion was restored by co-transfection
with NPAS4 but not NPAS4 mutant. These results suggest that
MAPK phosphorylates NPAS4 downstream of D1R and increases
its binding with CBP, thereby regulating BDNF expression and
reward-related learning and memory.
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N-terminus phosphorylation in the dopamine transporter
mediates gbc-stimulated dopamine efﬂux
J. Garcia-Olivares, J. A. Boris, S. G. Amara
NIH, NIMH, Bethesda, USA
Dopaminergic neurotransmission is altered in complex psychi-
atric conditions such as depression, attention-deﬁcit hyperactivity
disorder and drug addiction. The dopamine transporter (DAT)
clears extracellular dopamine through a sodium-coupled transport
mechanism. The DAT function is regulated by many intracellular
mechanisms including phosphorylation, ubiquitination, and pro-
tein-protein interactions. We recently reported a novel mechanism
of regulation of DAT by heterotrimeric G-proteins. We found that
Gbc subunits bind directly to the C-terminus of DAT, and upon
G-protein activation, the release of Gbc results in a decrease in
DA uptake. In a new set of studies, it was found that the decrease
in DA-uptake is a result of the promotion of DA-efﬂux, a
mechanism that has been described in the actions of ampheta-
mines. DA-efﬂux is dependent on calcium, sodium, and membrane
potential. It also involves phosphorylation of the N-terminus by
Serine/Threonine kinases such as protein kinase C (PKC) and
calmodulin kinase II (CamKII). Using radio-labeled-DA to mea-
sure DAT function, we are now exploring whether the DA efﬂux
promoted by the activation of Gbc subunits also requires
phosphorylation of the N-terminus. We used two DAT mutants,
hDAT-S/A and hDAT-S/D. These mutants have ﬁve N-terminal
serines (S2, S4, S7, S12, S13) substituted to alanine (S/A) or
pseudo-mimicking phosphorylation with a substitution to aspartate
(S/D). The induction of [3H]-DA efﬂux by mSIRK, a Gbc biding/
activating peptide, was abolish in the mutant carrier hDAT-S/A,
suggesting that those serine residues are important for the Gbc-
stimulated efﬂux. We also used pharmacological tools to inhibit
kinases and phosphatases in order to explore how the general
phosphorylation state of DAT is important in the regulation of
DAT. Our data suggests the effect on uptake and efﬂux mediated
by Gbc activation is dependent on the availability of phosphory-
lation sites in the DAT-N-terminus. These results are leading our
investigation to determine if the substitutions of putative phos-
phorylation sites modify the binding of Gbc to the C-terminus or if
phosphorylation is required for the conformational state of the
transporter to shift into efﬂux mode.
MTU08-08
A new way to create synapses: neuroplastin-TRAF6-
dependent signaling induces excitatory synapse
formation
R. Herrera-Molina1, S. K. Vemula1, M. Naumann2, C. I.
Seidenbecher1, E. D. Gundelfinger1
1Leibniz Institute for Neurobiology, Department of Neurochemistry
and Molecular Biology, Magdeburg, Germany
2Institute of Experimental Internal Medicine, Otto von Guericke
University, Magdeburg, Germany
The cell adhesion molecules Neuroplastins 55/65 (Np55, Np65)
are present in synapses. Polymorphisms in the Np gene promotor
are linked to cortical thickness, intellectual ability and schizophre-
nia. In mice, ablation of Np expression triggers deﬁcits in cortex-
and hippocampus-dependent learning, retrograde amnesia for
associative memories as well as reduces synapse plasticity
(Bhattacharya et al., 2017). Furthermore, Nps regulate acutely the
number and structural stability of hippocampal excitatory synapses
(Herrera-Molina et al., 2014). Because Np cytoplasmic domain
contains a tumor necrosis factor receptor-associated factor 6
(TRAF6) binding motif, we focus on the role of Np-TRAF6
interaction in synapse formation/stabilization. Np-deﬁcient hip-
pocampal neurons form less and shorter dendritic protrusions
during synaptogenesis. Rescue of dendritic protrusion formation by
Np expression did not occur in mutant neurons co-transfected with
TRAF6 siRNA. Different Np mutants in the TRAF6 binding site
failed to promote dendritic protrusion formation in wild type and
Np-deﬁcient neurons. Np-TRAF6 direct interaction was conﬁrmed
using molecule docking modelling in silico, surface plasmon
resonance, pulldown and immunoprecipitation assays and a series
of negative dominant and mutant constructs. In HEK cells over-
expressing different Nps tagged with ﬂuorescent proteins, we
observed multimerization of Nps (FRET experiments), recruitment
of cytosolic TRAF6 and robust Np-TRAF6 co-localization (confo-
cal imaging) in newly formed actin-based ﬁlopodia. All these
effects were reduced by TRAF6 siRNA transfection. Examination
of downstream signaling cascades lead us to identify a role for NF-
KB and PI3K/Akt/WASP pathways in Np-TRAF6-induced forma-
tion of dendritic protrusions and ﬁlopodia in neurons and HEK cells
respectively. Our data support the existence of a new synaptogenic
interaction between Np and TRAF6 resulting in mechanisms to
initiate signaling cascades able to regulate gene transcription and
actin cytoskeleton organization during early synapse formation/
stabilization.
RH-M thanks SFB854-B08; SKV thanks GRK1167.
MTU08-09
In vivo regulation of glycogen synthase kinase 3b activity
in neurons and brains
S. Hisanaga1, A. Krishnankutty1, T. Kimura1, T. Saito1, K. Aoyagi2,
A. Asada1, S.-I. Takahashi3, K. Ando1, M. Ohara-Imaizumi2, K.
Ishiguro4
1Tokyo Metropolitan University, Biological Sciences, Hachioji,
Japan
2Kyorin University School of Medicine, Biochemistry, Mitaka,
Japan
3The University of Tokyo, Animal Sciences, Bunkyo, Japan
4Juntendo University, Neurology, Bunkyo, Japan
Glycogen synthase kinase 3b (GSK3b) is a multifunctional
protein kinase involved in many cellular activities including
development, differentiation and diseases. GSK3b is thought to be
constitutively activated by autophosphorylation at Tyr216 and
inactivated by phosphorylation at Ser9. The GSK3b activity has
previously been evaluated by inhibitory Ser9 phosphorylation, but it
does not necessarily indicate the kinase activity itself. Here, we
applied the Phos-tag SDS-PAGE technique to the analysis of
GSK3b phosphoisotypes in cells and brains. There were three
phosphoisotypes of GSK3b; double phosphorylation at Ser9 and
Tyr216, single phosphorylation at Tyr216 and the nonphosphory-
lated isotype. Active GSK3b with phosphorylation at Tyr216
represented half or more of the total GSK3b in cultured cells.
Although levels of phospho-Ser9 were increased by insulin
treatment, Ser9 phosphorylation occurred only in a minor fraction
of GSK3b. In mouse brains, GSK3b was principally in the active
form with little Ser9 phosphorylation, and the phosphoisotypes of
GSK3b changed depending on the regions of the brain, age, sex and
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disease conditions. These results indicate that the Phos-tag SDS-
PAGE method provides a simple and appropriate measurement of
active GSK3b in vivo, and the activity is regulated by the
mechanism other than phosphorylation on Ser9.
MTU08-10
Membrane cholesterol prevents persistent activation of
muscarinic receptors by wash-resistant xanomeline
J. Jakubik1, A. Randakova1, E. Dolejsi1, V. Rudajev1, V. Dolezal1, E.
El-Fakahany2
1Institute of Physiology Czech Academy of Sciences,
Neurochemistry, Prague, Czech Republic
2University of Minnesota College of Pharmacy, Experimental and
Clinical Pharmacology, Minneapolis, USA
Alterations in signalling via muscarinic receptors play an
important role in a variety of neurological, psychiatric and internal
diseases, e.g. Alzheimer’s disease, schizophrenia, asthma and
syndrome of overactive bladder. Muscarinic receptors contribute
to the development of addiction and modulate analgesia, immunity,
thermoregulation, and other processes. Muscarinic receptors are thus
an important but difﬁcult pharmacotherapeutic target. Xanomeline is
muscarinic agonist that is unique prototypical M1/M4 functionally
selective agonist. Xanomeline has the same afﬁnity, potency and
efﬁcacy at all ﬁve subtypes of muscarinic receptors. Part of
xanomeline binding is resistant to washing. Wash-resistant xanome-
line activates muscarinic receptors persistently, except of M5
subtype. Mutation of leucine 6.46 to isoleucine at M1 or M4
receptors abolished persistent activation by wash-resistant xanome-
line. Reciprocal mutation of isoleucine 6.46 to leucine at M5
receptor made it sensitive to activation by wash-resistant xanome-
line. Lowering of membrane cholesterol made M1 and M4 mutants
and M5 wild type sensitive to activation by wash-resistant xanome-
line. Molecular docking revealed cholesterol binding site in the
groove between transmembrane helices 6 and 7. Molecular dynam-
ics showed that interaction of cholesterol with this binding site
attenuates receptor activation. We hypothesise that differences in
cholesterol binding to this site between muscarinic receptor subtypes
may constitute basis for xanomeline apparent functional selectivity
and may have notable therapeutic implications. Differences in
receptor-membrane interactions, rather than in agonist-receptor
interactions, represents a novel possibility to achieve pharmacolog-
ical selectivity. Our ﬁndings may be applicable to other G protein
coupled receptors.
This work was supported by the Czech Academy of Sciences
support [RVO:67985823] and the Grant Agency of the Czech
Republic grants [14-05696S] and [17-16182S].
MTU08-11
Post-translational modiﬁcation of apelin receptor is likely
to change the pharmacological function in the central
nervous system
T. Kinjo1, T. Yamada1, M. Oshio1, S. Hirano1, T. Yamashita1, H.
Higashi1, S. Maeda2, N. Kuramoto1
1Setsunan University, Molecular pharmacology, Hirakata, Japan
2Setsunan University, Pharmacotherapeutics, Hirakata, Japan
Apelin receptor, Aplnr, is a member of G protein coupled
receptor. The amino acid sequence suggests that Aplnr has two N-
glycosylation sites. Here, we have detected the Aplnr proteins which
was overexpressed in HEK293 cells, or was puriﬁed from the central
nervous system of the mouse. Western blot analysis revealed that, in
the HEK cells that was overexpressed of Aplnr, there are two bands
on the membrane around the molecular weight of Aplnr, that have
already been reported. Among of the two, the band with slow
mobility, was disappeared by the sample incubation with Peptide-N-
Glycosidase F (PNGase F) for cleaving N-glycosylation sites. On
the other hand, when attempting to detect Aplnr using the mouse
spinal cord, multiple bands at approximately 20 kDa greater than
the expected molecular weights were detected. Among of them, the
band with a slow mobility, was disappeared by PNGase F in the
same manner as described above. Therefore, it was suggested that
Aplnr in the central nervous system expresses with several post-
translational modiﬁcation, including N-glycosylation, and it func-
tions differently to peripheral organs.
MTU08-12
PAR1 activation induces calcium-dependent glutamate
release from RPE cells
A. Lopez-Colome, I. Lee-Rivera, E. Lopez
Instituto de Fisiologia, UNAM, Division de Neurociencias, Mexico
city, Mexico
The retinal pigment epithelium (RPE) is a highly specialized cell
monolayer located between neural retina and the choroid. Although
differentiated RPE cells remain quiescent, their proliferation is
activated under pathological conditions involving the alteration of
the blood-retina barrier (BRB). Among these pathologies, prolifer-
ative vitreoretinopathy (PVR) is characterized by the uncontrolled
proliferation of RPE cells, leading to the formation of contractile
membranes on both surfaces of the retina. The contraction of these
membranes results in retinal detachment and ultimately leads to
blindness. Under these conditions, RPE cells are exposed to serum
components, thrombin among them. Thrombin is a multifunctional
serine protease which participates in a wide range of cellular
processes such as proliferation, differentiation and survival in a
variety of cell types, including RPE cells. Thrombin effects are
exerted through the proteolytic activation of protease-activated
receptors (PARs 1, 3 and 4), particularly by PAR-1. Clinical studies
have shown that glutamate (GLU) concentration as well as thrombin
activity are signiﬁcantly increased in the vitreous humour of patients
suffering from retinal detachment. On this line, we have demon-
strated that GLU induces RPE cell proliferation through the
activation of signaling pathways involving type I metabotropic
glutamate receptors and NMDA receptor-mediated calcium increase.
In the present study we analyzed the effect of thrombin on GLU
release from rat RPE cells in primary culture. Results showed that,
under physiological conditions, the activation of PAR-1 by
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thrombin or by PAR-1 agonist peptide stimulates GLU release from
RPE cells in a speciﬁc, dose-dependent manner. This effect was
prevented by the chelation of intracellular calcium, suggesting the
requirement of calcium release form the endoplasmic reticulum.
Together with our previous ﬁndings, these results suggest that
thrombin and glutamate might exert a synergistic effect on the
promotion of RPE cell proliferation in ﬁbroproliferative diseases
derived from the disruption of the BRB, such as PVR.
This work was partially supported by grants 254333 from
CONACyT and IN205317 from PAPIIT/UNAM to AMLC.
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Modiﬁcation of perisynaptic extracellular matrix upon D1-
like dopamine receptor activation is PKA-dependent
J. Mitlo¨hner1, C. Seidenbecher1, A. Dityatev2, R. Frischknecht3, 1
1Leibniz-Institute for Neurobiology Magdeburg, Neurochemistry
and Molecular Biology, Magdeburg, Germany
2DZNE, Molecular Neuroplasticity, Magdeburg, Germany
3University of Erlangen-Nuremberg, Department of Biology,
Erlangen, Germany
The extracellular matrix (ECM) of the central nervous system
consists of chondroitin sulfate proteoglycans such as Aggrecan and
Brevican bound to hyaluronic acid, link proteins and tenascins. The
brain’s ECM has been shown to surround pre- as well as
postsynapses, to be formed and remodeled in an activity-dependent
manner; and could be important for synaptic plasticity and learning.
Dopamine, a crucial neuromodulator for motivated learning, acts
through either D1- or D2-like dopamine receptors in the brain.
Activation of protein kinase A (PKA) via stimulated D1/D5 dopamine
receptors was shown to lead to enhanced extracellular tissue-type
plasminogen activator (tPA) activity probably associated with an
increased release of this protease. We hypothesized that a similar
mechanism may underlie ECM remodeling by proteases, such as
ADAMTS 4/5.
Here, we studied the impact of dopamine in ECM modiﬁcation
by proteolytic cleavage and its relevance for synaptic plasticity, thus
learning. Therefore, D1-like or D2-like receptors were activated by
dopamine receptor agonists SKF81297 and Quinpirole, respectively.
Immunocytochemical analysis revealed that perisynaptic Brevican
cleavage is increased only after D1-like receptor activation at
excitatory synapses. We could block this effect by the D1-like
dopamine receptor antagonist SCH23390 as well as by using a PKA
inhibitor (cAMPS-Rp) or an inhibitor of ADAMTS 4 (TIMP-3).
Taken together, these ﬁndings underline the possibility of an
interplay between the dopaminergic system and the ECM, though
the exact molecular and cellular signaling mechanism remain to be
clariﬁed.
MTU08-14
Cleavage of ErbB4 after G-protein -coupled receptor
stimulation in hypothalamic neurons and anterior pituitary
cells
S. Nakamine, Y. Omoto, H. Yamamoto
University of the Ryukyus, Department of Biochemistry, Graduate
School of Medicine, Nishihara, Japan
ErbB4 belongs to the ErbB protein family of receptor tyrosine
kinases, and Neuregulin 1 (NRG1) is one of the ligands of ErbB4.
When NRG1 binds to ErbB4, tyrosine kinase is activated and
multiple tyrosine residues are autophosphorylated, resulting in the
initiation of multiple signal transduction pathways. Hypothalamic
GnRH neurons have a GnRH receptor belonging to the G-protein-
coupled receptors (GPCR). In the present study, we found that
EGFR and ErbB4 were involved in the activation of extracellular
signal-regulated protein kinase (ERK) by weak stimulation of GnRH
receptor in cultured GnRH neurons (GT1-7 cells). Moreover, strong
stimulation of GnRH receptor induced the cleavage of ErbB4 and
accumulation of an 80-kDa fragment. After treatment of the cells
with 50 nM GnRH for 5 min, about 80% of ErbB4 was cleaved.
The studies with selective inhibitors indicated that G q or G 11 were
involved in ERK activation and ErbB4 cleavage. TAPI-2, an
inhibitor of tumor necrosis factor-a-converting enzyme (TACE),
and siRNA for TACE inhibited the cleavage of ErbB4, suggesting
that TACE was involved. After ErbB4 cleavage, the activation of
ERK by NRG1 was almost completely inhibited. In addition to
GT1-7 cells, we found that ErbB4 was expressed in cultured anterior
pituitary gonadotroph cells, aT3-1 cells. GnRH treatment of aT3-1
cells also induced ErbB4 cleavage in a TACE-dependent manner.
These results suggested that the down-regulation of ErbB4 was
induced by GPCR stimulation.
MTU08-15
Dendritic spine formation is regulated by lemur kinase 1a
(LMTK1A) via Rab11A -positive endosome trafﬁcking
H. Nishino, T. Takano, K. Tsutsumi, A. Asada, T. Saito, K. Ando, S.-
i. Hisanaga
Tokyo Metropolitan University, Biological Science, Hachioujishi,
Japan
Synaptic transmission is crucial for propagation of excitation
between neurons. Synapse is a specialized structure composed of pre-
and post-synaptic terminals. In particular, a postsynaptic region of
excitatory synapses forms amushroom-like protrusion called dendritic
spine. Spine formation and stabilization are associated with neuronal
maturation and activity. However, it is not known yet how the spine
density is determined.While actin cytoskeleton plays an essential role
in spine formation, membrane supply is also required because cell
surface expands when spines are formed. In fact, it is reported Rab
GTPases are involved in spine formation. Nonetheless, the detailed
mechanisms how Rabs participate have not been addressed yet.
Lemur kinase 1A (LMTK1A) is a novel kinase that negatively
regulates neurite outgrowth via trafﬁcking of Rab11-positive
recycling endosomes. In this study, we investigated the role of
LMTK1A in dendritic spine formation. Knockdown of LMTK1 or
overexpression of kinase negative LMTK1A in primary hippocam-
pal neurons or mouse brains using in utero electroporation increased
the spine density. LMTK1-knockout neurons showed the same
phenotype. These results indicate that LMTK1A negatively
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regulates the dendritic spine formation. Most of those spines were
PSD-95 positive and showed the staining of anti-synaptophysin
presynaptic protein in its vicinity, indicating that spines induced by
downregulation of LMTK1 are mature and functional. Next we
investigated the role of Rab11A in dendritic spine formation.
Overexpression of constitutively active Rab11A (Q70L) increased
spine density and, on the contrary, constitutively inactive Rab11A
(S25N) decreased. To test the LMTK1-Rab11A-spine cascade, we
performed the knockdown of LMTK1A in the presence of active or
inactive Rab11A. The spine formation was mainly determined by
the activity of Rab11 but not by LMTK1A, indicated that LMTK1A
regulates spine formation upstream of Rab11A. Together, we show
here for the ﬁrst time the role of LMTK1A in spine formation.
LMTK1A would prevent overgrowth of axon, dendrites and spine
during neuronal development through endosomal trafﬁcking. We are
now analyzing what membrane components are supplied by the
LMTK1-Rab11A system in spine formation.
MTU08-16
Vitamin C regulates NMDA receptor activity and neuronal
survival in the retina
R. Paes-de-Carvalho1, I. Domith1, A. Duarte-da-Silva1, A. Munis1,
R. Socodato2, C. Portugal2
1Fluminense Federal University, Program of Neurosciences,
Institute of Biology, Niteroi, Brazil
2University of Porto, Institute of Investigation and Innovation in
Health (i3S) and Institute of Molecular and Cellular Biology
(IBMC), Porto, Portugal
Our previous work showed the presence of transporters regulat-
ing the uptake and release of ascorbate (AA) in the retina.
Interestingly, the activation of glutamate receptors induces AA
release from retinal cells in culture through a mechanism mediated
by the sodium-dependent vitamin C transporter type 2 (SVCT2). In
the present work we used mixed cultures of chick retinal cells in
order to study the reciprocal roles of vitamin C on glutamate
signaling in the retina. We show here that AA or its oxidized form,
dehydroascorbate (DHA), regulates NMDA receptor activity in a
biphasic way, since both forms activate receptor activity, as
measured by an increase of (3H) MK801 binding, but also prevent
receptor activation stimulated by glutamate. The increase of (3H)
MK801 binding was dependent on the activation of type III
metabotropic glutamate receptors as it was blocked by the selective
antagonist MAP4 and mimicked by the agonist L-SOP. On the other
hand, the inhibition of glutamate-stimulated (3H) MK801 binding
may be explained by the decrease of NMDA receptor N1 subunit
expression at the surface membrane as measured by biotynilation
and confocal imaging protocols. Interestingly, vitamin C is also able
to increase AKT and CREB phosphorylation in a NMDA-dependent
manner, to decrease (3H) D-aspartate uptake and to promote the
accumulation of glutamate in the extracellular medium of cultured
retinal cells. Moreover, a long-term incubation of retinal neuronal
cultures with low concentrations of AA (10 lM) promotes the
protection of retinal neurons from glutamate excitotoxicity. These
results demonstrate an intense modulation of glutamate signaling by
AA or DHA in the retina and therefore are consistent with a
neuromodulatory role for vitamin C in this tissue.
MTU08-17
Fluorescence anisotropy based assay for the
characterization of ligand binding to G protein-coupled
receptors
A. Rinken, R. Link, A. Allikalt, S. Veiksina, S. Kopanchuk
University of Tartu, Institute of Chemistry, Tartu, Estonia
G-protein-coupled receptors (GPCRs) are involved in a wide
variety of regulatory processes in the nervous system and abnormal-
ities in GPCR mediated signal transduction are associated with
numerous diseases. The development of novel drugs with less side
effects and higher efﬁcacy requires better understanding of the
mechanisms and kinetics of receptor-ligand interactions. Implemen-
tation of ﬂuorescence anisotropy assay for monitoring ligand binding
processes to GPCRs have opened new possibilities for this kind of
studies. However, there are several issues which have to be solved
before reliable results can be obtained. Ratiometric nature of the assay
requires that the concentrations of the reporter ligand and the receptor
are in the same range. We have shown, that budded baculovirus
particles, which display GPCRs on their surfaces are very suitable for
this kind of studies as they ensure high expresssion levels,
homogeneity and stability of receptor samples as well as good signal
to noise ratio in the assay [1]. Interpretation of the kinetic results of the
non-pseudo ﬁrst order reactions is alsomore demanding andmay even
require global numerical analysis to achieve physically meaningful
results. The ligands used have to be labelled with a suitable
ﬂuorophore, which life-time, color, bleaching stability and hydropho-
bic properties are suitable for the particular assay. Coupling of the
ﬂuorophore has to retain also ligand’s high afﬁnity and speciﬁcity and
the obtained reporter ligand has to have suitable kinetic properties for
the characterization of different unlabeled ligands.Up to now,wehave
achieved working systems for melanocortin 4 receptors [2, 3],
neuropeptide Y1 receptors, dopamine D1 receptors, serotonin 5-HT1A
receptors [4] and muscarinic acetylcholine M2 receptors.
References:
[1] Veiksina, S., Kopanchuk, S., Rinken, A. (2014) Biochim.Bio-
phys.Acta 1838, 372-81.
[2] Veiksina S., Kopanchuk S. and Rinken A. (2010) Anal.Biochem.
402, 32-9.
[3] Link R., Veiksina S., Rinken A., Kopanchuk S. (2017)
Eur.J.Pharmacol. 79, 58-66.
[4] T~ontson, L., Kopanchuk, S., Rinken, A. (2014) Neurochem.Int.
67, 32-8.
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Deepen human D-amino acid oxidase properties to get
insight in D-serine metabolism
S. Sacchi1, 2, G. Murtas1, L. Pollegioni1, 2
1Universita degli Studi dell’Insubria, Dipartimento di Biotecnologie
e Scienze della Vita, Varese, Italy
2
‘The Protein Factory’, Politecnico di Milano and Universita degli
Studi dell’Insubria, Milano, Italy
In the brain, the FAD-dependent enzyme D-amino acid oxidase
(DAAO, EC 1.4.3.3) plays a key role in the catabolism of D-serine,
the main endogenous co-agonist of the N-methyl-D-aspartate
receptors (NMDAR). Indeed, the ﬂavoenzyme activity, through
the regulation of D-serine cellular levels, may affect NMDAR-
dependent physiological functions. The over- or down-stimulation
of NMDARs is involved in neurodegenerative diseases and in
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psychiatric disorders, and a dysregulation in the processes deﬁning
the dynamics of D-serine levels likely concur to their onset. Hence,
there is an increased interest in shed light on the molecular
mechanisms modulating human DAAO (hDAAO) activity.
Over the past few years, hDAAO structural/functional relation-
ships have been inquired, but several aspects remain elusive. To ﬁll
this gap, we deepened the characterization of hDAAO properties
investigating the enzyme activity and stability at different pH and
temperature values, the kinetic parameters on alternative substrates,
the binding of potential ligands and the effect of L-amino acids on
the enzyme activity. Moreover, we evaluated the effect of ions on
hDAAO structural and functional properties.
hDAAO proved to be highly stable at physiological pH and
temperature. It oxidizes both D-DOPA and D-kynurenine, but with a
low kinetic efﬁciency. ATP, NMDA, glycine and glutamate do not
interact with hDAAO. Conversely, free L-amino acids can bind to
hDAAO. In particular, L-serine acts as a competitive inhibitor
(estimated Ki=26.2 mM); however, at physiological concentrations
(1 mM) it should not affect the enzyme activity. hDAAO confor-
mation appears moderately altered by Ca2+ and the concomitant
presence of ATP or GTP and 10 mM Mg2+, but its functionality is
not affected.
These results extend our knowledge and will help the design of
new effective strategies to modulate hDAAO activity.
MTU08-19
Lipid raft integrity impacts cannabinoid receptor 1
signalling
N. Sakellaridis1, E. Tsirimonaki2, D. Mangoura2
1University of Thessaly, Department of Pharmacology, Larisa,
Greece
2BRFAA, Basic Research Center, Athens, Greece
The Cannabinoid 1 receptor, CB1R, has evolved as a major
regulatory molecule for almost all known aspects of CNS develop-
ment and function, with actions ranging from proper cellularity to
complex behaviors such as fear, appetite, addiction. We have
previously demonstrated in neurons that CB1R forms signalling
complexes with proximal kinase PKCe to induce a/Gq/PLC/PKCe/
Src-Fyn/Ras/Raf-dependent ﬁrst peak of ERK pathway, while a
second CB1R pool induces a Gi/o/Src-Fyn/FGFR1/Ras/Raf-depen-
dent second ampliﬁcation of ERK activation, all emanating from
lipid rafts. To further elucidate the signiﬁcance of rafts in CB1
signalling we disrupted lipid rafts and associated cytoskeleton
systems and studied by confocal microscopy localization and
trafﬁcking of overexpressed CB1R in COS cells. In basal
conditions, GFP-CB1R ﬂuorescence was seen at the plasma
membranes of lamellipodia and ﬁlopodia, and in juxta/paranuclear
compartments - consistent with an ER/Golgi localization. The
speciﬁc CB1R-agonist methanandamide, R(+)-MA (15 min), min-
imized CB1R plasma membrane localization and increased by 3-
fold some perinuclear pools, seen as perinuclear rings, with no
signiﬁcant localization in lysosomes. Nocodazole-disruption of
microtubules, a functional partner of lipid rafts, distorted CB1R
patterns both in the surface and in small vesicles, seen along thicker
microtubule bundles, including those in mitotic structures. Methyl-
b-cyclodextrin, which sequesters cholesterol to disrupt rafts, min-
imized receptor presentation at plasma membranes and increased it
in some irregular vescicular structures. Similarly, after collapsing
the F-actin cytoskeleton with cytochalasin-D, CB1-GFP
ﬂuorescence appeared mostly as irregular, scattered cytoplasmic
foci; R(+)-MA did not cause, however, any increases in the peri-
nuclear pools, indicating that CB1R signalling may still occur when
F-actin is disrupted, yet, the signal may be modiﬁed because of
lesser intracellular trafﬁcking of CB1R and thus ‘consumption’ of
the signal in the cell periphery. Moreover, each of these perturba-
tions impacted both the duration and magnitude of ERK activation.
These data collectively indicate that CB1R targeting to and
signalling/trafﬁcking from the plasma membrane is regulated by
lipid rafts and its functional partners, the F-actin and the microtubule
cytoskeletons.
MTU08-20
b3-adrenoceptors inhibit cholinergic neurotransmission
in the bladder indirectly via ado release and A1 receptor
activation
I. Silva1, 2, A. F. Costa1, 2, S. Moreira1, 2, F. Ferreirinha1, 2, M. T.
Magalh~aes-Cardoso1, 2, I. Calejo1, 2, M. Silva-Ramos3, 1, P.
Correia-de-Sa1, 2
1Instituto de Cie^ncias Biomedicas Abel Salazar (ICBAS) -
Universidade do Porto (UP), Laboratorio de Farmacologia e
Neurobiologia, Porto, Portugal
2Center for Drug Discovery and Innovative Medicines (MedInUP),
Laboratorio de Farmacologia e Neurobiologia, Porto, Portugal
3Centro Hospitalar do Porto, Servico de Urologia, Porto, Portugal
The selective b3-adrenoceptor agonist, mirabegron, was recently
introduced in clinical practice for the treatment of overactive bladder
(OAB) syndromes. The direct detrusor relaxant effect of b3-
adrenoceptor agonists as the sole mechanism to improve OAB
symptoms has been increasingly questioned. Activation of b3-
adrenoceptors may negatively modulate nerve-evoked acetylcholine
(ACh) release, but there is no evidence for the presence of these
receptors on cholinergic nerve terminals. Our hypothesis is that
adenosine formed from the catabolism of cyclic AMP in the detrusor
may act as a retrograde messenger via prejunctional A1 receptors to
explain inhibition of cholinergic activity by b3-adrenoceptors.
Isoprenaline (1 lM) decreased [3H]ACh release from stimulated
(10 Hz,200pulses) human (47  5%) and rat (38  1%)
detrusor strips.Mirabegron (0.1 lM, 53  8%) and CL316,243
(1 lM, 37  7%) mimicked isoprenaline (1 lM) inhibition and
their effects were prevented by blocking b3-adrenoceptors with
L748,337 (30 nM) and SR59230A (100 nM), respectively in human
and rat detrusor. Mirabegron and isoprenaline increased extracellu-
lar adenosine in the detrusor. Blockage of A1 receptors with DPCPX
(100 nM) or the equilibrative nucleoside transporters (ENT) with
dipyridamole (0.5 lM) prevented mirabegron and isoprenaline
inhibitory effects. Dipyridamole prevented isoprenaline-induced
adenosine outﬂow from the rat detrusor and this effect was
mimicked by the ENT1 inhibitor,NBTI(30 lM). Cystometry
recordings in anaesthetized rats demonstrated that SR59230A,
DPCPX, dipyridamole and NBTI reversed the decrease of the
voiding frequency caused by isoprenaline(0.1-1000 nM). Data
suggest that inhibition of cholinergic neurotransmission by b3-
adrenoceptors results from adenosine release via equilibrative
nucleoside transporters and prejunctional A1 receptors stimulation
in human and rat urinary bladder. Work supported by FCT(PEst-OE/
SAU/UI0215/2014 and UID/BIM/4308/2016). IS is in receipt of a
PhD fellowship by FCT(SFRH/BD/88855/2012).
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Metabotropic glutamate receptor 7 (mGluR7) trafﬁcking
and signaling by post-translational modiﬁcations
Y. Suh, S. Lee, H. Lee
Seoul National University College of Medicine, Department of
Biomedical Sciences, Seoul, Korea South
The metabotropic glutamate receptors (mGluRs) are seven
membrane-spanning proteins that are linked via G-proteins to
intracellular signaling cascades. Among eight family members of
mGluRs, mGluR7 is highly expressed at the presynaptic active zone
where it modulates excitatory neurotransmission and synaptic
plasticity by limiting further neurotransmitter release in an auto-
regulatory manner. Like many GPCRs, mGluR7 undergoes consti-
tutive and agonist-dependent endocytosis. Although it has been
reported that protein turnover and endocytosis of GPCRs are
dynamically regulated by the ubiquitin-proteasome system, it
remains elusive that mGluR7 undergoes ubiquitination in response
to synaptic activity. In this study, using biochemical approaches
coupled with confocal imaging, we have explored whether mGluR7
is a target of ubiquitination. We found that mGluR7 is ubiquitinated
at the cytoplasmic loop 2 region and the C-terminal tail by the
treatment of agonist in HEK 293T cells and primary cortical
neurons. In addition, we identify Nedd4, the HECK domain
ubiquitin E3 ligase is responsible for mGluR7 ubiquitination and
regulate its endocytosis and degradation. Taken together, these data
support a model that the ubiquitination of mGluR7 is critical for
stable surface expression and function of mGluR7 in neurons.
MTU08-22
Substrate transport and anion permeation proceed
through distinct pathways in glutamate transporters
D. Torres-Salazar1, M. Cheng2, A. Gonzalez-Suarez1, S. Amara1, I.
Bahar2
1NIH, Laboratory of Molecular and Cellular Neurobiology,
Bethesda, USA
2University of Pittsburgh, Computational Systems Biology,
Pittsburgh, USA
Advances in structure-function analyses and computational
biology have enabled a deeper understanding of how excitatory
amino acid transporters (EAATs) mediate chloride permeation and
substrate transport. However, the mechanism of structural coupling
between these functions remains to be established. Using a
combination of molecular modeling, substituted cysteine accessi-
bility, electrophysiology and glutamate uptake assays, we identiﬁed
a chloride-channeling conformer, iChS, transiently accessible as
EAAT1 reconﬁgures from substrate/ion-loaded into a substrate-
releasing conformer. Opening of the anion permeation path in this
iChS is controlled by the elevator-like movement of the substrate-
binding core, along with its wall that simultaneously lines the anion
permeation path (global); and repacking of a cluster of hydrophobic
residues near the extracellular vestibule (local). Moreover, our
results demonstrate that stabilization of iChS by chemical modiﬁ-
cations favors anion channeling at the expense of substrate transport,
suggesting a mutually exclusive regulation mediated by the
movement of the ﬂexible wall lining the two regions.
MTU08-23
Mechanism of dopamine signaling for membrane
excitability
D. Tsuboi1, T. Shimomura2, T. Nakano5, T. Nagai3, M. Amano1, J.
Yoshimoto4, Y. Kubo2, K. Kaibuchi1
1Nagoya University, Graduate school of Medicine, Department of
Cell Pharmacology, Nagoya, Japan
2National Institute for Physiological Sciences, Division of
Biophysics and Neurobiology, Okazaki, Japan
3Nagoya University, Graduate school of Medicine, Department of
Neuropsychopharmacology, Nagoya, Japan
4Nara Institute of Science and Technology, Mathematical
Informatics Laboratory, Nara, Japan
5Hiroshima University, Institute of Biomedical and Health science,
Hiroshima, Japan
Neuromodulators, including dopamine and acetylcholine, are key
factors for reward-related behavior. Striatum/nuclear accumbens
(NAc) is the key brain region for determining reward-related
behavior by controlling dopamine D1 receptor-medium spiny
neuron (D1R-MSN)-mediated direct pathway and dopamine D2
receptor-medium spiny neuron (D2R-MSN)-mediated indirect path-
way. Dopamine enhances reward-related behavior by activating
D1R-MSN-mediated direct pathway. Recently, we developed a
novel proteomic system and clariﬁed that dopamine activates protein
kinase A (PKA)-Rap1-MAPK pathway to enhance D1R-MSN
neuronal excitability, leading to facilitated reward-related behavior.
However the mechanism of dopamine signaling underlying neuronal
excitability remains to be understood at the molecular level. In this
study, we identiﬁed a voltage-gated potassium channel KCNQ2,
which is involved in neuronal excitability, as a phosphoprotein
regulated by MAPK. Phosphorylation of KCNQ2 by MAPK
modulated the open propability of KCNQ2/3 heterochannels in
Xenopus oocyte system. Activation of D1R and PKA modulated the
KCNQ-sensitive current in striatal slice. These results suggest that
dopamine signaling regulate the activity of KCNQs channel, thereby
controling neuronal excitability.
MTU08-24
Amphetamine induced internalization of the dopamine
and glutamate transporters is mediated by the trace amine
receptor 1
S. Underhill1, J. Chen1, M. Rizzo2, S. Amara1
1NIH, NIMH, Bethesda, USA
2University of Maryland School of Medicine, Department of
Physiology, Baltimore, MD
Psychostimulants such as amphetamine (AMPH) are often useful
therapeutic agents, but can also pose a danger as a consequence of
their addictive properties. A better understanding of the biochemical
cascades that mediate the physiological outcomes of this class of
drugs is needed.
We previously reported that AMPH activates endocytosis of the
dopamine and glutamate transporters, DAT and EAAT3. This
trafﬁcking requires activation of RhoA, a small GTPase that can be
regulated by protein kinase A (PKA). PKA phosphorylation
inactivates RhoA as well as internalization of the transporters. The
trace amine-associated receptor 1 (TAAR1) is an intracellular GPCR
known to couple through Gs and contributes to the actions of
psychostimulants in dopamine neurons. These observations led us to
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examine the potential role of TAAR1 in RhoA activation and
inactivation.
We used CRISPR-Cas9 gene editing to disrupt endogenous
TAAR1 gene expression in HEK293. In cells that lack TAAR1,
AMPH did not induce DAT or EAAT3 internalization. We also
could not detect Rho activation in TAAR1(-) cells despite robust
AMPH-induced Rho activation in TAAR1(+) cells.
To identify the pathway of Rho activation through TAAR1, we
co-expressed mini-genes that interfere with activation of various
GPCR alpha-subunits and found that TAAR1 not only couples with
Gs, but also couples with the G13 alpha subunit, an established
activator of RhoA signaling. We designed cell-permeable peptides
based on these interfering sequences to conﬁrm these observations
in adult murine midbrain tissue.
To resolve the potential of distinct subcellular compartments
where these two different TAAR1-mediated events occur, we used
FRET sensors to assess PKA activation or RhoA activation that
were targeted to various cellular compartments. AMPH-stimulated
PKA activation was broadly distributed throughout the cell;
however, RhoA activation was highly concentrated in regions
surrounding the ER.
These observations demonstrate that TAAR1 serves as the
intracellular target for AMPH that mediates RhoA activation, cAMP
signaling and subsequent regulation neurotransmitter transporter
trafﬁcking. These data suggest new pathways to target in order to
better understand the mechanisms of action of AMPH.
MTU08-25
A fundamental chemical analysis of serotonin
transmission in genetic and environmental autism
spectrum disorder models
A. West, S. Berger, P. Hashemi
University of South Carolina, Department of Chemistry and
Biochemistry, Columbia, USA
Autism spectrum disorder (ASD) is a collection of developmental
disorders with growing prevalence. The pathophysiology of ASD is
not yet fully understood, hindering suitable prevention and treatment
options. Speciﬁcally, a universal underlying chemical mechanism is
lacking. We believe that serotonin dysfunction can be identiﬁed as a
common neurochemical mechanistic feature of this disorder,
however current techniques do not provide a complete representa-
tion of the serotonin system as they are only capable of measuring
basal levels at low temporal resolution. Here, we describe the
application of Fast Scan Cyclic Voltammetry, which operates on a
neurotransmission temporal resolution and allows us to examine
serotonin release and reuptake, to genetic and environmental ASD
models. These models allow us to establish a chemical phenotype
accompanying stereotypical ASD behavioral in mice. The results
demonstrated a signiﬁcant difference in the serotonin chemistry
between ASD models and controls. Identifying this chemical
phenotype will allow us to redeﬁne the serotonin chemistry within
ASD.
MTU08-26
Activation of PYK2 by PKD and CaM kinase II in cultured
hypothalamic neurons
H. Yamamoto, S. Higa-Nakamine, S. Okitsu, H. Torihara
Graduate School of Medicine, University of the Ryukyus,
Biochemistry, Nishihara, Japan
Gonadotropin-releasing hormone (GnRH) is secreted from
hypothalamic neurons (GnRH neurons). GnRH neurons have a
GnRH receptor belonging to the G-protein-coupled receptors
(GPCRs). In the previous study, we found that CaM kinase IId2
was involved in GnRH-induced ERK activation in cultured GnRH
neurons (GT1-7 cells). Recently, we found that novel protein kinase
C (nPKC) was also involved in ERK activation. It is well known
that protein kinase D (PKD), belonging to the CaM kinase family, is
activated by nPKC. It has been reported that proline-rich tyrosine
kinase 2 (PYK2) was activated by activation of PKC, as well as by
the increase in the intracellular Ca2+. It was reported that PYK2 was
involved in GnRH-induced ERK activation in GT1-7 cells. In the
present study, we examined the possibility that PKD and CaM
kinase IId2 were involved in GnRH-induced PYK2 activation. (i)
Fyn existed in the activated form in the cells, and dasatinib, a Src
family inhibitor, completely inhibited Fyn activation and GnRH-
induced PYK2 activation. (ii) PKD1 was activated by GnRH in an
nPKC-dependent manner. (iii) Knockdown of PKD1 and a PKD
inhibitor inhibited GnRH-induced PYK2 activation, while they had
no effects on Fyn activation. (iv) Knockdown of CaM kinase IId2
and KN93, an inhibitor of CaM kinases, inhibited GnRH-induced
PYK2 activation. These results strongly suggested that PKD1 and
CaM kinase IId2 activated the ERK pathway through PYK2
activation by Fyn.
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MTU09-01
Induced haploinsufﬁciency of kit receptor tyrosine kinase
impairs development of central nervous system
H. Aoki, T. Kunisada
GIfu University Graduate School of Medicine, Tissue and Organ
Development, GIfu, Japan
Background: Kit receptor tyrosine kinase has been shown to
regulate a wide range of biological functions in various cell lineages
including pigment cells, hematopoietic cells, germ cells, neuronal
cells of central nervous system (CNS). Kit mRNAs are expressed in
cells affected by Kit locus mutants, however, in developing or adult
brain which is one of the major tissues expressing Kit mRNA, no
clear phenotype lead to the loss of speciﬁc cell types or functions
was detected in the brain of Kit mutants.
Objective: To investigate the Kit function in neural lineage, we
introduced a conditional loss of function mutation of Kit from a
certain point of the developmental stage.
Methods: Transmembrane region of Kit was ﬂanked by loxP to
excise the Kit ﬂoxed allele by Cre recombinase. To take advantage
of CNS speciﬁc induction of Cre, Kitﬂoxed/+ mice were crossed with
Sox1-Cre mice expressing Cre directed by the neural lineage speciﬁc
promoter sequence. The morphology, histology, gene expression,
and the growth and differentiation of neural stem/precursor cells
were analyzed.
Results: Expression of endogenous Sox1 gene starts as early as
E8.0 and Kit mRNA expression in their brain reduced into one half
of the control in E10.5. The resultant Kit ﬂoxed/+; Sox1-Cre+
embryos showed signiﬁcant reduction of the size of the forehead in
E12.5, which generate a severe hypoplasia of CNS including brain,
spine, and eye. This was accompanied by the increase of apoptotic
cells in early embryonic brain and the gradual loss of self-renewal
capacity of neural stem/precursor cells leading to the accelerated
differentiation of neural stem cells to mature neural cells.
Conclusion: The phenotype appeared in Kit ﬂoxed/+; Sox1-Cre+
conditional Kit haploinsufﬁcient embryos suggests that Kit
expressed in developing CNS is functional signaling molecules
necessary for proper brain development as the other cell lineages
solely dependent for Kit in its certain developmental stage.
MTU09-02
Uncovering ﬂoor plate descendants in the ependyma of
adult mouse CNS using mapping of Nato3-expressing
cells
N. Ben-Arie
Hebrew University of Jerusalem, Cell & Developmental Biology,
Inst. Life Sciences, Jerusalem, Israel
During embryonic development of the central nervous system
(CNS), the expression of the bHLH transcription factor Nato3
(Ferd3 l) is unique and restricted to the ﬂoor plate of the neural
tube. In mice lacking Nato3 the ﬂoor plate cells of the spinal cord do
not fully maturate, whereas in the midbrain ﬂoor plate, progenitors
lose some neurogenic activity, giving rise to a reduced population of
dopaminergic neurons. Since the ﬂoor plate is considered to be
disintegrated at the time of birth, Nato3 expression was never tested
postnatally and in adult mice. Here, we utilized a Nato3 knockout
mouse model in which a LacZ reporter precisely replaced the coding
region under the endogenous regulatory elements, such as its
expression recapitulates the spatiotemporal pattern of Nato3
expression. Nato3 was found to be expressed in the CNS throughout
life in a highly-restricted manner along the medial cavities: in
subpopulations of cells in the third ventricle, the cerebral aqueduct,
the fourth ventricle, the central canal of the spinal cord, and the
subcommissural organ, a gland located in the midbrain. A few
unifying themes are shared among all Nato3-positive cells: all are
positioned in the midline, are of an ependymal type, and contact the
cerebrospinal ﬂuid (CSF) similarly to the embryonic position of the
ﬂoor plate bordering the lumen of the neural tube. Taken together,
Nato3 deﬁnes an unrecognized subpopulation of medial cells
positioned at only one side of circular ependymal structures, and
it may affect their regulatory activities and neuronal stem cell
function.
MTU09-03
ENU mutagenesis screening to identify mutations that
control corpus callosum development
E. Borisova1, E. Epifanova1, S. Tutukova1, V. Salina1, N. Zhidkowa1,
A. Rusanova1, E. Turovsky1, M. Turovskaya1, A. Babaev1, V.
Tarabykin1, 2
1Lobachevsky State University, Institute of Nuerobiology, Nizhny
Novgorod, Russia
2Charite Medical School, Institute of Cell- and Neurobiology,
Berlin, Germany
The two hemispheres of the cerebral cortex are well intercon-
nected by commissural axons, which allow for the synchronization
and lateralization of higher brain functions. The dominant commis-
sural ﬁber tract of the mammalian brain is the corpus callosum. Most
commissural axons originate from pyramidal neurons located in
layer II/III or to a lesser extent in layer V of the neocortex. During
evolution of higher mammals and speciﬁcally humans, the propor-
tion of upper versus deeper layer neurons has substantially
increased. This lead to strongly increased cortico-cortical connec-
tivity, which is thought to have enabled the emergence of higher
cognitive abilities. Corpus callosum (CC) essential for the lateral-
ization of highly specialized brain functions, such as speech
processing. The relatively high incidence of CC agenesis in humans
(1 : 4000) illustrates that callosal axon guidance and CC formation
during embryonic brain development are complicated and relatively
fragile processes. Abnormal CC development is associated with
more than 50 neurodevelopmental syndromes and often impairs
emotional, social and mental functions.
In order to identify genes that control CC formation we carried
out ENU mutagenesis in mice that express LacZ gene as a tag in all
callosal neurons. We identiﬁed several mutants that demonstrate CC
development abnormalities. The phenotype of these mutants will be
presented and discussed.
Research carried out with the ﬁnancial support of the grant of the
Russian Scientiﬁc Foundation (project №15-14-10021).
© 2017 The Authors
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Neurons on nanotopographies
I. Choi
KAIST, Chemistry, Daejeon, Korea South
Topography, the physical characteristics of an environment, is
one of the most prominent stimuli neurons can encounter in the
body. Many aspects of neurons and neuronal behavior are affected
by the size, shape, and pattern of the physical features of the
environment. A recent increase in the use of nanometric topogra-
phies, due to improved fabrication techniques, has resulted in new
ﬁndings on neuronal behavior and development. Factors such as
neuron adhesion, neurite alignment, and even the rate of neurite
formation have all been highlighted through nanotopographies as
complex phenomena that are driven by intricate intracellular
mechanisms. The translation of physical cues is a biologically
complex process thought to begin with recognition by membrane
receptors as well as physical, cell-to-surface interactions, but the
internal biological pathways that follow are still unclear. In this
respect, nanotopography would be a more suitable platform on
which to study receptor interfaces than microtopography because of
the subcellular topographical features that are relevant in scale to the
receptor activity. Ultimately, the characterization of this unknown
network of pathways will unveil many aspects of the behavior and
intracellular processes of neurons, and play an important role in the
manipulation of neuronal development for applications in neural
circuits, neuroregenerative medicine and prostheses, and much
more.
MTU09-05
Obesity leads to impairment in neurogenesis and reduces
brain size
C. D. Silva, L. Forny-Germano, M. Mendonca, J. Donato, J. Houzel,
S. Ferreira, F. D. Felice
Federal University of Rio de Janeiro, Intitute of Medical
Biochemistry, Rio de Janeiro, Brazil
Overweight and obesity are public health problems that affect
30% of the world population. It is known that accumulation of body
mass causes peripheral insulin resistance, diabetes, among other
comorbidities. Recent studies have show that overweight also
affects the nervous system, impairing cognition and increasing the
propensity to develop neurodegenerative diseases, particularly
Alzheimer’s disease. However, the modiﬁcations in the brain as a
consequence of obesity and how they affect cognition and behavior
remains unclear. To investigate the impact of obesity in brain
structure, we used C57/Bl6 transgenic ob/ob mice, which eats
excessively due to mutations in the gene responsible for the
production of leptin. Magnetic resonance imaging (MRI) was
initially performed for in vivo brain volume analysis. Preliminary
data show a 10% decrease in the total brain volume of the obese
mice when compared to age-matched non –transgenic C57/BL6
control mice. We next carried out analysis to investigate neuroge-
nesis, and further looked at immature neurons (using anti-
doublecortin-DCX) and at the cell proliferation marker anti- Ki-67
in the brain. Both the lateral ventricle and the hippocampus were
analyzed. We found important decreases in positive cells for
doublecortin, as well as in cells expressing the cell cycle marker ki-
67 in the lateral ventricle and in the hippocampus of ob/ob mice as
compared to controls. Our data suggests that impaired neurogenesis
in the brain may contribute to cognitive deﬁcits that obese mice
develop and to the overall impact of obesity in the brain.
MTU09-06
Study of the neurodifferentiative role of GM1
oligosaccharide chain in mouse primary cerebellar
neurons
E. D. Biase, E. Chiricozzi, M. Maggioni, D. Y. Pome, M. Samarani,
S. Prioni, M. Aureli, S. Sonnino
University of Milan, Department of Medical Biotechnology and
Translational Medicine, Segrate, Italy
One of the best studied ganglioside for its neurotrophic function
is ganglioside GM1. GM1 neuro-properties are exerted when the
GM1 membrane content increases in membrane microdomains,
known as lipid rafts. This local enrichment could be responsible for
(i) the GM1 content-dependent membrane reorganization, that alter
the membrane properties, ensures that the physical parameters
required for proper protein function is reached, (ii) the GM1
oligosaccharide-protein direct interactions, which can stereo chem-
ically and allosterically modify protein structure and function.
Despite several experimental data have been demonstrated the
GM1 involvement in neuronal differentiation, the molecular mech-
anism by which GM1 exerts its neurotrophic action has not yet been
elucidated. In this view, we decide to investigate the importance of
its oligosaccharide portion by using primary neurons from mice
cerebellum.
We found that the GM1 oligosaccharide portion is able to
inﬂuence the differentiation of these cells. By morphological
analysis we evidenced the outstanding ability of oligosaccharide-
treated cells to aggregate forming clusters. Moreover, the
immunoblotting analysis highlighted the acceleration of the neu-
ronal differentiation: there is an increase in the expression of
neurodifferentiation markers such as MAP2, Synapsin and Neu-
roglican C, with respect to untreated cells. We also found an
increase in GTPase RAC3 expression, that is involved in radial and
tangential migration.
Our results suggest that the oligosaccharide portion of GM1 is
responsible for the ability of GM1 to induce neuritogenesis. We
surmise that the neurotrophic effect of GM1 is due to a direct
interaction with extracellular domain plasma membrane proteins.
MTU09-07
Tau-dependent suppression of adult neurogenesis in the
stressed hippocampus
C. Dioli1, 2, P. Patrıcio1, J. Silva1, M. Morais1, A. Mateus-Pinheiro1,
A. J. Rodrigues1, S. Vyas2, N. Sousa1, J. M. Bessa1, L. Pinto1, I.
Sotiropoulos1
1Life and Health Sciences Research Institute (ICVS), Neuroscience
Research Domain, Braga, Portugal
2INSERM U1130, CNRS UMR 8246, Universite Pierre et Marie
Curie, Neuroscience Paris Seine, Paris, France
Stress, a well-known sculptor of brain plasticity, is shown to
suppress hippocampal neurogenesis in the adult brain; yet, the
underlying cellular mechanisms are poorly investigated. Previous
studies have shown that chronic stress triggers hyperphosphoryla-
tion of the cytoskeletal protein Tau, a process that impairs the
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cytoskeleton-regulating role(s) of this protein with impact on
neuronal function. Here, we analyzed the role of Tau on stress-
driven suppression of neurogenesis in the adult dentate gyrus (DG)
using animals lacking Tau (Tau-KO) and wild-type (WT) litter-
mates. Unlike WTs, Tau-KO animals exposed to chronic stress did
not exhibit reduction in DG proliferating cells, neuroblasts and
newborn neurons; however, newborn astrocytes were similarly
decreased in both Tau-KO and WT mice. In addition, chronic stress
reduced PI3K/mTOR/GSK3b/b-catenin signaling in the DG, known
to regulate cell survival and proliferation, in WT, but not in Tau-KO.
These data establish Tau as a critical regulator of the cellular
cascades underlying stress deﬁcits on hippocampal neurogenesis in
the adult brain.
MTU09-08
SIP1 controls dendritic arbor formation in the mammalian
neocortex
E. Epifanova1, V. Salina1, T. Naumann2, S. Sriwatsa2, M. Rosario*2,
V. Tarabykin*1, 2
1Lobachevsky State University, Institute of Neurobiology, Nizhni
Novgorod, Russia
2Charite Medical School, Institute of Cell and Neurobiology, Berlin,
Germany
The dendritic arbor is an elaborately branched and specialized
characteristic neuronal structure that acts as the main site of
information input to the neuron. Unsurprisingly, defects in the
formation of the dendritic arbor or in its differentiation and
maintenance are associated with cognitive impairment and occur
in a wide variety of human neurodevelopmental disorders in
particular intellectual disability-associated syndromes and neuropsy-
chiatric disorders. Heterozygous mutations in the transcription factor
Sip1 (Smad-interacting protein 1; also called ZFHX1b or ZEB2)
have been found to cause Mowat-Wilson syndrome, a human
condition associated with severe intellectual disability, multiple
congenital abnormalities and epilepsy. We used in utero electropo-
ration (IUE) to generate mosaic deletion of Sip1 gene in the
developing mouse neocortex. Mosaic deletion of Sip1 in the mouse
neocortex was achieved by electroporation of a construct expressing
Cre recombinase under the control of an ubiquitous (CAG)
promoter. During development, Sip1 is expressed in all postmitotic
neurons and is absent from progenitor cells.
In these experiments we observed striking alterations in the
dendritic morphology of mature neurons at P23. Apical dendrites of
Sip1 deﬁcient neurons did not maintain correct polarity. While the
orientation of an apical dendrite to pial surface in the neocortex is
90°, in Sip1 deﬁcient neurons it was randomised. On the other hand
the dendritic complexity was also affected by Sip1 deletion. Our
data indicate that Sip1 is required in the differentiating neurons to
establish neuronal morphology.
Research carried out with the ﬁnancial support of the grant of the
Russian Scientiﬁc Foundation (project №15-14-10021).
* equal author contribution:
MTU09-09
Pyridoxine modulates neurogenesis by regulating CB1
cannabinoid receptor-interacting protein
I. K. Hwang1, H. Y. Jung1, D. W. Kim2, J. W. Kim1, J. Y. Chung3, Y.
S. Yoon1
1Seoul National University College of Veterinary Medicine,
Department of Anatomy and Cell Biology, Seoul, Korea South
2Gangneung-Wonju National University College of Dentistry,
Department of Biochemistry and Molecular Biology, Gangneung,
Korea South
3Kangwon National University College of Veterinary Medicine,
Department of Veterinary Internal Medicine and Geriatrics,
Chuncheon, Korea South
Pyridoxal 50-phosphate has a major coenzyme to synthesize
monoamines such as serotonin, dopamine, and serotonin. In the
present study, we investigated the effects of pyridoxine on memory
function using a novel object recognition test as well as the changes
in protein proﬁles based on the proteomic approach. Eight-week-old
mice received intraperitoneal injections of physiological saline
(vehicle) or 350 mg/kg pyridoxine twice a day for 21 days. Changes
in protein and serotonin turnover levels were analysed using two-
dimensional ﬂuorescence difference gel electrophoresis (2D-DIGE)
and high-performance liquid chromatography (HPLC), respectively.
Differentially expressed proteins were identiﬁed using matrix-
assisted laser desorption/ionization time-of-ﬂight mass spectrome-
try. Approximately 2690 protein spots were detected by 2D-DIGE,
and increases > 1.5-fold were observed in several proteins in the
hippocampal homogenates of vehicle-treated mice relative to those
of pyridoxine-treated mice. Phosphoglycerate mutase 1 was up-
regulated, while CB1 cannabinoid receptor-interacting protein 1
(CRIP1) was down-regulated, in the pyridoxine-treated group.
Additionally, the 5-hydroxyindoleacetic acid/5-hydroxytryptamine
ratio was signiﬁcantly lower in the hippocampus of the pyridoxine-
treated group than in that of the vehicle-treated group. Furthermore,
discrimination indices based on the novel object recognition test
were signiﬁcantly higher in the pyridoxine-treated group than in the
vehicle-treated group. Administration of CRIP1a siRNA signiﬁ-
cantly increases the discrimination index as well as cell proliferation
and neuroblast differentiation in the dentate gyrus. These results
suggest that pyridoxine promotes short-term recognition memory
and increases serotonin levels in the hippocampus via CRIP1a
modulation.
MTU09-10
Glycoprotein M6a clustering of lipid-rafts and associated
signaling proteins for neuronal polarity
M. Igarashi1, 2, A. Honda1, 2, Y. Ito1, N. Matsushita3, K. Takeuchi3
1Niigata University Graduate School of Medical & Dental Scien,
Department of Neurochemistry and Molecular Cell Biology,
Niigata, Japan
2Niigata University, Transdisciplinary Programs, Niigata, Japan
3Aichi Medical University, Department of Medical Biology,
Nagakute, Japan
Lipid-raft domains, where sphingolipids and cholesterol are
enriched, concentrate signaling molecules. We focused on glyco-
protein M6a (GPM6a), which is expressed at a high concentration in
developing neurons, and is known to be one of the major
palmitoylated proteins in the brain. Since palmitoylated membrane
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proteins are generally known to accumulate in lipid-raft domains,
this protein should be a good candidate for the study of neuronal
lipid-rafts. We found that GPM6a is colocalized with D4, a
cholesterol-binding protein and a molecular imaging marker for
lipid-rafts. Lipid-rafts containing GPM6a were clustered; and, in the
absence of GPM6a, no rafts were clustered and D4 was dispersed in
the membrane. We identiﬁed the downstream signaling molecules of
GPM6a as the Rufy3-Rap2-STEF/Tiam2 complex, and the compo-
nents of this complex have been previously reported to be
determinants for cell polarity. GPM6a signaling pathway molecules
are collected and concentrated in lipid-rafts in a manner that is
dependent on the palmitoylated form of GMP6a, even at stage 1 of
neuron formation. The combined data indicate that palmitoylated
GPM6a induces the clustering of lipid-rafts, and that a palmitoy-
lation-dependent GPM6a-signaling protein complex is formed in the
lipid-rafts at stage 1 of neuron formation, which acts as one of the
earliest polarity determinants and accelerators for neuron forma-
tion1), 2).
References: 1) Nozumi, M. et al. Cell Rep. 18: 2203-18 [‘17]; 2)
Honda, A. et al.: J Neurosci 37: (in press) [‘17].
MTU09-11
Branching patterns and volume density of hippocampal
immature neurons exposed to exercise and complex
enriched environments
A. Ihunwo, C. Uzokwe, P. Nkomozepi, P. Manger
University of the Witwatersrand, School of Anatomical Sciences,
Johannesburg, South Africa
Adult neurogenesis in the dentate gyrus of the hippocampus was
investigated in the Long-Evans (LE) rats exposed to the standard
laboratory environment, running wheel exercise as a single inﬂu-
encing factor and a complex enriched environment. After 28 days
exposure six LE rats in each group were transcardially perfused with
4% paraformaldehyde (PFA) in PBS. Brains were carefully
removed, post-ﬁxed in PFA sagittal frozen sections cut at 50 lm.
The brain sections were treated with Cresyl violet for cytoarchitec-
ture. Immunohistochemical and immunoﬂuorescence techniques
using doublecortin (DCX) identiﬁed immature neurons and their
processes, synaptophysin for synapses and synaptobrevin for
spinogenesis. Volume density of the dentate gyrus was measured
using the VOLUMEST application on the Image J software. Results
showed a signiﬁcant increase in brain weight (p ≤ 0.5) for the
complex enriched compared to the running and control groups but
no statistical signiﬁcance in the brain/body index. The DCX
immunopositive results indicated the neuron structure, dendritic
branching patterns, as well as neuronal arrangements on the dorsal
and ventral limbs of the dentate gyrus was variable among groups.
DCX post mitotic neurons were distributed more on the ventral limb
of the dentate gyrus compared to the dorsal limb in exercise and
enriched groups compared to the standard group. In enriched group
were post mitotic neurons with single dendrite that extended to the
molecular cell layer of the dentate gyrus before dividing into
secondary and tertiary dendrites. Immunoﬂuorescence showed
neuronal soma and process of the DCX positive cells. Synapto-
physin and synaptobrevin presented as diffuse neuronal clusters
over the subgranular zone with no signiﬁcant differences. Volumet-
ric density was least in the control and greatest in the enriched
environment with no statistical signiﬁcant differences observed
between the groups. Enriched environment increased the potential
for preferential generation and integration of new neurons in speciﬁc
limb of the dentate gyrus.
MTU09-12
Promotion of mTOR signaling in neural progenitors
exposed to the green tea amino acid theanine
N. Kuramoto1, H. Higashi1, T. Kinjo1, Y. Yoneda2
1Setsunan University, Molecular Pharmacology, Hirakata City,
Japan
2Kanazawa University, Prophylactic Pharmacology, Kanazawa,
Japan
Chewable tablets enriched of theanine, which is an amino acid
ingredient in green tea by 2–3% with a structural analogy to
glutamine rather than glutamate in terms of the absence of free
gamma carboxylic acid, is now on sale in Japan as a dietary
supplement expected to be beneﬁcial for the prophylaxis of
cognitive impairments on the basis of our previous ﬁndings on
neural progenitor cells. In this study, we evaluated the intracellular
mechanisms underlying the promotion of both proliferation and
subsequent neuronal differentiation in neural progenitor cells
exposed to theanine. Neural progenitor cells were cultured with
theanine at different concentrations, followed by subsequent deter-
mination of the endogenous levels by Western blotting of several
key intracellular proteins for the mammalian target of rapamycin
(mTOR) pathway responsible for the cell growth in a manner
sensitive to intracellular glutamine levels. Exposure to theanine not
only induced marked upregulation of transcript expression of the
glutamine transporter Slc38a1 in neurospheres composed of clus-
tered proliferating progenitors from embryonic mouse neocortex at
concentrations above 10 mM, but also resulted in facilitated
phosphorylation of mTOR and downstream p70S6K and S6 proteins
without affecting the p70S6K protein level. Stable overexpression of
Slc38a1 markedly promoted the phosphorylation of mTOR and
downstream relevant proteins in proliferating embryonal carcinoma
P19 cells, while theanine failed to additionally promote the
facilitated phosphorylation of proteins related to the mTOR
signaling in these stable Slc38a1 transfectants. In embryonic murine
neural progenitor cells previously exposed to theanine, a signiﬁcant
increase was seen in the number of cells immunoreactive for the
neuronal marker protein MAP2 along with a decreased number of
GFAP-positive cells after spontaneous differentiation in the absence
of theanine. These results suggest that theanine promotes prolifer-
ation and neuronal differentiation through a mechanism relevant to
activation of the mTOR signaling pathway required for self-renewal
toward accelerated neurogenesis in murine undifferentiated neural
progenitor cells.
140 Journal of Neurochemistry © 2017 International Society for Neurochemistry, J. Neurochem. (2017) 142 (Suppl. 1), 78--164
© 2017 The Authors
MTU09 Neurogenesis and Cell Differentiation
MTU09-13
GM1 neurotrophic properties are related to GM1
oligosaccharide - TRKA interaction
M. Maggioni, E. Chiricozzi, D. Y. Pome, E. D. Biase, M. Aureli, S.
Sonnino
University, Department of Medical Biotechnology and Translational
Medicine, Segrate, Italy
Several data suggest a speciﬁc role of ganglioside GM1 in
neuronal differentiation and development, but the molecular mech-
anisms of these processes are largely unknown. The involvement of
GM1 ganglioside in the process of neurite production has been
reported for many years. Here, we report that the only GM1
oligosaccharide, rather than the ceramide portion or the total
molecule, is directly involved in these processes.
GM1, or its oligosaccharide, was added to the neuroblastoma cell
culture medium and neurite outgrowth evaluation was accomplished
by phase contrast microscopy; neuroﬁlament expression and Trk
pathway activation were evaluate by Western Blotting.
GM1 oligosaccharide induced neuritogenesis and stimulated Trk
pathway activation. Neurite elongation was accompanied by an
increase of the neuroﬁlament protein expression. The comparison of
the results obtained with GM1 suggests a direct action of GM1
oligosaccharide in the neuritogenesis processes and in Trk activation
in murine neuroblastoma cells. This means that the speciﬁc role
exerted by changes of the membrane ganglioside GM1 content,
described in the past, is determined by a direct interaction between
the GM1 oligosaccharide portion and speciﬁc proteins. This allows
considering both the trans- and cis -interaction via a head-to-head
and side-by-side interaction, respectively. Trk receptor is involved
in the process by direct interaction or by interaction through
intermediate proteins.
MTU09-14
Functional analyses of TPT1 in neural stem/progenitor
cells and glioma initiating cells
S. Ohta1, Y. Kawakami1, H. Okano2
1Keio University School of Medicine, Division of Cellular Signaling,
Institute for Advanced Medical Research, Tokyo, Japan
2Keio University School of Medicine, Department of Physiology,
Tokyo, Japan
MIF (Macrophage migration inhibitory factor) was identiﬁed as a
functional molecule, which supports the proliferation and/or survival
of murine neural stem/progenitor cells (NSPCs) using functional
cloning strategy (Ohta et al., JCS. 2012). In the functional cloning
procedure, we also identiﬁed a new factor, TPT1 (Tumor Protein
Translationally-Controlled 1). TPT1 is expressed in cultured mouse
NSPCs and the ventricular zone of mouse brain at embryonic day
14.5. Intriguingly, MIF-treated murine NSPCs increased the Tpt1
gene expression. Overexpression of Tpt1 in mouse NSPCs increased
the cell proliferation in vitro. In human ES-derived NSPCs (hES-
NSPCs), lentivirus-mediated gene silencing of MIF decreased the
gene expression of TPT1. Over-expression of TPT1 increased the
cell proliferation and in contrast, lentivirus-mediated gene silencing
of TPT1 decreased the cell proliferation and neurogenesis in hES-
NSPCs. In addition, the TPT1 gene silenced hES-NSPCs showed
the decrease of the S-phase fraction accompanied with the up-
regulation of p21 gene expression, and increased the apoptotic
activity. We also performed RNA sequencing and conﬁrmed the
gene expression changes of cell cycle related factors in the TPT1
gene silenced hES-NSPCs. Moreover, we tried to identify miRs
regulated by TPT1 in hES-NSPCs using Taqman array gene cards,
and identiﬁed miR338-3p as a TPT1 downstream target. The TPT1-
miR338-3p-SMO axis was newly identiﬁed as regulating the cell
proliferation of hES-NSPCs in vitro. Taken together, MIF-regulated
TPT1 contributes to the proliferation and/or survival of NSPCs in
both mouse and humans. Otherwise, we also reported the functions
of MIF and CHD7 (chromodomain-helicase-DNA-binding protein
7) in glioma initiating cells (Fukaya et al., Cancer Res., 2016; Ohta
et al., Mol. Brain, 2016), regulating the cell proliferation. Finally,
we found that TPT1 gene expression was regulated by MIF and
CHD7, respectively, and TPT1 gene silencing decreased the cell
proliferation in the glioma initiating cells. Together, these results
may contribute to the development of new therapeutic targeting for
glioma.
MTU09-15
Endogenous galectin-1 is not required for normal axonal
development in early embryo stages and posterior
locomotor function
H. Quinta1, F. Barrantes2, J. Pasquini1
1Instituto de Quımica y Fısico Quımica Biologica, Universidad de
Buenos Aires, Departamento de Quımica Biologica, Buenos Aires,
Argentina
2BIOMED UCA-CONICET, Laboratory of Molecular
Neurobiology, Buenos Aires, Argentina
It was recently described that Galectin-1 (Gal-1) promotes axonal
growth after spinal cord injury. This effect depends on protein
dimerization, since monomeric Gal-1 fails to stimulate axonal re-
growth. Gal-1 is expressed in vivo, at concentrations that favor the
monomeric species. The present study aims to investigate the role of
endogenous Gal-1 in normal axonal development and locomotor
behavior in mice.
In order to characterize axonal development in lgals-1/ mouse
embryos, we resorted to a combination of the 3-DISCO technique
and optical cutting-edge technologies, such as 1-photon and
epiﬂuorescence microscopies under high power LED illumination
followed by serial image section deconvolution and 3-D recon-
struction. Using cleared whole lgals-1/ embryos, 3-D axonal
cytoarchitecture was analyzed, evaluating axonal development,
number of ﬁbers and ﬂuorescence density, length and shape of
single neuroﬁlaments in the axonal sprouting, deep in the whole
tissue. Gal-1 deﬁcient embryos did not show morphological/
anatomical alterations in any of the axonal populations and different
parameters analyzed. In addition, speciﬁc guidance receptor
PlexinA4 did not change its axonal localization in the absence of
endogenous Galectin-1. Finally, the absence of endogenous Gal-1
did not change the normal locomotor activity in post-natal stages.
Taken together, our results show that the absence of endogenous
Gal-1 does not modify normal axonal development and in-vivo
locomotor abilities. In agreement with our previous observations,
the present results further validate the use of lgals-1/ mice as a
model system to evaluate the action of this lectin on different
traumatic neuropathologies such as spinal cord- or traumatic brain
injury.
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Molecular and cellular causes of severe heterotopia:
identifying new genes playing a key role in radial glial
cells
D. Romero1, 2, 3, N. Bahi-Buisson4, K. Poirier5, J. Chelly6, J.-F.
Deleuze7, F. Francis1, 2, 3
1INSERM_UMRS839, F75005, Paris, France
2Sorbonne Universite,Universite Pierre et Marie Curie, F75005,
Paris, France
3Institut du Fer a Moulin, F75005, Paris, France
4Ho^pital Necker Enfants Malades Pediatric Neurology APHP,
Universite Paris Descartes,75015, Paris, France
5INSERM_U1016,Universite Rene Descartes, Institut
Cochin,75014, Paris, France
6IGBMC-CNRS_UMR7104, INSERM_U964, Strasbourg, France
7CEA/DSV/Institut de Genomique, Centre National de Genotypage,
Evry, France
Subcortical heterotopias are malformations of cortical develop-
ment associated with epilepsy and intellectual disability, and
characterized by the presence of ectopic neurons in the white
matter. Mouse models of this disorder are rare, although mutations
were identiﬁed in the microtubule-binding protein Eml1/EML1 in
the spontaneous HeCo (‘heterotopic cortex’) mouse, and in patients
exhibiting giant ribbon-like heterotopia.
To explore the bases of this disorder, a cohort of patients showing
an EML1-like phenotype was selected for further investigations.
These patients showed giant heterotopia with polymicrogyria, or
periventricular heterotopia and partial agenesis of the corpus
callosum. Patient DNA samples were analyzed by exome sequenc-
ing. Candidate genes and pathways are being studied, particularly
DLGAP4, which belongs to a membrane-associated guanylate
kinase family. The role of this gene during neurodevelopment in
progenitor cells has not been previously studied. Expression
analyses conﬁrmed its presence in the ventricular zone from early
corticogenesis in the mouse brain. Using different cell lines,
potential partners of Dlgap4 were identiﬁed. Predicting the conse-
quences of a de novo human mutation using the I-Tasser method,
revealed the extent of loss and modiﬁcation of DLGAP40s potential
functions. To further test its role in RGCs during cortical
development, in utero electroporation was performed in mouse
embryos. Our results strongly suggest that Dlgap4 is involved in the
maintenance of cell polarity at the ventricular lining and when it is
mis-regulated, induces changes in ventricular lining integrity.
This work reveals unsuspected molecular mechanisms important
for the function of cortical progenitors, which when perturbed
produce severe EML1-like heterotopia phenotypes in mouse and
human.
MTU09-17
ENU mutagenesis screening in mice identiﬁes a mutation
that causes microcephaly
V. Salina1, S. Tutukova1, E. Borisova1, E. Epifanova1, N. Zhidkova1,
A. Rusanova1, E. Turovsky1, M. Turovskaya1, A. Babaev1, V.
Tarabykin1, 2
1Lobachevsky State University, Institute of Neuroscience, Nizhny
Novgorod, Russia
2Charite Medical School, Institute of Cell- and Neurobiology,
Berlin, Germany
Microcephaly is a neurodevelopmental disorder that is charac-
terized by smaller brain volume. Primary microcephaly is present at
birth, whereas secondary microcephaly develops postnatally and is a
progressive neurodegenerative condition. The birth incidence of
primary microcephaly in humans differs from 1.3 to 150/100000,
depending on the population type and consanguineous populations.
In order to identify genes causing primary microcephaly in mice
we conducted chemical mutagenesis using N-ethyl-N-nitrosourea
(ENU) as a mutagene. ENU was injected into 8 weeks old C3H
males in order to induce mutations in the sperm. 78 males recovered
fertility after 5 months and were mated to C3H females. The
offspring of these mating were crossed to C57B6 mice in order to
conduct screening for recessive mutations causing microcephaly.
We identiﬁed a recessive mutations S1-5 that demonstrated primary
microcephaly. The phenotype of this mutant will be presented.
Research carried out with the ﬁnancial support of the grant of the
Russian Scientiﬁc Foundation (project №15-14-10021).
MTU09-18
Adhesive property of neuromesodermal progenitor-
derived neural stem cells is regulated by wnt signalling
M. Shaker, J.-H. Lee, W. Sun
Korea University, Anatomy, Sungbuk-Gu, Korea South
It is becoming evident that the properties of neural stem cells
(NSCs) are highly heterogeneous depending on their locations and/
or the developmental origin. A subset of posterior NSCs have
recently shown to be derived from tail tip neuromesodermal
progenitors (NMPs) which exhibit bi-potential to produce either
neural cells or mesodermal cells. Junctional neurulation is a unique
developmental program where primary and secondary neurulation
meets to shape a discrete region of the spinal cord. This transition
zone of junctional neurulation is highly susceptible to neural tube
defects. In vivo lineage tracing with TcreER2:Rosa-EGFP transgenic
mice revealed that NMPs-NSCs are conﬁned to the secondary neural
tube at the lumbosacral level that overlaps dorsally with primary
neural tube to form the junctional neural tube. Interestingly, here we
discovered that NSCs in the secondary neurulation regions is
signiﬁcantly adhesive and exhibit collective migration properties
comparing to the NSCs in the primary neurulation region. By
alteration of Wnt/b-catenin signalling signiﬁcantly altered primary
neural tube-NSCs toward secondary neural tube-NSC-like pheno-
types. These data illustrate that different adhesive properties of
NSCs along with longitudinal axis of neural tubes may be
implicated in the formation of junctional neurulation.
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Establishment of human pluripotent stem cell reporter
lines expressing tdtomato in oligodendrocyte progenitors
H. Sidik, M. Pouladi
A*STAR Singapore, Translational Laboratory in Genetic Medicine,
Singapore, Singapore
Several protocols to generate oligodendroglial lineage cells from
human pluripotent stem cells (hPSC) have been successfully
established. A major obstacle to improving the efﬁciency of these
protocols is the inability to monitor differentiation in live cells in
real time. Here we report the generation of lineage-speciﬁc hPSC
reporter lines expressing tdTomato under the control of the
oligodendrocyte progenitor marker PDGFRa. We show that
PDGFRa-tdTomato hPSC reporter lines retain the features of
undifferentiated hPSCs. We also show that the expression of
reporter gene closely parallels that of endogenous PDGFRa. In
future applications, we aim to use these reporters to assess changes
in oligodendrocyte differentiation in models of neurological disor-
ders. These reporter lines can also be used to reﬁne differentiation
methodologies to increase the efﬁciency and homogeneity of
oligodendrocyte derived from hPSCs, an important requisite for
therapeutic applications.
MTU09-20
Radial glial cell anomalies contributing to ectopic
progenitors in Eml1 mouse mutants
A. U. Lopez1, 2, 3, S. Bizzotto1, 2, 3, A. Houllier1, 2, 3, F.
Francis1, 2, 3
1Institut du Fer a Moulin, Cortical Development and Pathology
team, Paris, France
2INSERM, UMRS 839, Paris, France
3Sorbonne Universites, Universite Pierre et Marie Curie, Paris,
France
Cortical development is a ﬁnely regulated process that depends
on different neuronal progenitors, whose division modes, morphol-
ogy and location within the developing cortical wall are critical
characteristics that determine accurate development of the neocor-
tex.
We are studying the spontaneously arisen HeCo mouse which
constitutes a model for subcortical band heterotopia (SBH), a severe
cortical malformation characterized by the presence of mis-localized
neurons in the white matter and beneath the normotopic cortex.
Mutations were found in the microtubule-associated protein Eml1/
EML1, in the HeCo mouse, as well as in patients with severe
atypical heterotopia (Kielar et al., 2014). In early corticogenesis,
HeCo mice present ectopic progenitors in regions where the
heterotopia forms, although the causes leading to their delamination
from the ventricular zone still need to be fully understood.
We are investigating the mechanisms leading to ectopic progen-
itors, by focusing on a main neural progenitor type particularly
affected in this mouse mutant, the radial glial cell (RGC). We have
shown HeCo RGCs present spindle orientation (Kielar et al., 2014)
and mitotic spindle length abnormalities when compared to the WT.
To study the HeCo ventricular surface in more detail, we are
focusing on interphase RGCs. In early corticogenesis, we observe a
proportion of bigger cells in the HeCo ventricular lining, associated
with a decreased density of the total number of apical domains
observed. In addition, we detected anomalies in centrosome and
primary cilia, indicating that apical end-feet of HeCo interphase
RGCs are perturbed. Experiments with patient ﬁbroblasts support
the defects in primary cilia revealed in the mutant mouse. Studying
these apical components in HeCo mice using different microscopy
techniques, as well as elucidating molecular mechanisms involving
Eml1, will shed light on progenitor cell regulation and position,
critical for correct cortical development.
MTU09-21
PGC-1a induces neural stem cell differentiation and
reverses cognitive deﬁcits in ab- induced toxin model of
AD
A. Yadav, R. K. Chaturvedi
CSIR-Indian Institute of Toxicology Research, Lucknow,
Developmental Toxicology Division, Lucknow, India
New neurons are continuously being generated from neural stem
cells (NSCs) to maintain critical functions and repair processes in
the adult brain. However, in Alzheimer’s disease (AD) the
proliferation and differentiation of NSCs is reduced and generation
of functional neurons is principally impaired resulting in progressive
memory decline and subsequent loss of cognitive functions.
Therefore, potential mechanisms that can prevent Ab toxicity and
support neuronal regeneration against Ab induced neurotoxic insults
are much needed. PGC-1a, a master integrator of energy metabolism
is known to regulate diverse functions, however, so far its role in the
regulation of NSCs self-renewal, proliferation and differentiation
remain largely uncharacterized. In the present study, we ﬁrst
evaluated whether PGC-1a integrates with the genes and transcrip-
tion factors that control self-renewal, proliferation, differentiation
and survival of NSCs in the hippocampus. Second, whether
promotion of PGC-1a expression in AD model can restore
diminished NSC pool, damaged neural circuitry and impaired
cognitive functions. To discern the role of PGC-1a in NSCs
proliferation and differentiation, we performed RNA interference
and AAV-mediated overexpression of PGC-1a in the hippocampus.
The shRNA-mediated knockdown of PGC-1a in the hippocampus
resulted in decreased pool of NSCs and BrdU-positive cell
proliferation consequently leading to dysregulation of neurogenesis.
On the contrary, PGC-1a over-expression both via viral-mediated
gene transfer and pharmacologically by Nicotinamide/AICAR up-
regulated the mRNA expression of neurogenic transcription factors/
genes such as neuregulin, neuroD1 and suppressed the expression of
STAT3. Furthermore, the co-localization of BrdU with DCX, NeuN
was enhanced signifying the importance of PGC-1a in the
generation of mature and functional neurons. In continuation with
this, we also examined the involvement of PGC-1a in the regulation
of hippocampal-dependent learning and memory processes by
generating Ab 1-42 induced AD model. AAV and Nicotinamide
mediated upregulation of PGC-1a expression in AD model
enhanced cognitive function. Overall, these results illustrate a
highly speciﬁc role of PGC-1a in regulating adult hippocampal
neurogenesis and selective upregulation of PGC-1a may provide an
effective strategy in ameliorating memory loss associated with AD.
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MTU09-22
The green tea amino acid theanine for possible
improvement of cognitive declines
Y. Yoneda1, N. Kuramoto2
1Kanazawa University, Venture Business Laboratory, Kanazawa,
Japan
2Setsunan University, Molecular Pharmacology, Hirakata, Japan
Theanine is an amino acid enriched in green tea by 2–3% with a
chemical structure analogous to glutamine rather than glutamic acid.
We have been studying pharmacological proﬁles of this green tea
amino acid in neural progenitor cells, which are endowed to
proliferate for self-replication and to differentiate into progeny
lineages such as neuronal, astroglial and oligodendroglial cells, in
embryonic, developing and adult rodent brains. Progenitor cells
were exposed to theanine at different concentrations for determina-
tions of the size of neurospheres composed of clustered proliferating
cells and MTT reducing activity, followed by culture in the absence
of theanine for immunocytochemical detection of the cells
immunoreactive for MAP2 and GFAP among cells stained with
Hoechst33342. In cultured neural progenitor cells from embryonic
rat and mouse neocortex, theanine invariably promoted the forma-
tion of neurospheres and MTT reduction in a concentration-
dependent manner at 1 to 100 lM, followed by facilitation of
spontaneous differentiation into cells immunoreactive for MAP2
with a concomitant decreased number of GFAP-positive cells. In
cultured progenitor cells from the hippocampus of adult nestin-GFP
mice, theanine signiﬁcantly increased the size of neurospheres. In
murine embryonic carcinoma P19 cells exposed to theanine, similar
facilitation was seen in proliferation and subsequent spontaneous
neuronal differentiation. Upregulation was induced for the glu-
tamine transporter Slc38a1 transcript in rat and mouse progenitors
exposed to theanine for 4 days, but not for 2 days, whereas theanine
failed to further promote both proliferation and neuronal differen-
tiation abilities already facilitated in P19 cells stably overexpressing
Slc38a1. Signiﬁcant alleviation was seen in cognition impairment
scores measured by double-blinded physicians in healthy age-
matched elderly people given capsules of green tea enriched of
theanine than those given normal green tea capsules after daily oral
intake for 7–12 consecutive months. We have made a dietary
supplement product enriched of theanine as a chewable tablet for
online sale to expect a beneﬁcial support for the prophylaxis of
particular cognition impairments.
MTU09-23
Regulation of proliferative activity by protease-activated
receptor 1 in neural stem/progenitor cells generated after
neuronal deg
M. Yoneyama, M. Takenaka, T. Yamaguchi, Y. Onaka, K. Ogita
Setsunan University, Department of Pharmacology, Faculty of
Phamaceutical Sciences, Hirakata, Japan
It is now clear that there is a continual turnover of the mammalian
hippocampal dentate gyrus (DG) neurons throughout life even in
adult. Various neurological injuries are widely recognized as
promoting endogenous neurogenesis in DG. Thrombin-activated/
protease-activated receptor-1 (PAR-1) is known to regulate prolif-
eration of neural cells following brain injury including intracellular
hemorrhage. Our previous studies demonstrated that the systemic
treatment with trimethyltin chloride (TMT) causes the granule cell
loss in the mouse DG, with being regenerated in the dentate granule
cell after neuronal loss. To elucidate the roles of PAR-1 in
neuroregeneration after neuronal degeneration, we evaluated the
expression of PAR-1 in the newly generated cells following
neurodegeneration in the DG of adult mouse. In vivo experiments,
mice were given TMT to prepare hippocampal slices for immuno-
histochemical analysis using antibody against PAR-1 and nestin
[neural stem/progenitor cells (NPCs) marker]. Cells positive for
PAR-1 and nestin markedly increased in the DG on day 3–5 after
TMT treatment. In vitro experiments, the exposure of NPCs derived
from the DG after neuronal degeneration to thrombin signiﬁcantly
attenuated cell proliferation by bromodeoxyuridine incorporation
assay. Our results suggest that PAR-1 has a critical role in
proliferative activity inNPCs generated following neuronal degen-
eration in the DG.
144 Journal of Neurochemistry © 2017 International Society for Neurochemistry, J. Neurochem. (2017) 142 (Suppl. 1), 78--164
© 2017 The Authors
MTU09 Neurogenesis and Cell Differentiation
MTU10 Brain Bioenergetics
MTU10-01
Impaired mitochondrial and metabolic activity in neurons
derived from human induced pluripotent stem cells of FTD
patients
B. A. Garcıa1, Y. Zhang2, J. Nielsen3, B. Holst4, P. Hyttel2, K.
Freude2, H. Waagepetersen1
1University of Copenhagen, Drug Design and Pharmacology,
Copenhagen, Denmark
2University of Copenhagen, Department of Veterinary Clinical and
Animal Sciences, Frederiksberg C, Denmark
3Rigshospitalet, University of Copenhagen, Danish Dementia
Research Centre, Copenhagen, Denmark
4Bioneer, A/S, Hørsholm, Denmark
Frontotemporal dementia (FTD) is the third most common form
of primary degenerative dementia, accounting for up to 20% of
young onset dementia. FTD is a neurodegenerative disorder
characterized by cognitive impairment affecting the frontal and/or
temporal lobes of the brain associated with progressive brain
atrophy. Given that mitochondrial defects are commonly observed
in neurodegenerative diseases, we investigated whether mitochon-
drial respiration and energy metabolism are affected in neurons
derived from human induced pluripotent stem cells (hIPSC)
obtained from FTD patients. With this aim, forebrain region-
speciﬁc neurons were derived from FTD patients hiPSC lines
expressing NESTIN, FOXG1, OTX2 and PAX6 mRNA. After
subsequent maturation, glutamatergic cortical neurons expressing
MAP2AB, TUJ1, TAU, VGLUT1, TBR1 and CTIP2 mRNA were
obtained. Mitochondrial morphology and function were assessed
using transmission electron microscopy and real-time monitoring of
oxygen consumption via the Seahorse XFe96 Analyzer, respec-
tively, in cultured hiPSC-derived neurons. The results were
compared to CRISPR/Cas9-edited isogenic controls and neurons
derived from an age-matched healthy subject. Ultrastructure analysis
revealed mitochondria with poorly developed cristae as well as
abnormal localization in the FTD patient-derived neurons. In line,
oxygen consumption associated with mitochondrial activity was
decreased in the FTD neurons. All of the observed phenotypes were
reversed after targeted gene corrections in the isogenic controls. Our
ﬁndings indicate that hiPSC-derived neurons from FTD patients
display signiﬁcant mitochondrial dysfunction that could potentially
be targeted for treatment development.
MTU10-02
Augmented cerebral mitochondrial function and
hippocampal ketone body metabolism in Db/db mice
J. Andersen, J. Nissen, S. Christensen, H. Waagepetersen
University of Copenhagen, Dept. of Drug Design and
Pharmacology, Copenhagen, Denmark
Aim: Type 2 diabetes mellitus (T2DM) is a risk factor for the
development of Alzheimer’s disease (AD). Hypometabolism of
glucose have been observed in pre-symptomatic patients and animal
models of AD, suggesting a fundamental pathological mechanism.
The aim of this study is to elucidate cerebral metabolic
consequences of T2DM to possibly reveal accelerating factors of
T2DM on AD pathology.
Materials and methods: Db/db mice were used as a T2DM
animal model at 16 weeks of age. Acutely isolated cerebral cortex
and hippocampus slices of db/db mice were incubated in media
containing [U-13C]glucose or [U-13C]b-hydroxybutyrate. Oxygen
consumption and ATP synthesis rate of isolated whole-brain
mitochondria were assessed by SeaHorseXFe96 and on-line
luciferase based assay, respectively.
Results: Decreased 13C enrichment from [U-13C]glucose meta-
bolism were observed in key metabolites in extracts of both cerebral
cortical and hippocampal slices of the db/db mice. However, the
glucose hypometabolism was more prominent in the cerebral cortex.
Incubations with the ketone body [U-13C]b-hydroxybutyrate
showed increased 13C labeling in citrate, glutamate and glutamine
in hippocampal slices of db/db mice. These changes were absent in
the cerebral cortex. Isolated whole-brain mitochondria from db/db
mice, surprisingly displayed augmented oxygen consumption when
stimulated with ADP, when pyruvate and malate were provided as
substrates. This ﬁnding was supported by a signiﬁcantly increased
ATP production from isolated brain mitochondria of the db/db mice.
Conclusion: Cerebral metabolism and energetics are affected in
the db/db mouse. Hypometabolism of glucose is evident in the
cerebral cortex and hippocampus. However, the hippocampus of db/
db mice, exhibits augmented ketone body metabolism. Mitochon-
dria isolated from the db/db brain showed a signiﬁcant increase in
respiration and ATP synthesis. The results suggest that the
hypometabolism of glucose is the major deleterious effect of
T2DM on brain energy metabolism. However, the increased ketone
body utilization and augmented mitochondrial efﬁciency suggests
compensatory mechanisms, possibly related to the glucose hypo-
metabolism, in the diabetic brain.
MTU10-03
Compartmentalised signalling-metabolism coupling in
brain cells - putative drug targets for neurological
diseases?
L. Bak, A.-K. Reuschlein, C. Kjær, E. Jakobsen, J. Hedehus, C.
Mertz, S. Madsen, M. Jensen, N. Bergstedt, A. Knezevic, S.
Lindholm
University of Copenhagen, Dept. of Drug Design and
Pharmacology, Copenhagen, Denmark
Faulty cellular signalling and metabolism is a hallmark of a
number of brain diseases. In the ﬁeld of cell biology it is becoming
increasingly apparent that signalling pathways are compartmen-
talised in both space and time within the cell, and that an increased
understanding of these signalling events may lead to the discovery
of novel drug targets.
Compartmentalised coupling of cAMP and calcium signalling to
brain cell metabolism has already been demonstrated implying a
relevance to brain physiology and pathology.
In this poster presentation, we attempt to make the case that an
appreciation of compartmentalised cellular signalling and metabo-
lism is warranted to advance our understanding of cellular
neuroscience, and to discover novel drug targets.
© 2017 The Authors
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MTU10-04
Comparison diffusion behavior of metabolites in brains of
congenital portal systemic shunt and healthy mice in vivo
at 14.1 t
M. Dehghani1, N. Kunz2, R. Gruetter1, 2, 3, H. Lei2, 3
1Ecole Polytechnique Federale de Lausanne, Laboratory for
Functional and Metabolic Imaging, Lausanne, Switzerland
2Ecole Polytechnique Federale de Lausanne, Center for Biomedical
Imaging, Lausanne, Switzerland
3University of Geneva, Faculty of Medicine, Geneva, Switzerland
Diffusion-weighted 1H MRS allows investigating the cellular
compartmentalization of molecules in the living organs and may
shed insight on alterations of cellular restrictions faced by metabo-
lites in different cerebral abnormalities and diseases. The aim of this
study was to determine whether diffusion behavior of metabolites in
the congenital portal systemic shunt (PSS) mouse brain is different
from ones of the healthy mouse in vivo, combining large diffusion
weighting and 1H MRS methods.
All experiments were performed on a 14.1T magnet using a
home-built quadrature transceiver. Six adult PSS and six age-
matched healthy (Ctrl) C57BL/6J mice have been prepared and
anesthetized using isoﬂurane. 1H-MRS data were acquired using
localized diffusion-weighed STEAM-based spectroscopic pulse
sequence (TE=16 ms and a mixing time of 113 ms), covering the
b range from 0 to 45 ms/lm2. Quantiﬁed data by LCModel were
ﬁtted using bi-exponential equation. Diffusion behavior of metabo-
lites in the mouse brain was compared between PSS and Ctrl group.
The remarkable sensitivity and spectral resolution of localized
short-echo 1H MRS at 14 T allowed a precise measurement of the
diffusion properties of metabolites in the brain of PSS and Ctrl
mouse in vivo at very high diffusion weighting. The comparable
diffusion properties of most investigated metabolites in the brain
in vivo between PSS and Ctrl mice may indicate that unaltered
barrier and cellular restriction dominate on the diffusion of
metabolites in both group and therefore could support the hypothesis
about the similarity of intracellular distribution space for these
metabolites in PSS mice when compared to Ctrl mice. The slightly
different diffusivity of Tau may be ascribed to possible cellular
redistribution of Tau in PSS mice, however, it needs to be further
explored.
MTU10-05
Intracisternal injection of [U-13C]glucose for investigating
brain metabolism in freely moving mice
M. DiNuzzo1, S. Sanggaard1, S. Kostrikov1, A. Xavier1, S.
Christensen2, B. Aldana2, L. Bak2, U. Sonnewald2, A. Schousboe2,
H. Waagepetersen2, M. Nedergaard1
1University of Copenhagen, Center for Basic and Translational
Neuroscience, Copenhagen N, Denmark
2University of Copenhagen, Neuromet Laboratory, Copenhagen,
Denmark
Purpose: To investigate brain metabolism using intracisternal
delivery of [U-13C]glucose, thus bypassing blood-brain barrier and
avoiding effects of peripheral metabolism.
Methods: Mice (C57BL/6JRj, 8wo) were implanted a chronic
cannula into cisterna magna. After recovery (24 h) an isosmolar
0.3M [U-13C]glucose solution was infused using a microinjection
pump. Animals were sacriﬁced by microwave irradiation. 13C-
labeling and metabolite amounts were determined using mass
spectrometry and HPLC. Glycogen content was determined as
glucose units after amyloglucosidase treatment.
Results: [U-13C]Glucose injected at 2 lL/min (10 lL) resulted
in fast label incorporation into brain lactate as well as glutamate and
glutamine. Lactate labeling rapidly (within 10 min) decreased by
about 50%, while enrichment in glutamate and glutamine kept
increasing in the same time interval. Lactate was the only labeled
compound recovered in cervical lymph nodes. [U-13C]Glucose
injected at 0.3 lL/min (4.5–18 lL) resulted in progressive rise of
label incorporation into brain lactate, glutamate, glutamine, aspartate
and GABA. Labeling of these compounds was signiﬁcantly faster in
awake than anesthetized animals. The absolute concentrations of
glutamate and GABA were higher in the awake state whereas that of
glutamine was lower (~20% changes). Brain glycogen was higher
(+50%) during anesthesia and was negatively correlated with
glutamate/GABA and positively correlated with glutamine.
Conclusions: Our results indicate that lactate is produced in
excess of its utilization and rapidly leaves the brain, possibly
through brain lymphatics. The rate of aerobic glycolysis is higher
during wakefulness than anesthesia and so is the rate of transmitter
synthesis, suggesting higher glutamatergic and GABAergic tone in
awake animals. The correlations between brain glycogen content
and glutamate/GABA and glutamine in different states indicate that
glycogen synthesis/breakdown is modulated by brain activity and
contributes as substrate to neurotransmitter synthesis, underlining its
functional importance.
MTU10-06
Physiological roles of brain glycogen
J. Duran1,2, J. M. Delgado-Garcıa3, J. J. Guinovart1,2
1IRB Barcelona, Molecular Medicine Programme, Barcelona, Spain
2CIBERDEM, CIBERDEM, Madrid, Spain
3Universidad Pablo de Olavide, Neuroscience Division, Sevilla,
Spain
The role of brain glycogen has been traditionally associated with
the preservation of neuronal function during energetically challeng-
ing states such as hypoxia, hypoglycaemia, ischemia, and seizures.
Nevertheless, glycogenolysis also occurs in euglycaemia during an
increase in neuronal activity, thus indicating that brain glycogen also
supports neuronal function in non-pathological conditions. In order
to address the physiological roles of glycogen in the brain, we
generated a brain-speciﬁc glycogen synthase knockout mouse.
These animals, that completely lack brain glycogen, show a
signiﬁcant deﬁcit in learning capacity and in the activity-dependent
changes in synaptic strength. Furthermore, they show greater
susceptibility to hippocampal seizures and myoclonus following
the administration of kainate and/or a brief train stimulation of
Schaffer collaterals, which is in agreement with reports describing a
relationship between brain glycogen and susceptibility to epilepsy.
Within the brain, the presence of glycogen has been restricted
mainly to astrocytes. Therefore, all physiologic roles of brain
glycogen have been attributed exclusively to astrocytic glycogen.
However our ﬁndings demonstrate the presence of an active
glycogen metabolism also in neurons, which changes the current
view of the role of glycogen in the brain. Taken together, our results
reveal the relevant role played by glycogen in brain metabolism.
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Heterogeneity of energy metabolism of astrocytes
J. Hirrlinger1, 2, S. K€ohler1, U. Winkler1
1University of Leipzig, Medical Faculty, Carl-Ludwig-Institute for
Physiology, Leipzig, Germany
2Max-Planck-Institute for Experimental Medicine, Department of
Neurogenetics, G€ottingen, Germany
Astrocytes are a cell type in the brain which plays an important
role in brain energy metabolism. However, astrocytes are most
likely a heterogeneous population of cells as the environment and
therefore the requirements for these cells are very different in
different areas of the brain and – most likely – also at different
positions within the same brain region. Therefore, we hypothesized
that both basal and stimulated energy metabolism as well as
functional properties of astrocytes might be substantially different in
different brain regions reﬂecting these diverse environments and
requirements. To address these questions we took advantage of
genetically encoded, ﬂuorescent sensors for metabolites and studied
in cultured cells and in acutely isolated brain slices the dynamics of
key metabolites including lactate, ATP, and the NAD+/NADH-
redox state. We identiﬁed distinct differences in basal energy
metabolism as well as in the main regulatory mechanisms within
populations of astrocytes but also between astrocytes located in
different brain regions. These results support the hypothesis that
metabolism of astrocytes is subject to cellular heterogeneity, which
might also contribute to brain region speciﬁc vulnerability in disease
states.
MTU10-08
Inhibition of soluble adenylyl cyclase (SAC) causes a
robust increase in glycolysis in cultured astrocytes
E. Jakobsen1, S. F. Madsen1, J. Hedehus1, C. Rubio-Villena2, 3, N.
H. Jørgensen1, L. K. Bak1
1University of Copenhagen, Department of Drug Design and
Pharmacology, Copenhagen, Denmark
2Instituto de Biomedicina de Valencia, CSIC, Valencia, Spain
3Centro de Investigacion en Red de Enfermedades, CIBERER,
Valencia, Spain
One of the rate limiting steps in glycolysis is catalyzed by the
enzyme phosphofructokinase-1, which is allosterically activated by
fructose 2,6-biphosphate (F2,6BP). The bifunctional enzyme phos-
phofructokinase 2/fructose-2,6-bisphosphatase (PFK2/FBPase-2) is
responsible for the production and degradation of F2,6BP and thus
involved in regulating glycolysis. The activity of PFK2/FBPase-2 is
regulated by phosphorylation by cAMP dependent Protein Kinase A
(PKA) which couples cAMP signaling and thereby the adenylyl
cyclases to glycolytic activity. At present time, there is no
knowledge on which role sAC has in regulating PFK2/FBPase-2
and thereby glycolysis.
This work characterizes the effect of inhibition of sAC on
glycolytic activity and whether this change is mediated via a change
in F2,6BP levels. Working with cultured astrocytes, C6 glioma cells
and HEK cells we show that that inhibition of sAC causes a robust
increase in glycolytic activity and glucose uptake. The ratio between
PFK2 and FBPase-2 activity is investigated to determine if the
increase in glycolytic activity is caused by an increase in the level of
F2,6BP. The ﬁndings provide novel insight into the cAMP signaling
mechanisms mediated by sAC and how these are involved in
metabolic regulation.
A greater understanding of the pathways between cAMP
formation and the endpoint, increased glycolytic activity in this
case, can potentially provide new drug targets. In neurogenerative
diseases such as Alzheimer’s disease a decreased cerebral glycolytic
activity has been observed in both patients and animal models of the
disease. Thus, sAC could potentially become a drug target for
treating Alzheimer’s disease.
MTU10-09
Homocysteine affects the glucose and glutamate
metabolism of human glioblastoma cells
R. Murin, S. Mahmood, J. Hatok, D. Dobrota
Jessenius Faculty of Medicine in Martin, Comenius University in
Bratislava, Dep. Medical Biochemistry, Martin, Slovakia
Homocysteine is an intermediate of S-adenosylmethionine cycle,
which increased level in blood positively correlates with occurrence
of several diseases including neurodegeneration. In addition to its
neurotoxic effect, homocysteine is also capable to initiate death of
human astrocytes. Since glia-neuronal cooperation is considered to
be essential for sustaining neuronal energy metabolism and
glutamate-glutamine cycle, we investigated the putative effect of
homocysteine on the human glial cells to metabolize glucose and
glutamate. The human glioblastoma cells, T98G, were used as a
study model. The cells were incubated in medium supplemented
with D,L-homocysteine in levels up to 0.1 mM for 4 or 28 h. After
desired time of incubation, the concentrations of glucose, lactate and
glutamate in the media were analyzed enzymatically. Short term
incubation of human glioblastoma cells in the presence of homo-
cysteine had no effect on their glucose, lactate and glutamate
metabolism. Prolonged incubation for 28 h with D,L-homocysteine,
even at the level of homocysteine 0.05 mM, has signiﬁcantly
stimulated the glucose and glutamate uptake. The rate of lactate
released remained unchanged at all tested conditions. Our results
show that prolonged presence of homocysteine at the levels
reachable during hyperhomocysteinemia in human may affect the
glial metabolism of glucose and glutamate. Since glucose is a major
substrate for energy metabolism in brain parenchyma, increased
glial uptake of glucose during hyperhomocysteinemia that is not
accompanied by lactate release may lead to decreased availability of
the fuel molecules for sustaining the energy needs of neurons.
Furthermore, stimulated uptake of the glutamate into the glial cells
could disturb the glutamatergic neurotransmission. Taking together,
homocysteine could inﬂuence not only the physiological functions
of neurons but also glial cells and such combine effect may play a
role in etiopathogenesis of neurodegeneration associated with
hyperhomocysteinemia.
MTU10-10
Beta-hydroxybutyrate metabolism and metabolic
compartmentation in brain
C. Rae1, 2, L. Achanta1, 2, B. Rowlands1, 2, G. Housley1
1UNSW, School of Medical Sciences, Sydney, Australia
2Neuroscience Research Australia, (NeuRA), Randwick, Australia
There is renewed interest in the use of the ketone body b-
hydroxybutyrate (bOHB) to treat neurological disorders but its
metabolism in brain still requires thorough characterisation. Here,
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we studied guinea pig cortical brain slices using increasing
concentrations of [U-13C]D-bOBH ([U-13C]D-bOHB) in conjunc-
tion with [1-13C]D-glucose under conditions of normo- and
hypoglycaemia, as well as under high potassium (40 mmol/L K+)
depolarization in normo- and hypoglycaemic conditions. [U-13C]D-
bOHB at lower concentrations (0.25 and 1.25 mmol/L) was mostly
metabolized in neurons and stimulated mitochondrial metabolism. In
astrocytes it was incorporated into glutamine but did not stimulate
metabolism in the cytosol. At higher concentrations (2.5 mmol/L)
bOHB inhibited metabolism of [1-13C]D-glucose and reduced total
label incorporation and total metabolite pools. [U-13C]D-bOHB
could not substitute for glucose when glucose levels were reduced.
Incorporation of label from [U-13C]D-bOHB was decreased under
depolarising conditions, showing that glucose was the preferred fuel
under these circumstances. Unlike the case with labelled glucose,
lactate and pyruvate, label from [U-13C]D-bOHB was not used to
make labelled acetate, suggesting that mitochondrial citrate made
from [U-13C]D-bOHB was not exported to the cytosol. Finally,
inhibition of glutamine synthesis with MSO had no signiﬁcant effect
on incorporation of label from [U-13C]D-bOHB into GABA C2,1
indicating that the majority of this GABA was synthesized in situ
from [U-13C]D-bOHB rather than from Gln C4,5 imported from
astrocytes.
MTU10-11
Metabolism of mannose in cultured primary rat neurons
W. Rastedt1, 2, E. Blumrich1, 2, R. Dringen1, 2
1University Bremen, 1Centre for Biomolecular Interactions Bremen,
Faculty 2 (Biology/Chemistry), Bremen, Germany
2University Bremen, Centre for Environmental Research and
Sustainable Technology, Bremen, Germany
Glucose is the main peripheral substrate for energy production in
the brain. However, as other hexoses are also present in blood and
cerebrospinal ﬂuid, we have investigated whether neurons have the
potential to metabolize, in addition to glucose, also the hexoses
mannose, fructose or galactose. Incubation of primary cerebellar
granule neurons in the absence of glucose or in the presence of
fructose or galactose caused severe cell toxicity within 24 h, while
the cells remained viable during incubation in the presence of either
mannose or glucose. In addition, cultured neurons produced
substantial and almost identical amounts of lactate after exposure
to either glucose or mannose, while lactate production was low in
the presence of fructose and hardly detectable during incubations
without glucose or with galactose as carbon source. Determination
of the KM values of hexokinase in lysates of cultured neurons for the
hexoses revealed values in the micromolar range for mannose
(32  2 lM) and glucose (59  10 lM) and in the millimolar
range for fructose (4.4  2.3 mM), demonstrating that mannose is
efﬁciently phosphorylated by neuronal hexokinase. Finally, cultured
neurons contained reasonable speciﬁc activities of the enzymes
phosphomannose isomerase, which is required for isomerization of
the hexokinase product mannose-6-phosphate into the glycolysis
intermediate fructose-6-phosphate. These data demonstrate that
cultured cerebellar granule neurons have the potential and express
the required enzymes to efﬁciently metabolize mannose, while
galactose and fructose serve at best poorly as extracellular carbon
sources for neurons.
MTU10-12
Rates oxidative metabolism in astrocytes and neurons are
coupled to the glutamate-glutamine cycle in the tree
shrew visual cortex
S. Sonnay1, J. Poirot2, N. Just3, A.-C. Clerc1, R. Gruetter1, 4, G.
Rainer2, J. M. N. Duarte1
1Ecole Polytechnique Federale de Lausanne, Laboratory of
Functional and Metabolic Imaging, Lausanne, Switzerland
2Unversity of Fribourg, Department of Medicine, Fribourg,
Switzerland
3University Hospital M€unster, Department of Clinical Radiology,
M€unster, Germany
4University de Geneva/Lausanne, Department of Radiology,
Geneva/Lausanne, Switzerland
Neuronal oxidative metabolism was shown to be coupled to the
glutamate-glutamine cycle that represents glutamatergic neurotrans-
mission. While metabolism in astrocytes is also stimulated by
glutamatergic neurotransmission, it remains unclear whether the
glutamate-glutamine cycle is coupled to glial oxidative metabolism.
We took advantage of the columnar characteristics of the Tupaia
belangeri primary visual cortex (V1) to measure metabolic changes
induced by continuous stimulation of V1 using 13C magnetic
resonance spectroscopy (MRS) during infusion of [1,6-13C]glucose
in vivo.
Each animal under light isoﬂurane underwent the three MR
modalities at 14.1T, namely blood oxygenation level-dependent
functional magnetic resonance imaging (BOLD fMRI), 1H and 13C
MRS localized in V1, either at rest (n = 4) or during stimulation
(n = 5).
Visual stimulation resulted in a relatively large activated area in
V1 that allowed localized MRS. Cortical brain activity resulted in a
decrease in both brain glucose concentration (-17%; -0.34 lmol/g)
and phosphocreatine/creatine ratio (9%; 0.07) after 15 min of
stimulation. At the individual level, close relationships between the
neurotransmission rate (VNT) and total cerebral metabolic rate of
glucose oxidation (CMRglc(ox), R
2=0.68, P = 0.006), glial (VTCA
g
,
R2=0.66, P = 0.008) and neuronal (VTCA
n
, R
2=0.40, P = 0.066)
oxidative metabolism were measured. At the group level, 20%
increase in VNT (+0.038  0.042 lmol/g/min) resulted in a 24%
(ΔVTCA
g=0.063  0.057 lmol/g/min) and 12%
(ΔVTCA
n=0.061  0.032 lmol/g/min) increase in glial and neu-
ronal TCA cycle activity, respectively, resulting in 14% increase in
CMRglc(ox) (+0.058  0.032 lmol/g/min).
We conclude that cortical brain activity resulted in a signiﬁcant
increase in cerebral metabolic rate of glucose, and an increase in
both glial and neuronal oxidative metabolism. In both cells, the
tricarboxylic acid cycle rate was correlated with the rate of the
glutamate-glutamine cycle.
MTU10-13
Cortical neuronal glucose metabolism is impaired at mid
stage in the hSOD1G93A mouse model of amyotrophic
lateral sclerosis
T. Tefera, K. Borges
University of Queensland, Department of Pharmacology, Brisbane,
Australia
Amyotrophic lateral sclerosis (ALS) is a multi-pathogenic
disorder mainly characterized by the selective loss of motor neurons
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in brain and spinal cord. Although metabolic alterations have been
reported in this disease, the speciﬁc biochemical changes in the
energy producing pathways are unknown. We therefore investigated
glucose metabolism in the superoxide dismutase (hSOD1G93A)
mouse model of ALS. Wild-type and hSOD1G93A mice (n = 11) at
17 weeks old were injected with 543 mg/kg [1-13C] glucose and
504 mg/kg [1,2-13C] acetate (i.p.) 15 minutes before sacriﬁced.
Cerebral cortices were collected and extracted using methanol/
chloroform. The labelled and unlabelled metabolites of amino acids
were quantiﬁed using 1H and 13C nuclear magnetic resonance
spectroscopy and high performance liquid chromatography. Numer-
ous metabolic alterations were found mainly related to neuronal
glucose metabolism. Reductions in the amounts of glycolysis
derived metabolites such as total and labelled lactate (by 28 and
54%) and total and labelled alanine (by 18 and 65%) respectively
(p < 0.05) indicating impairments in glycolysis. Also, the
incorporation of 13C glucose via pyruvate dehydrogenase (PDH)
enzyme into the 1st turn tricarboxylic acid (TCA) cycle metabolites
such as [4-13C] glutamate, [4-13C] glutamine and [2-13C] GABA
was reduced by 42–54% (p < 0.05) showing less entry of glucose
into the TCA cycle. The levels of some of the branched chain amino
acids (BCAAs) such as isoleucine and leucine (p < 0.05) were
reduced indicating a compensatory degradation of BCAAs mainly
due to an increased energy demand and need for anaplerosis. There
were minor changes in astrocytic metabolism including increased
transfer of [1,2-13C] acetate-derived glutamine towards the forma-
tion of GABA but no changes in the levels of [4,5-13C] glutamate,
[4,5-13C] glutamine and [1,2-13C] GABA or pyruvate carboxylase-
derived metabolite levels. In conclusion, we found defective cortical
neuronal glucose metabolism in the hSOD1G93A mouse model of
ALS at symptomatic stage of the disease.
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Role of ck2 in t-cell differentiation and autoimmunity
E. Benveniste
University of Alabama at Birmingham, Cell and Developmental
Biology, Birmingham, USA
CD4+ T cells are the major pathogenic cells in many autoimmune
and inﬂammatory disorders, including Multiple Sclerosis (MS) and
Experimental Autoimmune Encephalomyelitis (EAE), an animal
model of MS. Th17 cells are important effector cells in the
pathogenesis of MS, whereas regulatory T cells (Treg) are crucial in
disease resolution. Current therapies for MS patients are incapable
of stopping disease progression and are not curative. Thus, studies
on the mechanisms of enhancing anti-inﬂammatory responses, such
as enhancing trans-differentiation of pathogenic Th17 cells into
beneﬁcial Treg cells, may lead to new potential therapies for MS.
Protein kinase CK2 (Casein Kinase II) is a constitutively active
serine/threonine kinase composed of two catalytic subunits (alpha
and/or alpha’) and two regulatory beta subunits. CK2 is involved in
the activation of multiple signaling pathways, including PI3K/AKT/
mTOR and JAK/STAT, which are essential for the differentiation of
CD4+ T cells. However, little is known about the speciﬁc function of
CK2 in T cells, and the consequences of CK2 inhibition during
CD4+ T cell differentiation and the pathogenesis of MS/EAE. Our
data indicate that expression of the major catalytic subunit of CK2,
CK2alpha, is induced in a time-dependent manner upon activation
of CD4+ T cells both in vitro and in vivo. Utilizing a small molecule
CK2 inhibitor CX-4945 (Silmitasertib), we ﬁnd that inhibition of
CK2 kinase activity signiﬁcantly ameliorates the severity of EAE
disease, which is correlated with regulation of Th17 and Treg cell
frequencies. Treatment with CX-4945 inhibits the differentiation of
Th17 cells, while promoting the differentiation of Tregs. Our
preliminary results indicate that conditional deletion of CK2alpha in
CD4+ T-cells inhibits Th17 differentiation and promotes Treg
polarization, comparable to what was observed with CX-4945
treatment. Thus, we propose that CK2 kinase activity in CD4+ T
cells correlates with the pathogenesis of MS/EAE by promoting
inﬂammatory Th17 cell responses and suppressing anti-inﬂamma-
tory Treg cell development, thereby affecting the ratio of these two
important CD4+ T-cell subsets. Furthermore, inhibition of CK2
kinase activity may be a potential novel therapeutic treatment for
MS patients.
MTU11-02
Generation of IL33 knockout mice and cell-based reporter
assay for functional studies of IL-33 in vitro and in vivo
W.-Y. Chen
Kaohsiung Chang Gung Memorial Hospital, Institute for
Translational Research in Biomedicine, Kaohsiung City, Taiwan
Background: Interleukin-33 (IL-33), an IL-1 family cytokine, is
a tissue-derived nucleus alarmin that drives inﬂammatory responses
through binding to its receptor ST2. IL-33 is expressed by multiple
tissues and released from nucleus upon tissue damage or inﬂam-
mation.
Aims: In this study, we aimed to generate a cell-based
functional reporter assay for screening of IL-33 activity. We also
aimed to generate IL33 knockout mice for in vivo loss-of-function
studies.
Methods and Results: We established the IL-33 reporter cells
with stable expression of functional receptor complex for IL-33
(ST2L and IL-1RacP) and an AP-1/NF-kB/SEAP reporter cassette.
The reporter cells secrete alkaline phosphates to the culture in
response to IL-33 stimulation and the levels of the enzyme activity
can be determined using colorimetric enzyme assay. Our results
demonstrated the speciﬁcity of IL-33 in activation of ST2 signaling
in the IL-33 reporter cells.
For generation of IL33 conditional deletion mice, the exon 5,
exon 6 and exon 7 of the IL33 gene were ﬂanked by two directional
Lox-p sites. Germ line transmission and the establishment of
IL33 ﬂoxed mice (IL33 ﬂ/ﬂ) were conﬁrmed by allele-speciﬁc
genotyping and diagnostic restriction analysis of PCR products.
The IL33/ were further generated from IL33 ﬂ/ﬂ mice by crossing
the mice to C57BL/6-Tg(UBC-Cre) to remove the loxP-ﬂanked
exons. Deletion of targeted exons was conﬁrmed using allele
speciﬁc PCR and RNA-sequencing analysis. Immunoﬂuorescent
staining and ELISA analyses also conﬁrmed the deﬁciency of IL-33
protein in IL33/mice.
Conclusions: We have established a cell-based reporter assay
for functional analysis of IL-33 activity. We also generated IL33/
mice and IL33 ﬂ/ﬂ mice for conditional knockout studies. These
materials will be useful for further investigation of the role of IL-33
in health and diseases.
MTU11-03
Curcumin reverses altered expression of GFAP
astrocytes marker and hypercorticosolemia in depressed
rats
T. Ekanem1, 2, E. Wogu1, 2, A. Akpantah1, M. Eluwa1
1University of Calabar, Department of Anatomy, Calabar, Nigeria
2University of Port Harcourt, Department of Anatomy, Port
Harcourt, Nigeria
Astrocyte pathology has been consistently observed in Major
Depressive disorders (MDD) and this could be seen in the altered
expression of proteins for astrocyte markers such as the Glial
Fibrillary Acid Protien (GFAP). Astrocyte deﬁcit observed in MDD,
astrocytes may become novel targets for antidepressant medication.
The present study investigated the effect of curcumin and ﬂuoxetine
antidepressant drug on the expression of GFAP astrocyte marker
and corticosterone (CORT) in depressed rats. Depression was
induced in albino wistar rats using a modiﬁed Chronic Unpre-
dictable Stress (CUS) method for 42 days. The rats were grouped
into six groups of ten rats each. The Control received distilled water
only. Depressed group received distilled water after CUS. Olive oil
group received 0.8 ml/kg of virgin olive oil for 42 days after CUS.
Curcumin group received 30 mg/kg of curcumin for 42 days after
CUS. Fluoxetine group received 20 mg/kg of ﬂuoxetine for 42 days
after CUS. Fluoxetine+Curcumin group received 30 mg/kg of
curcumin and 20 mg/kg of ﬂuoxetine for 42 days after CUS. There
was increased astrocyte pathology as indicated by the increased
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intensity in expression of GFAP astrocyte marker, hypertrophy of
the astrocyte cell bodies and processes as well as increased scar
formation in the Prefrontal cortex, dentate gyrus and CA3 region of
the hippocampus of depressed rats compared to the control group.
On the other hand, there was reduced intensity of GFAP expression
in astrocyte cell bodies and processes in the Prefrontal cortex,
dentate gyrus and CA3 region of the hippocampus of curcumin
treated rats as well as the curcumin+ﬂuoxetine treated group and in
the control group. The CORT level was signiﬁcantly increased in
depressed rats compared to the control group whereas there was no
signiﬁcant difference observed in the curcumin treated group and
other treatment groups. Hence, curcumin has shown to ameliorate
the increased astrocyte pathology and hypercortisolemia seen
inMDD.
MTU11-04
c-Abl regulates rotenone-induced inﬂammatory response
via the activation of NLRP3 inﬂammasome
A. Kanthasamy, V. Lawana, N. Singh, A. Kanthasamy
Iowa State Univ., BMS, Ames, USA
Multiple evidences support the hypothesis that exposure to
pesticides increases the risk of PD. Emerging evidence indicates that
intracellular inﬂammasome complex namely NLRP3 complex is
involved in the recognition and execution of host inﬂammatory
response. Thus in the present study we investigated the hypothesis
that NLRP3 inﬂammasome activation is linked to rotenone- induced
microglial activation which is dependent upon a priming stimulus by
a pathogen associated molecular pattern (PAMP) or damage
associated molecular pattern (DAMP) respectively. We employed
primary microglia, BV-2 microglial cell culture, and an in vivo
endotoxin model of neurodegeneration to address the stated
hypothesis. We found that LPS priming accelerated rotenone-
induced NLRP3 inﬂammasome activation that was associated with
the activation of caspase-1 and subsequent proteolytic processing
and release of IL-18 and IL1b as well as the release of TNFa and IL-
6 as assessed via WB analysis and Luminex multiplex technology.
Mechanistic studies revealed c-Abl/PKCd kinase signaling axis as a
proximal signal that exacerbated rotenone-induced NLRP3 inﬂam-
masome activation, that is mediated via mitochondrial and
autophagolysosomal system (ALS) dysfunction and accompanying
downregulation of TFEB, a lysosomal transcription factor. Intrigu-
ingly, gene silencing and pharmacological inhibition of c-Abl
attenuated NLRP3 inﬂammasome activation, mitochondrial and
ALS dysfunction and PKCd activation; while, c-Abl overexpression
potentiated that response in LPS primed rotenone treated microglial
cells. Furthermore, using an in vivo LPS model of neurodegener-
ation we showed that c-Abl upregulation positively correlated with
NLRP3 inﬂammasome activation and accompanying sickness-like
behavior. Our ﬁndings demonstrate for the ﬁrst time that c-Abl/
PKCd signaling axis is a key regulator of NLRP3 inﬂammasome
activation which is mediated partly via dysregulation of ALS and
mitochondrial function during rotenone-induced microglial activa-
tion (supported by NS088206).
MTU11-05
S-guanylation of SNAP-25 by 8-nitro- cGMP attenuates the
interaction of snare complex with complexin
Y. Kishimoto1, K. Kunieda2, T. Akaike3, H. Ihara1
1Osaka Prefecture University, Department of Biology, Graduate
School of Science, Sakai, Japan
2Fukushima Medical University, Medical-Industrial Translational
Research Center, Fukushima, Japan
3Tohoku University Graduate School of Medicine, Department of
Environmental Health Science and Molecular Toxicology, Sendai,
Japan
Introduction: 8-Nitroguanosine 30,50 -cyclic monophosphate
(8-nitro-cGMP) is an unique second messenger, which is generated
in the nitric oxide/reactive oxygen species signal. This molecule
covalently binds to protein thiol groups, called protein S-guanyla-
tion, and alters protein functions. On the other hand, exocytosis is
catalyzed by soluble N-ethylmaleimid-sensitive factor attachment
protein receptor (SNARE) proteins and is modulated by some
modulatory proteins. Complexin is a small protein that binds to
SNARE complex with high afﬁnity and modulates exocytosis.
Previously we reported synaptosomal-associated protein 25 (SNAP-
25) as a target protein of S-guanylation, however, the neurophys-
iological functions have not been clariﬁed. Here, we investigated the
role of S-guanylation of SNAP-25 by 8-nitro-cGMP in neurons.
Material and methods: The localization of 8-nitro-cGMP and
S-guanylated proteins in the Wistar rat brain were conﬁrmed by
immunohistochemistry using each speciﬁc antibody. To conﬁrm the
effect of 8-nitro-cGMP for the interaction between SNARE complex
and complexin, we performed pull-down assay using GST-tagged
complexin, co-immunoprecipitation and blue native (BN)-PAGE
followed by western blotting. SH-SY5Y neuroblastoma cells were
transfected with FLAG-tagged SNAP-25 (wild-type and C90A) or
V5-tagged complexin, treated with 8-nitro-cGMP, and then used as
samples.
Results and discussion: The result of the immunohistochem-
istry revealed that the 8-nitro-cGMP and S-guanylated proteins were
localized in neurons in the brain. Pull-down assay revealed that the
amount of SNAP-25 pulled-down by GST-complexin was decreased
by S-guanylation of cys90 in SNAP-25. We could obtain almost the
same results from co-immunoprecipitation. Furthermore, BN-PAGE
followed by western blotting revealed that the amount of V5-
complexin detected in high molecular mass was decreased by 8-
nitro-cGMP treatment. Our results suggest that S-guanylation of
cys90 in SNAP-25 attenuates the interaction of SNARE complex,
which would form a large oligomer, with complexin.
MTU11-06
Apoptosis and host-defense peptide cathelicidins
determine different outcomes of bovine alpha-
herpesviruses neuropathogenesis
M. Marin1, M. Burucua2, D. Rensetti3, A. Odeon2, E. Cobo4, S.
Quintana1, S. Perez1
1CONICET, Research Council, Buenos Aires, Argentina
2INTA, Animal Production, Balcarce, Argentina
3UNCPBA, Faculty of Veterinary Science, Tandil, Argentina
4University of Calgary, Veterinary Medicine, Calgary, Canada
Alpha-herpesviruses are closely related viruses that cause
neurological disease in humans and cattle. Bovine herpesvirus
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(BoHV) type 5 is an important cause of encephalitis in cattle.
However, encephalitis by BoHV-1 occurs occasionally. It is
unknown how the innate immune response contributes to their
differences in neuropathogenesis. BoHV-5 speciﬁcally induced the
expression of Toll-like receptors (TLRs) in bovine neural inﬂamed
tissue (Marin et al., 2014). Antimicrobial cathelicidin peptides
modulate TLR4 expression in epithelial cells although their function
in the nervous system remains elusive. These innate factors together
with speciﬁc BoHV-apoptotic potential could be determinant in the
neuropathogenesis as they could promote or limit the inﬂammatory
response. In this study, we determined apoptosis and the expression
of cathelicidins in the bovine nervous system during BoHV-1 and 5
acute infections. Calves were inoculated with BoHV-1 Cooper or
BoHV-5 97/613 strains (106.3 TCID50) or inert culture medium
(control). At 6 days post-infection (dpi), different regions of central
nervous system (CNS) and trigeminal ganglion (TG) were collected
for immunocytochemical detection of cleaved caspase 3 and
messenger gene determination of bovine cathelicidins BMAP27
and BMAP28 (RT-qPCR). At 6 dpi, caspase 3-apoptotic neurons
were detected in the TG of BoHV-1-infected calves, whereas fewer
numbers of caspase 3 positive neurons were observed in BoHV-5-
infected calves. Cathelicidins expression was up- and down-
regulated in CNS from BoHV-1- and BoHV-5-infected calves,
respectively. BMAP27 was noticeably up-regulated in TG from
BoHV-1-infected calves, while BMAP28 was only detected in
BoHV-5-infected calves. Our ﬁndings suggest that modulation of
apoptosis and cathelicidin expression orchestrate the ﬁnal inﬂam-
matory outcomes of alpha-herpesviruses infection of the nervous
system. Inhibition of both factors might be responsible for
neurological lesions in BoHV-5 infection. Further research will be
required to determine the role of cathelicidins during infectious
diseases of the CNS.
MTU11-07
Potential link between C5a receptor and mood disorders
in mouse exposed to experimental malaria in utero
A. Okojie1, 2, 3, K. Rauf2, E. Iyare1
1University of Nigeria, Reproductive and Developmental
Programming Research Group, Physiology, Enugu, Nigeria
2COMSATS Institute of Information Technology, Pharmacy,
Abbottabad, Pakistan
3Madonna University, Physiology, Elele, Nigeria
In Africa, a large number of pregnancies are exposed to
Plasmodium falciparum infection during pregnancy. The in-utero
environment extremely inﬂuence childhood neurodevelopment and
behaviour. The complement 5a receptor is linked to several disease
conditions. However, the inﬂuence of Plasmodium berghei during
pregnancy on maternal complement 5a receptor and subsequently on
fetal behaviour is unknown. Pregnant mice were intra-peritoneal
infected on gestational day 13 with 1.02x105 infected red blood
cells. Infected red blood cells used in this experimental infection
were obtained from in vivo passage of P. berghei in mice when the
percentage of iRBCs reached approximately 10-20%. A section of
pregnant mice (both infected and uninfected) were allowed to
deliver and the progenies monitored up to postnatal day 42 when
depression-like behaviour was evaluated using tail suspension test
model. The other pregnant mice were subjected to cardiac puncture
on gestational day 19 for C5a receptor estimation using Elisa assay.
We show that pregnant mice infected with P. berghei had elevated
C5a receptor compared with uninfected pregnant females. We also
show that P. berghei-exposed offspring presented a depressive like
behaviour compared to unexposed controls. Our results demon-
strates a pathogenic role of complement 5a receptor signaling and its
possible role in mediating depression which is linked to Plasmodium
berghei infection during pregnancy.
MTU11-08
Neonatal proinﬂammatory treatment affects the cognitive
functions development and brain neuroplasticity-related
gene expression
A. Schwarz1, A. Trofimov1, E. Veniaminova3, O. Zubareva1, 2
1Institute of Experimental Medicine, I.P. Pavlov Department of
Physiology, Saint-Petersburg, Russia
2Sechenov Institute of Evolutionary Physiology and Biochemistry,
Russian Academy of Sciences, Laboratory of Molecular
mechanisms of neuronal interactions, Saint-Petersburg, Russia
3I.M. Sechenov First Moscow State Medical University, Laboratory
of Psychiatric Neurobiology, Moscow, Russia
Pro-inﬂammatory cytokines such as IL-1b, IL-6, and TNFa are
the main mediators of the neuro-immune interactions and are known
to affect learning and memory. Pro-inﬂammatory cytokines eleva-
tion during neonatal period is associated with high risk of
neuropsychiatric symptoms in later life. However, their effects on
the maturation of brain functions during early postnatal development
are not completely deﬁned.
We have investigated the effects of the treatment with IL-1b or
bacterial mimetic lipopolysaccharide (LPS, pro-inﬂammatory cyto-
kine inducer) during the 3rd week of life, which corresponds to
human perinatal period in terms of the CNS development, on the
development of behavior and brain gene expression in Wistar male
rats. Early-life IL-1b injections impaired working memory, while
LPS enhanced anxiety. Long-term memory in active avoidance and
Morris water maze paradigms was affected in adult rats both after
neonatal IL-1b and LPS treatment, whereas in adolescent animals,
exploratory behavior and locomotor activity was changed. IL-1b
treated animals had long-lasting changes in the D2 dopamine
receptor, FGF2, TIMP1 and MMP9 mRNA expression in the medial
prefrontal cortex and hippocampus in the region- and task-
dependent manner. The treatment of rats with LPS during early
life induced the short-term and long-term changes in the expression
of AMPA и NMDA glutamate receptor subunits, TIMP1 and
MMP9 genes in the hippocampus and medial prefrontal cortex.
The impairments induced by the elevation of pro-inﬂammatory
cytokine level during the early postnatal period may be associated
with the development of psycho-neurological decline of young and
adult patients with attention deﬁcit hyperactivity disorder or other
cognitive dysfunctions, and the mechanisms of that may be
explained by dysregulation of brain neuroplasticity-related gene
expression. Supported by RFBR projects 17-04-02116 A, 16-34-
00873 mol_a, 16-34-00316 mol_a.
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Neurotrophin-3 modulates microglial phenotype in the
traumatized CNS
D. Shine1, S. Mandreekar-Colucci2, Q. Chen1, Y. Qian1, P.
Popovich2
1Baylor College of Medicine, Department of Neuroscience & Center
for Cell and Gene Therapy, Houston, TX, USA
2The Ohio State University, Center for Brain and Spinal Cord
Repair, Columbus, OH, USA
Over two-thirds of spinal cord injury (SCI) patients have
anatomical preservation at the injury site, yet this preserved tissue
is typically completely or partially dysfunctional. Therefore, to
provide improved function in these patients, strategies are needed
that enhance the function of the remaining connections by enabling
the inherent plasticity of the CNS. We found an unanticipated
interplay between a neurotrophin and cellular immune processes that
may provide a means to promote plasticity after SCI. Moreover, we
have evidence that this interplay may be exploited to induce
neuroplasticity in chronic SCI. Our earlier work showed that
unilateral viral-vector mediated over-expression of Neurotrophin-3
(NT-3) in lumbar motoneurons induced axon growth from the
contralateral corticospinal tract (CST) towards the source of the NT-
3. Subsequently, we showed that there is an immune component to
the NT-3-induced axonal sprouting and that microglia and T cells
are likely involved. When the host animals were rendered
immunocompetent by pharmaceutical or genetic manipulations the
NT-3 did not induce sprouting. Grafting normal T cells into
immunocompetent rats enabled NT-3-induced axonal sprouting.
Recent data show that microglia and macrophage have the NT-3
receptor TrkC and that NT-3 re-programs inﬂammatory macro-
phages and microglia to a more pro-regeneration phenotype. These
experiments suggest that future therapeutic strategies based upon
manipulation of microglia may promote enhanced neuroplasticity
and increase functional recovery in patients with chronic SCI.
Supported by the Mission Connect a project of TIRR Foundation,
The Dana and Christopher Reeve Foundation and the NIH-NINDS.
MTU11-10
Inorganic arsenic mediated disturbance in microglial
glutathione metabolism leads to bystander death of
immature neurons
V. Singh, R. Gera, A. Sharma, D. Ghosh
CSIR- Indian Institute Of Toxicology Research, Immunotoxicology
Laboratory, Lucknow, India
Low level environmental arsenic exposure has toxic effects on
neurons leading to cognitive dysfunction. Inspite of this fact,
microglial role in arsenic mediated neurotoxicity remain elusive. In
this study, arsenic -exposed microglial (N9) culture supernatant
induces bystander death of neuro-2a (N2a) cells, which resembles
developing neurons; contrarily, arsenic-exposed N2a culture super-
natant did not affect N9 viability. These results indicated that
microglia create toxic environment for N2a in presence of arsenic.
Screening for involvement of toxic factors like reactive oxygen
species (ROS), nitric oxide (NO), interleukin 6 (IL-6) and tumor
necrosis factor a (TNF-a) secreted from N9 cells in bystander N2a
death is found to be negative. Arsenic exposure induces GSH
synthesis in N9 cells by uptake of cystine from culture medium
through cystine/glutamate exchanger (xCT) resulting in lower
cystine and higher glutamate concentration compared to control
culture supernatant. Cystine/glutamate imbalance is also enhanced
by increased xCT expression in Nrf2 dependent manner in
microglia. Bystander death of N2a is rescued by supplementation
of 200 lM cystine to arsenic-exposed N9 culture supernatant.
Simultaneous exposure of excessive glutamate and arsenic compro-
mises N2a viability which is again rescued by cystine addition.
Therefore, microglia executes bystander N2a death simultaneously
by reduction of extracellular cystine concentration and competitive
inhibition of cystine transport due to high extracellular glutamate
levels. Ex-vivo microglia from gestationally arsenic exposed mice
releases excessive glutamate and reduces cystine levels in culture
supernatant as compared to control and n-acetyl cysteine co-treated
group. Immunoﬂuorescence staining of brain cryosections from
treated group showed more apoptotic immature neurons. Interest-
ingly, TUNEL ﬂuoresecence did not merged with microglia speciﬁc
Iba1. Finally bystander death of primary immature neuronal cultures
using primary microglia arsenic treated culture supernatant is also
conﬁrmed. Collectively, xCT is indispensable for survival of
immature neurons both in-vitro and in-vivo in presence of arsenic
and microglia.
MTU11-11
One-two punch, combination of immune tolerance and
myelin repair therapy to effectively target disease course
and severity in MS
H. Titus, L. Schuhknecht, V. Eaton, S. Beddow, A. Robinson, S.
Miller
Northwestern University, Microbiology-Immunology, Chicago, USA
The CNS autoimmune disease Multiple Sclerosis (MS) is
characterized by demyelination and neurodegeneration. Available
FDA-approved disease modifying therapies are global immunosup-
pressants and have limited efﬁciency. We have developed a novel
method of inducing immune tolerance to selectively regulate known
immune responses without compromising the entire adaptive
immune system. We have demonstrated an effective means of
ameliorating disease in a mouse model of MS through tolerance
induction in autoreactive T cells using i.v. infusion of nanoparticles
coupled with or encapsulating myelin peptides (Ag-PLG) that
effectively reduces disease burden in relapsing-remitting (RR-EAE)
and chronic-progressive (C-EAE) mouse models of experimental
autoimmune encephalomyelitis. This works to prevent disease
induction, but more importantly can stop disease progression in
mice treated following the initial clinical episode resulting in
antigen-speciﬁc blockade of disease relapses. At present, there are
no available therapies marketed for myelin repair in MS. The
objectives of the study were to prevent disease progression as well
as to promote CNS repair and neuroprotection. We tested an FDA
approved cardiac glycoside (Na+/K+ ATPase) and uncovered it
promoted an increase in the oligodendrocyte cell lineage in vitro and
in vivo, in the non-T cell-mediated Cuprizone model of demyeli-
nation/remyelination promoted a quicker restoration of myelin
integrity, and improved clinical score throughout the autoreactive
Th1/Th17 driven C57BL/6 Chronic EAE time course. Additionally,
we tested the hypothesis that to effectively target disease course and
severity in MS, regulated by autoimmunity and neurodegeneration,
a combination of selective immune regulation and myelin repair
therapy is required. Combination therapy using Ag-PLG
immunoregulatory therapy and the cardiac glycoside completely
MTU11 Neuroimmunology
© 2017 The Authors
Journal of Neurochemistry © 2017 International Society for Neurochemistry, J. Neurochem. (2017) 142 (Suppl. 1), 78--164 153
ameliorated clinical disease severity. Findings from these studies
may not only prove a rapid and safe therapeutic strategy for EAE
reversal, but will pave the way for future clinical studies in MS
undertaking this combinatorial therapeutic approach.
MTU11-12
Role of MECP2 in neuroimmune interactions
M. I. Z. Figueroa, M. L. Bertoldi, C. Fabio, C. Casta~nares, G. Roth,
A. L. Degano
Centro de Investigaciones en Quımica Biologica de Cordoba
(CIQUIBIC, UNC-CONICET), Quımica Biologica, Facultad de Cs.
Quımicas. Universidad Nacional de Cordoba, Cordoba, Argentina
Rett Syndrome is an autism spectrum disorder (ASD) caused by
mutations in Methyl Cytosine Binding Protein 2 (MeCP2) and
mouse models of Rett have been widely used for studying ASDs.
The main goal of our project is to use this monogenic model of
ASD, in order to evaluate the role of altered immunity in the
pathogenesis of this disorder. To this end we ﬁrst evaluated the
autoimmune response in the context of the experimental autoim-
mune encephalomyelitis (EAE). Male MeCP2 WT and MT mice,
were immunized with MOG 35-55 peptide, scored daily for EAE
symptoms and sacriﬁced at 12 dpi (acute stage) or at 30 dpi (chronic
stage). When WT-EAE animals and MT-EAE animals were
compared, we found that MeCP2 MT mice showed an accelerated
onset of the disease and more severe clinical scores. Coronal
sections of spinal cord were subjected to IHC to analyze the level of
expression of Iba1 (microglia) and to assess CNS lymphocyte
inﬁltration during EAE. MeCP2 MT animals showed increased
levels of inﬁltrating cells and microgliosis compared to WT mice;
this observation correlated with the individual clinical score reached
by each animal. To determine the response of immune cells, we re-
stimulated spleen mononuclear cells derived from MeCP2 WT and
MT mice with MOG peptide in vitro. Proliferation index and
cytokine production was assessed. We observed increased prolifer-
ation index in all EAE animals compared to CFA in response to
MOG stimulus, with no signiﬁcant differences between MT and WT
MeCP2 mice. Nevertheless, when the cytokine response was
analyzed, MT-EAE group showed increased IFN-gamma levels in
response to MOG in comparison with WT-EAE animals. Our results
showed a more severe neuroinﬂammation in the absence of MeCP2,
suggesting that Mecp2 has an active role in regulating the immune
response and maintaining the neuroimmune homeostasis.
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MTU12-01
Effects of presenilin-1 mutations in mitochondrial
dynamics
G. Bahn, J. H. Han, J. H. Sul, H. K. Kim, Y. S. Cho, S. H. Baek, J. M.
Lee, D. G. Jo
Sungkyunkwan Uni., Pharmacy, SUWON-SI, Korea South
Early stage of Alzheimer’s disease reveals mitochondrial deﬁcit
and dysfunction. Mitochondrial dysfunction in Alzheimer’s disease
causes synaptic alteration, imbalance of lipid homeostasis, calcium
homeostasis, and lack of ATP production. Familial Alzheimer’s
disease-linked Presenilin-1, catalytic subunit of c-secretase, muta-
tions cause early onset Alzheimer’s disease. All mutation types have
different pathological mechanism and ultimately break down
cellular homeostasis. Our research shows more details about
relationship between Presenilin-1 mutations (PS1A431E,
PS1E280A, PS1H163R, PS1M146V, PS1DE9) and mitochondrial
dysfunctions. All of PS1 mutants-expressing cells exhibited mito-
chondrial dysfunctions and reduced levels of proteins involved in
mitochondrial dynamics without alteration of total mitochondrial
biogenesis.
MTU12-02
Protective effect of periodic dietary restriction on
behavior and hippocampal deﬁcits in a mouse model of
Alzheimer’s disease
J. Beauquis1, 2, M. F. Todero1, 2, C. Pomilio1, 2, A. Vinuesa1, 2, R.
Gorojod2, A. Alaimo2, S. P. Alcon2, M. Kotler2, F. Saravia1, 2
1Instituto de Biologia y Medicina Experimental - CONICET,
Neurobiology of Aging, Buenos Aires, Argentina
2Facultad de Ciencias Exactas y Naturales, Universidad de Buenos
Aires, Dept. Quimica Biologica, Buenos Aires, Argentina
Alzheimer’s disease (AD) is a neurodegenerative pathology
associated with progressive decline in cognition and brain functions.
Accompanying amyloid b (AB) deposition, astrocytes and microglia
lose their neuroprotective functions and induce pathways that
amplify inﬂammation. Dietary restriction (DR) has been shown to
decelerate the aging process and reduce the impact of age-associated
diseases, probably modulating oxidative and inﬂammatory status,
regulating autophagy and inducing cell protection.
Our objectives were to evaluate neuroprotective effects of DR in
a model of familial AD and to parallelize in vivo results using an
in vitro model of nutrient restriction on glial cells exposed to AB.
We established a model of periodic DR in control and PDAPP-J20
transgenic mice. Daily food consumption was restricted to 60% for
5 days/week every one week for a total of 6 weeks.
At 8 months of age, cognitive deﬁcits and anxious-like behavior
were found in ad libitum fed transgenic mice and were prevented by
DR. In parallel, hippocampal neurogenesis was decreased in
transgenic mice under ad libitum diet whereas transgenic mice
under DR showed a neurogenic status similar to controls. In vitro
experiments were done on C6 astroglial cells exposed to AB with
and without nutrient restriction (FBS 2% vs. 10% in RPMI). Serum
deprivation and AB induced autophagy. Subsequently, conditioned
media (CM) from C6 were used to stimulate BV2 microglia.
Microglial NFkappaB nuclear translocation was increased when
exposed to CM from C6 cells with ABeta but not from C6 cells
exposed to AB and serum restriction. Our results suggest neuro-
protective effects of nutrient restriction in the context of AD, with
glial activation and autophagy as potentially involved pathways.
MTU12-03
Inhibition of DRP1 ameliorates mitochondrial ﬁssion and
and cognitive impairment in Alzheimer’s disease model
D.-H. Cho1, D.-G. Jo2
1Kyung Hee University, Gerontology, Yongin, S. Korea
2SungKyunKwan University, Phamacy, Suwon, S.Korea
Excessive mitochondrial ﬁssion is a prominent early event, and
contributes to mitochondrial dysfunction, synaptic failure and
neuronal cell death in the progression of Alzheimer’s disease
(AD). In the present study, we examine the role of Drp1, a key
regulator of mitochondrial fragmentation, in mitochondrial and
synaptic dysfunction-induced by Ab, and AD-like neuropathology
and cognitive functions in AD mice. Our results demonstrate that the
inhibition of Drp1 alleviates mitochondrial fragmentation, loss of
mitochondrial membrane potential, ROS production, and ATP
reduction in neurons treated with Ab oligomers. An inhibitor of
Drp1 also signiﬁcantly restores Ab-mediated depression of synaptic
vesicle exocytosis. Furthermore, Drp1 inhibition signiﬁcantly
improves learning and memory, synaptic density, and prevents
mitochondrial ﬁssion, lipid peroxidation, BACE1 expression and Ab
deposition in an AD mouse model. These results provide evidence
that Drp1 plays an important role in Ab-mediated and AD-related
neuropathology, and in cognitive function in an AD animal model.
Thus, inhibiting excessive Drp1-mediated mitochondrial ﬁssion may
be an efﬁcient therapeutic avenue for AD.
MTU12-04
Untargeted 1 h-NMR spectrometry to detect central and
systemic metabolic changes in a rat model of early
Alzheimer’s disease
M. Dalmasso1, M. Aran1, C. Ferrari2, C. Smal1, E. Casta~no1, C.
Cuello3, L. Morelli1
1Fundacion Instituto Leloir, Amyloidosis and Neurodegeneration
Laboratory, Ciudad Autonoma de Buenos Aires, Argentina
2Hospital Italiano, ICBME, Ciudad Autonoma de Buenos Aires,
Argentina
3McGill University, Department of Pharmacology and
Therapeutics, Montreal, Canada
Characterization and comprehension of the Alzheimer’s Disease
(AD) presymptomatic stage would help to better understand disease
progression, develop early detection methods and improve treat-
ment. Our main goal was to perform untargeted NMR metabolomics
in hemizygous McGill-R-Thy1-APP (TG) rats which compiles
several biochemical and neuropathological characteristics detected
in presymptomatic human AD brain. Experiments were performed
in male TG+/- (n = 8) and non-transgenic littermate (WT) (n = 8)
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rats of 9 months of age. CSF, hippocampus, and plasma were
collected to study changes at central and systemic levels. Hip-
pocampus were homogenized in 80% methanol to extract soluble
metabolites. Differences between TG+/- and WT were analyzed by
1D 1H-NMR, whereas metabolite identiﬁcation was performed by
2D NMR and conﬁrmed by spiking with standard compounds.
Experiments were carried out on a Bruker Avance II spectrometer
operating at 600.3 MHz. Only few metabolites changed between
TG+/- and WT rats in each sample type (n = 2 in CSF, n = 1 in
plasma, and n = 3 in hippocampus). In plasma, lactate levels were
higher in TG+/- than WT (p < 0.07), resembling the already
described increase in presymptomatic AD patients. By contrast to
what was described using MRI in dorsal hippocampus of homozy-
gous McGill-R-Thy1-APP rat, which mimic late stages of AD, we
did not ﬁnd signiﬁcant decrements in the N-acetylaspartate, GABA,
and Glutamate levels in TG+/- as compared to WT. However, we
did observe increased levels of NAD/H (p < 0.01) and decreased
levels of nicotinamide (p < 0.01). These two metabolites are part of
the NAD+ salvage pathway, which is essential to maintain the
NAD+ pool. Our results suggest that a rise in NAD+ synthesis,
probably to ameliorates mitochondiral disfunction, and/or an
impairment in NAD+ conssumig enzimes activity like sirtuins,
affecting epigenetic and metabolic processes, are taking place in the
brain at early stages of AD.
MTU12-05
Amyloidogenic processing of b-amyloid precursor protein
promotes ferroptosis: implications for Alzheimer’s
disease
J. Duce1, 2, 5, B. Wong1, 2, A. Tsatsanis1, A. Gunn2, 3, L. Lam2, 4, S.
Ayton2, 5, D. Devos3, A. Bush2, 5
1University of Leeds, Faculty of Biological Sciences, Leeds, United
Kingdom
2The Florey Institute of Neuroscience and Mental Health, Oxidation
Biology Unit, Melbourne, Australia
3Lille University, Department of Medical Pharmacology, Lille,
France
4University of Melbourne, Department of Pharmacology and
Therapeutics, Melbourne, Australia
5University of Melbourne, Department of Pathology, Melbourne,
Australia
Intraneuronal iron imbalance is a predominant catalyst for
reactive oxygen species production, particularly within iron accu-
mulating neurodegenerative diseases such as Alzheimer’s disease
(AD). In AD, amyloid precursor protein (APP) has historically been
associated with amyloid-b (Ab) derived neurotoxicity, but we
recently discovered that APP also has a role in neuronal iron
homeostasis by, in part, promoting iron efﬂux through cell surface
stabilization of the iron pore ferroportin. Detailed cell surface
characterization conﬁrms that the location of ferroportin on the
neuron surface is increased upon iron incubation and is dependent
upon APP. Altering the proteolytic processing of APP at the cell
surface by suppressing secretase expression or activity, expression
of APP carrying familial AD mutations or disrupting lipid rafts,
causes consequential changes in neuronal iron homeostasis.
Enhancing the amyloidogenic pathway of APP processing leads to
intracellular iron accumulation and contributes to oxidative stress
and toxicity. Iron induced toxicity caused by increased amyoido-
genic processing of APP appears to be mediated by the ferroptosis
inhibitor ferrostatin-1. With increased amyloidogenic processing of
APP being a major contributor to sporadic AD, these studies
increase our understanding as to why iron accumulation and
increased susceptibility to reactive oxygen species neurotoxicity are
prevalent with the disease.
MTU12-06
Imbalance in BDNF and probdnf levels in serum and
cerebroespinal ﬂuid in untreated Alzheimer’s disease
patients
C. Espinet, G. Pi~nol, C. Fleitas, A. Arias, E. Blasco
IRBLleida, CMB, Lleida, Spain
Brain-derived neurotrophic factor (BDNF) is essential for the
survival and differentiation of neurons, and it’s considered a key
target in the pathophysiology of various neurodegenerative diseases.
There are not full consensuses regarding the serum levels of BDNF
in Alzheimer’s Disease (AD). In this study, we measured serum and
CSF BDNF levels in patients with AD newly diagnosed without
treatment with drugs that can upregulate the expression of BDNF.
BDNF serum concentrations were lower in AD with depression
follow to AD without depression, controls with depression and
ﬁnally controls without depression. Apathy, MMSE, semantic
verbal ﬂuency and several depression scales also correlated with
lower levels of BDNF. Contrarily to BDNF, pro-BDNF induce
apoptosis through its interaction with p75NTR and its co-receptor,
sortilin. In CSF the ratio proBDNF/mBDNF is increased compared
to controls. In the hippocampus of human AD samples, proBDNF is
modiﬁed by AGE/ALEs preventing its processing to the mature
form and thus, increase the pathogenicity of the proform.
MTU12-07
The role of olfactory dysfunction in the pathogenesis of
Alzheimer disease
R. Graham1, 2, M. A. Otaibi1, 2, M. Lessard-Beaudoin1, 2, A.
Loudghi1, 2, R. Chouinard-Watkins1, 2, M. Plourde1, 2, F. Calon5, A.
Castellano1, 2, S. Cunnane1, 2, H. Payette1, 2, P. Gaudreau6
1University of Sherbrooke, Pharmacology and Physiology,
Sherbrooke, Canada
2Research Centre on Aging CIUSSS de l’Estrie - CHUS,, F,
Sherbrooke, Canada
3University of Sherbrooke, Medicine, Sherbrooke, Canada
4University of Sherbrooke, Community Health Services, Sherbrooke,
Canada
5Universite Laval, Centre de Recherche du CHU de Quebec, Laval,
Canada
6University of Montreal, Medicine, Montreal, Canada
7University of Montreal, Medicine, Montreal, Canada
Alzheimer disease (AD) is a chronic disorder that affects millions
of individuals worldwide. Olfactory dysfunction is a common
symptom of several neurological disorders including AD. Studying
the mechanisms underlying the olfactory dysfunction may lead to
the discovery of potential biomarkers and/or treatments for
neurodegenerative diseases. Objective: to determine if olfactory
dysfunction predicts future cognitive impairment and to characterize
the olfactory system in a murine model expressing a genetic factor
of AD. For the human study, quantitative olfactory tests have been
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done on 93 subjects from the NuAge cohort accepting to participate
in the ORCA secondary study. The t-MMSE was used to assess
cognition status, and an olfactory self-report collected. In a separate
cohort, olfactory cortical volume was calculated using MRI from
healthy old adults and AD individuals. Based on the self-report,
81% of our participants claimed to not suffer from any problem with
olfaction. However, based on the UPSIT, 94% show olfactory
dysfunction. We also detected a signiﬁcant decrease in olfactory
cortical volume in AD compared to controls. Murine study:
Preliminary data demonstrate there is a signiﬁcant decrease in
expression of the proform of caspase-9, caspase-3 and the caspase
substrate STK3, in the olfactory bulb of mice expressing human
APOE4 compared with controls. The data also suggest that Iba-1 is
increased in the olfactory bulb of APOE4 mice compared to wild
type. The activation of caspase-3 may be the cause of the decreased
levels of STK3 through caspase cleavage and may play role in the
inﬂammation observed.
MTU12-08
The role of copper in ubiquitin-dependent protein
degradation in Alzheimer’s disease
M. Greenough, C. Opazo, A. Bush
Florey Institute of Neuroscience and Mental Health, Oxidation
Biology, Melbourne, Australia
Disruption to copper homeostasis is a feature of Alzheimer’s
disease (AD). Recently it was discovered that copper reduces
Amyloid Precursor Protein (APP) endocytosis from the plasma
membrane and promotes its ubiquitination. The importance of this
ﬁnding is underlined by studies that indicate that endocytosis is a
key step in amyloidogenic processing of APP to form neurotoxic
amyloid beta (Ab) peptides. Ubiquitin plays a fundamental
signalling role in proteasome-mediated protein degradation, endo-
cytic protein sorting and targeting membrane proteins to lysosomes
for degradation via autophagy. Our HYPOTHESIS is that APP
amyloidogenic processing is modulated by copper-responsive
ubiquitination of APP, signalling it towards a degradative pathway
rather than an endocytic pathway where it encounters the enzymes
responsible for Ab generation, namely b- and c-secretase.
SPECIFIC AIMS:: Aim 1: To determine the role of Cu-
responsive ubiquitination of APP on its localization and degradation
in cultured mouse neurons.
Aim 2: To compare Cu-responsive ubiquitination of APP in
differentiated neurons that have been re-programmed from healthy
and AD patient human ﬁbroblasts using induced pluripotent stem
cells (iPSCs).
Aim 3: To determine if mutations that cause familial AD affect
Cu-responsive ubiquitination of APP using cultured mouse and
human ﬁbroblasts.
Aim 4: To identify novel Cu-responsive ubiquitin targets in AD-
affected and healthy control ﬁbroblasts using an ‘ubiquitin-omics’
approach.
We propose that copper is a physiological co-factor for the
ubiquitination of APP, a neuroprotective mechanism that reduces
the level of amyloidogenic processing.
MTU12-09
The relationship between the amyloid precursor protein
and tar DNA binding protein 43 (TDP-43): links to
Alzheimer’s disease
D. Hicks
University of Manchester, Faculty of Biology, Medicine and Health,
Manchester, United Kingdom
An increasing body of literature supports a role for TAR DNA
binding protein 43 (TDP-43) in the pathogenesis of Alzheimer’s
disease (AD). Recent studies have founds TDP-43 inclusions
present in the brains of substantial numbers of AD patients, with
prevalence reported as between 19 and 57%. Other researchers have
suggested that TDP-43 inclusions are correlated with greater disease
severity as measured by Braak staging. In addition, TDP-43 has
been suggested to modulate the expression and proteolytic process-
ing of amyloid precursor protein (APP). In this study, co-
immunoprecipitation and immunocytochemistry were used in SH-
SY5Y cells and control induced pluripotent stem cell (iPSC)-derived
human neurons to assess the possible direct interaction between the
predominantly nuclear TDP-43 and the nuclear fragment of APP,
namely AICD. We were unable to show any co-immunoprecipita-
tion between TDP-43 and AICD. Furthermore, AICD and TDP-43
showed opposing nuclear localisation in SH-SY5Y cells and iPSC-
derived neurons, suggesting a lack of direct interaction between
TDP-43 and AICD. APP isoforms were subsequently over-
expressed in SH-SY5Y cells, and TDP-43 expression was monitored
by immunoblotting. Although no change was observed, preliminary
data generated by targeting APP with siRNA suggest that APP may
regulate TDP-43 expression in an indirect manner. In addition, TDP-
43 over-expression was preliminarily shown to modulate the
expression of the APP holoprotein and the b-secretase, BACE1.
Taken together, these ﬁndings suggest that the correlation of the
presence of TDP-43 inclusions with the severity of AD may derive,
at least in part, from the ability of TDP-43 to regulate the expression
of APP and BACE1. Furthermore, our data suggest that, in the case
of APP and TDP-43, the relationship may be bidirectional. An
improved understanding of the contribution of TDP-43 to the
pathogenesis of AD could reveal novel therapeutic avenues.
MTU12-10
Lupeol isolated from betula alnoides inhibit
phophodiesterase and ameliorates streptozotocin
induced cognitive impairment and NEU
M. Kaundal, M. Akhtar
Jamia Hamdard University New Delhi, Pharmacology, New Delhi,
India
Objective: To investigate the therapeutic potential of lupeol
(isolated from Betula alnoides) in STZ-induced experimental
dementia of Alzheimer’s type in rats.
Material and methods: Lupeol was isolated from the BA and its
phosphodiesterase (PDE) inhibitory activity was assessed through
in-vitro PDE inhibitory assay. STZ was administered intracere-
broventrically (ICV) on day 1 and 3 (3 mg/kg, ICV bilaterally) in
rats. lupeol was administered (25, 50 and 100 mg/kg/day p.o.) 1 hr
following 1st STZ infusion upto 21st day. Morris water maze
(MWM), locomotor activity and object recognition task (ORT) were
used to assess behavioral changes in rats. On 22nd day, animals
were sacriﬁced and hippocampus were isolated for biochemicals
MTU12 Cellular Mechanism of Alzheimer’s Disease
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(acetylcholinesterase (AChE), lipid peroxidase (LPO), reduced
glutathione (GSH and nitrite), neuroinﬂamatory (Tumor necrosis
factor alpha (TNF-a), Interleukin 1 beta (IL-1b), and IL-6),
neurotransmitters (NTs) analysis (dopamine, norepinephrine, sero-
tonin, 3,4-Dihydroxyphenylacetic acid (DOPAC), Homovanillic
acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) and cyclic
nucleotide (cAMP and cGMP) estimation. Histological estimation of
the brain slides were carried out using Hematoxylin and eosin
staining.
Results: STZ infusion signiﬁcantly impaired memory as
observed in MWM and ORT, increased oxidative stress (LPO,
nitrite, AChE) and decreased enzyme (GSH), increased pro-
inﬂammatory levels (TNF-a, IL-6 and IL-1b), altered NTs level
(DA, NE, 5-HT and their metabolites) and decreased cyclic
nucleotide levels. Lupeol showed potent PDE inhibitory activity
in in-vitro PDE inhibitory assay and post treatment of lupeol (25, 50
and 100 mg/kg) signiﬁcantly restore STZ induced behavioral,
biochemical, NTs abnormalities and cyclic nucleotide levels in rat
brain. Histological examination of lupeol treated brain show
improvement in neuronal ﬂora as compare to STZ treated rats.
Conclusion: The ﬁndings of the present study suggests that
lupeol inhibit PDEs, reduced neuroinﬂammation via acting through
multiple mechanisms and would be a used as a target molecule to
curb cognitive decline associated with neurodegenerative disorders
such as AD.
MTU12-11
Human TP53 ARG72PRO SNP dictates neuronal
susceptibility to Aß-neurotoxicity upon CDK5-induced
P53 stabilization in mitochondria
R. Lapresa1, 2, J. Agulla1, 2, A. Almeida1, 2
1Institute of Biomedical Research of Salamanca (IBSAL), University
Hospital, Salamanca, Spain
2Institute of Functional Biology and Genomics (IBFG), CSIC-
University of Salamanca, Salamanca, Spain
Alzheimer’s disease (AD) is a complex multifactorial disease in
which neural death occurs predominantly by apoptosis. The p53
tumour suppressor protein functions as a key regulator of cell
apoptosis and has been described to accumulate in affected brain
areas from AD patients. However, the role of p53 in AD is
controversial. This protein naturally occurs in humans in two
functional variants with single nucleotide polymorphism (SNP)
resulting in Arg or Pro at residue 72 that modulates the apoptotic
activity of the p53 protein. Our objective was to evaluate the impact
of the Tp53 Arg72Pro SNP on amyloid-ß (Aß)-induced neurotox-
icity. Cortical primary neurons from humanized Tp53 Arg72Pro
knock-in mice were treated with 10 mM Aß25-35 oligomers for
24 h and protein expression levels, mitochondrial function and
apoptosis were evaluated. In some experiments, neurons were
lipotransfected with siRNA against cyclin dependent kinase-5
(Cdk5) or plasmids containing apoe2, e3 and e4 variants. We found
that Aß triggered Cdk5-induced p53 phosphorylation and stabiliza-
tion in both Arg72-p53 and Pro72-p53-expessing neurons. However,
neurons carrying the polymorphic variant Arg72-p53 were more
susceptible to Aß-induced mitochondrial dysfunction and apoptosis
than neurons with the Pro72-p53 variant. Moreover, Arg72-p53
promoted p53 translocation to mitochondria after Aß treatment,
whereas this effect was not found in Pro72-p53 neurons. Then, the
Arg72-p53 variant promotes p53 accumulation in the mitochondria
and increases neuronal vulnerability to Aß-induced neurotoxicity.
Finally, the expression of apoe4, the well-known major risk factor
for AD, in both neurons abrogated this effect, and Pro72-p53
neurons became as vulnerable as Arg72-p53 to Aß-induced neuro-
toxicity. In conclusion, the Tp53 Arg72Pro polymorphism modu-
lates neuronal susceptibility to Aß toxicity and determines damage
extent. These results make this SNP a possible biomarker of genetic
risk and progression for AD. This study was funded by ISCIII grants
–PI15/00473, RD16/0019/0018-, European Union -686009- and
FEDER.
MTU12-12
Complement C3 and C3aR receptor promote tau
pathology and Alzheimer`s disease
A. Litvinchuk1, Y.-W. Wan2, Z. Liu2, H. Zheng1
1Baylor College of Medicine, Hufﬁngton Center on Aging, Houston,
USA
2Baylor College of Medicine, Department of Neurology, Houston,
USA
Background: Besides the pathological hallmarks of b-amyloid
(Ab) plaques and neuroﬁbrillary tangles (NFTs), increasing evi-
dence suggests that neuroinﬂammation plays a signiﬁcant role in
AD pathogenesis. The complement pathway is a key regulator of
innate immunity. Recent ﬁndings from our laboratory showed that
the central complement component C3 is upregulated in astrocytes
of AD patients and mouse models. Moreover, elevated astroglial C3
can modulate Ab dynamics and pathology and reduce dendritic
morphology and synaptic function through microglial and neuronal
C3a receptor (C3aR), respectively. Giving the importance of the C3-
C3aR axis in the CNS, we are interested in understanding whether
the complement pathway also impacts the NFT pathology.
Methods and Results: First, we analyzed the expression
patterns of complement pathway genes in AD, MCI and non-
cognitive impaired brain samples obtained from the ROS-MAP
cohorts and revealed a strong upregulation of complement pathway
genes that is highly correlated with Braak staging and cognitive
decline. Prominent complement upregulation was also observed in a
PS19 mouse model of tauopathy in response to NFT pathology.
Next, to study the functional effects of the C3-C3aR pathway on
reactive gliosis and NFT pathology we manipulated C3aR expres-
sion in PS19 animals. AAV-driven neuronal overexpression of
C3aR exacerbated tau/NFT pathology in PS19 mice. Conversely,
knocking out C3aR in PS19 mice resulted in signiﬁcant reduction of
inﬂammation, phospho-tau levels and associated pathology and
improved behavioral deﬁcits of PS19 animals. Finally, we utilized
RNA sequencing and reverse-phase proteomics (RPPA) to identify
C3aR downstream signaling pathways that promote such effects and
identiﬁed the Jak-Stat3 pathway as a potent regulator of reactive
gliosis and tau pathology in PS19 mice downstream of C3aR.
Conclusions: Our data shows that C3-C3aR activation promotes
reactive gliosis and tau pathology in PS19 mice through the
activation of the Jak-Stat3 pathway and indicates that blocking
C3aR can be therapeutically beneﬁcial for AD treatment.
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The distribution and function of neuronal PSER727-stat3
is modify by mediators released by astrocytes in
response to abos
Y. Munoz1, J. Diaz2, A. Paula-Lima2, M. Nu~nez1
1University of Chile, Department of Biology, Santiago, Chile
2University of Chile, Institute for Research in Dental Sciences,
Santiago, Chile
Amyloid-beta oligomers (AbOs) have been found in Alzheimer’s
disease (AD) brains and there is vast evidence that supports a role of
AbOS, which would trigger synapse failure and memory impair-
ment. Astrocytes respond to AbOs through a process called reactive
astrogliosis, which generates reactive oxygen/nitrogen species
(ROS/RNS) and inﬂammatory cytokines that affect surrounding
neurons. Stat3 is a crucial transcription factor involved in mainte-
nance and function of nervous system and its deregulation has been
implicated in AD. Growth factors induce serine-727 phosphoryla-
tion and this modiﬁcation is associated with modulation of
transcriptional activity of Stat3. The main goal in this work is
determine if hippocampal neuronal Stat3 is affected by reactive
astrocytes.
Methods: Primary hippocampal neuron and astrocytes cultures
were used. Changes in pSerStat3 distribution were detected by
immunocytochemistry. The oxidative tone and ROS production
were evaluated by redox cytochemistry and Hyper strategy. Protein
and mRNA levels were determined by Western blotting and qPCR,
respectively.
Results: We found that AbOs induced no changes in protein,
mRNA Stat3 levels and pSerStat3 cellular distribution, in neurons.
However, AbOs treatment in mixed neuron-astrocytes cultures
induced notorious neuronal pSerStat3 redistribution. Reactive
astrocytes increased the expression of pro-inﬂammatory cytokines,
and astrocyte-conditioned media treated with AbOs (ACM-AbOs)
increased the neuronal oxidative tone. ACM-AbOs induced a
decrease of Stat3 target genes (survival and antioxidant response)
and an increase of pro-apoptotic Bax/Bcl2 ratio.
Conclusion: We propose that in hippocampal neurons, pSerS-
tat3 is a sensor for stressor astrocyte-produced induced by AbOs
activation.
Financial support: This work was supported by CONICYT Ph.D.
fellowship 21130445 to YM and Fondecyt Grants 1150736 to APL
and 1130068 to MTN.
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Role of DRP1 in ad pathogenesis
J. Sul, S. Baek, J. Lee, B. Choi, H. Kim, Y. Cho, G. Bahn, J. Han, D.
Jo
Sungkyunkwan university, School of pharmacy, Su-won, Korea
South
Alzheimer’s disease (AD) is an age-related disorder characterized
by deposition of neurotoxic form of beta-amyloid (Ab) and
degeneration of neurons. In the brain, accumulation of Ab in the
mitochondrial compartment has a responsible role in impairing
mitochondrial physiological functions. Impaired regulation of
mitochondrial dynamics, which shifts the balance towards ﬁssion,
is associated with neuronal death in age-related neurodegenerative
diseases, such as AD. We investigated the effect of inhibition of
mitochondrial ﬁssion protein Drp1 (dynamin-related protein 1) by
Mdivi-1 in AD mice and neuronal cells. Mdivi-1 reduced reactive
oxygen species, oxidative stress level, BACE1 level, and amyloid
plaques. The treatment of Mdivi-1 also improved memory and
cognitive functions in AD mouse models. Mdivi-1 treatment
delayed Ab-mediated mitochondrial fragmentation and oxidative
stress in neurons. These results indicate that inhibition of mito-
chondrial ﬁssion can be a therapeutic approach for AD.
MTU12-15
Critical roles of cathepsin b in Alzheimer’s disease-like
phenotypes following chronic systemic exposure to
porphyromonas gingival
Z. Wu, J. Ni, Y. Liu, H. Nakanishi
Kyushu University, Department of Aging Science and
Pharmacology, Fukuoka, Japan
A number of clinical and experimental studies have revealed a
strong association between periodontitis and accelerated cognitive
decline in Alzheimer’s disease (AD), however, the precise mech-
anism of their association remains unclear. In this study, we found
that chronic systemic exposure to lipopolysaccharide derived from
Pg (PgLPS; 1 mg/kg, daily, i.p.) for ﬁve consecutive weeks induced
learning and memory deﬁcits with the intracellular accumulation of
Ab in neurons in the middle-aged (12 months old) wild-type (WT)
mice, but not in young (2 months old) WT or middle-aged CatB-
deﬁcient (CatB-/) mice. PgLPS signiﬁcantly increased the expres-
sion of cathespin B (CatB), a typical cysteine lysosomal protease, in
both microglia and neurons in middle-aged WT mice, while
increased expression of mature IL-1b and TLR2 was restricted to
microglia in the hippocampus of middle-aged WT mice, but not in
that of the middle-aged CatB/ ones. In in vitro studies, PgLPS
(1 lg/ml) stimulation upregulated the mean mRNA expression of
IL-1b, TLR2 and downregulated the protein levels of IjBa in the
cultured microglia. These PgLPS-induced responses were signiﬁ-
cantly inhibited by pharmacological or genetic inhibition of CatB.
Furthermore, the mean mRNA expression of APP and CatB were
signiﬁcantly increased in the primary cultured hippocampal neurons
after treatment with conditioned medium from PgLPS-treated WT,
but not from CatB/, primary cultured microglia (MCM). Taken
together, these ﬁndings indicate that chronic systemic exposure to
PgLPS induces AD-like phenotypes, including microglia-mediated
neuroinﬂammation, intracellular Ab accumulation in neurons and
impairment of the learning and memory functions in the middle-
aged mice in a CatB-dependent manner.
We conclude that CatB plays a critical role in the initiation and
exacerbation of neuroinﬂammation following chronic systemic
exposure to Pg, leading to induce AD-like phenotypes. Therefore,
CatB can be a potential therapeutic target for AD.
MTU12-16
HMGB1 promotes autophagy and increase amyloid-b
clearance in Alzheimer disease models
X. Zhang
Xi An Jiaotong University Suzhou Academy, Department of
molecular biology, Suzhou, China
The accumulation of amyloid-b (Ab) neuritic plaques and
intracellular tau protein tangles are key pathological characteristics
MTU12 Cellular Mechanism of Alzheimer’s Disease
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of Alzheimer’s disease (AD). There is evidence that the autophago-
some-lysosomal degradation is a central role in AD, and disturbing
the processing of autophagy lead to Ab accumulation and provoke
AD pathology. Previous studies showed that high-mobility group
box 1 (HMGB1) promotes mitochondrial dysfunction–triggered
striatal neurodegeneration via autophagy activation. In this study,
we focused on whether the HMBG1 could regulate autolysosome
formation and clearance of Ab in AD models. We administrated
HMGB1 inhibitor Glycyrrhizin in hippocampus with Ab-treated
mice by stereotaxic injection, then analyzed changes in expression
of autophagic protein and phospho-c-Jun amino-terminal kinases (p-
JNK). p-JNK and autophagic marker LC3-II were signiﬁcantly
reduced by the HMGB1 inhibitor glycyrrhizin. Glycyrrhizin also
signiﬁcantly inhibited survival of hippocampal neurons with Ab-
treatment. Moreover, neuronal death was replicated by exposing
hippocampal neurons in culture to Ab. Furthermore, to elucidate the
role and mechanism of HMGB1 in clearance of Ab, we investigated
the impact of HMGB1 on autophagy activation and autolysosome
formation in vitro. shRNA-HMGB1 inhibited cellular viability and
reduced LC3-II expression compared with cells treated with Ab
only. Immunoﬂuorescence revealed that HMGB1-shRNA in Ab-
treated neuronal cells increased the number of LC3-II-positive
autophagosomes that were colocalized with the lysosomal marker.
p-JNK expression was signiﬁcantly reduced by shRNA knockdown
of HMGB1, an effect that was reversed by exogenously increased
expression of HMGB1. Furthermore, HMGB1-shRNA markedly
reduced Ab immunoreactivity colocalized within lysosomes and
increased intracellular Ab levels compared with Ab-treated cells.
These results suggested that HMBG1 regulated autolysosome
formation and clearance of Ab in AD models, and exerted a
neuroprotective effect through modulation of Ab clearance in Ab-
treated neuronal cells. HMGB1 would be a future strategy for AD
treatment via autophagy pathway for clearance of Ab in AD.
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PNR2B mediates the role of FYN kinase in levodopa
induced dyskinesia in a mouse model of Parkinson’s
disease
M. Bordone1, L. Isaja1, S. S. Blasco1, A. Damianich1, E. Avale2, O.
Gershanik1, J. Ferrario1
1Instituto de Investigaciones Farmacologicas, Facultad de
Farmacia y Bioquımica, UBA-CONICET, Ciudad Autonoma de
Buenos Aires (CABA), Argentina
2Instituto de Investigaciones en Ingenierıa Genetica y Biologıa
Molecular (INGEBI), ‘Dr. Hector N. Torres’, Ciudad Autonoma de
Buenos Aires (CABA), Argentina
Levodopa (L-DOPA) induced dyskinesia (LID) is one of the
undesired side effects of Parkinson’s disease (PD) treatment. To
reduce the development of LID, without affecting the positive
restorative effect of dopamine stimulation, is one of the greatest
challenge in this area. We have previously explored the pathway
Pleiotrophin/RPTP f/b/Fyn at the postsynaptic density complex and
found that Fyn-KO mice developed less LID than WT littermates.
Fyn kinase modulates the N-methyl D-aspartate (NMDA) receptor
through phosphorylation of the NR2B subunit and this could explain
the role of Fyn in LID. The main goal of this work is to demonstrate
the direct relation between Fyn and NMDA receptor in a paradigm
of dyskinesia. We lesioned Fyn-KO and WT mice with 6-
hydroxydopamine (6-OHDA) and treated them daily with L-DOPA
to model LID. Postmortem dopaminergic denervation was con-
ﬁrmed by immunodetection of tyrosine hydroxylase in the substan-
tia nigra pars compacta. Several molecular markers, in particular the
amount and phosphorylation status of NR2B subunit of NMDA,
were determined in the striatum by Western blot. As expected, in
WT mice we found upregulated the transcription factor DFosB and
ERK phosphorylation, both previously reported markers of LID,
while Fyn-KO mice showed a signiﬁcant reduction of LID
accompanied by a downregulation of DFosB and NR2B phospho-
rylation (pNR2B). In conclusion, pNR2B is downregulated in
dyskinetic Fyn-KO mice, what can explain a reduced NMDA
signaling and therefore the observed reduced dyskinesia. In this
sense, Fyn would be an attractive target to modify the NMDA
signaling and a promising treatment to modulate LID without
affecting the therapeutic efﬁcacy of L-DOPA in PD.
MTU13-03
Brain preconditioning reprograms the inﬂammatory
response to neuronal damage in rat model of Parkinson’s
disease
M. Golpich1, E. Amini1, Z. Mohamed2, R. A. Ali1, N. M. Ibrahim1, A.
Ahmadiani3
1UKM Medical Centre (HUKM), Medicine, Kuala Lumpur,
Malaysia
2University of Malaya, Pharmacology, Kuala Lumpur, Malaysia
3Shahid Beheshti University of Medical Sciences, Neuroscience
Research Center, Tehran, Iran
Background: Neuroinﬂammation is considered as both cause
and consequence of neuronal injuries and has a key role in the
pathogenesis of neuronal disorders such as Parkinson’s disease
(PD). Based on this, modulation of inﬂammation in the brain can be
offered as one of the therapeutic approach to control neuronal
damage in PD. Recent studies have indicated that Lipopolysaccha-
ride (LPS) preconditioning could be used as a potential alternative
strategy to attenuate, postpone or even cure the deﬁcits of neuronal
disorders. The purpose of this study was to study the effect of the
brain preconditioning with single low dose of LPS on inﬂammatory
proﬁle in 6-OHDA model of PD.
Methods: To clarify the neuroprotective effect of brain LPS
preconditioning on inﬂammatory proﬁle in PD rats, motor coordi-
nation and balance were evaluated using rotarod in all animals. In
addition, the effect of the LPS preconditioning on neuronal damage
were observed in the substantia nigra by using nissl staining.
Finally, gene and protein expressions associated with different
cascades induced by LPS preconditioning including TLR4 and
inﬂammatory signaling pathways were analyzed using RT-PCR and
Western Blot.
Results: Based on the behavioral assessments, preconditioned
animals performed signiﬁcantly better on the behavioral perfor-
mance in 6-OHDA rat model of PD. Furthermore, neuroprotective
effect of brain LPS preconditioning were consistent with the
histological observation. In addition, our result showed that the
brain LPS preconditioning reduced inﬂammatory response in the
brain of PD rat by enhancing NFjB inhibitors (e.g. SHIP1 and
TOLLIP) as well as anti-inﬂammatory cytokines. These ﬁndings
were conﬁrmed by western blot analysis.
Conclusion: Generally, reduction in inﬂammatory response
through the brain LPS preconditioning may contribute to the
induction of tolerance to neuronal damage in PD. This neuropro-
tection parallel the reprogramming strategy that leads to the
synthesis of new markers to change molecular response against
brain lesions. Altogether, our ﬁndings demonstrate that LPS
preconditioning has a therapeutic effect on the modulation of
neuroinﬂammation and this could suggests a promising therapeutic
strategy for various neuronal disorders such as PD.
MTU13-04
Addressing the mechanism of priming of dopamine
receptors and its effect on drug-induced dyskinesia
G. Gomez, B. Pedro, F. Juan, G. Oscar, T. Irene
Institute of Pharmacological Research (ININFA), University of
Buenos Aires-CONICET, Laboratory of Experimental
Parkinsonism, Buenos Aires Autonomous City, Argentina
The gold standard treatment for Parkinson’s disease is still the
use of L-DOPA, which after prolonged use induces severe motor
complications known as L-DOPA-induced dyskinesia (LID). In
contrast, D2 agonists are frequently used in clinical practice because
its low propensity to induce dyskinesia. Priming is deﬁned as the
behavioral and molecular sensitization occurring after the ﬁrst
exposure to L-DOPA or a full DA agonist. Priming is not
necessarily associated with dyskinesia but once it has occurred,
lower doses of L-DOPA or dopamine agonists are enough to induce
dyskinesia. Priming has been pharmacologically studied but the
underlying molecular mechanism is not well understood. The aim of
© 2017 The Authors
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this work is to understand the mechanisms of priming and evaluate
the effect of D1/D2 receptor stimulation on subsequent DA agonist
responses. C57BL/6 mice injected with 6-OHDA received a
dyskinetogenic dose of L-DOPA or saline to induce priming, and
then were treated with the D2R agonist Quinpirole. We compared
Quinpirole-induced dyskinesia after increasing doses vs prolonged
treatment with the maximum dose of Quinpirole, and observed
higher dyskinesia scores in primed vs non-primed animals.
Immunohistochemistry of striatal FosB and cFos, showed increased
levels of both dyskinesia markers in primed mice compared to saline
pre-treated. Furthermore, we analyzed selective cFos expression in
D1R expressing cells, using bacterial artiﬁcial chromosome trans-
genic mice expressing tdTomato in striatal projection neurons that
express D1 receptor. We reproduced L-DOPA priming and Quin-
pirole administration protocol, and observed signiﬁcant cFos
immunoreactivity in D1R expressing neurons in primed mice but
was almost insigniﬁcant in non-primed mice. These results conﬁrm
once again the importance of behavioral sensitization and increased
dyskinesia marker expression after D1/D2 receptor stimulation.
Furthermore, they demonstrate that D2 receptor stimulation has a
great impact onto D1R expressing cells only after priming and
shows the important role of D2 receptor in dyskinesia development,
even though current concepts emphasize the role of D1 receptor as
the major player in dyskinesia induction.
MTU13-05
IGF-1 gene therapy in early parkinson0s disease
M. Herrera1, E. Falomir2, F. Dolcetti2, M. Bellini2, C. Here~nu1
1IFEC-FCQ-UNC-CONICET, Pharmacology, Cordoba, Cordoba,
Argentina
2INIBIOLP-FCM-UNLP-CONICET, Biochemestry, La Plata,
Buenos Aires, Argentina
Backgound: Insulin-like growth factor-1 (IGF-1) is an endoge-
nous peptide transported across the blood brain barrier that is
protective in several brain injury models, including in an animal
model of Parkinson’s disease (PD).
Objectives: To determine in an experimental model of the
neuropathology if IGF-1 gene therapy could: 1) improve the
cognitive dysfunctions and 2) induce changes in the neuronal
activity of the affected brain areas.
Methods: Male Wistar rats were bilaterally injected in CPu with
either the neurotoxic 6-hydroxydopamine (6OHDA rats), or vehicle
(SHAM rats) as controls. Then they were divided into 6 experi-
mental groups according to the gene therapy with adenovirus in
hippocampus: G1) SHAM (vehicle-vehicle), G2)6OHDA (neuro-
toxic-vehicle), G3) SHAM-RAd-DS-Red, G4) SHAM-RAd-IGF-1,
G5) 6OHDA-RAd-DS-Red, G6) 6OHDA-RAd-IGF-1. At 3 weeks
post lesion with 6OHDA and injection with adenovirus the animals
were tested for spatial memory with Y-maze test and for locomotor
activity. At the end of the study the rats were perfused, the brains
ﬁxed and immunohistochemistry performed for TH and IGF-1. All
data were compared by 2-way ANOVA (p < 0.05 considered as
statistically signiﬁcant).
Results: 6OHDA causes cognitive deﬁcits in G2 compare to G1
(p > 0.05) indicated by a decreased in spontaneous alternation
percentage. This effect could not be attributed to decreased motor
activity, because the number of arm entries was not signiﬁcantly
changed and neither the number of cm performed after amphetamine
administration. This effect was partially reverted with IGF-1
overexpression in G6 respected to G5 (p > 0.05). There were no
signiﬁcant changes in G2 respect G5 and in G1 respected to G3 and
G4. Preliminary results showed that IGF-1 gene therapy induce an
increase in TH expression in the nigrostriatal pathway.
Conclusions: our results suggest that IGF-1 could be an
important neuroprotective molecule against neurodegeneration. Its
effect on neuronal activity could explain in part the improvement in
the cognitive symptoms that we observed in this animal model of
PD.
MTU13-06
TRKB agonist provide neuroprotection via attenuating
neuroinﬂammatory cascade and regulator of g-protein
signaling 4 (RGS4)
M. Kwatra1, S. Ahmed1, V. G. M. Naidu2, M. Lahkar1, 3
1NIPER Guwahati, Pharmacology and Toxicology, Guwahati, India
2NIPER Hyderabad, Pharmacology and Toxicology, Hyderabad,
India
3Gauhati Medical College, Pharmacology, Guwahati, India
Parkinson disease is (PD) a debilitating motor disorder affected
million populations worldwide. The objective of our study was to
investigate the effect of TrkB agonist; 7,8-dihydroxyﬂavone (7,8-
DHF) on 6-hydroxydopamine (6-OHDA) induced inﬂammation
cascade in Neuro-2a (N2a) cells and MPTP-induced neuroinﬂam-
matory cascade connecting the link with RGS4 in striatum region of
male swiss albino mice (weight 25–30 g). The Neuro-2a (N2a) cells
treated with 6-OHDA of various concentrations (1.5–100 lM) for
24 hrs and the cytotoxicity (6-OHDA, 25 lM) was prevented by
7,8-dihydroxyﬂavone (3, 6 and 12 lM) evaluated by MTT and
LDH assay. The neuroinﬂammatory markers such as NF-jB and
Cox-2 protein expression were markedly upregulated by 6-OHDA
treatment which further reduced with 7,8-DHF cotreatment. Further,
animal studies, MPTP (30 mg/kg, i.p. for 5 days i.e. 10th day to
14th day) were conducted for 28 days study period. The 7,8-DHF
(10 mg/kg) treatment for 28 days mitigated symptoms in MPTP-
treated animals induced motor deﬁcits as evaluated on rotarod test,
open ﬁeld test, and grip strength test. The biochemical oxi-
donitrosative stress markers such as lipid peroxidation, nitric oxide
level and reduced glutathione (GSH) level, proinﬂammatory
cytokines (TNF-a, IL-1b) level in striatum and substantia nigra
were found to be high in MPTP-treated animals. Furthermore, the
real-time PCR for the genes (iNOS, COX-2, NF-jB, Nrf2, PARP-1,
RGS4) and western blot for the protein expression studies were
found to be altered in the striatum (NF-jB, Nrf2, PARP-1, RGS4)
and substantia nigra (NF-jB, Nrf2) of animals which got reversed
by the 7,8-DHF treatment. Hence, 7,8-dihydroxyﬂavone signiﬁ-
cantly ameliorated the induced neuroinﬂammatory cascade in N2a
cells and animals as well as downregulated the RGS4 activation in
striatum region of mice model through its potential antioxidant
activity. Thus, TrjB agonist may be the futuristic non-dopaminergic
candidate to treat Parkinson’s disease progression.
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Pathological a-synuclein transmission initiated by binding
lymphocyte-activation gene 3
X. Mao1, M. Ou1, S. Karuppagounder1, 2, T.-I. Kam1, 2, X. Yin1, 2, Y.
Xiong1, 2, 3, P. Ge1, G. Umanah1, 2, S. Brahmachari1, 2, J. Shin1, 2,
H. Kang1, 2, J. Zhang1, 2, J. Xu1, 2, R. Chen1, 2, H. Park1, 2, S.
Andrabi1, 2, S. Kang1, 2, R. Goncalves1, Y. Liang1, S. Zhang1, C. Qi1,
S. Lam1, J. Keiler1, J. Tyson1, D. Kim1, 2, N. Panicker1, 2, S.
Yun1, 2, C. Workman1, D. Vignali1, V. Dawson1, 2, H. Ko1, 2, T.
Dawson1, 2
1The Johns Hopkins University School of Medicine, Neurology,
Institute of Cell Engineering, Baltimore, USA
2Adrienne Helis Malvin Medical Research Foundation, Helis, New
Orleans, USA
3Kansas State University, Anatomy and Physiology, Manhattan,
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Parkinson’s disease (PD) is the second most common neurode-
generative disorder causing serious movement disability and
cognitive impairment in those afﬂicted. Pathologically, PD is
characterized by the accumulation of a-synuclein (a-syn) in Lewy
bodies and neurites. There is dopamine neuron degeneration in the
substantia nigra pars compacta which causes many of the major
symptoms of PD. Emerging evidence indicates that the pathogenesis
of PD may be due to cell-to-cell transmission of misfolded
preformed ﬁbrils (PFF) of a-syn. The mechanism by which a-syn
PFF spreads from neuron to neuron is not known.
Here, we show that LAG3 (lymphocyte-activation gene 3) binds
a-syn PFF with high afﬁnity (dissociation constant = 77 nanomolar),
whereas the a-syn monomer exhibited minimal binding. Tau-biotin
PFF, b-amyloid-biotin oligomer, and b-amyloid-biotin PFF do not
bind to LAG3, indicating that LAG3 is speciﬁc for a-syn PFF. a-
Syn-biotin PFF binding to LAG3 initiated a-syn PFF endocytosis,
transmission, and toxicity. Neuron-to-neuron transmission of patho-
logic a-synuclein and the accompanying pathology and neurotox-
icity is substantially attenuated by deletion of LAG3 or by
antibodies to LAG3. Lack of LAG3 substantially delayed a-syn
PFF–induced loss of dopamine neurons, as well as biochemical and
behavioral deﬁcits in vivo. The identiﬁcation of LAG3 as a receptor
that binds a-syn PFF provides a target for developing therapeutics
designed to slow the progression of PD and related a-synucleino-
pathies.
MTU13-08
Antidyskinetic effect of acute guanosine administration in
reserpinized mice
C. Massari, D. Lanznaster, N. Marques, C. Tasca
Universidade Federal de Santa Catarina - UFSC, Departamento de
Bioquı%ADmica, Florianopolis, Brazil
Dyskinesia is characterized as involuntary movements that affect
several body parts. Several neurological disorders can exhibit this
symptom, such as Parkinson’s disease. Dyskinesia can be induced
by the alkaloid reserpine that acts as an inhibitor of vesicular
monoamine transporter (VMAT-2). The consequent monoamine
neurotransmitters depletion induces hypolocomotion, muscle rigid-
ity and involuntary movements. Guanosine (GUO), an endogenous
nucleoside, has been evidenced as a neuroprotective agent, although
the exact mechanism of GUO action is not fully characterized. This
study evaluated the therapeutic potential of GUO as an
antidyskinetic agent in mice treated with reserpine (1 mg/kg,
subcutaneously, every other day). GUO (7.5 mg/kg p.o.) was
administered 24 h after the last reserpine injection and 20 min
before behavioral test. GUO prevented the increase of orofacial
dyskinesia induced by reserpine. Additionally, the antidyskinetic
effect of GUO was abolished by prior administration of the A1
adenosine receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine
(DPCPX, 0.75 mg/kg). Reserpinized mice also showed a cataleptic
state when evaluated in the bar test. Likewise, this behavior was
prevented by GUO. Interestingly, DPCPX also abolished the anti-
cataleptic effect of GUO, besides presenting an anti-cataleptic effect
per se. Reserpine increased cells damage and reactive oxygen
species (ROS) levels in the striatum of treated mice. GUO was
effective in reducing the increase of ROS levels, but it did not alter
cells damage induced by reserpine. This study shows for the ﬁrst
time an antidyskinetic effect of GUO and its effect of modulating
motor and neurochemical impairments induced by reserpine.
MTU13-09
Sphingosine 1-phosphate receptors modulators decrease
neuroinﬂammation and prevent Parkinson’s disease
symptoms in mptp mice
E´. Pe´pin, G. Massicotte, M. Cyr
Universite du Quebec a Trois-Riviere, Medical biology, Trois-
Riviere, Canada
Sphingosine-1-phosphate receptors (S1PR) may be an attractive
molecular target to the treatment of neurodegenerative diseases. For
instance, Fingolimod (FTY720), an immunomodulator that acts on
S1PR, has been documented to display neuroprotective effects in
multiple sclerosis and animal model of Alzheimer’s disease. We
postulated that the immunomodulatory effects associated to FTY720
treatments might also be beneﬁcial to Parkinson’s disease patho-
genesis. Therefore, the present study investigates the effects of an
oral FTY720 treatment (1 mg/kg/day, 14 days) on the behavioral
and molecular alterations induced by the administration of MPTP
(30 mg/kg/day, i.p., 5 days) in mice. We ﬁrst established that
FTY720 has the capacity to prevent the motor deﬁcits observed in
the Pole test after MPTP treatments. In the striatum of MPTP mice,
Western blot analysis revealed diminutions of ~50% in the levels of
tyrosine hydroxylase and dopamine transporter proteins following
MPTP injections, which were both prevented by FTY720 treat-
ments. In parallel, while striatal levels of phosphorylated extracel-
lular signal-regulated kinases and S1PR subtype 1 were unaffected,
tumor necrosis factor-alpha and glial ﬁbrillary acidic protein levels
were robustly increased in MPTP-treated mice, an outcome that was
totally prevented by FTY720 treatments. Notably, FTY720 treat-
ments was also able to prevent the reduction of brain-derived
neurotrophic factor levels observed in the striatum of mice treated
with MPTP. Altogether, our ﬁndings propose that oral FTY720
treatments halt the detrimental effects of MPTP on striatal dopamine
terminals and motor behaviors. The mechanism of action may
involve inhibition of inﬂammatory pathways and the modulation of
brain-derived neurotrophic factor production. This study is provid-
ing novel evidence for the clinical utility of targeting S1PR in
Parkinson’s disease therapy.
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A novel approach to detect the presence of levodopa (l-
DOPA) in the polypeptide chains of proteins
K. Rodgers, J. Steele, M. Padula
University of Technology Sydney, School of Medical and Molecular
Biosciences, Sydney, Australia
Background: Deposition of protein aggregates in neurons is a
hallmark of neurodegenerative diseases. Genetic mutations in
proteins can result in the synthesis of non-native proteins that
accumulate in cystosolic aggregates. Certain non-protein amino
acids (NPAAs) can be mischarged onto tRNA and mistakenly
inserted into the polypeptide chain of proteins resulting in the
sporadic generation of non-native misfolded proteins [1,2]. We
utilise a novel approach to investigate the ability of the therapeutic
agent levodopa (L-DOPA) to replace L-tyrosine in proteins by
applying mass spectrometry (MS) whereby we can sequence
peptides to reveal the presence of DOPA.
Methods: We examine the ability of high resolution accurate
mass mass-spectrometry (HRAM-MS) to detect DOPA in neuronal
cell proteins avoiding the need for traditional protein hydrolysis and
to allow individual proteins to be identiﬁed.
Results: We successfully tested a novel approach for the
detection of DOPA in peptides generated from digestion of
DOPA-containing proteins and validated this method using syn-
thetic peptides. We showed that L-DOPA can be incorporated into
cell proteins. The presence of L-DOPA in proteins resulted in a
decrease in solubility. Speciﬁc structural and long-lived proteins
were most affected. We are now applying this approach to biological
samples.
1. Rodgers, K.J., et al., Toxic Nonprotein Amino Acids, in Plant
Toxins, 2015, Springer Netherlands: Dordrecht. p. 1-20. 2. Cox,
P.A., et al.,. Proceedings of the Royal Society B: Biological
Sciences, 2016. 283.
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